The development and evaluation of a self-management package for people with diabetes at risk of chronic kidney disease by Thomas, Nicola
Thomas, Nicola (2010). The development and evaluation of a self-management package for 
people with diabetes at risk of chronic kidney disease. (Unpublished Doctoral thesis, City, 
University of London) 
City Research Online
Original citation: Thomas, Nicola (2010). The development and evaluation of a self-management 
package for people with diabetes at risk of chronic kidney disease. (Unpublished Doctoral thesis, 
City, University of London) 
Permanent City Research Online URL: http://openaccess.city.ac.uk/16816/
 
Copyright & reuse
City University London has developed City Research Online so that its users may access the 
research outputs of City University London's staff. Copyright © and Moral Rights for this paper are 
retained by the individual author(s) and/ or other copyright holders.  All material in City Research 
Online is checked for eligibility for copyright before being made available in the live archive. URLs 
from City Research Online may be freely distributed and linked to from other web pages. 
Versions of research
The version in City Research Online may differ from the final published version. Users are advised 
to check the Permanent City Research Online URL above for the status of the paper.
Enquiries
If you have any enquiries about any aspect of City Research Online, or if you wish to make contact 
with the author(s) of this paper, please email the team at publications@city.ac.uk.
1The development and evaluation of a self-
management package for people with diabetes at 
risk of chronic kidney disease 
Nicola Thomas 
Senior Lecturer 
Department of Public Health, Primary Care and Food Policy 
School of Community and Health Sciences, City University London 
PhD (Professional Practice) 
City University London 
March 2010 
City, University of London 
Northampton Square 
London 
EC1V 0HB 
United Kingdom 
T +44 (0)20 7040 5060
www.city.ac.uk   Academic excellence for business and the professions
THE FOLLOWING PARTS OF THIS THESIS HAVE BEEN REDACTED 
FOR COPYRIGHT REASONS: 
Appendix 11: Publications directly related to thesis findings 
DOI: 10.1111/j.1755-6686.2008.00032.x 
Appendix 13: Publication: Journal of Diabetes Nursing 
2CONTENTS 
CONTENTS ............................................................................................................... 2 
LI ST OF FI GURES .................................................................................................... 8 
ACKNOWLEDGEMENTS .......................................................................................... 10 
DECLARATI ON ....................................................................................................... 11 
ABSTRACT ............................................................................................................. 12 
ABBREVI ATI ONS AND GLOSSARY ......................................................................... 13 
1. I NTRODUCTI ON ........................................................................................... 15
1.1. Background to the thesis ............................................................................... 15
1.2. Personal interest  ........................................................................................... 16
1.3. Rationale for the work undertaken .................................................................. 17
1.4. Prevention of kidney disease .......................................................................... 18
1.5. Diabetes and self-care ................................................................................... 19
1.6. Thesis outline ............................................................................................... 19
1.7. Aims of thesis ............................................................................................... 20
1.7.1. Linkage between elements of thesis .......................................................... 20
1.8. Chapter summary.......................................................................................... 21
2. THE CASE STUDY ......................................................................................... 22
2.1. Introduction ................................................................................................. 22
2.2. The Case Study Approach .............................................................................. 22
2.3. Rationale for the case study ........................................................................... 23
2.4. Aims of case study ........................................................................................ 23
2.5. Gaining access .............................................................................................. 24
2.6. Comparison of surgeries ................................................................................ 25
2.7. Situational analysis ........................................................................................ 26
2.7.1. Introduction ........................................................................................... 26
2.7.2. Framework used for analysis of case study data ......................................... 27
2.8. The theoretical framework ............................................................................. 28
2.8.1. The rapidly changing health care environment ........................................... 29
2.9. Method ........................................................................................................ 30
2.9.1. Data collection ....................................................................................... 30
2.9.2. Data reduction ....................................................................................... 30
2.9.3. Data display ........................................................................................... 31
2.10. Emerging themes ....................................................................................... 31
2.10.1. Measurement and monitoring of microalbuminuria .................................. 32
2.10.2. Measurement and monitoring of blood pressure ...................................... 36
2.10.3. Educational strategies .......................................................................... 39
2.10.4. Use of diabetes template on computer ................................................... 41
2.10.5. Interaction between practice nurses and GP ........................................... 42
2.10.6. National policy .................................................................................... 43
2.11. Limitations of a case study approach ............................................................ 44
 3
 
2.11.1. Validity of case-notes ........................................................................... 44 
2.11.2. I nfluencing practice ............................................................................. 44 
2.12. Summary .................................................................................................. 45 
2.13. Chapter summary ...................................................................................... 46 
3. CRI TI CAL REVI EW OF THE LI TERATURE ..................................................... 47 
3.1. I ntroduction ................................................................................................. 47 
3.2. The review question ...................................................................................... 47 
3.3. Aims of the literature review........................................................................... 47 
3.4. Methods ....................................................................................................... 48 
3.4.1. Definition ............................................................................................... 48 
3.4.2. Existing or commissioned reviews ............................................................. 50 
3.4.3. Conducting the review ............................................................................. 51 
3.4.4. Selection of studies and other information sources ..................................... 52 
3.5. The theoretical framework ............................................................................. 54 
3.6. I ntroduction to the literature review ................................................................ 55 
3.7. Society......................................................................................................... 55 
3.7.1. Societal beliefs about health .................................................................... 55 
3.7.2. National Service Frameworks ................................................................... 60 
3.7.3. Other nat ional policy documents............................................................... 60 
3.7.4. Supporting self-care ................................................................................ 63 
3.7.5. The Expert Patient  Programme ................................................................. 64 
3.7.6. Health-care professionals and empowerment ............................................. 66 
3.7.7. Summary ............................................................................................... 67 
3.8. Organisational system ................................................................................... 68 
3.8.1. I ntroduction ........................................................................................... 68 
3.8.2. Environment .......................................................................................... 68 
3.8.3. Social Context  ........................................................................................ 69 
3.8.4. Diabetes mellitus and cognitive function .................................................... 73 
3.8.5. Summary ............................................................................................... 74 
3.9. Pat ients and practit ioners ............................................................................... 74 
3.9.1. Context  ................................................................................................. 74 
3.9.2. DAFNE................................................................................................... 75 
3.9.3. DESMOND ............................................................................................. 76 
3.9.4. X-PERT .................................................................................................. 77 
3.9.5. Pat ient-preparedness .............................................................................. 78 
3.9.6. Learning and teaching media ................................................................... 78 
3.9.7. Other interactive technologies .................................................................. 80 
3.10. Discussion ................................................................................................. 81 
3.11. Chapter summary ...................................................................................... 82 
3.12. Conclusion ................................................................................................ 83 
4. RESEARCH REPORT: DEVELOPMENT OF THE SELF-MANAGEMENT PACK ... 84 
4.1. I ntroduction ................................................................................................. 84 
4.2. Background to the study ................................................................................ 84 
4.2.1. Diabetes and kidney disease .................................................................... 84 
4.2.2. Preventing deterioration of kidney function ................................................ 85 
4.2.3. Self-management of early kidney disease .................................................. 87 
4.2.4. Summary ............................................................................................... 89 
4.3. Main aims of the study .................................................................................. 89 
 4
 
4.4. Research question ......................................................................................... 90 
4.5. I nitial ideas that developed the research question ............................................. 90 
4.5.1. Timescale .............................................................................................. 91 
4.6. Development of the self-management package ................................................ 92 
4.6.1. Ethical approval ...................................................................................... 92 
4.6.2. Recruitment of practices .......................................................................... 93 
4.6.3. Representative sampling .......................................................................... 93 
4.7. Demographics and representation of local PCT ................................................. 94 
4.8. Part icipant observation .................................................................................. 94 
4.9. Findings from participant  observation and effect on method .............................. 95 
4.9.1. I dentification of patients with early kidney disease ..................................... 95 
4.10. Case-finding .............................................................................................. 96 
4.11. I nterviews ................................................................................................. 97 
4.11.1. I nterviewees ....................................................................................... 99 
4.11.2. Practicalit ies of interviewing ................................................................ 101 
4.11.3. Questioning techniques ...................................................................... 102 
4.12. Reflection on interviewing techniques ......................................................... 102 
4.13. Transcribing of interviews ......................................................................... 104 
4.14. Data analysis ........................................................................................... 105 
4.14.1. Thematic data analysis ....................................................................... 105 
4.14.2. Content analysis ................................................................................ 105 
4.14.3. Content analysis:  practical application .................................................. 106 
4.15. Data presentation:  background.................................................................. 107 
4.15.1. Aim of interviews ............................................................................... 107 
4.15.2. I nterviewees ..................................................................................... 108 
4.16. Data presentation:  themes ........................................................................ 109 
4.16.1. Impact of diabetes............................................................................. 109 
4.16.2. Barriers to control .............................................................................. 112 
4.16.3. Self-management .............................................................................. 115 
4.16.4. Learning and teaching leading to a change in behaviour ........................ 126 
4.17. Summary of interview findings .................................................................. 129 
4.18. Development of the self-management package ........................................... 130 
4.18.1. Educational package:  contents ............................................................ 130 
4.18.2. Findings from the 3-month participant  observation in 2004 .................... 130 
4.18.3. Findings from the literature review ...................................................... 130 
4.18.4. Findings from the interviews ............................................................... 130 
4.19. Curriculum .............................................................................................. 131 
4.20. Overall design of the package ................................................................... 133 
4.21. Costs ...................................................................................................... 137 
4.22. Packaging ............................................................................................... 137 
4.23. Logo and ‘house style’ .............................................................................. 137 
4.24. Pack contents .......................................................................................... 138 
4.24.1. Written information ........................................................................... 138 
4.24.2. Film ................................................................................................. 138 
4.24.3. Key Messages:  ‘Fridge Magnet’............................................................ 141 
4.24.4. Monitoring diary ................................................................................ 142 
4.24.5. Blood pressure machine ..................................................................... 143 
 5
 
4.25. Chapter summary .................................................................................... 144 
5. RESEARCH REPORT: TESTI NG OF THE SELF-MANAGEMENT PACK ........... 145 
5.1. I ntroduction ............................................................................................... 145 
5.2. Rationale for research design ....................................................................... 145 
5.3. Study design .............................................................................................. 146 
5.3.1. Changes to study design........................................................................ 147 
5.3.2. Control group ....................................................................................... 148 
5.3.3. Statistical tests ..................................................................................... 149 
5.3.4. Powering the study ............................................................................... 150 
5.3.5. Cluster design ...................................................................................... 151 
5.3.6. Time to complete data collections ........................................................... 153 
5.4. Dataset  ...................................................................................................... 153 
5.4.1. Dataset  pro-forma ................................................................................ 154 
5.4.2. Rationale for dataset ............................................................................. 155 
5.4.3. Risk factors associated with progression of CKD ....................................... 155 
5.5. Data collection ............................................................................................ 161 
5.5.1. Management of quantitative data ........................................................... 162 
5.6. Evaluation of educat ion package ................................................................... 162 
5.7. Chapter summary........................................................................................ 163 
6. RESEARCH REPORT: RESULTS ................................................................... 164 
6.1. I ntroduction ............................................................................................... 164 
6.2. Data from participating and control practices.................................................. 164 
6.2.1. I dentification of the participants ............................................................. 164 
6.2.2. Demographic data ................................................................................ 165 
6.2.3. Diabetes .............................................................................................. 171 
6.2.4. Clinical characteristics ........................................................................... 173 
6.3. Distribution of packs .................................................................................... 182 
6.3.1. Powering of study ................................................................................. 182 
6.3.2. Numbers not possible or suitable for self-management pack ...................... 182 
6.4. Outcomes .................................................................................................. 185 
6.4.1. Effects on study of national policy........................................................... 185 
6.5. Chapter summary........................................................................................ 192 
7. DI SCUSSI ON .............................................................................................. 193 
7.1. I ntroduction ............................................................................................... 193 
7.2. The findings ............................................................................................... 193 
7.2.1. The study population:  demographics ....................................................... 194 
7.2.2. The study population:  clinical parameters ................................................ 201 
7.2.3. The intervention versus control group:  clinical parameters ........................ 205 
7.2.4. Characteristics of t he group that  did not receive the pack .......................... 205 
7.2.5. People who did not want to part icipate ................................................... 207 
7.2.6. Health-care professionals and self-management ....................................... 209 
7.2.7. Characteristics of t he group that  did receive the pack ............................... 209 
7.2.8. Health literacy ...................................................................................... 210 
7.2.9. Differences between groups:  clinical parameters ...................................... 211 
7.3. Shortcomings of method .............................................................................. 217 
7.3.1. Recording of data ................................................................................. 217 
7.3.2. Powering the study ............................................................................... 219 
7.3.3. I nfluences on the study ......................................................................... 219 
 6
 
7.3.4. Summary ............................................................................................. 223 
7.4. Self-management initiatives in practice .......................................................... 223 
7.4.1. Commentary on wider use of self-management education packages ........... 223 
7.4.2. Planning of self-management programmes and interventions ..................... 223 
7.4.3. Methods to support  implementation of self-management init iatives ............ 224 
7.5. Summary of recommendations ..................................................................... 226 
7.5.1. Recommendations for pract ice ............................................................... 226 
7.5.2. Recommendations for further research .................................................... 227 
7.6. Dissemination and spread ............................................................................ 227 
7.6.1. The Spread Accelerat ion Model .............................................................. 229 
7.6.2. Study findings and translat ion into national programmes and initiatives ...... 231 
7.6.3. Pat ient empowerment ........................................................................... 231 
7.6.4. Educat ion of health care professionals..................................................... 232 
7.6.5. Collaboration with the DH Kidney Care team ............................................ 232 
7.6.6. Development of learning resources:  ckdonline.......................................... 233 
7.6.7. Development of an on-line learning module ............................................. 234 
7.6.8. Other publications and presentations to primary care professionals ............ 236 
7.7. Sustainability .............................................................................................. 236 
7.7.1. Staff .................................................................................................... 237 
7.7.2. Process................................................................................................ 237 
7.7.3. Organisation ........................................................................................ 237 
7.8. My reflection on the research process ............................................................ 238 
7.8.1. Relationship with practices ..................................................................... 238 
7.8.2. Ethical issues ....................................................................................... 238 
7.8.3. Challenges of undertaking a part-time Doctorate ...................................... 239 
7.9. Chapter summary........................................................................................ 240 
8. THE ARTEFACT ........................................................................................... 242 
8.1. I ntroduction ............................................................................................... 242 
8.2. Summary of artefact development ................................................................ 242 
8.2.1. Summary of how the artefact was tested................................................. 242 
8.2.2. Results of the testing phase ................................................................... 242 
8.3. Evaluation of artefact  and subsequent changes made ..................................... 243 
8.3.1. Ongoing feedback ................................................................................. 243 
8.3.2. Post-study feedback from pat ients .......................................................... 245 
8.3.3. Post-study feedback from pract ice nurses ................................................ 249 
8.3.4. Post-study update of national guidance that has affected pack content  ....... 250 
8.4. Overall changes to design of pack as result of thesis findings ........................... 252 
8.4.1. Detailed changes to self-management pack ............................................. 253 
8.5. Dissemination ............................................................................................. 255 
8.5.1. Local dissemination ............................................................................... 255 
8.6. The Medical Research Council (MRC) Framework for Complex Intervent ions ...... 257 
8.6.1. I ntroduction ......................................................................................... 257 
8.6.2. Review of papers using the MRC Complex Intervention Framework ............ 259 
8.6.3. Critique of the MRC Framework .............................................................. 261 
8.6.4. Reflection on the use of the Framework in different  stages of this thesis ..... 262 
8.6.5. Next steps ........................................................................................... 267 
8.6.6. Conclusion ........................................................................................... 268 
8.7. Chapter summary........................................................................................ 269 
9. FI NAL CONCLUSI ONS AND RECOMMENDATI ONS ..................................... 270 
 7
 
9.1. I ntroduction ............................................................................................... 270 
9.2. Conclusions:  the case study ......................................................................... 270 
9.3. Conclusions:  the literature review ................................................................. 270 
9.4. Conclusions:  the research project  ................................................................. 271 
9.5. Conclusions:  the artefact .............................................................................. 272 
9.6. Evaluation of the theoretical frameworks used in the study .............................. 272 
9.7. Summary of recommendations ..................................................................... 274 
9.8. Further development and dissemination of the artefact  ................................... 274 
9.9. Conclusion ................................................................................................. 276 
10. REFERENCES AND BI BLI OGRAPHY ........................................................... 277 
 
 8
 
LI ST OF FI GURES 
Figure 1.1:  Staging of CKD following NICE (2008) guidance 
Figure 1.2:  Care and management of patients with diabetes and renal impairment 
 
Figure 2.1:  Demographics and outline of diabetes care in each GP surgery in March 2004 
Figure 2.2:  Content Analysis Framework (Miles and Huberman, 1994)  
Figure 2.3:  Silverman’s (1970) act ion approach to organisations 
Figure 2.4:  Relevant QOF targets for diabetes mellitus (2004) 
Figure 2.5:  Data reduction and identification of themes 
Figure 2.6:  Diabetes QOF targets May 2004 
Figure 2.7:  Diabetes QOF targets December 2004 
Figure 2.8:  Case study themes and findings 
 
Figure 3.1:  Hierarchical levels of evaluation of inter-professional educational interventions 
developed from Kirkpatrick (1967) 
Figure 3.2:  Effects of educational interventions 
Figure 3.3:  Search criteria 
Figure 3.4:  Key literature sources (adapted from CRD, 2009) 
Figure 3.5:  Number of relevant information sources used in the review (in 2005)  
Figure 3.6:  Theoretical framework for literature review 
Figure 3.7:  The Trans-theoretical Stages of Change Model 
Figure 3.8:  I nformat ion in an HealthSpace account  
Figure 3.9:  Learning styles (adapted from Honey and Mumford, 1982) 
 
Figure 4.1:  QOF Targets for CKD 2006 
Figure 4.2:  Demographic data from each participating surgery (from 2004/2005 QOF data)  
Figure 4.3:  Semi-structured interview schedule 
Figure 4.4:  Demographics of  interviewees 
Figure 4.5:  Applied first (F) and second (S) level coding 
Figure 4.6:  Demographics of  individual interviewees 
Figure 4.7:  A summary of the findings that informed the development of the education pack 
Figure 4.8:  Main issues to be considered when developing learning materials for pat ients 
Figure 4.9:  Contents of the self-management pack 
Figure 4.10:  Photograph of the contents of the self-management pack 
Figure 4.11:  Acoust ic Bass font  
Figure 4.12:  Key messages on the fridge magnet 
Figure 4.13:  A comparison of two different models of BP machine suitable for self-monitoring 
 
Figure 5.1:  Summary of study design 
Figure 5.2:  QOF results (2004-2006) for %  people with diabetes having microalbuminuria 
testing in participating practices 
Figure 5.3:  Number of patients with diabetes and MA achieving BP target of < 135/ 75 mmHg 
in the part icipating surgeries in March 2005 
Figure 5.4:  Sample size and stat istical methods 
Figure 5.5:  Timeframe of study   
Figure 5.6:  Recommendations for microalbuminuria testing 
 
Figure 6.1:  Mean age and age range of participants in March 2005 
Figure 6.2:  Ages of participants in each surgery divided into 20 year bands 
Figure 6.3:  Gender of participants 
Figure 6.4:  Gender and age of participants   
Figure 6.5:  Ethnicity of participants recorded in November 2006 
Figure 6.6:  Ethnicity of the practice populations in the participat ing and control practices 
Figure 6.7:  Diabetes type of participants 
Figure 6.8:  Status of participants in each surgery at January 2008 
Figure 6.9:  Mean systolic blood pressure (mm Hg) at March 2005 and January 2008 
 9
 
Figure 6.10:  Mean diastolic blood pressure (mmHg) at March 2005 and January 2008 
Figure 6.11:  Mean HbA1c (% ) at March 2005 and January 2008 
Figure 6.12:  Classification of people who are overweight or obese 
Figure 6.13:  Mean BMI  of participants at March 2005 and January 2008 
Figure 6.14:  Codes used for smoking status 
Figure 6.15:  Smoking status at March 2005 
Figure 6.16:  Smoking amount at March 2005 
Figure 6.17:  Smoking amount at January 2008 
Figure 6.18:  % participants with different stages of CKD 
Figure 6.19:  Reasons why participants could not receive the pack 
Figure 6.20:  Participant possibility and suitability for the self-management pack  
Figure 6.21:  Reasons for non-distribut ion of  packs (by percentage of total number of 
part icipants)  
Figure 6.22:  Percentage of eligible people who received a pack 
Figure 6.23:  Data collections and CKD policy changes 
Figure 6.24:  Changes in mean systolic blood pressure over six time periods between 
intervention and control groups 
Figure 6.25:  Changes in mean diastolic blood pressure over six time periods between 
intervention and control groups 
Figure 6.26:  Changes in mean HbA1c over six time periods between intervention and control 
groups  
Figure 6.27:  Changes in mean BMI  over six time periods between intervent ion and control 
groups  
 
Figure 7.1:  Age profile of PCT inhabitants in 2007 (Adapted from LHO 2008) 
Figure 7.2:  Age profile of participants in 2007 
Figure 7.3:  Social grades in participating practice populations 
Figure 7.4:  Size of pract ice and prevalence of diabetes in participating pract ices in 2005 
Figure 7.5:  Prevalence rates by deprivation quintile 
Figure 7.6:  QOF returns for DM 12:  blood pressure less than 145/85 mm Hg  
Figure 7.7:  QOF returns for DM 13:  microalbuminuria testing 
Figure 7.8:  QOF returns for DM 15:  ACE inhibitor/ARB prescription 
Figure 7.9:  Silverman’s (1970) act ion approach to organisations 
Figure 7.10:  Key factors for spread of self-management pack into clinical pract ice 
Figure 7.11:  Results of GP survey:  where/how education on CKD should be delivered 
Figure 7.12:  Content of on-line learning module 
Figure 7.13:  The NHS Sustainability Model 
 
Figure 8.1:  Summary of pat ient replies to evaluation quest ionnaire 
Figure 8.2:  Summary of post-study interview findings 
Figure 8.3:  Specific changes made to self-management pack 
Figure 8.4:  The MRC Framework (2000) for the design and evaluation of complex 
interventions 
Figure 8.5:  The MRC Framework (2000 and 2008):  the main elements of the process and key 
questions to be asked 
 
Figure 9.1:  The Kirkpatrick Model (1967) 
 
 
 
 
 
 
 
 
 
 
 10
 
 
 
 
 
 
ACKNOWLEDGEMENTS 
 
I  am indebted to so many colleagues and friends and to my family, who have helped and 
supported me along the way.   
 
I  would like to thank all the research participants, especially those who have given their time 
to explain to me what it is like to have diabetes and to be at  risk of kidney damage. I  am 
really appreciative of all the support  and encouragement given to me by the practice nurses 
and GPs in the participating practices.  
 
Special thanks to my academic supervisors Rosamund Bryar and David Makanjuola, who have 
given their expertise and invaluable help. Also thanks to Fiona Warburton for her statistical 
advice. 
 
To my colleagues in the renal community and at  City University who have been so 
encouraging. I  would especially like to thank Mary Thomson who kindly assisted with some 
data collection. 
 
To the British Renal Society, Kidney Research UK, the SW Thames Kidney Fund, the St  Helier 
Association of Kidney Patients (SHAK), the Insulin-Dependent Diabetes Trust, the Hospital 
Savings Association (HSA) and City Universit y for supporting this doctoral work over the past  
five years. 
 
Finally, to say thank you to Paul and James who have t ravelled this Doctoral journey with me.  
 
 11
 
DECLARATI ON 
 
I  grant powers of discretion to the University Librarian to allow the thesis to be copied in 
whole or in part without further reference to the author.  This permission covers only single 
copies made for study purposes, subject  to normal condit ions of acknowledgement.   
 12
 
ABSTRACT 
 
Progression of chronic kidney disease (CKD) in diabetes can be slowed by strict blood 
pressure and blood sugar control, prescription of medicines that modify the renin-angiotensin 
system and lifestyle changes, such as smoking cessat ion. Because of the large numbers of 
people with diabetes whose condition progresses (and eventually require dialysis or 
transplantation), it is possible that the management of their diabetes remains sub-opt imal. 
The overall purpose of this thesis is to develop, test and evaluate an educat ional package to 
help people self-manage their risk of CKD progression. This thesis contains a case study, a 
crit ical review of literature, the main research study and an artefact (the self-management 
package).  
 
The case study developed from a three-month observation period in six general practit ioner 
(GP) practices. The literature review evaluates the effect of patient education and self-
management on diabetes control and outcomes. The research project develops and evaluates 
the self-management package. Development of the package was informed by the findings of 
the case study and literature review, and also through interviews with 15 people at high risk 
of CKD progression.  The resulting self-management package comprises written informat ion;  
a 20-minute DVD filmed with patients;  a fridge magnet (with key messages);  a monitoring 
diary;  and a blood pressure machine if required.  
 
Testing of the package was undertaken in the same six practices mentioned above, with one 
addit ional control practice. Patients with Type 1 or Type 2 diabetes at risk of kidney disease 
were included. Data on renal function (serum creat inine, eGFR and proteinuria), systolic and 
diastolic blood pressure (BP), glycated haemoglobin (HbA1c), body mass index (BMI ) and 
smoking status were collected at six time points, before, during and after the intervention. 
Outcomes in patients in the participating surgeries who did receive a pack (n= 116) were 
compared with patients in the control group (n= 61). 
 
At time point 4 mean systolic BP in the intervention group was 129.2 ±  19.2 mmHg vs. 134.6 
±  15.0 mmHg  in the control group (p= 0.057). At time point 5 there was mild significance 
(p= 0.053) in mean diastolic BP. At  the end of the study (time point 6)  the intervention group 
had a mean systolic BP of 132.1 ±  14.2 mmHg  vs. 136.2 ±  16.4 mmHg and mean diastolic 
BP of 74.9 ±  8.5 mmHg vs. 77.6 ±  9.1mmHg in the control group (p= ns). There were no 
significant differences in HbA1c and BMI  at  any time period.  
 
The results of the research project have shown the importance of self-management 
techniques to control blood pressure, which in turn can slow the rate of CKD progression and 
reduce cardio-vascular risk. Following evaluation by patients, the self-management package 
has been amended and strategies for local and national dissemination of the package have 
been put in place. 
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ABBREVI ATI ONS AND GLOSSARY 
 
NAME ABBREVIATION EXPLANATION 
Albumin-creatinine ratio ACR A test to quantify microalbuminuria (see 
below). An abnormal result for a man with 
diabetes is > 2.5 mg/mmol and an abnormal 
result for a woman with diabetes is > 3.5 
mg/mmol 
Angiotensin-converting 
enzyme inhibitor 
ACEi A drug that  inhibits ACE (angiotensin-
converting enzyme), which is important  for the 
formation of angiotensin I I . ACE inhibitors are 
used for blood pressure control and can 
reduce microalbuminuria in people with 
diabetes 
Angiotensin receptor 
blocker 
ARB A drug that blocks the actions of angiotensin 
I I . ARBs are used for blood pressure control 
and can reduce microalbuminuria in people 
with diabetes 
Blood pressure BP For people with diabetes and chronic kidney 
disease, a systolic blood pressure of below 
130mmHg (target range 120-129 mmHg) and 
a diastolic blood pressure below 80 mmHg is 
recommended (NICE, 2008) 
Body Mass Index BMI  The body mass index compares a person's 
weight and height using the formula:   
BMI  =  weight (kg)  /  (height (m) x height (m)). 
The result can be used to assess how much an 
individual's body weight departs from what is 
normal or desirable for a person of his or her 
height 
Chronic kidney disease CKD CKD is staged according to internat ional 
classification. CKD is defined as either kidney 
damage (proteinuria, haematuria or 
anatomical abnormality) or GFR < 60 
ml/min/ 1.73m2 present  on at  least 2 occasions 
for ≥3 months. 
Estimated glomerular 
filtration rate 
eGFR A formula to estimate kidney function usually 
based on serum creatinine, age, gender and 
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ethnicity. Normal GFR is approximately 
100mls/min/ 1.73m2 
Glycated haemoglobin HbA1c The test  shows how well diabetes has been 
controlled over the past 6-8 weeks. HbA1c is 
reported as a percentage of the total amount 
of haemoglobin in the blood. A target of less 
than 6.5%  is recommended. HbA1c results are 
currently given as a percentage, however the 
way in which HbA1c results are reported in the 
UK is changing. From 1 June 2009 HbA1c 
results will be also be given in millimoles per 
mol (mmol/mol). For t he purposes of this 
thesis, HbA1c results will be given as a 
percentage (% ). 
Microalbuminuria MA Albuminuria of a magnitude below the limits of 
detection by the urine dipstick. Characterised 
by an ACR 2.5–30 mg/mmol in men and 3.5–
30 mg/mmol in women. 
p values p The probability that an observed difference 
could have occurred by chance. A p value of 
less than 0.05 is convent ionally considered to 
be ‘statistically significant’, and not due to 
chance. 
Serum creatinine SCr An endogenous marker used to estimate 
kidney funct ion. Creatinine is derived from the 
muscles of the body and is normally removed 
from blood by the kidneys. As kidney disease 
progresses, the level of creatinine in the blood 
increases. 
Standard deviation SD 
Shown as ±  in 
this thesis 
A measure of the variability or dispersion of a 
population, a data set, or a probability 
distribution. A low standard deviation indicates 
that the data points tend to be very close to 
the same value (the mean), while high 
standard deviation indicates that the data are 
spread out  over a large range of values. 
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1. I NTRODUCTI ON 
 
1.1. Background to the thesis 
 
Chronic kidney disease (CKD) is now recognised as a major world-wide health problem (Davis 
et al. 2008). Mild to moderate CKD is very common in unselected populations, with some 
surveys suggesting that as many as 16%  of the adult population have some marker of kidney 
disease (Chadban et al. 2003). I t is estimated that the prevalence of chronic kidney disease 
in the UK is current ly around 8% (Stevens et al. 2007), although only around 0.4% of the 
whole populat ion may eventually require dialysis or a renal t ransplant.  
 
Diabetes mellitus has become the most  common cause of CKD, not  only within the developed 
world, but also increasingly within the emerging world, mainly due to the rise in the incidence 
of Type 2 diabetes (Atkins 2005).  
 
There has recently been a change in focus in managing CKD, from one of treating established 
kidney disease, to one of earlier identificat ion and prevention. As a result, there have been a 
number of important national initiat ives concerning the care of people with early CKD in 
recent years, namely:  
 
• the publication of the National Service Framework (NSF) for Renal Services Part  Two 
(Department of Health 2005b) 
• the recommendation that  all hospital laboratories should report estimated glomerular 
filtration rate (eGFR) as a measure of kidney function from April 2006  (Department of 
Health 2005b) 
• publication of local and nat ional guidance in 2005/ 6 for managing CKD in primary care 
(Joint Specialty Committee on Renal Medicine of the Royal College of Physicians and the 
Renal Association and the Royal College of General Practit ioners 2006) 
• the General Medical Services (GMS) contract (NHS Confederation and the General 
Practit ioners Committee (GPC) of the British Medical Association (BMA) 2006) included a 
new Quality and Outcomes Framework (QOF) domain for CKD in 2006, with amendments 
to the domain in 2008 and 2009 
• National I nstitute for Health and Clinical Excellence (NICE) guidance on CKD (National 
I nstitute for Health and Clinical Excellence 2008a) 
 
Collectively these initiatives have had an enormous impact on the way in which people at risk 
of CKD are managed in both primary and secondary care. The staging of CKD is now 
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recognised internationally and is based on the Kidney Disease Outcome Quality I nitiative 
(KDOQI ) study (Levey et al. 2006), although the staging of CKD has been amended in the 
recent NICE guidance (National I nstitute for Health and Clinical Excellence 2008a) with the 
inclusion of two categories for stage 3 CKD, namely stages 3a and 3b. The amended staging 
as recommended by NICE (2008) is shown in Figure 1.1. 
 
Figure 1.1:  Staging of CKD following NICE (2008) guidance 
 
Stage 
CKD 
eGFR 
mls/min/1.73m2 
Description 
1 > 90 Normal or increased eGFR with other evidence of kidney 
damage 
2 60-89 Slight decrease in GFR with other evidence of kidney damage 
3a 45-59 Mild decrease in GFR with or without other evidence of kidney 
damage 
3b 30-44 Moderate decrease in GFR with or without  other evidence of 
kidney damage 
4 15-29 Severe decrease in GFR with or without other evidence of 
kidney damage 
5 < 15 Established renal failure - dialysis or transplantat ion may be 
required 
 
I t is particularly important to recognise that  people with severe kidney damage (stage 5), 
who are managed in secondary care, make up a very small minority (0.4%) of those with the 
condition (de Lusignan et al. 2009). I t is health care professionals working in primary care 
who deal with large numbers of people with CKD, and who have the possibility to prevent  
and delay the progression of the disease.  
 
1.2. Personal interest 
 
I  have worked as a renal nurse for over twenty-five years in nephrology wards, haemodialysis 
and peritoneal dialysis units, mostly in London teaching hospitals. During this time I  
developed a keen interest in diabetes management and the ways in which people with long-
term conditions can self-care. Theses for both Bachelors and Masters degrees developed this 
interest. I n recent years I  have taught renal care to diploma and undergraduate nursing 
students and I  have taught and managed specialist  renal and diabetes courses.  
 
When I  commenced this Doctorate, I  was working on a secondment as the Lead Research 
Nurse in a tertiary renal centre in South-West London. This role involved supporting staff and 
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developing evidence and research-based renal practice. At  the time I  was involved in local 
projects concerning early kidney disease, including audit of the local pre-dialysis patient  
education programme, implementation of a local ‘Expert Pat ient  Programme’ (Department of 
Health 2001a) for people with CKD and, most  important ly, worked with a nephrologist in 
educating primary care professionals about managing chronic kidney disease (CKD) in the 
community. My previous clinical experience and then more recent  practice development in 
the areas of CKD and diabetes led to the ideas for this Doctorate. 
 
1.3. Rationale for the work undertaken 
 
I n the early part of this decade when ideas for the thesis were being developed, diabetes 
mellitus affected at least 3%  of adults in the UK with numbers of those with Type 2 diabetes 
increasing because of the ageing population and levels of obesity (Audit  Commission 2000). 
At the same time there was concern that that the rate of established renal failure (ERF) due 
to diabetes would be increased in the years ahead and, as cited by Roderick et al (2002), in 
the 2002 Renal Registry report,  
 
‘the key question is whether the transition to ERF can be prevented or reduced by 
more effective management and, by implicat ion, whether the rate of diabetic ERF can 
be reduced.’ (UK Renal Registry 2002)(p. 81) 
 
Although efforts were starting to be made nat ionally and locally to improve the management 
of patients with diabetic renal disease, a large number of patients st ill progressed to 
established renal failure and were often referred late for commencement of dialysis therapy. 
I n 2004, 30% of people requiring renal replacement were referred to a renal unit within 3 
months of requiring dialysis or a transplant (UK Renal Registry 2005), when the 
recommended time for dialysis preparation is one year (Department of Health 2005b). I t was 
questioned whether primary care professionals were making prevent ion of deterioration of 
kidney function one of the priorit ies of care or, perhaps, that  patient education initiat ives 
were inappropriate and/or under-researched. 
 
As over 2% of the total NHS budget is spent on renal replacement therapy (dialysis and 
transplantation) for those with established renal failure, strategies aimed at earlier 
identification and (where possible) prevention of progression to established renal failure are 
therefore clearly needed (National I nstitute for Health and Clinical Excellence 2008a). 
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1.4. Prevention of kidney disease 
 
Although several factors have been associated with an increased risk of developing diabetic 
kidney disease, no single factor has yet been shown to be predictive. Those at risk are those 
with proteinuria, uncontrolled blood pressure, poorly controlled blood sugar, those who 
smoke and those with a family history and/or specific ethnicity (Koppiker et al. 1998). 
 
Many studies have shown that the course of diabet ic kidney disease can be slowed by 
ident ifying those at risk and subsequently managing blood pressure to target, improving 
glycaemic control and giving advice and support on lifestyle changes, such as exercise, 
weight  loss and smoking cessation (Bilous 2008, DCCT Research Group 1995, Gerstein 2002, 
Mancia 2007). However at the start of this Doctorate there was evidence that implementat ion 
of these guidelines was less than optimal, with screening rates for microalbuminuria (MA) 
ranging from 10-48% (Sikka et al. 1999) and systolic blood pressure targets reached in only 
35%  of those with a positive MA (Craig et  al. 2003). By the end of the Doctoral work, there 
was still evidence that  risk factors for CKD and its progression remained sub-optimally 
managed (New et al. 2007). 
 
Figure 1.2 provides an overview of the NICE 2002 recommendations for the care and 
management of patients with diabetic kidney disease (National I nstitute for Health and 
Clinical Excellence 2002). 
 
Figure 1.2:  Care and management of patients with diabetes and renal impairment 
 
• Annual review for all those with Type 1 and Type 2 diabetes 
• Send annual urine sample for albumin-creatinine ratio (ACR) and t reat  
microalbuminuria (MA) if abnormal 
• Maintain blood pressure below 135/75 mm Hg (Type 2)   
• Treat  MA/hypertension with angiotensin converting enzyme inhibitors (ACEis) or 
angiotensin receptor blockers (ARBs) 
• Optimise glycaemic control (HbA1c below 6.5-7.5%, according to individual’s target)  
• Measure, assess and manage cardiovascular risk factors aggressively and educate 
about smoking cessation 
• Refer for nephrology opinion if serum creatinine greater than 150umol/ L 
Adapted from NICE guidelines (2002) 
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1.5 . Diabetes and self-care 
  
The best way to effectively manage diabetes is to empower patients with knowledge of their 
condition and likely outcomes. Most people with diabetes spend only a few hours in contact 
with health care professionals each year. The rest  of the t ime they manage their diabetes 
themselves. Supporting people to manage their own diabetes is therefore at the heart  of 
empowering people with diabetes, improving their experiences of services and improving 
their health outcomes (Department of Health 2001b). 
 
Just before the start  of the Doctorate, the National I nst itute for Health and Clinical Excellence 
(NICE) (National I nstitute for Health and Clinical Excellence 2003) produced an appraisal of 
structured education in diabetes. I t was found that education was often offered on an ‘ad 
hoc’ basis and was not  ongoing. The report  suggested that  patient education, if provided, 
does not tend to be based on proven educational or behavioural principles, nor is it usually 
evaluated properly to ascertain its effects in improving outcomes. Many healthcare 
professionals also have lit t le or no formal t raining in the adult  education or psychosocial skills 
required to educate patients effectively (Bradshaw 1999). Although empowering people to 
manage their diabetes is encouraged through education, further work needs to be carried out 
in the areas of implementat ion, evaluation and training needs of health-care professionals. 
 
Finally, despite the evidence that slowing-down of kidney disease progression can be 
achieved in those at risk, there have been no evidence-based educational resources 
developed to help health-care professionals and pat ients achieve that aim. Even the NICE 
(2003) guidelines mentioned in the above paragraph did not specifically mention kidney 
disease as a complicat ion of diabetes in the recommended list of topics for discussion with 
pat ients. 
 
I t is therefore possible that a patient-centred educational resource, delivered in primary care, 
may have benefits in terms of reduct ion of progression of renal disease. The aim of this 
thesis is t o develop and evaluate such a resource. 
 
1.6. Thesis outline 
 
This thesis is submitted as a PhD (Professional Practice), formally known as the Doctorate in 
Health. The University guidelines for submission of this type of Doctorate state that the 
emphasis is on developing a thesis that contains one or more reflective accounts of case 
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study work, a crit ical review of literature, a main research area and a dissemination artefact 
and plan. 
 
1.7. Aims of thesis 
The overall aim of the thesis is to develop, test  and evaluate a self-management package for 
people with diabetes who are at risk of kidney disease. Secondary aims are to carry out a 
case study in six general pract ice (GP) surgeries, to perform a literature review on diabetes 
and self-care, to undertake a research project that develops and tests the self-management 
package, and to evaluate the package prior t o further dissemination. 
 
1.7.1. Linkage between elements of thesis 
 
Chapter 1:  I ntroduction 
 
The introductory chapter outlines the rationale for the work, the context within which the 
thesis is set, the aims and the content of the thesis. 
 
Chapter 2:  Case study 
 
I n order to develop a patient-centred educational resource, it was important to understand 
the context within which the patients with diabetic kidney disease were being cared for and 
managed. The case study was undertaken from February-May 2004 through a period of 
part icipant observation. The main aim was to observe care and educat ion delivered by GPs 
and pract ice nurses to people with diabetes at risk of CKD. 
  
Chapter 3:  Literature review 
 
The main aim of the review is to evaluate the literature pertaining to diabetes and self-
care/management, thereby comparing the best ways in which a patient-centred self-
care/management programme can be developed. The findings of the review contributed to 
informing the development of the educational package to be evaluated in the subsequent 
research project. 
 
Chapter 4:  Research project  
 
The main aims of the research project are:  
 
 21
 
• to develop a self-management educat ion package which educates people with 
diabetes about the risks of kidney disease, and encourages them to self-manage their 
condition.  
• to test the package in six GP surgeries and compare results with a control group.  
• to evaluate the package following feedback from pat ients and health-care 
professionals. 
 
Ethical approval for the research project was granted by the Local Research Ethics Committee 
in November 2003 (see Appendix 1). 
 
The research design and method are discussed in Chapter 5, the findings are presented in 
Chapter 6 and discussed in Chapter 7. 
 
Chapter 8:  Disseminat ion artefact and plan 
 
The artefact  is the self-management  package and this chapter of the thesis will describe how 
the package has been evaluated, the subsequent changes made, and the ways in which the 
package can be disseminated to a wider audience. 
 
Chapter 9:  Conclusions and recommendations 
 
The last chapter will present  the final conclusions and recommendations from the entire 
thesis.  
 
1.8. Chapter summary 
 
This chapter had explained the background to the thesis and the rationale for undertaking the 
work. The main aims of the thesis have been described and the linkage between the different  
elements of the thesis has been discussed. The following chapter describes the rationale, the 
aims, the design and findings of the case study. 
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2. THE CASE STUDY 
 
2.1. I ntroduction 
 
This case study was written during August 2004 to March 2005, following a period of 
part icipant observation in six participating GP surgeries. This case study acts as an 
introduction to the literature review, research project and resulting artefact, all of which are 
requirements for the PhD (Professional Practice).  
 
2.2. The Case Study Approach 
 
A case study can be defined as  
 
‘…an empirical enquiry that investigates a contemporary phenomenon within its real 
life context.’ (Yin 1994)(p.8)  
 
Case studies can be used when ‘how’ or ‘why’ quest ions are being posed and where the 
invest igator has litt le control over events. Case studies can be utilised for an in-depth 
invest igat ion, where a variety of methods are used to investigate the phenomena in quest ion 
(Hamill 1999). The 'case' can be an individual or a 'group case' such as a hospital or 
community centre. 
 
For the purposes of this thesis, the ‘case’ will comprise six General Practit ioner (GP) surgeries 
in South-West London. The overall aim of the case study is to analyse and evaluate the 
diabetes care and management provided in these surgeries following a period of participant 
observat ion. The case study will set the context for the main research project that  is 
described later in the thesis.  
 
The case study will be written in the first  person. Although it has been noted and discussed 
by Hamill (1999), that first -person writing may be viewed by some as being less academic 
and does not necessarily require integration of evidence from published literature, this is not  
necessarily the case. Hamill (1999) observed that the ability of the student to write in a style 
appropriate to the demands of the exercise and to integrate relevant and up-to-date 
literature is the hallmark of a t ruly reflective pract it ioner. The case study demanded that I  
become involved and engaged with health professionals, patients and their families;  in other 
words I  have given of myself in the crit ique and writing of the study, and to write about this 
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in a distant and objective way (third person) would be incongruent . So this case study has 
been writ ten in the first person because of the compatibility with the approach.  
 
One main data collection strategy was used in this case study:  qualitative hand-written field 
notes taken when I  was observing consultations between practice nurses/GPs and patients. 
These notes were often supplemented by notes taken during direct questioning of practice 
nurses concerning clinical management issues. 
 
2.3. Rationale for the case study 
 
I t was important to me that this case study laid a solid foundation for the rest of the thesis 
and provided a rationale and cohesive argument for why the research project was justified. 
As discussed in the previous chapter, diabetes mellitus affected at least  3%  of adults in the 
UK in the early part of the decade, with numbers of those with Type 2 diabetes increasing 
because of the ageing population and levels of obesity (Ryan and Ryan 2009). As diabetes is 
one of the leading causes of kidney disease, there will be a resulting increase in people with 
kidney disease if the global epidemic of increased prevalence of diabetes continues (Wild et 
al. 2004). 
 
At the start  of the Doctorate, nat ional initiat ives such as the NSF for Renal Services 
(Department of Health 2005b) were urging improvements in the management of patients 
with diabetic renal disease, part icularly as a large number of patients with diabetes still 
progressed to established renal failure and required dialysis.  I t was hypothesised that patient 
education initiatives were not being implemented, were inappropriate and/ or under-
researched. A case study could provide some of the answers to these questions. 
 
2.4. Aims of case study 
 
I n order to develop a patient-centred educational resource, it was important to understand 
the context within which the patients with diabetic kidney disease were being cared for and 
managed. I  was unfamiliar with working practices in GP surgeries, such as the scope of the 
extended role of the practice nurse and the working relationships between practice nurses 
and GPs. I  had brief experience of working in South-East London in the community (1985-
1987) with patients on home dialysis, but generally my knowledge of primary care was poor. 
I  also needed to update my knowledge on managing people who were newly diagnosed with 
diabetes, as this had been outside my past clinical experience.  
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Case study data were collected from February-May 2004 through a period of participant  
observat ion. The main aim was to observe and reflect  on the ways in which pract ice nurses 
and GPs delivered care and education to people with diabetes at risk of CKD.  
 
As the case study progressed it became clear that some additional aims were emerging. 
These were to provide educational input about  kidney disease to practice nurses, GPs and 
pat ients, and to investigate and recommend practical guidelines on chronic kidney disease 
(CKD) management. These secondary aims will be discussed in more detail later.  
 
The main aim of the case study was:  
 
• To observe care and education delivered by GPs and practice nurses to people with 
diabetes at risk of CKD 
 
Secondary aims were:  
 
• To analyse data collected during the period of participant observation using a 
theoretical framework 
• To ident ify themes within these data to subsequently inform the development of a 
self-management package for people with diabetes at risk of CKD 
• To provide educat ional input about kidney disease to practice nurses, GPs and 
pat ients 
 
2.5. Gaining access  
 
I n December 2003 I  was invited by one of the clinical nurse specialists in the local diabetes 
centre to present two seminars on diabetic kidney disease to a group of practice nurses. The 
seminars were part  of an ongoing programme that  was provided monthly for community 
nurses interested in diabetes care. 
 
The main aim of the seminar was to educate primary care nurses on the importance of 
screening for diabetic kidney disease.  A secondary aim was to inform the participants about 
the forthcoming research study and to request their participation in the project, which had 
been granted ethical approval in December 2003 (see Appendix 1). At  the end of the 
seminars twelve practice nurses had registered their interest  in the project. A letter was sent  
to all the interested surgeries in January 2004, and of these, six volunteered to be actively 
involved in the project. I  then visited all six surgeries to discuss their involvement. At this 
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meeting, I  met with either the Practice Nurse (PN) (four surgeries) or the Pract ice Nurse and 
General Practit ioner (two surgeries) who were responsible for diabetes care. 
 
I t is recognised that the surgeries were self-selecting and therefore it is likely that the 
diabetes care and management provided in each surgery was likely to be of a good standard.  
However, I  discussed this possible methodological limitation with the clinical nurse specialist 
in the diabetes centre, and she felt that involvement of other, perhaps less-motivated 
pract ice nurses would perhaps be difficult at  this stage. She suggested that once the first  
phase of the project was complete, and my intervent ion viewed as perhaps less threatening, 
she would help me make contact  with other local surgeries that  did not  have such a keen 
interest in improving diabetes care. However this suggestion did not prove viable after the 
first stage of the study because I  had already recruited six practices as per the study 
protocol. See section 8.5 for discussion on the dissemination plan for the self-management 
package throughout the Primary Care Trust (PCT). 
 
2.6. Comparison of surgeries 
 
Figure 2.1 compares the demographics and structure of diabetes care in each surgery.  
Figure 2.1:  Demographics and outline of diabetes care in each GP surgery in March 2004 
Surgery Total 
number of 
patients 
Total number 
of patients with 
diabetes 
Dedicated 
diabetes 
clinic? 
Person 
responsible for 
diabetes clinic  
Times of 
diabetes 
clinics 
1 
 
10 060 299 N - - 
2 
 
7650 194 Y PN Wednesday 
pm 
3 
 
14 000 396 Y PN /  GP Friday am 
4 
 
9 000 340 Y PN Wednesday 
am 
5 
 
9 500 250 Y PN Wednesday 
pm 
6 
 
10 850 431 Y PN  Varied 
 
All surgeries are within a five-mile radius of the tert iary renal centre, and are located within 
the same primary care trust  (PCT). The overall management structure of pat ients with 
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diabetes did not appear to vary much between surgeries. I n five surgeries, one or two 
pract ice nurses ran nurse-led diabetes clinics at specified times each week. Surgery 1 did not 
run a dedicated clinic for diabetes at that  time, but rather saw patients on unspecified days, 
at a time convenient to the patient.  
 
2.7. Situational analysis 
 
2.7.1. I ntroduction 
 
Observation of diabetes care took place from February–May 2004. All six surgeries were 
visited on two occasions during a normal diabetes clinic. As Surgery 1 did not hold rout ine 
diabetes clinics, the practice nurse (PN) organised for me to visit one afternoon when a small 
number of patients with diabetes had a booked consultation. 
 
On each occasion I  recorded hand-written field notes. The notes were taken when I  was 
sit t ing in on patient consultations with pract ice nurses and GPs and when I  was talking with 
pract ice nurses about how patients were managed. I  often wrote personal reflections about  
the surgery visits once I  had returned home. The notes covered all aspects of communicat ion 
between nurse and pat ient/ family member;  details concerning care and management of 
diabetic kidney disease, such as patient education strategies and use of nursing protocols;  
the interaction between the practice nurses and other members of the professional team; and 
the use of the computer database. The questions that  I  wanted to answer were:  
 
• How many pat ients have diabetes and how is diabetes care organised? 
• I s the care and management of diabetic kidney disease based on evidence/best-practice? 
• What educat ional strategies are used to empower patients about their diabetes? 
• How do practice nurses interact with colleagues? 
 
From June 2004 onwards I  also started to identify all patients in each surgery who had 
chronic kidney disease (CKD) and diabetes. This activity was carried out with the help of the 
pract ice manager/ informat ion technology (IT) assistant in each surgery. I  needed to identify 
all patients at risk of CKD (defined by an albumin:creatinine ratio recording > 3)1 so I  could 
map their care throughout the whole research project and ultimately see if the educat ion 
programme had made any difference to the parameters (blood pressure, blood sugar, body 
mass index and smoking status) that affect progression of their renal disease. 
                                               
1
 I n 2004 local PCT/ laboratory guidance regarding the threshold for abnormal ACR results was > 3 for 
both men and women, despite NICE (2002) guidance recommending > 2.5 in men and > 3.5 in women. 
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2.7.2. Framework used for analysis of case study data 
 
I  was unclear how to analyse and evaluate the hand-written field notes into identified themes 
that could then be used as a basis for development of the subsequent literature review 
required for the thesis submission. My first  supervisor suggested that I  should enrol on a day 
course in social research methodology at the University of Surrey. This was an update for me, 
as I  had used this type of approach in an earlier Master’s degree thesis. 
 
I  at tended a day course on ‘I ntroduction to Qualitative Analysis’ at Surrey University in 
October 2004.  The course enabled participants to understand the complexities of managing 
qualitative data and during practical exercises demonstrated how hand-written field notes 
could be managed and analysed. Subsequently I  decided that a framework of content  
analysis used for the practical exercise during the day course (Miles and Huberman 1994) 
would be utilised for the analysis of this case study. An outline of this framework is shown in 
Figure 2.2. 
 
Figure 2.2:  Content Analysis Framework (Miles and Huberman, 1994)  
D ata  R e d u ction
D ata  D isp la y
C o n c lu s io n s  an d  V er ific a t ion
Su m m arise ; cod e; d iv id e  in to
them es ,c lu sters , ca teg or ie s
D ia gram s, p ic tu res , v isua l form s
In terpre t d isp layed  da ta , lo ok
for  com p ar ison s an d  con tras ts ,
n o te  and  exp lore them es
M iles a n d  H u be rm a n  (1 9 9 4 )  (2 n d  ed .)  Q u a lita t iv e  D a ta  A na ly sis: A n ex pa n de d
s o u rceb o o k . S a g e  P u b lica t io n s
 
 
 
Miles and Huberman (1994) describe content analysis as a process that facilitates the 
production of core constructs from textual data through a systematic method of reduct ion 
and analysis. Text is coded into established themes to support the generation of ideas. The 
number of times a similar piece of text or idea is attributed to a particular theme is counted 
and the importance of that theme can therefore be deduced.  
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2.8 . The theoretical framework 
 
A number of theoretical frameworks were considered for use in the case study and for the 
rest of the thesis. I  had used the locus of control framework (Rotter 1966) in a previous 
Master’s thesis (Master of Arts Education), and also considered the use of a change theory 
(Kotter 1995) as a framework. Although both these frameworks would be useful in explaining 
an individual’s att itude and behaviour change to health education, they would not necessarily 
be useful in engaging the wider variables, such as the importance of societal beliefs or 
organisational constraints, on an individual’s care and management. 
 
I  have therefore utilised Silverman’s action approach to organisations (Silverman 1971) as the 
theoretical framework, which suggests that change is dependent on the interrelationship of a 
number of factors, including the knowledge, attitudes and beliefs held by the wider society, 
by the organisational structure, as well as by individuals. This model was adopted by Bryar in 
a project  which aimed to introduce more individualised care for women into midwifery 
pract ice (Bryar 1995). Figure 2.3 shows an adaptation of the Silverman (1970) model which 
will be used as the theoretical framework for the case study. 
Figure 2.3:  Silverman’s (1970) act ion approach to organisations 
Society
Patients and practitionersOrganisat ional system
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2.8.1. The rapidly changing health care environment  
 
I t is important to place this case study within the rapidly changing renal care environment. 
During the time that  the case study took place two significant events took place. The first 
was the int roduct ion of the General Medical Services Contract (GMS) contract for GPs, which 
was introduced in April 2004. For the first t ime General Practit ioners were to be financially 
rewarded for achieving a number of quality standards in the areas of  coronary heart  disease 
(CHD), stroke or transient ischaemic at tacks, hypertension, diabetes, chronic obstructive 
pulmonary disease (COPD), epilepsy, cancer, mental health and asthma.  
 
There are targets for diabetes, and targets relevant to this study are shown in Figure 2.4. 
 
Figure 2.4:  Relevant QOF targets for diabetes mellitus (2004) 
 
DM 13. The percentage of patients with diabetes who have a record of micro-albuminuria 
testing in the previous 15 months (exception reporting for patients with proteinuria). Target  
90%  (3 points)  
 
DM 14. The percentage of patients with diabetes who have a record of serum creat inine 
testing in the previous 15 months. Target 90% (3 points)  
 
DM 15. The percentage of patients with diabetes with proteinuria or micro-albuminuria who 
are treated with ACE inhibitors (or ARBs). Target 70% (3 points)  
 
 
I t was possible that this contract could improve the rates of MA testing, serum creat inine 
testing and prescribing of medication for those with renal disease. Almost  concurrently the 
Renal Association (RA) of the UK published a draft document out lining the care and 
management of patients with CKD that  emphasised primary care management. Although the 
final draft did not appear on the RA website until January 2005, many nephrologists were 
becoming interested in collaborating with primary care physicians particularly as it was well-
known that  the second part of the National Service Framework for Renal Services was due to 
give further recommendations on CKD management.  
 
Although I  was not aware of any nephrologist colleagues having direct involvement with local 
GP surgeries at that time, there was much publicity around CKD. I  was involved in running a 
nat ional symposium in June 2004 which debated the issues of renal disease prevention, and 
this possibly also had an effect on CKD management in primary care.  
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As a consequence of all these initiatives, the practice nurses and GPs in the study were most  
interested in MA screening and during the course of t he part icipant observation, they began 
to involve me more in the care of patients. For example, I  was asked direct questions about  
the practicalit ies of providing urine samples for MA testing such as ‘was it crucial to have the 
first sample of  the day and could the sample be kept in the fridge overnight?’ I  was also 
asked to give advice to patients about the need to reduce blood pressure and give up 
smoking. I  therefore moved from non-participant  to participant researcher as the observat ion 
period progressed. I  was aware that my objectivity was becoming curtailed but realised that  
ethically I  had to impart  my specialist knowledge when asked. Further discussion and analysis 
on practit ioner research is included at  the end of this chapter. 
 
2.9. Method 
 
2.9.1. Data collect ion 
 
The analytical process began during data collection, as once exposed to the case study 
environment I  immediately began to start  thinking about  what was being heard  and seen. As 
the data collection progressed I  was able to go back and refine questions and pursue 
emerging avenues of  inquiry which I  had not thought about before. Continuous analysis was 
inevitable because I  was "in the field" collecting data on a number of consecutive weeks. I  
was also able to reflect on examples of situations or events that ran counter to emerging 
themes, and I  was able to use these situations to further refine the case study’s questions.  
 
2.9.2. Data reduction  
 
Once I  had completed the observation, I  made photocopies of the field-notes and cut the 
photocopied sheets to sort the data into large categories defined by the case study’s 
questions. I  then sorted into smaller discreet sections informed by the analyt ical and 
theoretical ideas developed during the observation. I n other words, I  selected sections of data 
on like or related themes and put  them together. Themes were derived inductively, that is, 
they were obtained gradually from the data as the observation progressed. By the end of this 
process I  was very familiar with the data, and realised that there were some gaps in my 
knowledge. I n October 2004 I  went  back to each surgery to check the accuracy of some 
information and to fill in some knowledge deficits. 
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2.9.3. Data display 
 
Figure 2.5 shows how the large categories of data were reduced into smaller themes within 
the theoretical framework. 
 
 
Figure 2.5:  Data reduction and identification of themes 
Society
Pat ients and practitionersOrganisational system
Microalbuminuria
Blood pressure
Educational strategy
Diabetes template on EMIS
Interact ion between GPs and practice 
nurses
Nat ional policy changes
 
2.10. Emerging themes 
The hand-written field notes taken during the observat ion were summarised, displayed and 
then divided into themes. I n the following section, each theme will be described and 
evaluated alongside pertinent evidence and literature. The conclusions from the thematic 
analysis of the case study will form the basis of the literature review and result ing 
methodology for the main research project. 
 
A theme is an abstract entity that brings meaning and identity to a recurrent experience and 
its variant  manifestations. As such, a theme captures and unifies the nature or basis of the 
experience into a meaningful whole (DeSantis and Ugarriza 2000)p. 362). 
 
Six main themes emerged from the data. Two related to clinical care (microalbuminuria and 
blood pressure measurement and management), one related to the educational strategies 
used by the practice nurses, one related to the use of the computer during patient 
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consultation, another theme was concerned with the doctor-nurse relationship. A theme 
around the effect of national policy change also emerged. Although each theme is important  
in its own right, together they can provide information about  the impact and outcome of 
diabetes management in the primary care setting.  
 
2.10.1. Measurement and monitoring of microalbuminuria 
 
The most  important theme which was identified following the analysis of the field-notes was 
measurement and monitoring of microalbuminuria (MA). I n every surgery on my first visit, 
the monitoring, measuring and interpretation of MA was raised as an issue. The challenges of 
understanding the importance and relevance of MA appeared to be partly historical (“ I  have 
never really understood the kidneys”), but  also there was increased interest  in MA test ing 
because of the recent introduction of the General Medical Services (GMS) contract for GPs. 
Diabetes was included as one of the ten clinical indicators within the Contract’s framework, 
with testing of MA recommended for 90%  of patients with diabetes within a fifteen-month 
period.  
 
Pract ice nurses seemed aware of the importance of MA test ing but spoke of the difficulties of 
what information to tell patients, the challenges of obtaining samples, how to receive and 
interpret  results and how to act on abnormal values. On three occasions I  was asked to give 
information directly to patients (why the test was necessary;  what  the results meant;  why a 
pat ient may need to be referred to the renal unit). 
 
The main theme of MA will be broken down into the following sub-topics:  
  
• Measurement of MA 
• Patient education and MA testing 
• I nterpretat ion of results of abnormal MA values 
• Quality and Outcomes Framework (QOF) and MA test ing 
 
2.10.1.1. Measurement of MA 
 
Microalbuminuria (MA) is the earliest indicator of kidney disease at tributable to diabetes. 
Values of MA are between 30-300 mg of albumin in the urine. MA is predictive of total 
mortality, cardiovascular mortality and cardiovascular morbidity for pat ients with diabetic 
kidney disease and can be measured in three ways (Miedema 2003):  
 
• Timed test (by 24 hour urine) 
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• Albumin:creatinine ratio (ACR) (by early morning urine (EMU)) 
• Point  of care testing (by dipst ick eg. Micral test strips)  
 
Since current clinical guidelines (NICE, 2002) recommended the use of albumin:creat inine 
ratio to measure MA because of  convenience and consistency, five out  of  six surgeries in this 
case study screened for MA using the ACR test . However there were reported difficulties in 
two surgeries with patients not  being able to return EMUs to the surgery in time for the early 
morning courier to the hospital where the ACR is measured. Patients also reported difficulties 
in taking the sample directly to the hospital laboratory because of  the distance involved (up 
to five miles for Surgery 3). There were also reported problems with the hospital laboratory 
allegedly not report ing all results back to the surgery. 
 
Surgery 2 had been using Micral (ImmunoDip® ) test strips for some time, as it was decided 
that point-of-care testing would overcome some of the challenges of low testing rates. At the 
time of observation of diabetes care and management at  the surgery (May 2004), I  found 
difficulty in identifying any evidence that  gave comparisons of Micral tests with ACR tests on 
specificity and accuracy of measurement. Discussion with a nephrologist  in North Wales (oral 
communication) suggested that Micral st rips accounted for 30%  false negative readings. I  
also had email discussion with the author of a paper who had systematically reviewed the 
evidence to establish whether a dipstick method of  detecting MA was as effective as a 
laboratory method (Berry 2003). The conclusion was that Micral testing has a high sensitivity 
but not very high specificity with low positive predict ive value;  that is, it is adequate as a 
screening tool but not as a diagnostic tool. 
 
I nterestingly there have been a number of recent ly published studies on the performance 
characteristics of Micral test strips for MA, since the debate with surgery 2 was raised. One 
study (Parikh et al. 2004) found that the performance characteristics of the Micral test strips 
for detecting microalbuminuria (30-300 mg albumin/ 24 h) were adequate but not optimal. I n 
this prospect ive study, a total of 444 urine samples of patients with Type 2 diabetes were 
obtained. Urinary albumin concentrat ions were determined using Micral test  strips and 
compared with results measuring albumin by the immunoturbidimetry method of t imed 
collections. They concluded that  while the use of Micral test strips provides a rapid approach 
to detecting microalbuminuria in diabetes, this method has limitations because the positive 
predictive value was 69%, and negative predictive value found to be 92% . However as this 
study did not  compare point-of-care testing with EMU test ing (which is random and therefore 
less accurate than a timed collection), it was necessary to keep searching the literature for 
newly published studies. 
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A study published in July 2004 compared the advantages and disadvantages of using the 
‘gold standard’ method of 24 hour timed collect ion compared with a random sample such as 
an EMU. A systematic review and meta-analysis (Ewald and Attia 2004) was carried out on 
studies comparing albumin to creatinine ratio (ACR) on a random specimen with albumin 
excretion rate from an overnight or 24 hour timed sample. Studies were identified using 
Medline and EMBASE to June 2003 and ten studies covering 1470 patients were included. The 
authors suggested there was a marginal benefit  of using a timed urine collection over a spot 
ACR to detect  microalbuminuria in the screening of diabetic pat ients, but not  worth the cost  
and inconvenience of collecting a timed sample. 
  
I n July 2004 I  discussed the practical issues of using Micral strips with surgery 2, and 
provided them with the above evidence that suggested that EMU testing was preferable. 
After meeting with the practice nurse and practice manager, the protocol in the surgery was 
changed. All patients now have annual ACR testing with an EMU which is sent to the hospital 
laboratory. I n July 2004 it was not possible to evaluate whether the practical problems of 
gett ing the samples to the hospital would be resolved, so further audit  to measure the 
percentage of pat ients who had been tested was suggested to the pract ices affected. 
 
2.10.1.2. Patient education and ACR testing 
 
There was variation in the information given to patients. The following is a summary of the 
advice given to patients when I  first visited each surgery:  
 
• Surgery 1 told patients to use the first  sample of the morning (EMU) 
• Surgery 2 used point  of care testing (Micral test strips) 
• Surgery 3 told patients to use the first  or second sample of the morning (EMU) 
• Surgery 4 was very strict in the guidance given to patients, telling patients that the 
sample had to taken immediately upon rising from bed in the morning. The practice 
nurse had questions for me about whether an EMU sample could be taken if the patient 
had passed urine in the night  
• Surgery 5 told patients to use the first  sample of the morning (EMU) 
• Surgery 6 told patients to use the first  sample of the morning (EMU)  
 
I t appeared that practice nurses needed more guidance on the testing of MA, particularly as 
ongoing monitoring of MA has shown to be an important issue in diabetes management.  
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2.10.1.3. I nterpretat ion of results of abnormal MA values 
 
There was variation in how the results of the ACR were interpreted. All surgeries were aware 
of the likelihood of false positive readings if the pat ient had a urinary infection, but there did 
not appear to be consistency in how this was put into practice. Two surgeries required two 
positive readings (ACR> 3) in order to make the diagnosis of MA, whilst two surgeries 
reported that infection needed to be ruled out  (by sending off  a mid-stream specimen of 
urine) once a posit ive MA was found. More specific guidance was needed to clarify when a 
positive diagnosis of MA could be made.  
 
NICE guidance on MA testing (NICE, 2002) recommended that an ACR >  2.5 mg/mmol (in 
men) or > 3.5 mg/mmol (in women) classified patients at high risk of kidney disease. 
However in all six surgeries, an ACR of greater than 3, regardless of whether they were men 
or women appeared to define a patient  as being high risk. I t was not clear why the local 
laboratory/PCT used the threshold of >  3 for all patients, although the thresholds were 
changed during 2005. 
 
2.10.1.4. Quality and Outcomes Framework (QOF) targets and MA testing 
 
As described earlier, in April 2004 the new GMS contract  commenced.  Figure 2.6 shows the 
relevant QOF targets for diabetes achieved for each surgery in May 2004.  
 
Figure 2.6:  Diabetes QOF targets May 2004 
SURGERY MA % testing in past 15 months Serum creatinine % testing in past 15 
months 
1 59 80 
2 86 (using Micral strips)  95 
3 64 86 
4 38 91 
5 62 87 
6 47 91 
 
 
There was an improvement on May 2004 testing rates for MA as the year progressed. Rates 
for December 2004 are shown in Figure 2.7. Possible reasons for increased testing rates 
could have been the effect  of QOF incentivisation (although financial remunerat ion was not  
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high for MA testing), increased awareness due to my visits to the surgeries, or ease of taking 
a random urine sample compared with an EMU (see sect ion  below for explanation).  
 
Figure 2.7:  Diabetes QOF targets December 2004 
SURGERY MA % testing in past 15 months Serum creatinine % testing in past 15 
months 
A 72 83 
B 93 95 
C 66 91 
D 66 92 
E 73 90 
F 58 93 
 
2.10.1.5. Summary  
 
During 2004 practice nurses needed more guidance on the testing of MA. I  searched for 
evidence-based guidance on MA test ing and the following recommendations were 
communicated to the practice nurses. 
 
• An ordinary urine specimen (preferably taken in the morning) is acceptable for 
measurement of ACR.  
• I t is preferable to have a morning sample as the urine needs to be reasonably 
concentrated for the laboratory test to be carried out . 
• I t is possible for samples to be taken from the pat ient in the afternoon and kept 
refrigerated overnight (this is beneficial to surgeries as often the courier to the 
hospital laboratory leaves in the early morning). 
 
 
2.10.2. Measurement and monitoring of blood pressure 
 
Control of blood pressure is one of the most important variables in delaying progression of 
renal disease in diabetes (Perry et al. 2003). During the observation of diabetes care and 
management in the six selected GP surgeries, the challenges of measuring and managing 
blood pressure was the second most  significant theme to be identified. This was partly 
because most  practice nurses wanted to discuss the ongoing challenge of controlling BP in 
diabetes, and more specifically wanted advice on which BP target they should be aiming for. 
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The following topics will now be discussed within the context of the case study:  
 
• Ways in which blood pressure was measured 
• Ways in which blood pressure was controlled 
• Use of clinical guidelines in ident ifying blood pressure targets 
 
2.10.2.1. Measurement of blood pressure 
 
I n all surgeries, BP was routinely measured in every patient at each visit. I n all surgeries the 
BP was measured at  the start  of the consultation, usually because this was prompted by the 
diabetes template on the computer (see section 2.10.4). Surgery 6 employed a health care 
assistant to t ake BP and test urine samples prior to the consultation with the PN, whereas in 
all other surgeries the PN took the BP recording. 
 
BP readings were mostly taken using electronic Omron upper arm monitors (all surgeries 
except surgery 2). Some pract ices used both manual (mercury) and electronic 
sphygmomanometers.  Only one surgery (Surgery 6) offered BP machines to patients to take 
home, but  this appeared to be a rare event. Two PNs did raise the pertinent issue of ‘white 
coat hypertension’.  The white coat effect on BP was first described in 1983 (Mancia 1983)  
and since then various alternative definitions of white coat  effect  and white coat  hypertension 
have appeared in the literature. One definition of white coat hypertension describes it as a 
condition in which a person's BP rises above the normal range when measured in the clinic 
but falls within the normal range when measured outside the clinic (Tsai 2002). I t was this 
definition to which the PNs referred, but neither offered any solution to the problem. 
 
Pat ients were advised not to talk when their BP was being measured (four surgeries), but on 
no occasion did I  observe other actions being taken to yield more accurate recordings of BP, 
such as cuff size tailored to the size of patient (Mansoor 2003), or t aking the mean value of 
two-three readings as recommended by the European Society of Hypertension (O'Brien et al. 
2003). 
 
Consistent  underestimation of blood pressure values can have an impact on the numbers of 
pat ients treated with medication. I t has been suggested that constant underestimation of 
diastolic pressure by 5 mm Hg would reduce by 62%  the number of patients perceived as 
hypertensive (Campbell and McKay 1999). Although it is likely that  the variables described 
here (white coat hypertension;  talking;  small cuff size) would be most likely to overestimate 
blood pressure in t his group of patients, the large clinical trials on which treatment 
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recommendations are based use standardised blood pressure measuring techniques and 
pat ient preparation. 
 
I t is likely that home blood pressure monitoring would yield less overestimation of  blood 
pressure. To determine the effect of home blood pressure monitoring on blood pressure 
levels, a meta-analysis of 18 randomised controlled t rials was carried out  (Cappuccio et al. 
2004). They concluded that blood pressure in people with hypertension is more likely to be 
controlled to target when home blood pressure monitoring is used, compared with standard 
blood pressure monitoring in a clinic. Clearly there are implications for practice. As BP is likely 
to be overestimated when measured in a clinic set ting, the importance of measures to 
facilitate accurate readings for this high-risk patient group is crucial.  
 
2.10.2.2. Ways in which blood pressure was controlled 
 
There is generally accepted evidence that  BP can be reduced through weight loss and 
exercise (Costa 2002, Kastarinen et  al. 2002) and reduction of salt  in the diet  (Siani et al. 
2000). During the observation of diabetes care, there was never any occasion when I  
observed a PN or a GP giving advice to pat ients in this way. Control of blood pressure was 
always managed through prescription of medications, although there did not appear to be a 
clear evidence-base as to why one medication was prescribed over another. I n surgery 6 
15/ 71 (21%) patients were prescribed bendrofluazide (a thiazide diuretic) to control their BP, 
often instead of the recommended angiotensin-converting enzyme inhibitor (ACEi) or 
angiotensin-receptor blocker (ARB) (Nat ional I nstitute for Health and Clinical Excellence 
2002). 
 
2.10.2.3. Use of clinical guidelines in ident ifying blood pressure targets 
 
I n 2004 there were a number of recent  evidence-based guidelines that had been published 
on care and management of those with diabet ic renal disease. The National I nst itute for 
Health and Clinical Excellence (NICE) produced guidelines for Type 1 (National I nstitute for 
Health and Clinical Excellence 2004) and Type 2 diabetes (National I nst itute for Health and 
Clinical Excellence 2002);  the Scottish Intercollegiate Guidelines Group published guidelines 
for diabetic nephropathy (Scott ish Intercollegiate Guidelines Network 2001);  the local 
diabetes centre also had standardised guidelines for diabetes care.  I n each surgery I  asked 
the practice nurses if their care was based on evidence and all answered that this was the 
case. I n two surgeries I  asked if I  could see the guidelines on which care was based, but 
neither could produce anything on paper. However when I  asked specifically about  
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management of patients with renal disease, all the practice nurses could describe the 
management which generally followed the evidence-base, that is:  
  
• aim for annual MA test ing 
• prescribe ACEi or ARB when MA was present or when the patient is hypertensive 
• refer to a nephrologist when serum creatinine reaches 150umol/L. 
 
I n practice of course these guidelines are difficult  to follow. The most  difficult aspect of care 
is control of blood pressure, especially in African-Caribbeans (Oparil and Wright 2005) and 
many patients were having multiple therapy. Blood pressure was always controlled through 
medication, and I  never observed any other advice or therapy being offered such as lifestyle 
modification or weight loss. 
 
2.10.3. Educational strategies 
 
I t is recommended that structured patient educat ion is made available to all people with 
diabetes at the time of init ial diagnosis and then as required on an ongoing basis, based on a 
formal, regular assessment of need (National I nst itute for Health and Clinical Excellence 
2003). However, NICE in the 2003 report, concluded that there was insufficient evidence 
currently available to recommend a specific type of education or provide guidance on the 
setting for, or frequency of, sessions.  
 
However, some principles of good practice were recommended, and these included:  
 
• educational interventions should reflect established principles of adult learning 
 
• educational programmes should use a variety of techniques to promote active 
learning (engaging individuals in the process of learning and relat ing the content of 
programmes to personal experience) 
 
• programmes should be adapted wherever possible to meet the different  needs, 
personal choices and learning styles of people with diabetes, and should be 
integrated into rout ine diabetes care over the longer term 
 
Throughout the entire three months of observation in the diabetes clinics, I  never observed 
one occasion when a patient or family member was of fered any written advice on any aspect 
of diabetes care. Neither did I  see any patient  being offered information through a relevant  
website or other resource/ interact ive medium.  
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The reasons for this are unclear. I t may be that practice nurses believe that educat ion is best 
delivered on a one-to-one basis using personal experience and individualised examples. This 
was said to me by two of the practice nurses when I  asked them whether they thought  
written patient information might be useful. Other reasons were not suggested by the 
pract ice nurses, but  it may be that they do not  know that suitable materials are available. 
This may have been the case in 2004 for diabetic kidney disease, but  not the case for general 
aspects of  diabetes. Diabetes UK www.diabetes.org.uk offers numerous patient informat ion 
leaflets on-line and also in hard copy, on all aspects of the condition.   I t could also be 
possible that practice nurses believe that education should be provided by the local diabetes 
centre. To some extent this might be true, as the local diabetes centre at the time did offer 
all new patients a structured education programme, backed-up with written materials and 
information. However it is important  to recognise that education has the most effective 
outcome when key messages are reinforced on a regular basis (Renders et al. 2001). 
 
As discussed already, NICE (2003) guidance on patient education initiatives is not 
encouraging, yet there is a plethora of other pertinent research literature on the benefits of 
good diabetes education. A Cochrane Systematic Review (Renders et al. 2001) suggested 
that the addition of patient-oriented intervent ions in primary care can lead to improved 
pat ient health outcomes in diabetes. The review concluded that pract ice nurses can play an 
important role in patient-oriented intervent ions, through pat ient education and facilitat ing 
adherence to treatment.  
 
For me, another crucial issue which emerged is how far the patients felt empowered by their 
pract ice nurses or GPs. I  rarely saw a consultation were patients were asked:  
 
• how they felt they were managing their diabetes 
• how far they were able to control their diabetes 
• what was realistic and acceptable in terms of goal setting 
• what was preventing them changing their attitude or behaviour to diabetes 
 
This is despite Standard Three of the Diabetes National Service Framework (Department of 
Health 2001b) which focuses on patient empowerment, which stated that:  
 
“All children, young people and adults with diabetes will receive a service which 
encourages partnership in decision-making, supports them in managing their 
diabetes and helps them to adopt  and maintain a healthy lifestyle. This will be 
reflected in an agreed and shared care plan in an appropriate format and language. 
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Where appropriate, parents and carers should be fully engaged in this process.”   
(Department of Health 2001b)(p.5)  
 
Clearly the way in which patient education and empowerment is facilitated in primary care 
requires further analysis and evaluation. There may well be a good rationale why care is 
delivered in this way, and of course it is easy for me to quest ion the educational methods 
when I  am not the nurse responsible for implementing them. However renal nurses are very 
familiar with the empowerment philosophy and traditionally have promoted the concept  of 
self-care. I t seems that  the way in which consultations are carried out has to be challenged. 
I f the focus continues to be on data input  to the computer and questioning being led by the 
diabetes template, there is litt le chance for a patient-centred approach.  
 
2.10.4. Use of diabetes template on computer 
 
Each surgery utilises the Egton Medical I nformation Systems (EMIS) LV system for patient 
record management, and it is one of the leading text-based clinical systems in the primary 
care market. Approximately 5,000 GP practices currently use EMIS LV. The system offers 
consultation mode, medical record, search and reports, prescribing and appointment modes.  
 
EMIS LV enables GPs to easily meet the requirements of the GMS contract. The ‘Populat ion 
Manager’ contains a set of approximately 160 searches that extract the information required 
for the new Contract. All surgeries in this case study use the Population Manager facility.  
 
All surgeries reported that they had access to the newly developed (end of 2003) PCT 
template for diabetes care, and surgery 3 described how they were involved in the steering 
group that developed the template. However only four surgeries appeared to use this 
template in practice and two surgeries seemed to be using both the new template and the 
original template, which made extraction of data complicated. Each surgery had then made 
local adjustments to t he template, so for example pat ient ethnicity was recorded on the 
diabetes template in two surgeries, and amount of exercise undertaken by patients was only 
recorded on the templates in three surgeries. 
 
During the period of observat ion it was interesting to note how the interaction between PN 
and patient was directed by the diabetes template on the computer. I n five surgeries 
(Surgery 5 excepted) all the questions asked during the consultation were initiated by use of 
the template, and the PN inputted the data (weight, BP measurement, blood glucose level) as 
the consultation progressed.  
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I n Surgery 5, the consultation was led by the PN and there was a greater likelihood that the 
consultation would be directed by the patient or family member. I n this surgery the PNs 
inputted data at the end of the clinic. To the uninitiated researcher at my first  visit, it 
appeared that  the PNs in this surgery wanted to encourage a more patient-centred approach 
to the consultation. On my second visit, I  asked one of the PNs the reason for this 
arrangement and was told of the simple pragmatic reason why the data entry did not happen 
concurrently during the consultat ion:  the electrical lead to the computer did not stretch to the 
chair/ couch where the consultation took place! 
 
I n all surgeries it was rare that  patients were asked about  how well they were coping with 
their diabetes. Although it is recognised that many of the patients had been diagnosed with 
diabetes many years ago and therefore were well known to the PN and GP, it was notable 
that they were rarely asked about how far they felt  able to control their illness.  
 
When computers started to become a part  of nurse/GP consultat ion in the primary care 
setting in the early 1990s, there were many papers exploring the impact of computers on 
interaction with patients (Mitchell and Sullivan 2001). A review (Brown 1998) described the 
position and use of computers during the consultat ion, the behaviour associated with the 
computer, and also the patient and doctor perspect ive.  At that time, the review concluded 
that computers had potentially had a deleterious effect  on patient interaction with the health-
care professional, although this does not appear to have affected the rise in computer use in 
general practice consultations. At  a later date (Hsu et al. 2005) a study into the effect  of 
computer on patient-centred consultations appeared to show that  the computer had positive 
effects on physician-patient interactions without  significant negative effects on other areas 
such as time available for patient  concerns. 
 
2.10.5. I nteraction between practice nurses and GP 
 
I t was interesting to note the different ways in which GPs and pract ice nurses work together. 
I n surgeries 3, 4 and 6, the PN appeared to direct care, making suggestions to the GP about  
MA testing, prescribing of medication and referral to the renal unit. I n other surgeries the PNs 
took a less pro-active role, and in some cases made suggestions which were not  taken up. 
Examples of this were recommendations to control blood pressure which clearly were above 
accepted evidence-based standards, but were ignored by GPs as unnecessary.   
 
An historical perspective to the role of the PN makes interesting comparison. An historical 
review (Atkin and Lunt 1996) describes how the origins of practice nursing are closely 
associated with the development of general practice. I t  was back in 1966 that  amendments 
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to the general practit ioner (GP) contract established the potential for employing nurses, and 
GPs slowly took advantage of this by employing nursing staff to undertake 't reatment room' 
tasks. I n 1990, further amendments to the GPs' system of payments and associated 
incentives created an expanded role for nurses in general practice and family doctors were 
attracted to the idea of directly employing a nurse (Robinson et  al. 1993) . At  that time, 
although many GPs created a new nursing post or expanded the role of existing nurses to 
meet contractual requirements, their views varied considerably in the tasks that practice 
nurses should undertake. 
 
There is an important question as to who makes the decisions concerning diabetes care and 
management in the primary care team. In some practices, the nurses with specialist  
knowledge are directing and managing care, whilst  in other surgeries the doctors are leading. 
Some surgeries have strong links with the local diabetes centre (surgery 5 for example did 
not manage any patients with Type 1 diabetes), whilst others do not. For the purposes of this 
case study and resulting research project, the importance of who the key players are in 
diabetes care and management cannot be underestimated. I n a truly pat ient-centred 
environment of course, it is the person with diabetes who should be empowered to be in 
charge of their care, in partnership with health-care professionals. 
 
2.10.6. National policy 
 
As already discussed, the period of time from April 2004 to early 2005 saw many changes to 
renal health care practice, culminating in the publication of the National Service Framework 
(NSF) for Renal Services (Part Two) (Department of Health 2005b). Two of the quality 
indicators described in this NSF made recommendations for the management of CKD in the 
community.  
 
As a result of my findings regarding inconsistency in managing diabetic kidney disease in the 
local PCT, I  developed some evidence-based local guidelines for diabetic kidney disease in 
collaboration with a local nephrologist, at the end of 2004. The aim was to ensure that all 
pract ices in the forthcoming research project were providing consistent care. To complement 
this guidance, draft  guidelines for general CKD management (not  specific to diabetes care) in 
primary care were published on the Renal Association website www.renal.org in January 
2005. I n February 2005 local clinical guidelines on CKD management were developed by the 
local renal unit and in April 2005 an educat ional programme for GPs and pract ice nurses in 
management of CKD was implemented.  
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Later in 2005, a number of local GP practices had improved knowledge of CKD management, 
either through the published local/national guidance, or from attendance at local seminars on 
the subject. Chapter 5 will explain the timelines of the national agenda on CKD in relation to 
the research project which was carried out after the case study. 
 
2.11. Limitations of a case study approach 
 
2.11.1. Validity of case-notes 
 
Following a period of reflection once the case study observation period was completed, I  
realised that many questions were still unanswered and many issues were still being raised. 
This may have been because the questions which I  had identified at  the start of the 
observat ion period were not  specific enough, or it may have been that the case notes that I  
wrote during the observation period were too superficial. 
 
On reflection, the notes which I  had made during each visit at  the start of the observat ion 
period were scanty in parts.  At  t imes it seemed to be inappropriate to write notes during 
sensitive pat ient consultations, so sometimes I  would write notes after returning home. 
However it was not  until I  was coming to the end of the case study observation period that  I  
realised that I  had not always written enough detail on two topic areas, such as the 
interaction between nurse and patient and also the educational strategies which were used to 
explain diabetic kidney disease to the patient and family. Once I  had realised this I  t ried to 
‘f ill in the gaps’ as best I  could by direct  questioning of the practice nurses. Examples of the 
questions I  asked were ‘do you have written materials for handing out  to patient regarding 
early kidney disease?’ and ‘do you like the PCT diabetes template for managing diabetes/early 
kidney disease?’ 
 
2.11.2. I nfluencing practice 
 
The other main challenge which I  encountered when observing care and subsequently writ ing 
the case study was the extent  to which I  wanted to influence practice during the observation 
period. As the main aim of the research project, which is described later in the thesis, is to 
develop and test a patient-centred education programme, it was preferable that I  did not 
change care/management too much prior to the start of the main study. However the 
observat ion period and subsequent identification of pat ients with early kidney disease showed 
that some patients were receiving sub-optimal care with respect  to prescription of ACE 
inhibitors, and a very small minority of patients did indeed require referral to the renal unit.  
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As described in the previous section, draft  clinical guidelines for care of patients with diabetes 
and CKD were developed following the observation period so it  could be assumed that patient 
management would change prior to the educational intervention which is to follow. Although 
the challenges of ‘practit ioner research’ have been identified to some extent  in the literature 
(Meyer et al. 2003), the tension for me between being a researcher and being a practit ioner 
was very challenging. The main ethical dilemma which I  encountered was t rying to do the 
best for the patient yet  at the same time avoiding change in practice which could 
subsequently affect results. This was never really completely resolved for me, although I  did 
attend a student seminar on ‘action research’ (Bridges et al. 2001) in March 2005 which went 
some way in justifying the changes that I  had made to practice. 
 
2.12. Summary 
 
I n summary, a number of important issues have been raised as a result of this case study. 
The main aim was to observe care and education delivered by GPs and practice nurses to 
people with diabetes at risk of CKD. This was achieved and as a result I  gained valuable 
insight into the ways in which CKD was managed in primary care. The secondary aims were 
to analyse collected using a theoretical framework and to ident ify themes within these data to 
subsequently inform the development of the self-management package. These themes and a 
summary of the case study findings are shown in Figure 2.8 
 
Figure 2.8:  Case study themes and findings 
Society
Patients and practit ionersOrganisational system
Microalbuminuria
Blood pressure
Educational strategy
Diabetes template on EMIS
Interaction between GPs and practice 
nurses
National policy changes
Period of rapid policy change in managing CKD
Computer-led consultat ions
Variat ion in decision-making models
Variat ion in clinical pract ice – not always evidence-based
Empowering philosophy not always encouraged
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These aims were also achieved as a number of uncertainties regarding specialist clinical 
pract ice were identified, namely problems with undertaking MA testing and understanding 
blood pressure targets. These uncertainties experienced by the staff would have a result ing 
effect on patient care and education.  
 
I  had also intended that the case study would be an opportunity for me to provide 
educational input  about  kidney disease to practice nurses, GPs and patients. This was also 
achieved, as I  gave clinical support especially in the areas of MA testing, blood pressure 
control and controlling CKD progression.  
    
 
2.13. Chapter summary  
 
The case study was undertaken five years ago, and it is recognised that clinical practice in 
the care of diabetes in primary care is likely to have changed and developed since then. The 
introduction of the QOF targets for both diabetes (2004) and CKD (2006) has certainly made 
pract it ioners aware of how they might improve the care of people at  risk of CKD. 
 
However, at the time of the case study, the conclusions that were drawn provided a very 
useful framework upon which to base the literature review and resulting research project. 
The next chapter will discuss the relevant underpinning literature that supports the evidence 
base for diabetes self-management. 
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3. CRI TI CAL REVI EW OF THE LI TERATURE 
 
3.1 . I ntroduction 
 
This review is directly linked to the findings of the case study and aims to identify and 
understand the best ways in which patients with diabetes can positively influence the 
evolution of their disease and its potential complications by self-care and self-management. 
The review utilises the theoret ical framework developed in the case study. The findings of the 
review will shape the next  stage of the Doctorate, that is, the development of  a patient-
centred education programme for patients with early diabet ic kidney disease who are being 
managed in primary care.  
 
The review is divided into sections:  aims, method, findings and discussion. The review will 
conclude with concrete recommendations for development of the educational programme, 
which will subsequently be implemented and evaluated as part of the research project. 
 
The overall aim is to carry out a comprehensive review of the literature that evaluates the 
effectiveness of educat ional interventions aimed at improving outcomes for pat ients with 
diabetes.  
 
3.2. The review  question 
 
The review question is ‘how far can self-care and self-management make a difference to 
improving outcomes for pat ients with diabetes?’ 
 
3.3. Aims of the literature review  
 
• To carry out a review of the literature pertaining to diabetes and self-care/management 
• To analyse the societal, organisational and inter-personal variables within the theoretical 
framework which impact  on diabetes self-care/management  
• To evaluate the different ways in which a patient-centred self-care/management 
programme can be developed 
• For the findings of the review to inform the development of the educational model to be 
evaluated in the subsequent research project  
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The review was first developed at the start of the Doctorate in 2004, and written up in the 
following year. I t  is recognised that over the following three years, as the Doctorate 
progressed, further pertinent  papers were published. As the thesis was being written up in 
2008/ 9, the review was revisited and additional, important  studies were added. 
 
3.4.  Methods 
 
Whilst preparing to commence the review, many questions concerning structure, method, 
writing style and scope were raised. The accepted method for undertaking a ‘systemat ic’ 
review is well-documented (Woolf 1992). However it was not clear how far the requirement 
to undertake ‘a crit ical review of the literature’ (as defined in the City University guidelines to 
undertake the Doctorate) meant that the review had to be systemat ic in its truest sense. A 
discussion now follows. 
 
3.4.1. Definition 
 
The Centre for Reviews and Dissemination (CRD) University of York (2009) explain that the 
aim of a ‘systematic review’ is  
 
“ to identify, evaluate and summarise the findings of all relevant individual studies, thereby 
making the available evidence more accessible to decision makers. When appropriate, 
combining the results of several studies gives a more reliable and precise estimate of an 
intervention’s effectiveness than one study alone.”  (Centre for Reviews and Disseminat ion 
2009)(p.1)  
 
The question is how far this review, which is essentially evaluating research papers with no 
hard endpoints, can be defined as systematic. I f the CRD definition is broken down, it is 
possible to conclude whether a ‘systematic review’ is realistic within the time and word limits 
of this thesis.  
 
There is certainly a clearly formulated question, that is, how far can self-care/management 
improve the outcome for pat ients with diabetes? I t is possible that explicit methods of data 
collection can be developed in order to identify and select  relevant primary research. But it is 
how far these papers can be crit ically appraised that is the tension here. Critical appraisal of 
literature with a qualitative methodology is possible (Boulton and Fitzpatrick 1997), but it is 
likely that many of the reports, unpublished studies, internal documents and articles in non-
indexed journals (narrative literature) which are valuable to this review, cannot be appraised 
in a systematic way. 
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Other authors have been confronted with the same challenges. A strategy designed to 
overcome the barriers associated with integrat ing narrative literature into a systematic review 
of student  interdisciplinary learning was carried out (Cooper et al. 2001) by one study group.  
This group developed a hierarchy (Kirkpatrick 1967) to judge the size of the effect  of the 
intervention based on reported outcomes. They discovered that  narrative reports, rather than 
quantitative outcomes, were the common mode of describing the effects of student learning. 
To evaluate these reports and papers, they used this hierarchy to monitor both the 
educational process and its effects. As shown in Figure 3.1, each stage ‘reflects a hierarchy of 
levels of evaluation, with the complexity of behavioural change increasing as the evaluat ion 
of the intervention ascends the hierarchy’ (Cooper et al. 2001). 
 
Figure 3.1:  Hierarchical levels of evaluation of inter-professional educational interventions 
developed from Kirkpatrick (1967)  
RESULTS
Effect  on learning environments
BEHAVIOUR 
Transfer of learning into behaviour
LEARNING  
Effects on knowledge, attitudes and beliefs
REACTION 
Evaluation of the learning experience
 
 
As this review faces similar challenges in evaluating the literature on pat ient-centred 
education, it was considered that this instrument of evaluation would also be helpful here. 
Figure 3.2 shows how the ef fects of the educational intervention identified within the 
Kirkpatrick model could be used to rate the outcomes of research studies evaluated in this 
review.   
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Figure 3.2:  Effects of educational interventions 
 
Effect Relevance to this review  
Effect on learning environment Whether participants were asked to 
evaluate/modify the learning resources  
Transfer of learning into behaviour Whether participants had a change in 
behaviour measured (eg. controlling blood 
pressure and blood sugar, reducing weight, 
stopping smoking) 
Change in knowledge, attitudes and beliefs Whether participants had their knowledge or 
attitudes/beliefs assessed  
Change in the learning experience Whether participants evaluated the teaching 
and learning experience 
 
The literature review undertaken here could therefore be defined as a ‘narrative review 
undertaken in a systematic way’. I n other words, I  have undertaken a literature review within 
an identified framework which collates relevant studies and draws conclusions from them. 
However I  have not been able to make explicit the review methods or decision-making rules 
that are possible to undertake with studies that have hard end-points such as randomised 
controlled t rials  (Smith 1996). 
 
Rating the literature can only be successfully carried out if as much of the relevant  research 
base as possible has been considered. The following sections explain how the CRD 
framework, first  developed in 2001, then modified in 2009 (Centre for Reviews and 
Dissemination 2009) was used to collect and appraise all relevant information sources.  
 
I n summary, the data collection methods recommended by the CRD were used in this review, 
and the literature will be appraised using the Kirkpatrick (1967) model. Literature will be 
organised within the theoret ical framework identified within the case study, which was based 
on the work of Silverman (1970).  
 
3.4.2. Existing or commissioned reviews  
 
The CRD (2009) makes recommendat ions for first identifying whether a good quality review 
already exists.  
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The original search question was ‘how far can self-care and self-management make a 
difference to improving outcomes for patients with diabetes?’ At the commencement of this 
Doctorate in February 2004, few specific reviews on this topic could be found. 
 
One technology appraisal (NICE, 2003) had examined the clinical and cost-effect iveness of 
pat ient education models for adults with Type 1 or Type 2 diabetes. The review found that  
educational programmes for those with Type 1 diabetes could result in significant and long-
lasting improvements in metabolic control and reduction in complications, however a diversity 
of educational programmes in Type 2 diabetes did not  yield consistent results. The review 
concluded that:  
 
“…..the paucity of high quality trials that have tested education per se in diabetes 
reveals a need for more research.”  (National I nst itute for Health and Clinical 
Excellence 2003)(p.xi) 
 
However, the NICE (2003) committee was convinced of the importance of  patient educat ion 
in improving glycaemic control and quality of life, while reducing the rate of complications 
associated with diabetes. 
 
I n June 2005, a joint report from the Department of Health and Diabetes UK, reported gaps 
in education provision, and recommended that local services ensure that all people with 
diabetes have access to high-quality education to support  self-management. 
 
Since this literature review was written at  the beginning of the Doctorate in 2004/5, there has 
been an increasing interest in the evaluation of self-care/management programmes, not just 
for people with diabetes but  also for all those with long-term conditions. As a consequence a 
number of pertinent reviews have been published (Boren et  al. 2007, Loveman et al. 2008a). 
I f these reviews had been published prior to the start of the research project, the findings 
would have contributed to the development of the self-management package. As they were 
published after this date, their findings will be discussed later in this thesis in Chapter 7. 
 
3.4.3. Conduct ing the review 
 
Collection of pert inent literature was commenced immediately after the regist ration for the 
Doctorate had been confirmed. The init ial collection of material was not structured in any 
way, but rather was noted and/ or filed as pertinent  papers were found. During the time 
period February 2004-April 2005 relevant papers and publications were filed in categorised 
folders until the formal review commenced in May 2005. 
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Reading around the method of developing and writing the review started in mid 2005, and 
init ially an experienced hospital librarian was involved in the search process. He made good 
suggest ions for addit ional information sources (e.g. the TRIP database) which had been not  
been originally identified.  
 
As discussed above, guidance from the Information Service Centre for Reviews and 
Dissemination, University of York (December 2004) was used to provide a framework for the 
review process.  
 
3.4.4. Selection of studies and other information sources 
 
Figure 3.3 describes the search criteria used in this review.  
 
Figure 3.3:  Search criteria 
 
Keywords diabetes mellitus, diabetes, education, health 
education, pat ient education, self-care, self-
management, learning, teaching, learning 
strategies, program(me) evaluation, 
effect iveness, outcome, evaluation 
Date of publicat ion 1996 – present  
Language English 
 
 
Figure 3.4 summarises the key sources and ongoing reviews which were searched during the 
period May-August  2005, and is structured on guidance from the Centre for Reviews and 
Dissemination (CRD), York (2009). I n addition, the reference lists of all retrieved papers were 
examined for pertinent studies useful to the review.  
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Figure 3.4:  Key literature sources (adapted from CRD, 2009) 
 
The Cochrane Library 
Three databases of published and ongoing systematic reviews:  
 
• The Cochrane Database of Systematic Reviews (CDSR) 
• Database of Abstracts of Reviews of Effectiveness (DARE) 
• Critical appraisals of systematic reviews not published in the CDSR.  
Health Technology Assessment (HTA) Database 
Abstracts of completed technology assessments and ongoing projects being conducted by 
members of the International Network of Agencies for Health Technology Assessment 
(INAHTA) and other healthcare technology agencies.  
 
Selected Internet sites and indexes (focusing on clinical effectiveness) 
• TRIP - http: / /www.tripdatabase.com 
• Health services/ technology assessment text (HSTAT) - ht tp: / / text.nlm.nih.gov/  
• National Coordinating Centre for Health Technology Assessment 
http: / /www.hta.nhsweb.nhs.uk/  
• ARIF appraisals – http: / /www.arif.bham.ac.uk/crit ical-apraisal-index.shtml 
• NICE appraisals – http: / / nice.org.uk/  
• SIGN guidelines - http: / /www.sign.ac.uk 
General databases 
MEDLINE, EMBASE, CINAHL, PsycINFO 
Researchers 
Personal contact with experts in the field 
Research in progress 
National Research Register (NRR) – https: / / portal.nihr.ac.uk/Pages/NRRArchive.aspx 
(site has now changed to https: / / portal.nihr.ac.uk/Pages/NIHRResearchInfoStatement.aspx) 
 
 
Figure 3.5 shows the number of studies and relevant papers that were found during the 
search. Abstracts to all papers were retrieved, and if thought to be relevant and pertinent t o 
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the review, the full paper was found either on-line or by visit ing local hospital and university 
libraries. Few requests for inter-library journals or book loans were needed. 
 
Figure 3.5:  Number of relevant information sources used in the review (in 2005)  
Source  Number of 
papers 
found 
Number of papers used 
in the review 
COCHRANE CDSR 6 4 
 DARE 22 2 
 HTA 2 1 
INTERNET SITES TRIP 0 0 
 ARIF 0 0 
 NICE 6 4 
 DEPARTMENT OF 
HEALTH 
7 6 
 SIGN 2 2 
GENERAL DATABASES MEDLINE 147 27 
 EMBASE 9 1 
 CINAHL 23 15 (some duplication 
with MEDLINE) 
 PsycINFO 10 8 
 BIDS 6 1 
 Blackwell Synergy 26 10 
PERSONAL CONTACT  1 Personal communication 
RESEARCH IN PROGRESS National Research 
Register 
3 2 
HAND SEARCH  Journals in local 
library (eg. Diabetes 
Educator)  
26 14 
 
 
3.5. The theoretical framework 
 
The framework used for the review is the same as that utilised in the case study, and is 
shown in Figure 3.6. This framework will be used to structure the review within the themes of 
society, organisational system and patients/practit ioners. 
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Figure 3.6:  Theoretical framework for literature review 
 
 
Society
Pat ients and practitionersOrganisational system
Diabetes-specific 
educational models and 
tools
The educational system 
and barriers to learning
Health beliefs 
Empowerment and self-management
 
3.6. I ntroduction to the literature review  
 
Each of the three sect ions identified in the theoretical framework (society, organisational 
system, patients/practit ioners) will be analysed, discussed and evaluated in this review. The 
first section explores how health behaviours can be influenced on a societal level. First, it is 
important to describe and evaluate how far the theory underpinning health beliefs can explain 
the health behaviours of those with diabetes.  
 
3.7. Society 
 
3.7.1. Societal beliefs about health 
 
There are a number of significant theories and models that underpin the practice of health 
education and many of these can be attributed to beliefs about health. The most utilised 
theories which underpin research into education of patients with diabetes appear to be the 
health belief model (Rosenstock et al. 1988) and the locus of control model (Rotter 1966). A 
detailed explanation of these seminal theories and models can be readily found in textbooks 
(Connor and Norman 2005). For the purposes of this analysis, the relevance and validity of 
these models to diabetes care will be explored. 
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3.7.1.1. Health belief model 
 
The Health Belief Model (HBM) (Rosenstock 1966) which was modified at a later date (Janz 
and Becker 1984) attempts to explore why individuals with a chronic illness behave as they 
do. Rosenstock (1966) postulated that in order for a person to take action about his/her 
health they must  believe that  they are susceptible to the illness, have beliefs about the 
severity of the illness, and believe that the advantages of taking action outweigh the 
disadvantages.  
 
I n diabetes there have been a number of studies which have evaluated the use of the 
Rosenstock model to explain health-related behaviour (Cosby and Houlden 1996). A Chinese 
study (Tan 2004) concluded that  poor preventive behaviour was associated with lack of 
perceived seriousness of diabetes and lack of perceived susceptibility to complications of 
diabetes. Cosby and Houlden (1996) reported health behaviours of those with diabetes in a 
Canadian aboriginal population. All the interviewees expressed the belief that the increased 
prevalence of diabetes was related to the loss of traditional lifestyle and therefore this made 
them susceptible. However they also described the importance of the role of family caregiver 
– this was believed to strongly influence adherence to dietary advice.  
 
So it is not  just  an individual’s belief about the disease which must be taken into account but  
also the att itudes of the people around them. The importance of assessing beliefs about  
health prior t o commencing educational intervention is clear, although the evolution of health 
behaviours cannot be wholly understood through the application of the HBM.  
 
This assertion is supported by other authors (Coates and Boore 1998) who concluded that :  
 
‘it is apparent that there are methodological weaknesses which need to be addressed 
in attempting to examine the relationship of the variables described in this (HBM) 
model and behaviours related to management of the condition (diabetes)’. (p. 532) 
 
3.7.1.2. Locus of control 
 
Rotter’s theory of locus of control (LOC), written in 1966, is based on social learning theory. 
He described LOC as  
 
'the amount of personal control over the environment individuals believe that they 
possess'. (Rotter 1966)(p. 2)  
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The construct describes three variables:  internal control, external control, and the influence 
of powerful others. People differ in the degree to which they believe that the events which 
occur to them are due to their own behaviour (internal LOC) or are due to circumstances 
outside their control (external LOC).  
 
I t could be expected that  those with an internal LOC could take more responsibility for their 
condition, and this would manifest in better outcomes. However, findings from studies which 
explore this relationship are conflicting. Although pat ients with internal LOC are more likely to 
achieve greater levels of self-care and management of their illness, (Chin et al. 2000) there 
are studies (Lowery and Ducette 1976) which have not  found this correlation. I n Lowery and 
Ducette’s study, the hypothesis that ‘internals’ know more about  their illness and therefore 
have better outcomes, was unfounded. As predicted, those with internal control did have 
more information about their diabetes, although this superiority over ‘externals’ diminished as 
the length of the disease increased. What was surprising was that those with internal control 
seemed to incur more problems with disease as the disease progressed.  
 
I t could be argued that it is the way in which health professionals respond to those who want 
information (more control) about  their condition which affects the long-term outcome. Firstly, 
information has to be valid, up-to-date and consistent  for internally controlled people to use it 
effectively. Dietary advice given to patients with diabetes for example can often be outdated, 
and conflicting. There is also evidence to suggest that internally controlled patients (often 
termed ‘expert patients’) are not necessarily being well accepted by the health professionals 
they interact with. As Liam Donaldson, Chief Medical Officer, Department of Health, 
commenting on the Department of Health’s Expert Patient Programme, said 
 
“A true partnership will be achieved only with a significant  change in the attitude of 
both patients and healthcare professionals and the way in which they interact with 
one another” . (Donaldson 2003)(p. 1279) 
 
Using the LOC theory, it may be possible to understand what it is like to live with diabetes, in 
terms of how patients make behaviour changes to achieve self-management goals. However 
it  may not be possible to find the positive correlation between internal control and health 
outcome as long as health professionals’ behaviour is at odds with the underlying concept of 
empowerment.  
 
According to the findings of a study by Coates and Boore (1998), neither health beliefs nor 
perceptions of control have a demonstrable influence upon the outcomes of diabetic 
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management. They suggested that despite the large amount of research that uses these 
models as a theoretical framework to explain participants’ behaviour, their value in practice 
remains unclear.  
 
3.7.1.3. Changing behaviour 
 
A number of studies have at tempted to utilise a theoretical model of change to understand 
the stages that individuals may go through when contemplating a change in behaviour. One 
study (Wells 1998) describes how the trans-theoretical model (Prochaska and DiClemente 
1982) can explain why diabetes self-care can somet imes result in behaviour change, yet  
sometimes does not. The author supports the assertion underpinning Prochaska and 
DiClemente’s model, that  patients must have reached a specific point in the stage of change 
continuum (at  least  contemplation stage) before change is likely. An overview of the model is 
shown in Figure 3.7. 
Figure 3.7:  The Trans-theoretical Stages of Change Model 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
One study (Jones et al. 2003) compared usual diabetes management with a new ‘Pathways 
To Change’ model - an intervention developed from the Trans-theoretical Model, to determine 
whether this new intervention would result in greater readiness to change, greater increases 
in self-care, and improved diabetes control (n= 1029 patients).  I ndividuals who were in one 
Pre-contemplation  
Has no intention to take action within the next 6 months  
Contemplat ion  
I ntends to take action within the next 6 months  
Preparation  
I ntends to take action within the next 30 days and has taken some 
behavioural steps in this direction.  
Action  
Has changed overt behaviour for less than 6 months  
Maintenance  
Has changed overt behaviour for more than 6 months 
Termination  
Overt  behaviour will never return, and there is complete confidence that one 
can cope without fear of relapse 
 
Adapted from Prochaska and DiClemente, 1982 
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of three pre-action stages, either self-monitoring of blood glucose, healthy eating or smoking, 
were recruited.  
 
43.4%  of those having access to the new model moved to an action stage. I n those who 
moved to an action stage for the blood glucose and healthy eating interventions, blood 
glucose levels (HbA1c) were significantly reduced (p <  0.001). This adds support to the 
hypothesis that individuals can only change when they are well prepared to do so. 
 
However another study (Gaede et al. 2001) contradicted this hypothesis. Patients, aged 45-
65 years, were randomly assigned either to an intensive group focusing on change of 
behaviour (n =  80) or to a control group receiving conventional treatment (n =  80). Despite 
the ‘many resources invested in behaviour modification’ in their study, only modest changes 
were obtained in dietary intake, measured by decreases in total and saturated fat in the diet. 
Changes in exercise and smoking habits did not differ between groups. The authors 
suggested that  further studies are required to determine the best ways to induce long-last ing 
changes in behaviour in pat ients with diabetes.  
 
So can these theoretical models translate into real changes in behaviour? The answer should 
not necessarily be framed in terms of changing behaviour, but  rather in terms of  facilitat ion 
and support. Recent ly in the UK there has been increased interest  in exploring ways in which 
pat ients themselves can achieve health-related goals in partnership with health care 
professionals. The patient empowerment model is based on the pioneering work of  Dr. Bob 
Anderson and Martha Funnell at  the University of Michigan. At the heart  of the patient  
empowerment model is the concept  that health care providers listen to, and collaborate with, 
pat ients.  As Funnell wrote,  
 
"Within this model, our role is not to change our patients’ behaviours,  but to inspire, 
inform, support, and facilitate their efforts to identify and attain their own goals . . ." 
(Funnell 2004)(p.202)   
 
The Department of Health in the UK has supported this concept of empowerment on a 
number of different levels:  national service frameworks, national policy and support for local 
init iatives which empower people to take responsibility for their health. 
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3.7.2. National Service Frameworks 
 
The National Service Frameworks (NSFs) of relevance to this review are the NSF for Diabetes 
(2001) and the NSF for Long-Term Conditions (Department of Health 2005a).  
 
I nterestingly, the concept  of empowerment is not overtly recognised or discussed in either of 
these documents, despite the Department’s assert ion that ‘patient empowerment is at the 
heart of the government 's plan to modernise the National Health Service’ (Department of 
Health 2000). I n spite of this, recognisable support for this underlying philosophy is promoted 
in the NSF for Long-Term Conditions (2005) as Quality Requirement One is termed: A Person-
Centred Service. However there is no evidence in this document of practical ways in which 
pat ients can be empowered to take control of their condition.  
 
The NSF for Diabetes (Department of Health 2001b) is a litt le more explicit and explains that  
 
“The aims will be to empower people with diabetes through skills, knowledge and 
access to services to manage their own diabetes and fulfil their potential to live long 
lives free of the complications that can accompany diabetes”  (Department of Health 
2001b)(p.14) 
 
3.7.3. Other national policy documents 
 
Other national policy documents are more encouraging. I n 2004, the White Paper ‘Choosing 
Health’ was published (Department of Health 2004). This publicat ion set out the key 
principles for support ing the public to make more healthy and informed choices with regards 
to their health. I nformation and practical support to get people motivated and improve 
emotional wellbeing and access to services were included. I nterestingly there were few 
references to self-care or self-management within the 207 page document. Two pages 
highlight the success of self-care approaches in managing long-term conditions but  
confusingly appear to use the terms ‘self-care’ and ‘expert patient ’ interchangeably. 
 
“ I n recent years there has been growing evidence of the success of the ‘self-care’ or 
‘expert  patient’ approaches to people when they are ill. This approach helps people to 
learn more about their own illness, and how to manage it effectively without  always 
depending on professionals for support. I t  helps to put  patients in control of their 
plans for how they manage their own disease.”  (Department of Health, 2004) (p.111) 
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The term ‘expert patient’ is clearly a misnomer and this inappropriate label was discussed on 
a radio programme entit led ‘The Expert Patient’. Joanne Shaw, Director of the Medicines 
Partnership, spoke for many by saying that   
 
“ the ‘expert  patient’ is a difficult term and it certainly is one that's caused some 
barriers within the NHS and with doctors. Our view is that the term ‘involved patient’ 
is possibly a better one”. (Joanne Shaw, Director of the Medicines Partnership talking 
on BBC Radio 4 broadcast, 11 August 2005)  
 
Whether the term ‘expert patient’ or ‘involved pat ient’ is used, the Department of Health has 
discussed the need to extend this approach into prevention of ill-health, enabling people to 
take greater control of their condition and enabling them to plan for their health on their own 
terms. 
 
An interesting init iative based on this philosophy is the development of a personal health 
guide called HealthSpace. This is a secure personal health organiser on the internet 
(www.healthspace.nhs.uk). People can record personal information and preferences in 
HealthSpace and make decisions on sharing information with the professionals who organise 
their care. Figure 3.8 shows the type of information which can be accessed and inputted.  
 
Figure 3.8:  I nformat ion in an HealthSpace account  
• access to NHS information services;  
• graphical presentation of variable personal data (weight, height , dietary intake, smoking, 
alcohol intake, blood sugar levels, peak flow readings;  immunisation log and reminder 
service;  
• location maps for NHS services;  
• access to ‘Choose and Book’ service 
 
I t was launched in 2003, although data on the number of users are not available. However a 
spokesperson for NHS Connect ing for Health said, in March 2009, that it  was hoping to sign 
up 4 million pat ients by 2014. I t was hoped that the new communicator tool on Healthspace 
would enable patients to carry out e-mail consultations with GPs and other clinicians. 
Although the scheme had originally been given the go-ahead for launch in 2009 (cost ing 
£80m) pat ients have recently been invited to give their views on the future development.  An 
online survey in July 2009 www.healthspace.nhs.uk asked patients to give their views on 
what functionality they would find useful and how often they would be likely to use such 
features. 
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The long term aim for the portal is to provide patients with a secure way of accessing their 
transactions with the NHS from anywhere in the world. Pat ients will be able to view their 
‘Summary Care Record’, see the results of tests and letters sent  about  them, make GP 
appointments and order repeat  prescriptions. The future of this scheme now seems 
uncertain. 
As part of the implementation of  the NSF for Long-Term Conditions, an NHS and Social Care 
Model to support local innovation was published (Department of Health 2005c). This report  
said:  
  
“Health and social care providers will need to develop appropriate and accessible 
information, skills training and tools and equipment in order to empower patients and 
their carers to maximise their role as providers of  care.”  (Department of Health 
2005c) (p.31) 
“By increasing the amount of informat ion available to patients, health and social care 
providers can empower them to take better care of themselves and their own 
conditions.”   (Department of Health 2005c) (p.32) 
This report contains practical details about how to empower patients with knowledge of their 
condition and recommends local initiatives such as the Expert Patient  Programme (EPP) to 
develop generic self-care skills. Disease-specific programmes such as Dose Adjustment for 
Normal Eating (DAFNE) and Diabetes Education and Self-Management for Ongoing and Newly 
Diagnosed (DESMOND) for diabetes are also recommended. The EPP, DAFNE and DESMOND 
education programmes will be discussed later in this review.  
 
I n January 2006, the Health Secretary announced the publication of a White Paper (WP) “Our 
health, our care, our say:  a new direction for community services” (Department of Health 
2006). 
 
The National Diabetes Support Team (NDST) which helps support the implementation of the 
Diabetes NSF by working with local services to improve diabetes care, commented that the 
principles at  the heart of the WP go right  back to the NHS Plan and are aimed to accelerate 
the move into a new era where ‘the service is designed around the pat ient rather than the 
needs of the patient being forced to fit around the service already provided’ (Department of 
Health 2006)(p.1).  
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The whole focus of this WP is to put patients at centre-stage in designing health services and 
place them as equal partners in the provision of care through promotion of the self-
management philosophy. The emphasis is on supporting self-care, promoting well-being and 
community engagement, as well as prevent ion and early intervention. The WP recommended 
a number of areas for consideration:  the topic of most  significance to this review is ‘Support 
for people with longer-term needs’.  
 
3.7.4. Supporting self-care 
 
“People will be supported to take better control of their care and condition through a 
wide range of initiat ives. These include a major new focus on self-care and self-
management.”   (Department of Health 2006)(p.112) 
 
The WP stated that a comprehensive framework with guidelines on developing local 
strategies to support self-care for people with long-term conditions will be published by the 
Department of Health in due course. Examples of changes to current provision include an 
increase in capacity to deliver the EPP from 12,000 course places a year to over 100,000 by 
2012. There was also emphasis on engaging general practice in self-care. I t was proposed 
that the Government would seek to ensure that pract ices use the information in their QOF 
(Quality and Outcomes Framework) registers to effectively commission services that  support  
self-care for pat ients with long-term conditions.  
 
There is the possibility that people with diabetes will benefit from these initiatives, perhaps 
most  importantly where the General Services Contract (GMS) contract will increasingly 
contain requirements to support  people in self-care. Practit ioners will offer patients real 
involvement in planning their own care, whilst  increasing access to the EPP has the potential 
to reap enormous benefits.  
 
Overall the use of self-management programmes in chronic disease is developing, and some 
of these programmes are beginning to show success (Chodosh et al. 2005).  Unfortunately 
there is “a lack of empirical evidence about the essent ial elements of such a program”  
(Chodosh et  al. 2005)(p. 436).  I n a systematic review, (Boren et  al. 2007) found evidence of 
the benefits of educational self-management intervent ions for reducing risks for diabetes. 
Boden et al (2007) stated that “ future research should include intervention studies on 
diabetes risk reduction where evidence is lacking, such as diabetic nephropathy.”  (p.1075) 
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3.7.5. The Expert  Patient Programme 
 
The Expert Patient Programme (EPP) is a NHS-based t raining programme that provides 
opportunit ies to people who live with long-term chronic conditions to develop new skills 
to manage their condit ion better on a day-to-day basis. Set up in April 2002, it is based 
on research from the US and UK over the last  two decades which shows that people 
living with chronic illnesses are often in the best posit ion to know what they need in 
managing their own condition (www.expertpatients.nhs.uk). The EPP is one among a 
range of new policies and initiat ives to modernise the NHS to emphasise the importance 
of the patient in the design and delivery of services.  
Examination of the evidence shows that this type of self-management can potent ially be 
beneficial for those with diabetes.  Evaluation is ongoing in many centres but evaluation data 
from approximately 1000 EPP part icipants who completed the course between January 2003 
and January 2005 in the UK (Department of Health 2005) indicated that  the programme was 
achieving its aims in:  
 
a. Providing significant numbers of people with long term conditions with the confidence and 
skills to bet ter manage their condit ion on a daily basis:  
 
Pat ient self-reported data were showing 
• 45% more confident that they would not let  common symptoms 
(pain, t iredness, depression and breathlessness) interfere with their lives. 
• 38% felt  that such symptoms were less severe 4 – 6 months after complet ing 
the course. 
• 33% felt  better prepared for consultations with health professionals 
 
b. Providing significant reductions in service usage by people with long-term conditions 
completing the EPP course:  
 
Pat ient self-reported data were showing 
• 7% reduct ions in GP consultations 
• 10% reductions in outpatient visits 
• 16% reductions in A&E at tendances 
• 9% reduct ions in physiotherapy use 
 
A local EPP for those with kidney problems was developed by me, my colleagues and pat ients 
in the renal unit. Courses for 10-12 participants ran in April 2005, March and June 2006. 
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Evaluation was only anecdotal, but the words of one participant suggest the potential impact  
of these programmes:  
 
“ I  feel 100%  bet ter in my attitude and outlook and am proud of what I  have 
achieved”  
 
Since the time when this literature review was first undertaken, there have been 
developments in the Expert Patient Programme. The Health Foundation are now funding a 
new initiative called ‘Co-creating Health’, whereby self-management programmes, including 
those for people with diabetes, are being evaluated by the University of Coventry (Health 
Foundation 2008). Results are awaited. 
 
A two arm, patient level, randomised controlled trial (RCT) and economic analysis has been 
carried out by the National Primary Care Research and Development Centres at Manchester 
and York Universities in partnership with Bristol University. The RCT involved 629 part icipants 
in England with self-defined long-term condit ions, who were randomised to either the EPP 
course or to a waiting list for the course. Patient outcomes were measured at six months.  
Results showed that the EPP increased patients' self-efficacy by a moderate amount, and had 
a relatively smaller impact on the amount of energy people reported (chosen as the health 
status outcome most relevant to people with a range of long-term conditions)(Kennedy et al. 
2007).  
 
There was no change in health services ut ilisat ion (sum of GP consultations, practice nurse 
appointments, A&E at tendances and outpatient visits)  although overnight  hospital stays and 
use of day-case facilit ies were reduced in the EPP group. There were small gains in secondary 
outcomes including psychological wellbeing and partnerships with doctors. There was high 
satisfaction with the course and particularly the experience of being in a group. The authors 
concluded that the EPP is likely to be a useful addition to current chronic disease 
management provision (Kennedy et al. 2007). 
 
A systematic review (Foster et al. 2007) into lay-led self-management education programmes 
found that they could lead to small, short-term improvements in participants’ self-efficacy, 
self-rated health, cognitive symptom management and frequency of aerobic exercise. 
However the review found that there was no evidence to suggest that such programmes 
improve psychological health, symptoms or health-related quality of life. The authors of this 
review suggested that further research was needed into clinical and longer term outcomes 
arising from such programmes.   
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3.7.6. Health-care professionals and empowerment 
 
 Although a self-management approach has shown some benefits in chronic disease 
management, there is evidence that  health professionals are not necessarily promoting an 
empowering ideology. I n 1999, a survey of 200 doctors was undertaken by the Associat ion of 
the British Pharmaceut ical I ndustry (ABPI  1999). The survey found that only 21 per cent of 
doctors were in favour of the idea of ‘Expert Patients’. 58 per cent  thought it would increase 
workload and 42 per cent  thought it would increase NHS costs. Only 24 per cent thought the 
EPP would lead to better health outcomes and 37 per cent  thought it would lead to 
deterioration in the doctor-patient  relationship.  
 
I t could be argued that  the results of this survey are now outdated and many health care 
professionals are beginning to support the concept of self-management. The Brit ish Medical 
Association (BMA) conducted a review into the EPP, because it believes that self-management 
of long-term condit ions is a crucially important issue for the NHS and the medical profession 
(British Medical Associat ion 2005). 
 
At the same time, diabetes educators are being encouraged to develop behaviourally based, 
effective education programmes (Funnell and Anderson 2004). However it could be argued 
that although clinical specialists are well-placed to provide the content of these programmes 
they do not have the necessary skills to deliver this approach. I t appears that minimal 
research concerning the actual process of providing such programmes to patients has been 
carried out (Arnold et al. 1995).  
 
One important topic for patients with diabetes and health care professionals alike is how far 
pat ients are enabled to take control of insulin requirements on a daily basis. Many hospital-
based services do not allow patients to vary their insulin dose. However one study (Howorka 
et al. 2000) investigated short- and long-term effects of structured outpatient education on 
perceived control over diabetes and related health beliefs. A four-week study with 32 
part icipants, and a 3 year uncontrolled pilot study with 68 participants, were performed. The 
programme focused on an individual’s choice of insulin dosage. I n the three-year study, 
part icipants were increasingly freed from the feeling of being under the control of physician 
and treatment-related restrictions which together, with higher perceived self-efficacy, 
contributed to the feeling of empowerment. Other outcome measures were not  included in 
the study. 
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The conflict in roles for physicians and nurses implement ing empowerment group educat ion 
(EGE) in diabetes was investigated (Adolfsson et  al. 2004). After implementing the 
‘empowerment approach’, in two groups of patients with Type 2 diabetes, they were asked 
after three to nine months to evaluate the EGE. The authors asserted that the physicians and 
nurses were comfortable in their traditional role but not with the empowering approach. They 
needed to grow into this role as it had changed from being an expert to being a facilitator, 
and asserted that as experts they felt secure;  as facilitators they needed support in their 
educational process.  
 
This assertion was supported by another study group (Cooper et al. 2003) who found that  
whilst patients can be educated toward greater autonomy, not all health professionals are 
ready to work in partnership with them. I t highlighted the importance of clinical staff not only 
gaining a bet ter understanding of diabetes management, but also of the theoretical principles 
underlying patient empowerment.  
 
Some practit ioners might argue that empowerment is defined in different  ways and therefore 
they find it difficult  to practise in a consistent  way. However, there seems to be commonly-
accepted constituents of ‘empowerment’, namely that  people are encouraged to participate 
as equal partners in decisions about the health care they receive and health care 
professionals respect patients’ abilit ies to make decisions, value their input in such decisions, 
and are able to relinquish control when a patient rejects their advice (Chapman 1994). 
  
So it cannot be that health professionals do not simply understand what the concept is. I t  
could be that  commit ting to its principles and philosophy is rather more difficult. I t is possible 
that some health care professionals are not  able to ‘let go’ and are unable to facilitate rather 
than ‘control’ (Cooper et al. 2003). These authors concluded that  whilst education can 
empower pat ients to take on greater responsibility for the management of their disease, they 
cannot  achieve long-term success without the co-operat ion of health professionals who can 
support and facilitate achievement of patients’ goals. 
 
3.7.7. Summary 
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This section on societal beliefs about health has described the significant theories and models 
that underpin the practice of health educat ion with respect to diabetes mellitus. Despite a 
plethora of literature that attempts to evaluate the use of the models in explaining health 
behaviour in diabetes, there appears to be litt le consensus on whether these models are of 
value in practice.  
 
The notion of empowerment however is becoming increasingly accepted as a positive way to 
change behaviour through patient involvement and support . National policy appears to 
consistently support this view, although there is litt le convincing data that  shows improved 
pat ient outcome as a result of empowering interventions. I t is possible that there is a 
mismatch between what is written about empowering pat ients and what is actually practised 
by health care professionals. Clearly any new intervent ion which is based on an empowering 
philosophy requires careful and consistent  investment in staff education and training. 
 
3.8. Organisational system 
 
3.8.1. I ntroduction 
 
A central question in the debate about pat ient educat ion is how far the health care system 
can influence patient outcomes. The educational system in healthcare is diverse and 
sometimes ‘ad hoc’. I t ranges from individual consultat ions and interactions with a variety of 
health care professionals, through group education sessions to self-help groups and 
charitable advisory services. Of course much information ‘learnt’ by patients with a long-term 
condition is serendipitous – casual learning whilst waiting in out-pat ient clinics or as an in-
pat ient. Learning also takes place through a variety of media, such as television, radio, or the 
internet.  
This section will explore the effect of formal education provided by the health care system on 
pat ient outcomes, focussing on patients with diabetes. Literature pertaining to the 
educational systems for diabetes such as the environment, the effect of the social context  
and the effect of the condition itself will be discussed here. 
 
3.8.2. Environment 
 
Only one review that  evaluated the environmental impact on educational intervention and 
outcome was identified (Norris et  al. 2002b). The authors reported the results of a systematic 
review into the effectiveness and economic efficiency of self-management educat ion in a 
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variety of set tings. The review concluded that  education is more effective in community-
gathering places for adults with Type 2 diabetes, yet can be effective in the home for 
adolescents with Type 1 diabetes. 
 
Evidence was insufficient to assess whether self-management programmes at work or at  
summer camps were more effect ive for either people with Type 1 or Type 2 diabetes or in 
the home for people with Type 2 diabetes. The quest ion is whether it  is the positive effect of 
having other people with the same condition sharing the experiences which promote learning, 
or whether it is the environment alone. 
 
 
3.8.3. Social Context  
3.8.3.1. Social support  
 
A systematic review of literature which assessed how far family interventions are effective in 
improving outcomes in people with diabetes and family members (blood or non-blood 
relatives) residing in their homes was carried out (Armour et al. 2005). The search identified 
19 randomised controlled trials. Positive effects of family interventions on knowledge were 
demonstrated in five studies and on glucose control (HbA1c) in eight studies. The conclusion 
was that family support  and advice for people with diabetes may be effective in improving 
diabetes-related knowledge and glycaemic control. 
  
The positive ef fect of social variables on learning has been identified by a number of studies 
(Gleeson-Kreig et al. 2002). However, it  is well-recognised that social support  is not a simple 
variable which can be easily quantified, but rather a multi-dimensional concept , which has 
been described primarily according to three characterist ics:   
 
(a)  the structural aspects of the support (who) 
(b) the functional types of assistance (how) 
(c) the nature of the support (what , where) (Vrabec 1997) 
 
So when studying the effect of good/poor social support on diabetes education, the different  
aspects of social support must  be taken into account. One Japanese study (Fukunishi et al. 
1998) examined the influence of social support (measured by perception and utilisation) on 
178 patients with diabetes mellitus. They concluded that although diabetes education is 
effective for decreasing HbA1c, a combination of two social supports (perceived and utilised) 
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decreases the HbA1c value, independent of diabetic education. This makes comparison 
between studies difficult.  
 
Socio-economic status can also play its part. I t is well accepted, and supported by one study 
(Kumari et al. 2004), that an inverse relationship exists between social posit ion and incidence 
of diabetes, that can only be partly explained by health behaviours and other risk factors. But  
the quest ion under review here is not just concerning the effect of socio-economic status on 
incidence, but  rather how far self-management can be affected by social standing.  
 
A review of the development of diabetes self-management programmes in under-served and 
minority populat ions has been carried out  (Eakin et  al. 2002). The review identified five 
formative evaluations and ten controlled intervention t rials focusing on under-served (low-
income, minority or aged) populat ions. The authors evaluated the methodological quality of 
the articles and found them to be generally good. Although they found that  short-term 
reporting of behavioural outcomes was encouraging, data on implementation of the 
programmes were almost  never reported. They concluded that ‘the promising formative 
evaluation work that has been conducted needs to be extended for more systematic study of 
the process of intervention, implementation and adaptation.’ (Eakin et al. 2002)(p. 26) 
3.8.3.2. Culture 
 
Much is written about  how cultural issues need to be taken into consideration when 
implementing diabetes education programmes. One study (Chowdhury et  al. 2000) 
emphasised the importance of considering culture when designing health educat ion 
messages. They suggest that dietary advice should reflect religious restrictions, ethnic 
customs and the different cultural meaning of particular foods.  
 
Cultural beliefs in the West I ndian community have been explored (Scott 2001), but no 
evidence that cultural beliefs or practices conflicted with medical advice was found. However, 
the West I ndian interviewees stated that  the dietary advice provided did not take into 
account  their traditional foods or cooking methods. More importantly, the subjects expressed 
a general distrust  of doctors, the majority having developed a range of strategies which they 
used to negot iate consultat ions with doctors and the heath service. I t is this aspect of belief 
which is strangely absent in the literature. Despite rigorous searching there was litt le strong 
evidence to suggest that cultural belief had a deleterious effect on outcome in diabetes.   
 
The question of how far culture-specific education programmes make a difference to outcome 
is not well evaluated in the literature. For example, one study from the Netherlands (Uitewaal 
et al. 2004) described a specific programme for Turkish people with diabetes, and reported a 
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41%  drop-out from the course of 54 patients. The only explanation was that most of the 
part icipants did not finish the course because they were travelling back to their country of 
birth. 
 
Another programme specifically for Bangladeshi people in East London (Griffiths et al. 2005) 
was implemented and evaluated by comparing with a control group. The study aimed to 
determine the effectiveness of this culturally-adapted lay-led self-management programme 
for Bangladeshi adults with chronic disease. The findings showed that a culturally-adapted 
self-management programme could improve self-efficacy and self-care behaviour in this 
group, although the effects on health status were marginal. Benefits were limited by 
moderate uptake and attendance (34% out of 1363 invited agreed to take part). The 
challenge of improving uptake of self-management programmes, especially in so called ‘hard-
to-reach’ groups, remains difficult to overcome.  
  
Kidney Research UK started a project in 2004 whereby ‘peer educators’, who are active 
members of their community and representative of the diverse religious and cultural sub 
groups, were trained in health promotion matters and received extra training in renal health. 
Through the ABLE (A Better Life through Empowerment) programme, peer educators, with 
supervision and guidance from the project team, delivered imperat ive messages in a 
culturally sensitive manner, with a good knowledge of the needs, attitudes and experiences 
of their audience. This programme is still being evaluated in terms of outcome, although 
init ial findings have shown posit ive feedback from participants, increased knowledge and 
evidence of positive lifestyle change (Jain et al. 2008).  
 
A systematic review (Hawthorne et al. 2008) into ‘culturally-appropriate’ diabetes health 
education concluded that education specifically for people from a variety of different ethnic 
groups appears to have short  term effects (3-6 months) on glycaemic control and knowledge 
of diabetes and healthy lifestyles. The definition of ‘culturally appropriate’ however does 
further discussion. I n the Hawthorne review it was taken to mean any programme which was 
developed specifically for people from an ethnic minority, rather than a programme which 
was underpinned by a specific culture’s health beliefs and values.  
 
I t was disappointing that few research projects which evaluated the effect of cultural beliefs 
about diabetes could be found. I n my clinical experience and as found in the patient  
interviews (see section 4.16), it is often fatalistic beliefs (‘only God can decide what happens 
to me’) or beliefs about body size (being overweight is a sign of affluence) which have a 
strong impact on behaviour. These variables need to be researched in more depth in relat ion 
to changing behaviours in care of people with diabetes. 
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3.8.3.3. Literacy 
 
Few studies were found which rigorously examined the interventions that could improve 
outcomes for patients with low literacy. The impact of low literacy skills on the effectiveness 
of a comprehensive disease management programme for patients with diabetes have been 
invest igated by (Rothman et al. 2004).  217 patients with Type 2 diabetes and poor 
glycaemic control (HbA1c ≥8.0%) were included in their study. Each of these patients with 
low literacy were either given intensive disease management from a multidisciplinary team or 
offered an init ial management session and continued with usual care (control group).  
 
The intensive management group received education from three clinical pharmacist  
pract it ioners (two were certified diabetes educators). The intervent ion included (1) one-to-
one educational sessions (2) application of evidence-based t reatment algorithms (3) help with 
pract ical aspects such telephone reminders, transportat ion, and insurance. Patients were 
contacted by telephone or in person every 2 to 4 weeks (more frequently if indicated). 
Communication to patients was individualised - verbal education with concrete, simplified 
explanations, “ teach-back” to assess patient comprehension and picture-based materials. 
Outcome measures were HbA1c levels and systolic blood pressure at 12-months. Although 
pat ients receiving the intervention were more likely than pat ients in the control group to 
achieve HbA1c levels of < 7.0%, (p= 0.02), patients with higher literacy had similar odds of 
achieving goal HbA1c levels regardless of intervention status.  
 
Unfortunately there are few other studies which have tested an intervention for patients with 
low literacy. These findings are from a small cohort with perhaps expected results. Yet the 
intervention requires extensive input  with regard to expertise, time and of  course, mot ivat ion 
from the participants. The debate is whether health care professionals can eradicate the 
inequality in outcome between those who are literate and those who are not . 
 
3.8.3.4. Age 
 
Only two reviews which evaluated the effect of age on ability to self-manage diabetes were 
found. One review (Asimakopoulou and Hampson 2002) concluded that cognitive impairment 
is not associated with clinically significant impairment on self-management tasks. They 
cautiously suggested that  older people with diabetes can be reassured that  ‘even if diabetes 
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is associated with some modest cognitive decline, this decline in itself is unlikely to endanger 
their ability to self-manage their illness.’ (Asimakopoulou and Hampson 2002)(p. 116)  
 
Adolescents’ views on the acceptability and design of a diabetes educat ion programme have 
been studied (Waller et al. 2005). The authors found, through a focus group analysis, that  
young people preferred to use electronic reference materials, and more importantly that  
education should always be enjoyable. The focus group participants (n= 24) recommended 
fun and practical educational sessions and that educat ion should sometimes be held away 
from the hospital or clinic setting. 
3.8.3.5. Gender 
 
Hawthorne and colleagues studied over one hundred British Pakistani women within a larger 
randomised controlled trial of two hundred patients with diabetes of Pakistani origin 
(Hawthorne 2001). The trial used one-to-one structured diabetes health education, delivered 
by a link worker with pictorial flashcards as a visual aid. Earlier published results from this 
study have shown that the women in the study knew less about diabetes and had poorer 
glycaemic control than men, which is why this assessment was performed to see what 
happened to them when they received appropriate health education. All pat ients were 
assessed before, and six months after intervention by HbA1c blood tests to measure their 
overall blood sugar control. Nearly everyone improved their knowledge scores after 6 months 
in the intervention group, with women showing a significant catch-up improvement such that 
they equalled men in HbA1c outcomes.  
 
What is not  clear however, is how far literacy or language had an impact. Was it the pictorial 
flashcards which made a difference (women may learn best with visual images) or was it that 
prior education had been given by written or verbal education only (these women did not  
have English as their first language)? What could be concluded is that women may learn in 
different ways from men, and this has to be considered when developing educat ion 
programmes. 
 
3.8.4. Diabetes mellitus and cognitive function 
 
Although the impact  of the illness on learning could not  necessarily be described as an 
organisational variable, issues concerning the possible barriers to learning brought about by 
the disease process are highly pertinent t o the debate. I t was decided to include the sect ion 
on the disease process here, rather than in the following section on pat ients and 
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pract it ioners. This is because the condition of diabetes itself (altered cognit ive function for 
example) can impact on learning, and therefore should subsequent ly shape the organisat ion 
of the educational intervent ion. 
 
Both chronic hyperglycemia (Ryan and Williams 1993), recurrent episodes of severe 
hypoglycemia (Deary, 1993) and the subsequent occurrence of the complications of diabetes 
(Ferguson et  al. 2003) are thought  to be associated with cognitive dysfunct ion in pat ients 
with diabetes. I n a meta-analysis (Brands et al. 2005) of 33 studies on the effects of 
cognitive function in Type 1 diabetes, the authors concluded that cognitive dysfunction in this 
group is characterised by a slowing of mental speed and a diminished mental agility. They 
hypothesise that learning and memory are not necessarily affected, but go on to suggest  that  
even mild forms of cognitive dysfunction might  hamper everyday act ivities.   
 
I t appears that from the outset of any learning process, patients with diabetes may have 
challenges with regard to the mental agility that is required for processing information. 
Clearly this has implications for the teaching method and media – it is possible that ‘bite-size’ 
chunks of information delivered in an uncomplicated way would be most beneficial. 
 
3.8.5. Summary 
 
This section has reviewed the organisational issues that can affect educational interventions 
in diabetes care. I nterestingly this is one area that appears to have a deficit in terms of 
evaluative research. Quest ions relating to whether individual or group education has a better 
outcome; and who can get the most effective message across when teaching about diabetes;  
remain unanswered. What has been seen is that  any educat ional intervention has to take into 
account  the possible barriers to learning, such as poor family support , and that any 
educational programme should ensure that learning and teaching materials are appropriate in 
terms of culture, age and gender. 
 
3.9. Patients and practitioners  
 
3.9.1. Context  
 
The NSF for Diabetes (2001) recognised that the provision of  information, educat ion, and 
psychological support  that facilitates self-management is the cornerstone of diabetes care. 
The NSF set  primary care trusts (PCTs) the task of providing ‘empowering education’ by 
March 2006. But it is likely that PCTs were already well-behind with the identified timeframe, 
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with the Department of Health report (2005) on structured patient education in diabetes 
citing three national programmes that meet the key criteria for diabetes education. Of these, 
DESMOND was only ready to start implementation of courses at  the end of 2005. 
 
A review of the three national programmes for diabetes educat ion now follows.  
 
3.9.2. DAFNE 
 
The Dose Adjustment for Normal Eating (DAFNE) study was originally carried out as a 
randomised controlled trial in three centres (DAFNE study group 2002). Outcomes were 
measured by glycated haemoglobin (HbA1c) and quality of life. DAFNE has since been 
successfully rolled out to centres in the United Kingdom. I t is a skills-based structured 
education programme in intensive insulin therapy ( I IT) delivered by specially trained diabetes 
specialist nurses and diet it ians. The course is taught in groups of 6-8 over a consecutive 5-
day period on an outpat ient basis. 
 
The main principles of the DAFNE course are:  
 
•  Skills based t raining to teach flexible insulin adjustment to match carbohydrate in a 
free diet on a meal-by-meal basis. 
•  Emphasis on self-management and independence from the diabetes care team. 
•  Use of adult education principles to facilitate new learning in a group setting. 
 
The course consist s of three main topic areas:  nutrit ion;  insulin dose adjustment at mealtimes 
and special circumstances (exercise, illness);  other topics such as hypoglycaemia and 
complicat ions of diabetes. An evaluative economic study by the York Health Economics 
Consort ium showed that reduced complicat ions meant that DAFNE pays for itself within 5 
years (DAFNE study group 2002).  
 
The course was evaluated with a randomised design with participants either  attending 
training immediately (the immediate DAFNE group) or act ing as controls (the delayed DAFNE 
group) and attending t raining 6 months later (DAFNE study group 2002). 169 adults with 
Type 1 diabetes and moderate or poor glycaemic control took part. Outcome was measured 
by glycated haemoglobin (HbA1c), and at 6 months, HbA1c was significant ly bet ter  in 
immediate DAFNE patients (mean 8.4%) than in delayed DAFNE patients (9.4%) (p< 0.0001). 
The authors concluded that  skills training that  promotes dietary freedom  improves the quality 
of life and glycaemic control in people with  Type 1 diabetes without worsening severe 
hypoglycaemia or cardiovascular risk (DAFNE study group 2002).  
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3.9.3. DESMOND 
 
The Diabetes National Service Framework (NSF) (Department of  Health 2001b) and the NICE 
technology appraisal of patient-education models for diabetes (National I nst itute for Health 
and Clinical Excellence 2003) make it clear that pat ients with Type 2 diabetes need to be able 
to access structured education programmes as well as those with Type 1 diabetes. The 
Diabetes Education and Self-Management for Ongoing and Newly Diagnosed (DESMOND) 
programme is for people with Type 2 diabetes. The programme was piloted in 15 Primary 
Care Trusts in England in 2004, and was subject  to reflection and revision following feedback 
from all those participating in the pilot process.  The second version of the programme has 
been the subject of a randomised control trial of 1000 patients taking place in selected PCT 
sites in England and Scotland (Davies et al 2008a).  
 
The programme has the following characteristics:  
 
• I t provides 6 hours of st ructured group education according to a formal curriculum 
• Groups consist of 6-10 people newly diagnosed with Type 2 diabetes  
• Each person attending a group can choose to be accompanied by a partner, family 
member or friend 
• Each person attending a group is provided with patient  material especially developed 
to accompany the programme and intended as a reference guide subsequent t o 
attending the course 
 
The programme is delivered by two healthcare professionals who:  
 
• Have at tended a two-day initial formal training programme to graduate as DESMOND 
Educators 
• Will submit to a quality assurance programme in the first year of ‘graduating’, and 
subsequently every three years 
• Will use defined resources to deliver the programme 
• Will deliver 5 courses annually to maintain competency as a DESMOND Educator 
 
When this literature review was first written, results from the programme evaluation were not 
available. However a large cluster randomised controlled trial, to measure the effect and 
duration of the intervention, involving 170 subjects had commenced. The primary outcome 
was HbA1c at 12 months, whilst  secondary outcomes included:  BP; lipids;  BMI ;  and waist 
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circumference at  4, 8 and 12 months. Patient  well-being quest ionnaires were also being used 
at the same time intervals and a health economic quest ionnaire was also to be implemented 
at 12 months.  
 
Results were subsequent ly published in 2008 (Davies et al. 2008). I t was found that the 
DESMOND programme resulted in improvements in weight loss and smoking cessation and 
positive improvements in beliefs about illness but no significant  difference in HbA1c levels up 
to 12 months after diagnosis. These results were disappoint ing but may be due in part to the 
limitations of HbA1c as an outcome measure as reported by the research team (Davies 
2008). I t is possible for example that  people newly-diagnosed with diabetes have lower 
baseline levels of HbA1c than those who have had diabetes for some time, therefore 
reductions in HbA1c as a result of the DESMOND programme might  not be significant.  
 
3.9.4. X-PERT 
 
The diabetes X-PERT Programme was designed in conjunct ion with patients and a local 
branch of Diabetes UK. I t is a six-week group education programme based on the theories of 
pat ient empowerment and patient activation. The programme has been evaluated by means 
of a randomised controlled trial involving 314 participants (Deakin et al. 2006). 
 
The control group received routine treatment, individual appointments from the GP, practice 
nurse and dietit ian. Each X-PERT session used visual aids to explore health issues related to 
diabetes and each participant  received a copy of their own health results with an explanation. 
The X-PERT Programme aimed to increase knowledge, skills and confidence so that  
individuals were able to make informed decisions regarding their diabetes self-management. 
Part icipants were then encouraged to set goals based on a five step empowerment model 
developed by Anderson and Funnell at  the Michigan Diabetes and Training Centre, USA 
(Anderson et al. 2000). 
 
Highly significant statistical differences were found in favour of the X-PERT Programme for 
biomedical, lifestyle and psychosocial outcomes. The participants assigned to the X-PERT 
programme had significantly improved diabetes control, a reduced requirement for diabetes 
medication, clinically important reductions to blood pressure and a three centimetre reduct ion 
in waist  circumference. They had improved diabetes self-management skills, increased 
physical act ivity levels and were enjoying a healthier diet. Quality of life had improved 
through freedom to eat and drink and enjoyment of food. Self-empowerment scores had 
significantly improved (Deakin et al. 2006).  
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As discussed, there are a number of nationally recognised educational interventions for those 
with diabetes in the UK, although evaluation in some studies has only identified increased 
satisfaction and not always a benefit in controlling glycaemia.  
 
Each of these programmes uses an educat ional method whereby patients come together in 
groups to learn from each other. I t is recognised however that other variables in learning and 
teaching method can impact on the outcomes. I t is possible that patient-preparedness when 
visiting for t radit ional consultations, interactive learning through DVD or CD-ROM, or by 
consultation over the internet  (telemedicine) could also be beneficial.  
 
3.9.5. Patient-preparedness  
 
Another consideration is how far patients need to be prepared for visiting a doctor or nurse in 
a traditional consultation. A systemat ic review (van Dam et al. 2003) was undertaken to test  
the effects of modification of provider-patient  interaction and provider consulting style on 
pat ient diabetes self-care and diabetes outcomes. The authors came to a tentat ive conclusion 
that focusing on pat ient  behaviour (such as enhancing patient part icipation in a consultat ion)  
is more effective than focusing on health professionals to change their consulting style into a 
more patient-centred one. The authors concluded that  trying to change health professionals’ 
behaviour is often hard to sustain and is not very effective in improving pat ient  self-care and 
health outcomes when executed alone.  
 
I t could be argued that outcome can only be improved when a true partnership between 
health professional and patient is init iated – even if patients know how to ask the right 
questions, they can surely only benefit if the health professionals have an open mind to true 
pat ient-centred care and empowerment 
 
A Mult idisciplinary Intensive Education Program (MIEP) (Keers et al. 2004), based on the 
empowerment approach, was developed to help patients obtain good glycaemic control and 
quality of life. The aim was to identify the ef fects of MIEP and it 's mechanisms of influence. 
MIEP consisted of 12 days of group-sessions and individual counselling. HbA1c measures and 
knowledge improved significant ly, whilst patients rated themselves healthier. Although this 
was just a pilot study it appeared that  MIEP benefited patients who had prolonged self-
management difficulties, and this form of care seemed to complement regular care. Although 
this type of approach may not be feasible or realistic for everyone, the importance of 
understanding why people may not find it easy to self-manage cannot be underestimated. 
 
3.9.6. Learning and teaching media  
 79
 
3.9.6.1. Telemedicine 
 
Telemedicine can be defined as the use of telecommunications technology for medical 
diagnosis and pat ient care when the provider and client are separated by distance (Currell et 
al. 2001). I ncreasingly this technique is being used in managing the care of people with 
diabetes.  
 
A Cochrane review (Currell et al. 2000) evaluated telemedicine versus face-to-face patient 
care, and also the effects on professional practice and health care outcomes. Seven trials 
involving more than 800 people were included in the review, with five of the studies 
concerned with the provision of home care or pat ient self-monitoring of chronic disease. The 
authors concluded that  although none of the studies showed any detrimental effects from the 
interventions, neither did they show unequivocal benefits and the findings did not constitute 
evidence of the safety of telemedicine. I n other words, establishing systems for patient care 
using telecommunications technologies is feasible, but  there is lit t le evidence of clinical 
benefits.  
 
Only two of the studies in the Cochrane review were concerned with diabetes management, 
and one of these evaluated paediatric care. Before dismissing telemedicine as a technology 
which does not necessarily have beneficial outcomes for patients with diabetes, it is important  
to review other papers. Two are of note. 
 
One paper (Farmer et  al. 2005) determined whether a system of telemedicine support could 
improve glycaemic control in Type 1 diabetes. They utilised a 9-month randomised trial and 
compared traditional glucose self-monitoring in a control group with an intervention group. 
The intervention group used phone-based feedback together with nurse-initiated support  
using a web-based graphical analysis of glucose self-monitoring. I n total, the intervent ion and 
control groups t ransmitted 29,765 and 21,400 results, respect ively.  
 
Findings showed a reduction in blood glucose levels between the two groups (p <  0.0001), 
although the reduction in HbA1c in the intervention group after 9 months was not statistically 
significant. The authors concluded that  telemedicine transmission and feedback of 
information about blood glucose results with nurse support is feasible and acceptable to 
pat ients. However to significant ly improve glycaemic control, access to real-time decision 
support for medication dosing and changes in diet and exercise may be required.  
 
I n a similar study (I zquierdo et  al. 2003) the researchers determined whether diabetes 
education could be provided as effectively through telemedicine technology as through in-
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person encounters with diabetes nurse and nutrit ion educators. A total of 56 adults with 
diabetes were randomised to receive diabetes education in person (control group) or via 
telemedicine and were followed prospectively. Similar changes in HbA1c were observed in 
both groups. Although these data suggest that telemedicine can be successfully used to 
provide diabetes education to patients, the authors asserted that there was no clear benefit 
in using a telemedicine approach. However using HbA1c as the sole hard end-point to 
evaluate the success of this initiative is perhaps misleading as patients only received three 
educational visits in both the control and the telemedicine group. As HbA1c measures longer-
term glycaemic control the effect may have been missed as only one HbA1c reading was 
taken 3 months after the intervention. 
 
3.9.7. Other interactive technologies  
 
The internet and read-only memory compact disks  (CD-ROMs) as supplements to, and 
extensions of, diabetes self-management education have been compared in an evaluative 
study (Glasgow and Bull 2001). A RE-AIM framework was used to consider how  different 
interactive technologies have been used to enhance the Reach, Effectiveness, Adoption, 
Implementation, and Maintenance (RE-AIM)  of interventions.  
 
One of the review authors’ own studies (Glasgow and Toobert 2000) compared a computer-
assisted, dietary goal-set ting intervention with normal practice, and found it to be moderately 
successful in producing dietary improvements but less so in producing HbA1c or quality-of-life 
outcomes. Another study (King et al. 2004) described the benefits and drawbacks of read-
only memory compact disks (CD-ROMs) to facilitate diabetes self-management,  using the 
experience from two efficacy trials with CD-ROMs as the primary modality for intervention. 
The CD-ROMs were designed to promote health behaviour change and prevent complications 
by increasing attention to diabetes care guidelines and providing tailored self-management 
plans to patients with Type 2 diabetes.  
 
A meta-analysis (Ellis et al. 2004) of randomised controlled trials of diabetes patient 
education published between 1990 and December 2000 summarises very well the discussion 
in this review. They identified which variables within an education intervention best  explained 
variance in glycaemic control. Twenty-eight educational interventions (n= 2439) were 
included in the analysis and meta-regression revealed that current patient education 
interventions only modestly improve glycaemic control in adults with diabetes. The 
interventions most likely to improve glycaemic control included face-to-face delivery, 
‘cognitive reframing’ teaching methods, and programmes with an exercise content.  
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3.10. Discussion 
 
The main aim of this chapter has been to examine the evidence to see to what extent patient  
education, specifically self-care or self-management programmes, can make a difference to 
pat ients with diabetes. The main flaw in drawing a finite conclusion has been the difficulty in 
comparing results that have been found from varying methodologies.  
 
Difficult ies in finding firm conclusions have also arisen because of differences in outcome 
measures. As suggested in the early part of this chapter, it is challenging to judge the size of 
the effect of the intervent ion, when results are based on very different reported outcomes. 
Some outcomes are measured by how well the participants evaluated the learning experience 
(were the facilitators friendly, were the learning resources easy to read), some are measured 
by change in knowledge (can participants explain what might happen with a low blood 
sugar), whilst some studies measure the transfer of learning into behaviour. With studies into 
diabetes, the most  common measurable outcome utilised by researchers, is the effect on 
HbA1c, although this too can have shortcomings.  
 
I t is likely that different  types of educational model and/or styles of teaching may suit 
different people in different  ways. Learning styles are often cited as being the most important  
attribute to assess before any learning plan or implementat ion of learning can take place. The 
four following learning styles have been suggested (Honey and Mumford 1982). See Figure 
3.9. 
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Figure 3.9:  Learning styles (adapted from Honey and Mumford, 1982) 
 
Act ivists  Like to be involved in new experiences. They learn best when involved in new 
experiences, problems and opportunities, and being thrown in the deep end 
with a difficult task. They learn less well when listening to lectures or long 
explanations, or reading, writing or thinking on their own. 
Reflectors They like to stand back and look at a situation from different perspectives.  
Reflectors learn best when observing individuals or groups at work but  learn 
less when acting as leader or role-playing in front of others, and doing things 
with no time to prepare.  
Theorists They like to adapt  and integrate observations into complex and logically sound 
theories. Theorists learn best when they are put in complex situat ions where 
they have to use their skills and knowledge, but they learn less well when they 
have to participate in situations which emphasise emotion and feelings.  
Pragmatists They like to try things out. They learn best when they have the chance to try 
out techniques with feedback. They learn less well when there is no obvious or 
immediate benefit that they can recognise, or there is no practice or guidance 
on how to do it.  
 
By thinking about a person’s preferred style, it  is possible that teaching and subsequent 
learning becomes much easier and quicker.  
 
3.11. Chapter summary 
 
This review identified some important conclusions about diabetes education, which in turn 
will inform the development of the education package.  
 
I t appears that  better outcomes can be achieved by face-to-face delivery of education. Group 
education has also shown some success although not  consistently. There is some evidence 
that educational interventions work best when tailored to individual circumstances (gender, 
age, ethnic group) although evidence for this assertion is patchy.  
 
The best medium by which the content is delivered is also inconclusive. Good results have 
been achieved with telemedicine, although long-term effects are not enduring. Similarly other 
findings suggest that the benefit of CD-ROMS in self-management programmes is not  always 
apparent. 
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Since this review was first writ ten there has been a systematic review of diabetes educat ion 
models undertaken (Vermeire et al. 2009). Twenty-one studies assessing interventions aimed 
at improving adherence to treatment recommendat ions, in people with Type 2 diabetes in 
primary care, outpat ient  settings, community and hospital settings, were included. 
Disappointingly the authors concluded that efforts to improve or to facilitate adherence of 
people with Type 2 diabetes to treatment recommendations do not show significant effects, 
although some interventions such as diabetes education, and adaptat ion of dosing and 
frequency of medication taking showed a small effect on a variety of outcomes, including 
HbA1c. I n other words, the quest ion of whether any particular type of educat ion or 
intervention is more effective than another remains unanswered. 
 
Vermeire et al (2009) go on to state that their conclusions are concordant with those of 
another systemat ic review (Loveman et al. 2008a), which found that although educat ional 
interventions can produce improvement in diabetic control in people with Type 1 diabetes, 
there are mixed results for people with Type 2 diabetes.  I n other words it is difficult to 
ident ify what specific features of education may be beneficial.  
 
Finally the review had identified that  health-care professionals may need training and support  
in facilitat ing a true patient-centred empowering approach. These findings might be of 
part icular significance when the pract ical aspects of rolling-out a self-management package 
are considered. 
 
 
3.12. Conclusion 
 
Whilst the case study ident ified some potent ial content  for the education programme, the 
literature review in contrast identified the need for further research part icularly as studies 
with differing methods are difficult to compare.   
 
The following chapter will explain how the development of the self-management pack was 
informed by the findings of the case study, also from the findings of some pert inent studies 
from the literature review and also from the results of  the interviews with patients.   
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4. RESEARCH REPORT: DEVELOPMENT OF THE SELF-MANAGEMENT 
PACK 
 
4.1. I ntroduction 
 
This report details the research study carried out between February 2003 and June 2008 in a 
Renal and Transplantation Unit/Research I nstitute in Greater London and six GP surgeries in 
one local Primary Care Trust (PCT). The research study evolved from the work undertaken for 
the case study (Chapter 2) and the literature review (Chapter 3).  
 
This chapter is divided into three main sections:  the background to the study;  the aims of the 
study and the way in which the self-management package was developed. The 
implementation and testing of the self-management package will follow in Chapter 5. The 
results and discussion are incorporated in Chapters 6 and 7. 
 
4.2. Background to the study 
 
4.2.1. Diabetes and kidney disease 
 
Diabetes mellitus affects at least 4% of adults in the UK (Evans 2007) with numbers of those 
with Type 2 diabetes increasing because of the ageing population and levels of obesity 
(Sorensen 2000). Consequently, it is likely that the rate of established renal failure (ERF) due 
to diabetes will be increased in the years ahead. At  present, diabetic nephropathy is the 
leading cause of ERF in new patients each year who require renal replacement therapy 
(dialysis or a transplant) (UK Renal Registry 2007). I n 2006 approximately 22% of the UK 
dialysis population had diabetes as the primary renal diagnosis, although there is a large 
variation due to ethnicity. I n Bradford and East London for example, more than 35%  of the 
dialysis population had diabetes as the underlying disease (UK Renal Registry 2007). The 
percentage of new patients with diabetes on dialysis in the UK has risen 2% since 2005 (UK 
Renal Registry 2007) and this increase in the rate of diabetic kidney disease is a cause for 
concern.  
 
As stated in the introductory chapter, many studies have shown that the course of diabetic 
kidney disease can be slowed by ident ifying those at  risk and subsequently managing blood 
pressure to target, improving glycaemic control and giving advice and support on lifestyle 
changes, such as exercise, weight loss and smoking cessation (Bilous 2008, DCCT Research 
Group 1995, Gerstein 2002, Mancia 2007). 
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4.2.2. Preventing deterioration of kidney function 
 
Many recent initiatives have identified the need to prevent the deterioration of renal disease 
in diabetes. The National I nstitute for Health and Clinical Excellence (NICE) published 
guidelines in 2002 for the management of renal disease in Type 2 diabetes (Nat ional I nstitute 
for Health and Clinical Excellence 2002). The General Medical Services (GMS) contract  for GPs 
introduced targets for diabetes such as blood pressure control, prescription of angiotensin-
converting enzyme (ACE) inhibitors, and microalbuminuria and creatinine testing (NHS 
Confederation and the General Practit ioners Commit tee (GPC) of the Brit ish Medical 
Association (BMA), 2004). The National Service Framework (NSF) for Renal Services 
(Department of Health 2005) called for:   
 
‘people at increased risk of developing or having undiagnosed chronic kidney disease 
(CKD), especially people with diabetes or hypertension, to be identified, assessed and 
their condition managed to preserve their kidney function’ (Department of Health 
2005)(p.vii). 
 
I n April 2006 the GMS contract (NHS Confederation and the GPC of the BMA 2006) included 
for the first t ime, targets for CKD. These Quality and Outcome (QOF) targets are shown in 
Figure 4.1. 
 
Figure 4.1:  QOF Targets for CKD 2006 
Indicator Points Payment Stages 
CKD 1:  The practice can produce a register of pat ients aged 18 
years and over with CKD. (US National Kidney Foundation:  Stage 
3-5 CKD) 
6 
 
 
CKD 2:  The percentage of patients on the CKD register whose 
notes have a record of blood pressure in the previous 15 months 
6 40-90%  
CKD 3:  The percentage of patients on the CKD register in whom 
the last  blood pressure reading, measured in the previous 15 
months, is 140/85 or less 
11 40-70%  
CKD 4:  The percentage of patients on the CKD register who are 
treated with an angiotensin converting enzyme inhibitor (ACE-I ) 
or angiotensin receptor blocker (ARB) (Unless a contraindication 
or side effects are recorded) 
4 40-80%  
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I n addition, the QOF indicator CKD 4 as shown in Figure 4.1, was changed in April 2008 to 
indicator CKD 5. This new indicator included proteinuria measurement, as follows, with 
changes in italics.  
 
CKD 5:  The percentage of patients on the CKD register with hypertension and 
proteinuria who are treated with an angiotensin converting enzyme inhibitor (ACE-I ) 
or angiotensin receptor blocker (ARB) (Unless a contraindication or side effects are 
recorded). 
 
I n April 2009, another additional QOF indicator was added:  
 
CKD 6:   The percentage of patients on the CKD register whose notes have a record 
of an albumin:  creatinine ratio (or protein:  creatinine ratio) value in the previous 15 
months. 
 
As the existence of proteinuria is known to be associated with accelerated decline in renal 
funct ion ( I seki et  al. 2003) this amendment to the QOF indicator may mean further 
improvements in the management and outcome of people with CKD.  
 
I n September 2008 NICE published guidance on the management of CKD in primary care 
(National I nstitute for Health and Clinical Excellence 2008). This new guidance will influence 
the way in which people with CKD are managed in primary care, and provides guidance on:  
 
•  ident ifying people who have or are at risk of developing CKD 
•  identifying who needs intervention to minimise cardiovascular risk and what that  
intervention should be 
•  identifying who will develop progressive kidney disease and/ or complications of 
kidney disease and how they can be managed 
•  ident ifying who needs referral for specialist  kidney care 
 
Since this research study has been running, national initiat ives have aimed to improve the 
management of pat ients with diabetic kidney disease. These initiatives are welcomed, 
although they will of course take t ime to have an effect  on patient outcomes. I n 2008, large 
numbers of  patients with diabetes st ill progress to established renal disease, and will 
eventually require dialysis or  a kidney transplant , equat ing to around 22%  of the total dialysis 
population, with huge regional variat ion due to ethnicity (UK Renal Registry 2007).  
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Another challenge is that around 24%  patients (range 10-38%) commencing renal 
replacement therapy are referred late to renal units, that is, within three months of needing 
dialysis (UK Renal Registry 2007), yet the NSF for Renal Services (Department of Health 
2005) has recommended that pat ients should be referred at least one year ahead.  Although 
there has been a sustained and significant reduction in late referral over the past five years 
(Renal Registry 2007), 16%  of all those who are late-referred have diabetes as their primary 
renal diagnosis. What is concerning is that this cohort should be in a system, the Quality and 
Outcomes Framework, that  recalls individuals for an annual review in primary care. Referral 
in good t ime to renal units, enabling a planned start to dialysis, should therefore be a top 
priority for primary care teams when caring for this vulnerable group. The greater the 
emphasis on early detection of CKD, the more likely it is that those at  risk will be managed 
better and referred to secondary care in good time. 
 
4.2.3. Self-management of early kidney disease 
 
Much is being done to improve primary and secondary care collaboration, which in turn might 
influence bet ter understanding of CKD, and, as a consequence, improved management and 
timely referral. However it could be argued that care from health care professionals can only 
be optimised if people themselves are given informat ion about their condition, and 
empowered to take control of the disease progression.  
 
Most people with diabetes spend only a few hours in contact with health care professionals 
each year, and the rest of the time they manage their diabetes themselves. Supporting 
people to manage their own diabetes is therefore at the heart of empowering people with 
diabetes, improving their experiences of services and improving their health outcomes 
(Department of Health 2001).  
 
I n 2003 NICE produced an appraisal of structured education in diabetes (National I nstitute 
for Health and Clinical Excellence 2003) . I t was found that education is often offered on an 
‘ad hoc’ basis and is not ongoing. Large studies have shown that patient education, if 
provided, does not tend to be based on proven educational or behavioural principles, nor is it 
usually evaluated properly to ascertain its effects in improving outcomes. Of concern is that  
these NICE guidelines do not specifically mention kidney disease as a complication of 
diabetes in the recommended list of topics for discussion with patients.  
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I n June 2005 a joint publicat ion between the Department of Health and Diabetes UK also 
reviewed structured patient education programmes for diabetes (Department of Health and 
Diabetes UK 2005). The report  out lines quality standards and key criteria for educat ion 
programmes and aims to be a useful reference point  for those involved in the provision of 
care for people with diabetes. The report also highlights gaps in education provision, such as 
involving people with poor language and literacy skills, and carers. This present study aims to 
develop and implement a programme for those with kidney disease in line with the 
recommended quality educational standards.  
 
A final question is whether there is enough evidence to demonstrate that self-management is 
effective. A British Medical Association (BMA) (2007) report evaluated how far self-
management could make a difference to long-term health outcomes. The BMA cites the 
Picker I nstitute review (Coulter and Ellins 2006) which reported that although a great deal of 
research had been undertaken into self care, the majority of trials tended to measure only 
short  term outcomes, typically 6 months or less. The review concluded that even though 
there was currently litt le known about the effect iveness of self care over the long term, self 
management education did lead to short term improvements in health behaviour.   
 
As a consequence, the BMA has made recommendations which include the following:  
• Every person diagnosed with a long-term condit ion should know how to gain 
information on their condition and how to develop their self-management skills 
through educat ion available from the NHS and voluntary and community sector 
organisations. Every patient should also know who, as well as their GP, may be able 
to give advice and support.  
• Resources and information need to be given to GPs to help them encourage self-care, 
including information on commissioning services, in order to assist patients who wish 
to improve their ability to self care through attending self-management educat ion 
programmes.  
• PCTs should encourage self-care through self-management education programmes at  
a local level as part  of a wider strategy for long-term condit ions. Costs involved for 
commissioners should be seen as a good investment to gain a long-term benefit .  
• Further research over a longer period should be undertaken in order to ascertain the 
effectiveness of self-management education to both patients and the health service.  
 
Self-management education programmes have resulted in small to moderate effects for 
selected chronic diseases (Warsi et al. 2004). A variety of reviews have concluded that, at  
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least in the short  to medium term, diabetes self-management support is effective (Glasgow et  
al. 2007). A systematic review of self-management programmes for diabetes (Warsi et al. 
2004) found small but significant  reductions in glycated hemoglobin levels (HbA1c) and 
improvements in systolic blood pressure. 
   
However the evidence for effective self-management programmes for those with early CKD 
appears to be lacking.  
 
4.2.4. Summary 
 
Around 4% of the population have diabetes and, of those, around one quarter is at risk of 
kidney damage. Although management of this group is improving because of recent nat ional 
init iatives, there is scope to improve this group’s health outcomes through self-management. 
Self-management has been shown to be of benefit in the short-term for those with chronic 
conditions, but  has not been shown to be of benefit in the longer-term. Following review of 
current literature (see Chapter 3) no self-management programmes or packages for those 
with diabetic kidney disease could be located. This study will therefore develop a self-
management package for people with diabetes and early kidney disease, with patients’ 
experiences informing package content and design. The second part of the study will then 
test the developed self-management programme in a selected population, by comparing with 
a control group. The aim of the self-management package is to control the factors that can 
contribute to kidney disease progression. 
  
 
4.3. Main aims of the study 
 
The aims of this research project have been formulated from the findings of the case study 
and literature review. I t is known that progressive kidney disease can be slowed down 
through bet ter blood pressure and blood sugar control and lifestyle modification, but not  
whether these variables can be controlled even bet ter if patients with evidence of early 
kidney disease are well-informed and supported in their responsibility to manage the 
condition themselves. 
 
The main aims of the study are:  
 
• To develop a self-management education package which informs patients with diabetes 
about the risks of kidney disease 
• To test the self-management package by comparing with a control group 
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• To evaluate the self-management package and consider ways to disseminate the package 
to a wider audience 
 
4.4. Research question 
 
The study aims to investigate whether the parameters that can lead to deterioration of kidney 
funct ion in diabetes can be better controlled through pat ient education and self-management.  
 
The research question is  
 
“Can an innovative self-management  package control the parameters that  contribute to the 
progression of kidney disease caused by diabetes?”  
 
This is a mixed-method study that entails two main separate stages:  
 
1. Development of the self-management package 
2. Testing of the self-management package 
 
There now follows a description and analysis of the first main stage of the study, outlining 
how the design of the study evolved.  
 
4.5. I nitial ideas that developed the research question 
 
The research question was first contemplated in 2003.  As a renal nurse, I  have had an 
ongoing interest in diabetes, and also patient  education. My dissertations for both Bachelor 
and Master’s Degrees had focused on quality of life issues and self-care activities of pat ients 
with diabetes and kidney disease. However these studies had focused on patients who were 
either undergoing or about to start  dialysis.  
 
I n 2005, with the publication of the NSF for Renal Services (DH, 2005) the nat ional agenda 
for renal care turned its focus towards the management of  those with early kidney disease in 
primary care.  Collaboration between primary and secondary care was improving, and I  
began to see the gap in the evidence for how best to self-manage the complicat ions of kidney 
disease in people who had diabetes.  
 
The idea for the study was debated with hospital, community and academic colleagues and a 
draft  project outline was submitted to the Research Degrees Committee in Autumn 2003. 
Two research supervisors were ident ified concurrently;  a Professor of Community and Primary 
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Care Nursing, School of Community and Health Sciences, City University London and a 
Consultant Nephrologist, Surrey.  
 
I t was important to submit concurrent grant applicat ions to fund this study and the 
submission date for the first grant  application (Nat ional Kidney Research Fund/Brit ish Renal 
Society Fellowship February 2004) ensured that initial ideas for the project design had to be 
realistic and well defined by early 2004. Successful grant applications are shown in Appendix 
2. 
 
4.5.1. Timescale 
 
I  registered for the PhD in February 2004. This overall t imeline was proposed at the start of 
the study. 
 
 
2004  2005           2006             2007                   2008 
 
Case study   Literature review  Data collect ion I nterviews Development of package  Implementat ion   Evaluation  
 
The research component commenced with baseline data collection in late 2005. Patient  
interviews took place during late 2005, with development of the self-management package 
being undertaken during 2006. Roll-out of the package was carried out in 2006-7, with final 
data collection and analysis of data in 2008. 
 
I t was hoped that the Doctorate could be completed within five years, particularly as I  was 
undertaking the study as part of my seconded role to the renal unit / research institute. The 
research institute was keen to promote a multi-professional focus to its portfolio, as 
previously it had only been concerned with laboratory-based renal research, particularly 
inflammation, fibrosis and signalling. As a consequence, it was possible for me to devote two 
days per week to the Doctorate at the outset, and this comprised one day per week funded 
from the research institute and one day per week funded from the Kidney Research 
UK/British Renal Society Fellowship.  
 
Later in the study, from October 2006, it was only possible to devote one day per week to the 
research, as the secondment to the renal unit had been terminated, and a return to 3 
days/week employment at City University was commenced. However it  was possible to use 
the School’s lecturers’ study leave allowance and this was utilised during 2007-2009. 
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4.6. Development of the self-management package 
 
4.6.1. Ethical approval 
 
Ethical approval was required for both parts of the study:  the development and also the 
testing of  the self-management package. Approval for both parts was requested concurrently. 
I nitial ethical approval was granted by the local NHS local research ethics committee (LREC) 
in December 2003. See Appendix 1. At t his time, changes to the national process for 
submission of ethics applications had not been made, so the application was submitted in 
hard copy to this LREC. The application was not  submitted on-line to the National Research 
Ethics Service (NRES) as this service was not launched until 1 April 2004.  Similarly Primary 
Care Trust Research and Development Approval was not required at the time, as procedures 
for research governance in PCTs had not been put in place.  
 
I  was not  invited to the LREC meet ing but subsequent ly received a let ter asking for 
clarification on a few issues. These questions were duly answered and a letter of approval 
was received in December 2003.  
 
An information sheet for participants was also devised for the ethics committee and this was 
approved (see Appendix 3) at the same time. 
 
Two amendments to the protocol were submitted over the course of the study period, 
namely:  
 
Amendment (not considered substantial by ethics committee):  March 2005. Addition of a 
named research nurse to the research protocol. A staff nurse in the renal unit was funded to 
collect data from GP practice databases to assist the main researcher. This role will be 
discussed later in the chapter. 
 
Amendment 1:  March 2006. A ‘control group’ was added to the research protocol. 
 
These amendments will be discussed in more detail in section 5.3. The research protocol was 
also registered with the Trust ’s Research and Development Department. The University 
Research Ethics Commit tee also gave approval for me to carry out the study in March 2004.  
 
A number of ethical considerations developed during the study, and these will be discussed 
later in Chapter 7.  
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4.6.2. Recruitment of practices 
 
This stage has been described in some extent  in the case study (see section 2.5), but is 
summarised again here to explain the context  within which the overall study has been set. 
 
I  was requested to facilitate a number of continuing education sessions on kidney disease for 
pract ice nurses in the local Diabetes Centre in early 2004. During these sessions an overview 
of my upcoming research project was presented and practice nurses (PNs) who were willing 
to take part were asked to leave their contact details so they could be sent  further 
information. Thirteen PNs left their names/contact  details and all were sent further 
information asking them to discuss the project with their GP and practice manager 
colleagues. Eventually six GP surgeries in one PCT agreed to take part in the project. The 
pract ices observed in the case study thus became the intervention practices. I n all six 
surgeries the main points of contact during the study have been the practice nurses and/ or 
nurse pract it ioners who are responsible for running diabetes clinics.  
 
There are issues around recruitment of participant  GP practices that  now need to be 
discussed in more detail.  
 
4.6.3. Representative sampling 
 
I t is possible that the practices that volunteered to take part were not representative of other 
pract ices in the same PCT, as individual practice nurses volunteered to take part  at  the 
education event. For many nurses, at tendance at an education programme was difficult 
because of time and financial constraints. Wide-scale recognition of the hiatus between 
research and practice exists (Hicks 1996) and it  is possible that only those with up-to-date 
knowledge, or those with an enquiring mind would have volunteered to take part. However it  
is quite often advantageous to enlist participants who have volunteered, as quality 
improvement programmes often have more success when enlisting the help of those who are 
innovative adopters rather than laggards or late adopters (Rogers 2005).   
 
Originally the study was to be of a t ime-series design, that is, the self-management package 
would be tested by comparing individual patients’ data over t ime, before and after the 
package (the intervention) had been implemented (Weiss and Heckbert  1988). However the 
method had to amended at  a later date (see sect ion 5.3.1)  because of changes to national 
policy in the management of CKD during the period of the study, so a control group was 
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subsequently introduced. Further details on the rationale for t he method and the statistical 
analysis will be discussed in more detail in Chapter 5.  
 
4.7. Demographics and representation of local PCT 
 
The demographics of the surgeries taking part in the study are shown in Figure 4.2. 
 
Figure 4.2:  Demographic data from each participating surgery (from 2004/2005 QOF data)  
SURGERY TOTAL NUMBER 
OF REGISTERED 
PATIENTS 
TOTAL NUMBER 
OF PATIENTS 
WITH DIABETES 
PREVALENCE OF 
DIABETES MELLITUS 
1 10536 315 3.0%  
2 7858 219 2.8%  
3 14241 393 2.8%  
4 9405 336 3.6%  
5 9041 247 2.7%  
6 10810 436 4.0%  
Mean 10315 324 3.15%  
 
There was 3.2%  mean prevalence of diabetes across the entire PCT in 2004/ 2005 (QOF 
database 2005) whilst the mean prevalence of diabetes in the participating practices was 
3.15% . Mean diabetes prevalence in each practice did not vary much from the mean 
prevalence across the whole PCT, apart  from a higher prevalence recording in Surgery 6. This 
is possibly because surgery 6 has a nurse practit ioner who runs a nurse-led clinic for 
diabetes, and it is possible that people with diabetes at tend that  practice because of the good 
reputation of that  clinic. There was some anecdotal evidence to support this, with part icipants 
in the study telling me that this is the case. 
 
4.8. Participant observation 
 
I  subsequent ly attended and observed diabetes clinics (led by both GPs and practice nurses) 
in each surgery over a three-month period. The aim was to understand the challenges of 
managing diabetes in primary care and to understand how far the pat ients were empowered 
to take control of their disease. A detailed analysis of this participant  observation phase is 
detailed in Chapter 2, the case study. 
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4.9. Findings from participant observation and effect on method 
 
I n summary, five main themes were identified during the part icipant observat ion period. 
These were:  
 
1. Confusion over microalbuminuria testing 
2. Discrepancies over blood pressure measurement and management 
3. Use of the computer during consultations 
4. How far patients were empowered to take control of their condition - differing learning and 
teaching strategies amongst pract it ioners. 
5. The doctor-nurse relationship. 
 
The three most important  issues that were considered to have the most  impact  on 
development of the educational package were themes 1, 2 and 4. Each of these themes was 
subsequently taken into account when developing the educational intervent ion. These themes 
will be discussed again later in this chapter.  
 
4.9.1. I dent ification of patients with early kidney disease 
 
Pat ients with early kidney disease needed to be identified for both developing and testing the 
education package. 
 
• Developing the package:  a small cohort  needed to be identified as possible 
interviewees.  
 
• Testing the package:  the entire population with diabetes and early kidney damage 
needed to be identified as possible participants to receive the package. 
 
The overall aim was therefore to identify all pat ients with early kidney disease in each surgery 
and then map these patients for the duration of the study, recording a variety of data from 
pract ice databases every six months. The starting point was to ident ify all patients in each 
surgery who had Type 1 or Type 2 diabetes and then to identify those who had the early 
stages of kidney disease.  
 
Microalbuminuria (MA) is the earliest indicator of renal disease attributable to diabetes 
mellitus and MA is predictive of total mortality, cardiovascular mortality and cardiovascular 
morbidity for patients with diabetic kidney disease (Klausen et al. 2007). Microalbuminuria is 
defined as 30-300 mg of albumin in the urine, measured by an albumin:creat inine ratio (ACR) 
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in an early morning urine (EMU) sample. An ACR > 2.5 mg/mmol in a male or > 3.5 mg/mmol 
in a female is consistent with MA (National I nst itute for Health and Clinical Excellence 2002) 2. 
A meta-analysis (Wang et  al. 1996) found that the death-rate among people with MA was 
more than double the rate in people with normal urinary albumin levels.  
 
4.10. Case-finding  
 
The init ial case-finding strategy used Egton Medical I nformation Systems (EMIS) LV. EMIS LV 
is a text-based clinical software system used by all surgeries in this study and this software 
allows users to search for clinical conditions that have been assigned a ‘Read Code’. Each 
clinical term has a unique Read Code, allowing recorded material to be stored as data which 
can be retrieved and analysed to provide information for act ivity stat istics and audit  in 
addit ion to clinical applications. When called up on screen, the information is presented not  
as a code sequence, but translated back into the original clinical language (Department of 
Health 1996). 
 
EMIS LV databases were searched by identifying all patients currently registered with the 
surgery;  who had Type 1 or Type 2 diabetes;  and who also had microalbuminuria (ACR> 3) 
on at least  three occasions. Patients with established renal disease (who were already under 
the care of the renal team) were not included. Read codes for diabetes (C10) and 
microalbuminuria (C10EL and C10 FM) were initially used for the search. These codes were 
those recommended by the Department of Health (Department of Health 1996) and this 
activity was ant icipated to be able to identify all patients with diabetes who also had known 
renal impairment. However, when numbers of pat ients identified in the initial search were 
checked with known prevalence data on microalbuminuria and also with practice nurses 
working in each surgery, it became apparent that not all patients with microalbuminuria had 
been identified. 
 
I n the initial search using Read Codes, only 9%  of patients with diabetes were identified as 
having MA. This compares with a known prevalence of around 20-30%  (Mather et al. 1998) 
in the UK and 58.6%  in Asia (Wu et al. 2005). Subsequently, personnel responsible for 
information services in three practices were asked to assist with the search. I t appeared that  
other Read Codes were also in use for MA (46TC, 46 TD, 46W, R1103) so the search was 
repeated. After identifying a new set  of patients with MA, (n=  224) I  checked with practice 
nurses once more but still could not be confident that  all patients with MA had been 
                                               
2
 I n 2004 local PCT/ laboratory guidance regarding the threshold for abnormal ACR results was > 3 for 
both men and women, despite NICE (2002) guidance recommending > 2.5 in men and > 3.5 in women. 
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ident ified. I t appeared Read Codes had not necessarily been assigned for all patients with 
MA. A manual search for ACR measurements > 3 was then conducted through the 
computerised records of all patients coded as having diabetes. A total number of 370 pat ients 
were identified in the six surgeries and these patients formed the initial cohort to be studied 
throughout the project. An additional number of possible participants joined the study at a 
later date because of increased MA screening rates. 
 
Each of these patients has had audit data extracted from the practice database six-monthly 
for the duration of the study. As these data have been used to test  the effect of the 
intervention, the dataset will be discussed separately in section 5.4. 
 
4.11. I nterviews 
 
The aim of the study is to find out  how far a patient-centred education programme can 
influence the progression of kidney damage. This thesis has hypothesised that  increasing 
pat ient knowledge about kidney disease could subsequently affect  pat ient behaviour. I n order 
to develop a patient-centred programme it was important to seek the views of those who 
already had early kidney damage. 
 
A semi-structured interview was identified as being the best way to elicit the experiences of 
those with early kidney disease. Structured interviews can force respondents to choose from 
answers already provided and there is litt le opportunity for free expression (Newell 1994). 
Semi-structured interviews can allow the interviewer to focus on issues that are of particular 
importance to the research quest ion, to probe and clarify comments made by the informant 
and to use prior knowledge to help him or her in this process (Dearnley 2005). 
 
There are limitations to the use of semi-structured interviews, namely the effects that  
interviewers can have on respondents and the effects that interviewers may have on the 
validity and reliability of the data (Fielding 1994). These limitations will be discussed later in 
the chapter in sect ion 4.12. 
 
The aim of the interviews was to find out  how much patients knew about t heir renal disease, 
how much they understood about  the consequences of renal impairment and to find out what  
they perceived to be the best ways of managing and controlling the renal complicat ions. 
Findings would inform the development of the educational package. Questions were 
developed during the observation period in diabetes clinics, from the literature review and 
during informal conversat ion with patients at the surgeries. Quest ions were collated together 
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around three key concepts identified from the observation period and review: impact of 
diabetes, barriers to control of diabetes and the concept of self-management. 
 
A pilot interview schedule was developed and discussed with two patients in the dialysis unit 
to see if the questions were easily understood. This informal discussion did not  radically 
change the interview schedule but rather highlighted the importance of the interviewer 
‘setting the scene’ for interviewees before the interview commenced. For example it was 
possible that not all patients would be aware that they were at risk of kidney damage, so it 
was important to check with the practice nurse before potential interviewees were contacted 
that they had been told that they were at risk. 
 
A pilot interview was carried out  in November 2005 at  Surgery 1 and although questions were 
not amended following the pilot interview, the ordering of questions was changed to improve 
the flow of conversation between interviewer and interviewee. 
 
The semi-structured interview schedule is shown in Figure 4.3. 
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Figure 4.3:  Semi-structured interview schedule 
 
General questions about diabetes (key concept =  impact  of diabetes)  
• For how long have you had diabetes? 
• How did you feel when you were first told? 
• How well do you think that you manage your diabetes? 
• What are the most difficult aspects of having diabetes – what is it like for you?  
 
More specific questions about diabetes and renal disease (key concept =  barriers to control)  
• Can diabetes cause kidney damage? 
• Have you ever been told that you are at risk of having kidney damage? 
• What do you think can slow down kidney damage? 
• How well do you think you control your blood sugar levels? 
• Are you taking blood pressure tablets? 
• Do you have any side effects from these tablets? 
• Do you smoke? 
• How difficult is it for you to take health care advice about your diabetes? 
• What can make it difficult? 
 
Quest ions about health education (key concept =  self-management)  
• How much information have you had about kidney damage from diabetes? 
• When did you realise that it was one of the major complicat ions of diabetes? 
• Do you try to take control of your diabetes? How? 
• How best do you take in information about  your health? (examples – one-to-one 
discussion, reading, videos, internet etc.) 
• I f you were going to try to educate people with diabetes about the risk of  
 kidney damage, what do you think would be the best way of doing it? 
• Do you use organisations such as Diabetes UK for advice? (website, magazine etc.)  
 
 
4.11.1. I nterviewees 
4.11.1.1. Selection of interviewees 
 
All the patients who had been ident ified as having diabetes and MA in each surgery were 
potential interviewees. After discussion with the pract ice nurses it was thought most  likely 
that patients with deteriorat ing kidney funct ion (now called the ‘high-risk’ group) were most  
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likely to have been informed about their potential risk, so were most  likely to be able to 
answer questions about kidney disease.  
 
Those at high risk were ident ified as being those with ACR> 30 and BP ≥140/ 80 mm Hg at  
their last clinic visit (Adler et al. 2003). These patients were then identified and discussed 
with the relevant pract ice nurse (PN), and a shortlist of suitable interviewees was drawn up. 
Pat ients thought  to be unsuitable by the PN included those who were acutely unwell, and 
those could not communicate easily in English without an interpreter. 
 
A list  of 48 patients was compiled (see Appendix 4) and I  accessed the GP databases to see 
when the pat ients were next due to attend the practice for a consultation. Each month I  
telephoned each surgery to check if any of the identified patients were due at the practice in 
the following month and, if so, the patient was sent a letter informing them about the project 
(see Appendix 3). I  asked them to return a form to me if they were interested in taking part. 
Once I  had received the names of interested participants, I  contacted them by telephone and 
a suitable time to be interviewed was agreed, usually before or after a clinic appointment. A 
small number of patients (n= 3) preferred to be interviewed at  home.  
 
Pat ients were asked if they had further quest ions prior to being interviewed and if they were 
still willing to take part . I f so, they were asked to complete a consent form (Appendix 5) and 
three copies were made – one for the patient, one for the pract ice record and one for me to 
keep on file. 
 
I  planned to interview 15 patients. Sample sizes are  
 
“not determined by hard and fast rules, but by other factors, such as the depth and 
duration required for each interview and how much it is feasible for a single 
interviewer to undertake.”  (Pope and Mays 2006)(p. 19) 
 
There were a number of reasons behind the rat ionale for picking 15 interviews. The main 
reason was saturation of themes – that is, the importance of ensuring that no new themes 
were likely to emerge with a greater number of interviews (Creswell 1998). A preliminary 
review of themes was carried out after 12 interviews had been completed to evaluate how far 
interviewees were making similar responses to the questions. The responses to crucial 
questions such as how far the interviewees understood whether they were at risk of kidney 
disease and what techniques they could use to slow down progression were analysed. At this 
point  it appeared that, in general terms, people understood that they were at  risk, but had 
little idea that  they themselves could do anything to self-manage. There were a wider range 
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of responses concerning the ways in which self-management could be facilitated (through 
face-to-face consultations, by talking to other patients, by watching a video etc), but given 
the inconclusive findings of the literature review, this was to be expected. 
  
Secondly there was only one interviewer and a short  timeframe. The interviews had to be 
completed before the end of 2005 in order to keep within the specified timeline and prior to 
the development of the learning materials. I n December 2005 a decision was made to 
undertake 15 interviews as planned, and the final interview was undertaken in January 2006.  
4.11.1.2. Demographics of interviewees 
 
A summary of the demographics of the pat ients who were interviewed is shown in Figure 4.4. 
Male gender and older age is to be expected, and is representative of people with diabetes 
and microalbuminuria (Klein et al. 1993).    
 
The PCT in which the participating practices are located has a population that lives within two 
local London boroughs. I n one borough the 2001 census (Office for Nat ional Statistics 2001) 
showed 84%  of the population was white whilst in the other borough 64% of the populat ion 
was white (average of two boroughs 74%). I n this cohort of interviewees 11/ 15 (73%) are 
white.  
 
Figure 4.4:  Demographics of  interviewees 
Gender Male:11           Female:  4 
Age range 45-78 years     
Ethnicity White:  11         Asian:  2       Mixed race:  1 
 
4.11.2. Practicalit ies of interviewing 
 
I  had experience of interviewing patients for  my Master’s dissertation, so the experience of 
interviewing patients was not new. Eleven interviews were carried out in the GP practices, 
usually a clinic room that was vacant because a GP was on leave or away for the day. There 
were few problems with this arrangement. The most difficult  problem was noise from traffic 
outside, although no tapes were spoiled because of this.  
 
The interviews were taped on a standard tape recorder that was placed near to the 
interviewer and interviewee. The quality of the recording was checked at the start of the 
interview, to ensure that the microphone had been placed near enough to the interviewer 
and the interviewee. Unfortunately on one occasion the recorder did not  work properly 
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(interview 10), and despite the test at the start  of the interview, the tape was blank once it  
was replayed at  the end. Fortunately I  was able to make notes of the interview once the 
mistake had been discovered, and key topics were written down and reviewed. Although this 
was not an ideal situation, I  telephoned the patient at home and asked whether she could 
verify the notes that had been made, and whether she wanted to add anything to them. She 
was happy with my notes and her contribution was subsequently used, although direct 
quotes were obviously not able to be included below.  
 
I nterviews lasted between 20 and 45 minutes. 
 
4.11.3. Questioning techniques 
 
Semi-structured interviews allow interviewees to be asked similar questions within a flexible 
framework. All the patients were asked questions from the same framework, but  the ordering 
of the quest ions varied according to how the interviewee responded to the questioning. After 
the pilot and first two interviews had been carried out, I  realised that answers to some of my 
questions were not  as detailed as I  had hoped. For example, when I  asked people whether 
they tried to control their condition themselves (see questions about health education in 
Figure 4.3), some people were not that forthcoming in their answers. Subsequently I  had to 
reflect on how far the difficulty in extract ing responses was due to my questioning technique, 
how far it was due to the nature of the questions or how far it was due to the interviewee not  
having really thought about these questions before. Latterly I  ensured that  my questions did 
not contain any medical jargon, I  emphasised to the interviewees that there was no right or 
wrong answers and that all responses were interesting and very much valued. 
  
I t was important to ‘reflect on action’ after each interview, by asking myself whether any new 
concepts emerged, whether I  probed an issue sufficient ly and whether I  had asked any 
leading questions (Dearnley 2005).  
 
4.12. Reflection on interviewing techniques 
 
Although there are benefits in using a semi-structured approach such as elicit ing certain types 
of information from all respondents, and allowing flexibility in phrasing and ordering of 
questions (Kvale 1996), the ‘credibility’ of data from semi-structured interviews needs to be 
reflected upon.  
 
I t is possible that the interview quest ions became shaped by my past  experiences of working 
with people who had diabetes and CKD. I t is possible that occasionally some quest ions arose 
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because of my interest in one aspect of an interviewee’s response, or that my concern for the 
interviewee’s well-being distracted me from the interview itself. For example, one interviewee 
stated that she was confused with the contradictory messages she was being given by nurses 
in primary and secondary care, so I  responded by offering care:  
 
NT:  I ’m sorry you have had somebody saying one thing and then somebody saying 
something else. 
 
I nterviewee: They confuse you, they really confuse you.  I  am with Hospital X and 
Hospital Y and it really does confuse me because I  get so much from one and then 
the other and I  don’t know where I  am.  I  would like one hospital to take over 
everything like it was before, because Hospital X is nearer, it is easier for me to go 
there. 
 
NT:  What we could do, when we have finished here, I  could come with you and look 
at your blood results and make some decisions on your diet because M (practice 
nurse) and I  are used to dealing with people with early kidney problems and we’ve 
got an idea about  what advice to give. I  know it is confusing.   
 
On reflect ion it was not necessary for me to respond in this way in the middle of the 
interview, as potentially it could have deflected the interviewee’s attent ion away from the 
focus of the interview. Nurses are socialised to care and to educate, and it is likely that I  
assumed my nursing role to the detriment of my researcher role during the early interviews.  
 
However some authors (Murray 2003, Parnis et al. 2005) have identified the potential 
therapeutic value of research interviews, and it is possible that this interviewee did gain some 
useful clinical support after I  intervened in this way.  
 
I t is also the case that when interviewees were not very responsive to my questions, I  
became more talkat ive, with the result being that  the transcript  revealed that I  engaged in 
more narrative than the interviewee.  
 
I  think that I  recognised these shortcomings in early interviews, and learnt to become more 
flexible in my questioning. Flexibility is an important  attribute for an interviewer to have, 
especially when it is important to listen attentively and to respond to cues by formulat ing 
addit ional relevant  quest ions (Hutchinson and Wilson 1992). I t is also possible that I  needed 
some formal preparation in interview technique and I  will keep this in mind when supervising 
students who also have litt le or moderate experience in interviewing techniques. 
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4.13. Transcribing of interviews 
 
I  evaluated whether it  would be beneficial for an outside agency to be employed to transcribe 
the taped interviews. With transcribing potentially taking up to 70 hours for every 15 
interviews (Aveyard and Schofield 2002), such help was thought to be welcome because of 
my t ime constraints. A number of colleagues advised me that I  could not become ‘fully 
immersed’ in the data unless the transcribing was carried out myself and some authors also 
support this (Duffy et al. 2004).  However this could be overcome to some extent by 
spending t ime in listening to the tapes before reading the returned transcripts. 
 
However there were some additional issues to be considered in making this decision. These 
were not just practical issues such as accuracy and reliability, but also less tangible concerns 
such as maintaining patient  confident iality and ensuring that the transcriber was not  upset by 
the content of the interviews. These issues were all taken into account, and the decision was 
made to employ a transcriber, mostly because it was crucial to keep to the intended 
timelines. 
 
A number of freelance typist/ transcribers were scrut inised, such as those who had either 
been identified through personal recommendation or via the internet. Once costs and 
timeframes had been discussed, the most suitable freelance typist was ‘interviewed’ by me on 
the telephone. I ssues discussed were those identified in the previous paragraph, including 
confidentiality. The freelancer confirmed that she had recently worked for another health care 
researcher in another university on a similar project and was happy for her previous employer 
to be contacted for a reference. She seemed to understand all the issues and was even 
familiar with the topic area.  
 
Once the terms had been agreed, all tapes were sent by recorded delivery to the typist who 
later sent  the t ranscriptions back by email. Confidentiality was assured as each interview was 
only identified by a number and places/names of institutions were not  used in the interview 
process. The transcriber was not local to the research area so it was unlikely that she would 
be able to identify the location of the hospital/PCT. 
 
There are questions as to whether interviewees should verify the transcript s once they had 
been typed up, but there are potential problems with returning t ranscripts (Kvale 1996). 
Kvale (1996) warns that some part icipants may experience shock when reading their own 
interview that is transcribed verbatim. He also warns that if oral language, when transcribed, 
appears as incoherent  or confused speech, participants may feel they are being portrayed as 
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having a lower level of intellectual functioning. The decision was made not to return 
transcripts to the interviewees after they had been transcribed, mostly because of the time-
lag between the interview and the returned transcript (up to six weeks), and also because of 
the logistics of making a new appointment for re-visiting. This decision was taken at  the start  
of the study when ethical approval was sought. However all transcripts were checked against  
the taped interviews for accuracy.  
 
All interviews had been completed by early 2006.  
 
4.14. Data analysis 
 
A manual system of thematic data analysis was used to collate and cross-compare the 
part icipants’ responses. Thematic data analysis involves the creation and application of 
‘codes’ to data. Codes are applied to different  sets of data that have the same themes. The 
coding process enables retrieval and collection of all the patient  responses that  have the 
same thematic idea, so that they can be examined together and then utilised in developing 
the self-management package. 
 
4.14.1. Thematic data analysis 
 
There are a number of different approaches that can be used to analyse and interpret data. 
The main approaches are grounded theory analysis, content analysis and narrative analysis 
(Priest et al. 2002).  All approaches were considered, and content analysis was chosen as the 
most appropriate approach. This is because the interviews are being conducted as part of an 
exploratory study into peoples’ views about  self-management of CKD, and the main analytic 
categories for this study were already known. I f the main categories for questions are already 
known, then content analysis is recommended (Priest et al. 2002). For example, key concepts 
in the interview quest ions formed the master codes, i.e. ‘impact of diabetes’, ‘barriers t o 
control’ and ‘self-management of kidney disease’.  
 
4.14.2. Content analysis 
 
Content analysis is a widely used method of  eliciting meaning from text  through the 
development of emergent themes (Elo and Kyngas 2008). All of the text  is reviewed and 
master codes (M1, M2, M3...), followed by first (F1, F2, F3...) and secondary codes (S1, S2, 
S3…) are applied, whereby more detailed indexing is undertaken. Repet ition of coding 
produces the significance of particular themes (Burns and Grove 2005), as the number of 
times a similar piece of text is attributed to a particular code can be counted. There are 
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different types of content:  manifest content, whereby respondents’ actual words form 
concepts, or latent content, whereby concepts are derived from the interpretation and 
judgement of participants’ responses (Woods et al. 2002). 
 
Although computerised analysis ( for example QSR NVivo™) can be used to rapidly code large 
sect ions of text, I  did not ultimately utilise a software package to do this.  
 
However QSR NVivo™ 7 (software developed by QSR International) was evaluated before 
rejecting its usage for this thesis. A half-day course on NVivo application and usage was 
attended in March 2006 and subsequent ly a copy of the QSR software was downloaded under 
the City University licence. The transcribed interviews were easily inserted into the software 
programme and it was easy to find similar words (manifest content) within the text in order 
to identify codes. The difficulty arose when latent  content needed to be coded, and at this 
point  it was decided that interviewee responses could be coded more accurately and quickly if 
the data were coded manually. Although the software could facilitate further development of 
the data, such as ‘visual index trees’ (concept formation comprising sub-categories), this 
addit ional application was not thought  to be worth the t ime and effort  required to learn the 
package in more detail.  
 
Although it is recognised that computerised analysis packages provide ‘perfect coder 
reliability’ (Robson 1994), it was decided that coder reliability could be checked in different 
ways. I n one way, reliability of coding decisions can be confirmed by revisiting previously 
coded data periodically to check the stability over time; also two different coders could be 
used to enhance reliability. I n summary, a manual coding process was utilised as the main 
limitations of using software, which is an ‘overemphasis on standardisation’ (Burton 2000), 
could detract from contextual meaning. 
 
4.14.3. Content analysis:  practical application 
 
An example of how first and second level codes were ident ified is now shown. The process 
undertaken was based on recommendat ions by Woods (Woods et al. 2002). Through line-by-
line analysis, the master level codes were applied, followed by first and second level coding. 
The master codes (impact of diabetes, barriers to control and self-management) had already 
been identified, as these were the three main categories that directed the semi-structured 
interview schedule. Text of differing size (one word, one sentence or even a paragraph) was 
highlighted and assigned to particular analytic categories. I n addit ion, an analytic category or 
‘free node’ was established for data that did not readily fit into existing codes. 
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I f several pieces of text, either from within one text or several texts pertained to the same 
concept  they would be copied and pasted under the appropriate sub-code. I t is then 
necessary to undertake themat ic interpretation of meaning. I n other words, if different  
interviewees use similar wording then it is possible to apply manifest content analysis.  Latent  
analysis is where the researcher can also interpret the interviewee’s meaning and apply a 
code.  
 
Figure 4.5 shows a piece of t ranscribed text from the pilot interview, with the applied master 
(M), first (F) and second (S) level codes highlighted. A list of the identified codes can be 
found in Appendix 6.  
 
Figure 4.5:  Applied first (F) and second (S) level coding 
Code Text  
 
 
F4 
S12 
 
S13 
 
 
S11 
 
 
 
 
F4 
 
 
What happens, it  is just like in this country, we see a lot  of food in the shops 
and a lot of food has a lot  of sugar, a lot of fat, a lot of calories, lots of 
different things.  So we are used to it and also eat a lot - that was the order of 
the day!    So what happens when we become middle aged and old, it all comes 
on, so that’s what happens to Mauritian people or I ndian people, they don’t  
think oh well – I  mean when we are young we take chances, we smoke a lot , 
drink a lot , go to bed late and all sorts of things and when you are middle aged 
it all comes on.  When you are a teenager, young and that, you have a set  
pattern and what happens... we accept a lot of bad things today.  When you 
are young in [ country name]  or anywhere, 16 or 17, you look for a girl and 
then 19 or 20 you get married and then you join the men’s club and you have 
to drink the strong stuff and a lot of it  and then you have a family whether you 
can afford it or not .  You might  finish off with half a dozen!  So we are in that  
thing.  As you know there are many people of 30 or 40 who seem to be very 
old, I  don’t know so much in this country but back home I  can see 50 is very 
old.   
 
I n this extract , the interviewee talked about the way of life in his home country which had an 
effect on the population’s health (F4:  health beliefs). This first -level code can be broken down 
to secondary codes (S11, S12 and S13), namely cultural beliefs, beliefs about ideal weight 
and fatalism respectively. 
 
4.15. Data presentation: background 
 
4.15.1. Aim of interviews 
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As discussed in chapter 3, in order to facilitate self-management in people with long-term 
conditions, a patient-empowering approach is warranted. This approach recognises the 
nature of the actual experience of having diabetes and views the health-care professional as 
a resource person or consultant. I n order to effect behavioural change, the empowering 
approach must  focus on patient goals and needs and acknowledge the individual’s experience 
of living with diabetes (Funnell and Anderson 2004). The main aim of the interviews was to 
ident ify how much knowledge individuals had about the risk of kidney disease and to assess 
how far individuals felt they could control their condition. I t was possible that interviewees 
would also talk about their experiences of living with diabetes, and it was possible that these 
insights might contribute to understanding why some people were able to self-manage their 
condition and others did not. 
 
I n order to acknowledge the actual experience of having diabetes, interview questions were 
centred around living with the condition;  finding out how much patients knew about kidney 
damage, and most importantly discovering what was perceived to be the best ways of 
managing and controlling kidney disease progression. 
  
I t must be emphasised that the (small number of) respondents’ views were obtained with the 
purpose that they would be used only as a basis for the development of the self-management 
package, rather than to make generalisable claims about the overall experiences of people 
with diabetes. 
 
4.15.2. I nterviewees 
 
Eleven men and four women were interviewed. The age range was 45-78 years (mean 60.8 
years). Twelve were white, two were Asian and one interviewee was of mixed race. The 
demographics of the interviewees were representative of the local PCT, as discussed in 
sect ion 4.7. See Figure 4.6 for an overview of the interviewees (data from October 2005). 
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Figure 4.6:  Demographics of  individual interviewees 
 
I nterviews were recorded and following transcription, thematic data analysis was carried out. 
Master and secondary codes (themes) were ident ified.  
 
4.16. Data presentation: themes 
 
4.16.1. Impact of diabetes 
 
I  started the interview by asking the interviewee if they could recall when they were first told 
that they had diabetes. Some people responded immediately with stories about  the day they 
were diagnosed accompanied by explicit explanations of how diabetes affects a number of 
aspects of their life quality:    
 
“Oh I  wish I  never had it, it ruins everything….it ruins your sex life for a start, you 
can’t do the things you like, I  couldn’t play golf no more, I  just didn’t have the energy 
and then I  got the angina which made it  worse and then the eyesight goes and 
I nterview Name 
(pseudonym) 
Age Gender Ethnicity 
1 Azam 65 M Asian 
2 Edward 55 M White 
3 David 65 M White 
4 John 61 M White 
5 Paul 58 M White 
6 Raju 45 M Asian 
7 Richard 48 M White 
8 Stelios 78 M Mixed race 
9 Anne 62 F White 
10 Elaine 64 F White 
11 Catherine 45 F White 
12 Fred 70 M White 
13 Brian 66 M White 
14 Tom 73 M White 
15 Judy 60 F White 
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everything goes and it’s all down to the diabetes really, I  was a very active man at  
one time but now…….” (Fred) 
 
 “ I  suppose the lack of energy, that  seems to be one of my problems, it ’s an effort to 
get out of the house, out of the bed.”  (Edward) 
 
Edward also said:  
 
“All in all it ’s not been the be all and end all of my life, but I  think the two things 
combined, the not having a job and the diabetes……” 
 
Other people discussed specific activities concerned with controlling the condition. David 
described the difficulties with injecting and monitoring:  
 
“Since I  started taking insulin I  have noticed that  it is a lot harder than taking the 
tablets, injecting all the t ime now and checking three times a day.”  (David)  
 
whilst others found difficulties with dietary recommendations, 
 
“The having to eat and having to lose weight at  the same time, they’re kind of 
mutually exclusive activit ies and to try and keep fat  down and not eat too many 
sugars, and watch the carbohydrates and must eat three times a day. I  have a very 
busy life so trying to then fit those meals in around lifestyle and it does get very 
difficult especially because I  work away from home, I ’m eating canteen food and 
restaurant food at least one meal a day.”(Catherine) 
 
“ I ’ve put on so much weight, ten years ago I  was only half this weight and it’s piled 
on now.”  (Edward) 
 
“Having to pack up eating foods that  I  like.” (David)  
 
and also with alcohol:  
 
“ I  used to like a drink but  I  don’t  bother now.  I ’d sooner have a Diet Coke or a Pepsi 
Max, so that suits me fine and I ’ve packed up smoking.”  (David) 
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The complications of diabetes were also identified as being challenging to cope with, and 
manage. Richard described sexual problems:  
 
“Sex, there isn’t none, that is the worst thing, even at my age, and I  don’t class 
myself being old. “ I  mean I  still feel I  can do it  and all that, but I  need help sort of 
thing, Viagra injections and all that, ever since I  got circumcised through the diabetes 
it ’s just hasn’t, you know, hasn’t worked properly and it is, that is the biggest….I  
mean I  say to doctors and all that, it doesn’t bother me, but it does bother me, 
bothers me big time.  I  mean don’t get me wrong, I ’m not no oil painting but you 
know I  do, I  miss it, at  the end of the day, been all over the world, you know what I  
mean, so….. that is the biggest  downfall of diabetes, it ’s from that.”  (Richard) 
 
and one person ident ified eye problems:  
 
“ I  have noticed in the last two years and I  talk to the optician about this, I  f ind 
reading more of a strain now even though I ’ve had my glasses upgraded.  I  saw him 
in December and I ’m seeing him again, I ’ve got  a bit of diabetes in this eye.”  (Tom) 
 
I n contrast some respondents described how were able to cope with the condition by not 
necessarily taking on health-care advice, sometimes called non-compliance or non-adherence 
(Martin 2008):  
 
“….but it ’s not always easy and somet imes you think, oh to hell with it, I  want to live life, I  
don’t want to be, don’t do this, don’t do that , don’t eat this and don’t eat  that, every now 
and again I  say, oh sod it I ’m going to have a piece of fried bread you know.”  (Fred) 
 
“ I  must confess you cheat sometimes……diabetics cheat  all over the place….” (Tom) 
 
Stelios and Azam suggested that they did not  always keep to dietary recommendations, but 
doing that was acceptable:  
  
“As far as I ’m concerned, I  more or less, what I  say….. cheese and butter and all 
that, animal fat , keep off it, a little bit I  can have, and as much as I  like, but I  do 
watch it and I  more or less lead normal life, no problem at  all.”  (Stelios) 
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“ reading the diabetic things (informat ion sheets), you can spoil yourself now and 
again but if you do bad food regularly, fatty or sugary, that is not good.”   (Azam) 
 
The main messages from this theme appear to be that  the impact  of having diabetes is often 
intense, with many people reporting that  the condition has daily and long-term effects. For 
some people this means that activities of daily living are severely restricted, whereas others 
try hard to integrate the condit ion into their day-to-day lives. These experiences reflect the 
findings from other, larger studies (Phillips and Phillips 2007, Stodberg et al. 2007) .   
 
For the purposes of this study, these short extracts illustrate the importance of not  
underestimat ing the impact that diabetes can have on everyday activities and life quality. As 
a consequence, guidance on self-care for kidney damage must be realistic, that is, not  based 
on unattainable goals, and must show appreciation of how hard it can be to take on health-
care advice.   
 
4.16.2. Barriers to control 
 
When questioned about how far they were able to manage their condition (diabetes), a 
number of barriers t o enablement of controlling the condition emerged. These included some 
physiological barriers such as poor sight or memory:  
 
“ I  have a terrible memory and it has got to the stage where I  have got a system for 
taking my medications but that doesn’t always help.”  (Edward) 
 
Catherine cited difficulties at  work which did not  enable her to take the recommended dietary 
choices:  
 
“with canteen people and point ing out  to them that the foods they’re providing are 
not very diabetic friendly and ask for more choices other than pieces of fresh fruit in 
a basket, there are no other fruit opt ions and just at lunch it’s like a sandwich and a 
bag of crisps  - and the crisps are full of fat so you can’t have the crisps, and there’s 
all the puddings on the side - and I ’m not supposed to eat  the puddings, and if I  
have a whole meal - then I  can’t eat with my family in the evening.”  (Catherine) 
 
 113
 
Another generally accepted barrier to adherence, is differing cultural beliefs and health beliefs 
(Naeem 2003).  
 
Raju spoke about some prejudices that he had against western medicine:  
 
“ I ’m not totally convinced that  being on Western medication is the right  way forward, 
there are alternatives, my wife is a nurse and she doesn’t believe in a lot of 
medicines, it has side effects. So there must be an alternat ive, so, she just went  
home yesterday, her mum suffers for example, from blood pressure, all her mum 
does is go in the garden, pull up a lot  of  weeds, but  they’re just  growing there, mixes 
it  all up and you drink it, and that ’s it, so that  sounds like a positive way forward, but 
what about  the kidneys?” (Raju)  
 
 
whilst Azam thought that  eat ing well was a cultural issue – not just that food was widely 
available but also perhaps that  being overweight was accepted and a sign of wealth (Powell 
and Kahn 1995).  
 
“What happens (in [ country name] ), it is just like in this country, we see a lot of food 
in the shops and a lot  of food has a lot of sugar, a lot  of fat , a lot of calories, lots of 
different things.  So we are used to it, and also eat  a lot , that  was the order of the 
day!”   (Azam) 
  
Some people thought that not taking diabetes seriously enough could lead to people not  
taking on health care advice:  
 
“But I  was a bit blasé about it  when I  was initially diagnosed with it…….but no, I  
think if I  had taken it  seriously in those days and learnt  what I  know now, I  would be 
a completely different person.”  (Edward) 
 
David also spoke about  not taking advice seriously enough, but when he was asked about  
kidney damage he said:  
 
“and your kidneys, how that comes into it, and I  think, that was a shock, that bit.” 
(David) 
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The importance of get ting good consistent advice was also highlighted. I t could be argued 
that people are not able to self-manage if the advice is contradictory or unachievable.  
 
One example of inconsistency of message was part icularly noticeable when Anne and her 
husband were discussing nutrit ion:  
 
“ I  go to the doctor and she told me not to have vegetables, or just boil the 
vegetables, throw away the water, boil it again and then you can eat it.  They 
confuse me so much.  Then I  go to the diabetic nurse and told her what she said and 
she said oh no, you mustn’t do that, you must  have this and that.”  (Anne) 
 
This inconsistency was summed up by David:  
 
“Sometimes you think you can’t win.”  (David)  
 
Another cited issue was difficulty in putting the health-care advice into practice:  
 
“so I  was looking at that (blood sugar reading) and calling them up and saying it is 
so and so and so and so today and I  could never find out, and they couldn’t explain it  
either, why I  can go a whole week with no problems and no highs or anything, 
nothing has changed and all of  a sudden I  get a massive great blip and I  don't  know 
why that happens….”. (Edward) 
 
“You are so disappointed when you st ick to what you are supposed to be eat ing and 
not supposed to eat , you follow it right through and you take a reading later on and 
it  is about 15 and it ’s ridiculous.”  (David)  
 
 
David went on to say:  
 
 
“ I t is disheartening, yes. I  found when I  went on holiday, I  went to Greece about  
three years ago and I  more or less had what I  wanted, because you don’t get the 
food you have over here obviously, but I  just had anything and I  found my numbers 
was low all the time.  That's what annoys me.”  (David) 
 
Anne agreed with David:  
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“ I  go through so many t imes with the nurses, the diabetic nurses and if you look at  
what I  eat , it  is nothing out of the normal, you know.  But they st ill don't understand 
why that  diabetes goes up and down, up and down.  Sometimes it goes up to 28, 27, 
25…….” (Anne) 
 
I n summary this master theme has highlighted three barriers to taking and acting on the 
advice. These are physiological barriers, health beliefs and inability to take-on health-care 
advice. These barriers can be sub-divided into secondary themes (codes) including cultural 
beliefs, fatalism and the belief that diabetes is not a serious condition.  
 
For the purposes of this study these themes must be considered when developing the self-
management package. For example advice must  be practical and it must recognise the 
different ways in which people have accepted and coped with the disease. Most  importantly, 
the information must be agreed on by all the health-care team (to avoid inconsistency of 
message), and must  give advice that enables people to take control of their condition.  
 
4.16.3. Self-management  
 
4.16.3.1. Risk of kidney disease 
 
The interviewees were asked in detail about how far they thought they were at risk of kidney 
damage. Some respondents were aware of the risk of kidney damage in diabetes. Fred said:  
 
“Well yes, I  mean when they first told me they said to me something like, you’re 
likely to have kidney damage by the time you’re 85 and I  just thought, to hell with 
being 85……. I ’ll probably never make 85 anyway.”  
 
NT: How old are you now? 
 
“72, so I  thought I ’ll never make 85 anyway but  I  was only, I  don’t know how old I  
was then, 70’s or 65, so I  didn’t  worry too much as I ’ll probably have so many things 
wrong with me by then that  would be the least of my worries but when you start to 
think about it , I  mean I ’ve got enough problems I  don’t want  another problem, it 
frightened me in a way because my father had kidney damage, he died of TB, he was 
only 46 years old. I ’m the oldest surviving man in my family thanks to you lot, 
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nobody has ever lived as long as me in our family, none of my brothers lived over 60, 
no uncles who lived over 50.”  (Fred) 
 
Catherine commented:  
 
“ I ts only been in the last year or two that someone happened to mention that the 
three were related and that by having my blood pressure under control it would help 
to stop kidney damage and so on.”  (Catherine) 
 
 
When Edward was asked about the risk of kidney damage, he replied: 
 
“That was never said, never. I ’ve never been told that.”  (Edward) 
 
whilst Tom said:  
 
“ they said that  that  I  could be vulnerable but they haven’t said to me in terms of the 
data that  they have that I  have a kidney problem.  I  go to Doctor B every six 
months.”  (Tom)   (Note:  Dr B is a nephrologist).  
 
Catherine reinforced the point by saying:  
 
“ I  would say that I ’m much less well-informed about the link between diabetes, heart 
disease and kidney disease (compared with other complications).”  (Catherine)  
 
4.16.3.2. Opportunities for self-management 
 
When the interviewees were questioned further about how far they thought they could 
control kidney disease progression, with the question, “do you know of any things that you 
yourself can do to try and delay the kidney disease getting worse?”, this answer typified 
many responses:  
 
“Not at all.”  (Raju) 
 
Although later, when pushed, Raju was able to identify some strategies that could help. Only 
a few people were able to offer any suggestions:    
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“ I t could be the blood pressure.”  (Azam)  
 
However only Azam thought it may be blood pressure. One person ment ioned blood sugar 
control;  diet was mentioned by one person;  taking tablets as prescribed and watching for 
proteinuria was mentioned by one person:  
  
“check the protein levels in the urine, the medication I ’m on, obviously the beta 
blockers, etc etc, got  to watch the kidneys and protein in the urine is not high.” 
(Raju)  
 
No-one ment ioned lifestyle modification such as smoking cessation although two respondents 
thought  that alcohol was a key factor:  
 
“ I  don’t know hardly anything about  what causes it;  I  always thought  too much 
alcohol caused a lot of trouble with the kidneys.”  (Brian) 
 
 
“Kidneys? I  think it was drink, oh no that’s liver isn’t  it?  Oh the bad thing that’s 
made…. no I  don’t  know, is the answer.”  (Paul) 
 
Generally these quotes typify the responses:  
 
“Well they didn’t really enlighten me, nobody has said you have got this because you 
indulge in A or B.”  (David) 
 
“ I t is just decay of the kidneys presumably and that’s irreversible isn’t it?”  (Edward) 
 
Only one pat ient understood why they were providing a urine sample for microalbuminuiria. 
Most believed the sample was being taken to check there was no infection in the urine.  
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4.16.3.3. Blood pressure 
 
Concerning blood pressure control, interviewees were asked about  the link between kidney 
damage and blood pressure:  
 
“Well, I ’ve had more blood pressure taken than anyone in England! I ’m always 
having my blood pressure taken. The doctor’s always keeping an eye on my blood 
pressure. I  don’t know what it has to do with kidneys.”  (Brian) 
 
I f the interviewees did not realise there was a link between kidney damage and blood 
pressure control, they were then questioned further about their own blood pressure:  
 
“ I  think part  of it is a bit high but  there are the two parts of course, one is good and 
one is bad but which one, I  don’t  know which way round it is.”  (Azam) 
 
“ I  think I ’ve always been the type of person who’s had high blood pressure, I ’m sure 
of it , the environment I ’ve worked in, I ’ve been pressurised and I  react appropriately, 
blood pressure’s down, I  feel like I ’m asleep, so I ’m not sure how that relates but  I ’m 
still of the opinion that  levels the doctors want it to be down to, are not  realistic for 
me as an individual, but not having any medical background, I  cannot comment.”  
(Raju)   
 
Stelios was confused about the blood pressure readings:  
 
NT:  And what about your blood pressure, is that high?  
 
“Blood pressure, when I  had a slipped disc, it was very high, so it does affect, the 
illness does affect it. I t was up 112, 116 and on my operation day, you know they 
were talking about  it ’s very risky for my slipped disc.”   
 
NT: Do you know what the top number was?   
 
“Top number about  100, around, anything around 120, I  was in the hospital…..”   
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NT:  Ah, would it be…. the top number would have been higher than that , it ’s 
probably the bottom number.   
 
“Oh I  see.  Anyway they say it ’s very high to have operation.”  (Stelios)   
 
Further questions were asked more specifically about medication (ACEIs and ARBs) and their 
role in kidney disease progression:  
 
NT:  I t is called an ACE inhibitor, lisinopril, which is the one you take. 
 
“Oh I  thought that was for blood pressure.”  (Edward)  
 
They were also asked about side-effects:  
 
“Yeah, I  was terrible, I  had terrible headaches, I  was itching, cough, terrible cough 
yeah.”  (Fred) 
 
“ I  did at  first (have side-effect s)  yes.  When I  first took it I  was very heavy, heavy 
headed and things like that.”  (David) 
 
NT:  Did you just carry on or did you stop taking them? 
 
“ I  did stop taking them at first but then I  saw Dr Y and he said you’ve got t o take it 
morning and evening, I  had one in the morning and one in the evening. I  think since 
I ’ve retired from work that's helped because you don’t  get the side effects like I  did 
before, getting up at three in the morning, unhealthy hours.”  (David) 
 
“All the pills I ’m taking and there is the side effects, say may make you drowsy, so no 
wonder I  keep falling asleep, I  take all these pills and they just knock me out and 
then they say I  don’t get  exercise, well I  can’t I ’m asleep all the time. You know ones 
fighting against the other, that’s what I  find personally.”  (Raju) 
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4.16.3.4. Smoking 
 
A small number of people who were interviewed used to smoke, and generally there was 
recognition that smoking contributed to bad health, and might  be potentially dangerous to 
continue:   
 
“No, I  don’t smoke.  I  used to but  I  don’t now. I  gave up three years ago now.  That  
was my own choice, one day I  had a wheezing and I ’d never wheezed before and I  
thought  this is stupid so I  just gave it up and it wasn’t a problem to me after that.”  
(Edward) 
 
“ I  had a heart  bypass and that  frightened the life out  of me and I  thought  that’s it, 
now’s the time.  I  don’t regret it neither although I  used to like smoking to tell you 
the truth.”  (David) 
 
Two people however were st ill smoking, and did recognise that it was potentially harmful to 
their health:  
 
“Okay, doctors, nurses, hospital have all advised and saying, you know I ’m the only 
smoker in the family, started smoking to stay awake…..the work I  was doing in 
sales…. I  was out of the house by eight in the morning, or earlier, and which I  did 
until one and two in the morning, sometimes way out of town, needed something to 
keep me awake, so I  started smoking those huge cigars and moved on to cigarettes, 
went  from the lite to something a bit stronger, 20 years later I ’m hooked, well and 
truly hooked, I  accept fully the benefits of coming off it, especially being a diabetic, 
mind’s willing but my body doesn’t want to know.”  (Raju) 
 
“ I  know it’s the smoking, I  don’t need telling, I  know smoking does my blood 
pressure.  And I  know it ’s silly what I ’m doing but it ’s very hard, very hard.”  (John)  
 
NT:  You said you have t ried hypnosis, have you tried anything else? 
 
I ’ve tried patches.  Without  lying, I ’ve had a patch on, been chewing the chewing 
gum and smoking at the same time.  You don’t have to tell me I  have to be backward 
to do it, but I  can’t stop.  I  can’t  help it. 
 
NT:  I s there anything that would make you stop? 
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“Yes, if I  died.”  (John) 
 
4.16.3.5. Exercise 
 
Only Raju mentioned taking exercise when asked about managing kidney disease, and his 
response was:  
 
“As far as I ’m concerned, it ’s all well and good saying to me exercise and everyone 
says that, doctors, nurses, hospitals, whatever, where the hell are you supposed to 
walk?” (Raju)  
 
 
4.16.3.6. How to get key messages across 
 
One question concerned the different ways in which people can get information about  
diabetes care and management:   
 
“ I t is good to have things on the television and the radio - that  is good to put over a 
message.”  (Azam)  
  
A few people mentioned the positive use of internet to find out  informat ion:  
 
"Yes, I  have done that (searched the internet) a few t imes, yes.” (Edward) 
 
Oh yes, oh yes.  I  mean it’s there (the internet) and it’s free. I  don’t remember 
everything I  read about it  but there are things that go at you, punch at you and I  
think, right and it gets left  there whereas a lot of the stuff you read, you don’t  
remember it.”  (David) 
 
but David later added:  
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“ I t can cause all sorts of problems, when you read what’s on the computer – and 
there were a couple of reports from the Lancet on there and things like that  – what!”  
(David)   
 
Others described why they did not use the internet at all: 
 
“….and in general that’s what I  find with the internet, there’s so much informat ion 
and separat ing the wheat from that  chaff, and it  can be scary of course as well.”  
(Catherine) 
 
“No, I  can’t  get into that, too complicated” (Judy) 
 
“but us people who it’s all new to, over 50s or over 55s anyway, they’re not going to 
bother too much are they?” (Paul) 
 
A number of people mentioned books or other written information that informed them about 
diabetes and its management:  
 
“And I ’ve got  a book about diabetes, which I ’ve had for many a year now. I t tells you 
what you should eat  and what you shouldn’t eat and all that.”  (Brian) 
 
“ I ’ve had some stuff from them (Diabetes UK) and it’s quite good…….but if I  tend to 
read too much into I  find I  can’t have this and I  can’t have that.”  (David) 
 
Stelios was asked:  
NT: So if you have any quest ions about your diabetes where do you normally go? Do 
you ask D (practice nurse) or ……..? 
 
“Well no, not really, in the hospital, the nurse, before I  left the hospital, they come, 
the diabetes, she showed me how to, come down and all that  and the booklet they 
told me that’s the best thing, you know about  low and high and the blood pressure 
and sugar level and. ….”   
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NT:  So do you have any other questions?   
 
“No not really.  Keep it simple.”  (Stelios)  
 
 
Two people thought that DVDs might  be a good way to get the information across:  
 
“ I  would use DVDs.  I f there was a DVD which gave me direct relevant informat ion 
about that sort of thing, I  would use that either on the PC or on the television, that  
could be quite useful. I  think in the DVD you need some visual aids so that it actually 
describes what you might call the physiology and the anatomy of the kidney as to 
how it is approached.”  (Tom) 
 
“ I  think a picture will tell a thousand words…..if you can get people to watch a video 
or DVD…..”(Paul) 
 
The implicat ion is that generally people like to basic information which is presented in a visual 
and understandable way, and is not  too complicated. 
4.16.3.7. I ndividual versus group sessions 
 
When asked about the best way to get  information, many people spoke of individual 
consultations, and somet imes ‘group sessions’:  
 
“Of all the various sessions that  I ’ve had through the course of my diabetes the one 
that worked the best  was a classroom session, it was myself and a number of other 
diabetics, this was in [ country name]  by the way, we came to the local hospital, it 
was a one day session and it wasn’t any one particular facet of diabetes but whole 
diabetes, very intensive, classroom time as a group, individual t ime, it was 
part icularly helpful, sort  of realising, I ’m not the only person trying to deal with this 
and hearing about some of the problems others were having.”  (Catherine) 
 
“ I  don’t know, sometimes large groups work, because a lot of people ask the 
questions and then other people do, but I  think a one to one’s a lot better, 
personally, maybe like a group therapy afterwards but  a one to one is better.”  
(Richard) 
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Only two people mentioned ‘group sessions’ as a place to get information, and although the 
question was not asked explicitly, it appears that very few have had access to formalised 
education programmes such as DESMOND, or those offered by the local diabetes centre.  
 
Two people did talk about information giving on a one-to-one basis:  
 
 “ I  think people like yourself, nurse J and the doctor, them saying things, then I  take 
notice of it.”  (David) 
 
“My preference is one to one, big difference, for example both of you make eye 
contact, a lot  of people don’t, once you’ve got  the attent ion, you open up, speak your 
mind, say what you need to say, ask what you need to ask……” (Judy) 
 
A number of interviewees talked about learning from other people, not just those with the 
condition, but from family and friends:  
 
“ they show you a video all about diabetes and I  happened to be sitt ing to another 
chap and afterwards he said to me, well whatever you do listen to what they tell you, 
he said, I ’ve been diagnosed 10 years ago, I ’ve already lost my foot and I ’m here 
because I ’m trying to save this one, and obviously I  was very interested in what you 
had to do.”  (Fred) 
 
“…..he was on insulin and he used to eat anything, cream cakes and things like that  
but to me that is ridiculous because you are just going from one extreme to the 
other. He ended up having a heart attack.”  (David)  
 
“ I  think it is a lot to do with the family, the family should just keep pointing out to 
them, look it ’s bad, it ’s bad.”  (Azam)  
 
4.16.3.8. Location 
 
Fred said that  the location of the information-giving was important, and thought that kidney 
problems should be dealt with in a separate clinic:   
 
“ I  think it would be better to separate it from the diabetes clinic in a way, if it  was 
done at like the renal centre I  think because you know that it is the kidney and it is a 
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different thing and if you got a leaflet or a let ter from them, I  think you’d be more 
likely to take notice, I  mean I  get  things from the diabetes society all the time and 
you just don’t read them, it ’s like junk mail you know but  if it  was something more 
serious like the kidney I ’d be more inclined to take not ice from say someone like you 
and dealing with it  separately from the diabetes.” (Fred) 
 
4.16.3.9. Timing 
 
Other people mentioned timing of education sessions. Catherine thought  that too much 
information at  the start might be detrimental to learning:  
 
“ I  guess it depends, if I  was planning a training programme, right up front I  would 
make sure people were aware there was a link but I  probably wouldn’t t ry and front  
load because when you’re first diagnosed you’re so busy with, again Type 2 
specifically, what you’re eating, watching your sugar, all the other things, there’s just  
not enough t ime left but your mind is so busy with those things that  to take in some 
of the other things, it ’s just too much.”  (Catherine) 
 
whereas Richard thought that  the risk of kidney disease should explained at the outset:  
 
 “ I  think, yes, I  think st raight from scratch, straight from the start , because obviously, 
people should be informed as well, you know it ’s going to change big time, so I  think 
they should be you know, you’re going to get a shock, if you’ve got somebody with 
diabetes, second biggest  disease in the country and also, going to have a problem, 
you should tell them right  from the start, not  wait.”  (Richard) 
 
Edward suggested that  he was not told early enough about  the risk of kidney disease:  
 
“As I  say, after five years of just taking pills and being blasé about  things, I  got the 
first lectures and there were lit t le alarm bells ringing then but if I  had known then 
what I  know now I ’m sure I  would have been a lot  better now in a lot of respects, 
including my kidneys.  I t is just  education isn’t it? Which is what you are all about.”  
(Edward) 
 
The opt imum delivery point  for educat ion concerning the risk of kidney disease appears to be 
contentious amongst  this group. This warrants further consideration when making 
recommendations for timing of distribution of the self-management package. 
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Comments concerning educational content were made by Edward:  
 
“ I  think explaining to them in layman’s terms exactly what the problem is and I  can 
guarantee that about 50%  of the people I  know don’t even know what the kidney 
funct ion is. So you have got to start with what the actual kidney does, why it is not  
working properly and the reasons why it is not  working properly.”  (Edward) 
 
whilst Azam thought  that follow-up was important:  
 
“ I  think also if someone doesn’t attend the surgery someone should say why is 
Johnny not coming to the surgery, they need to check up to see if he is all right and 
get in contact with him and say there may be a problem maybe with your blood 
pressure or your blood sugar.”  (Azam) 
 
4.16.4. Learning and teaching leading to a change in behaviour 
 
Although people were asked about  how best t o deliver education and promote self-care, 
interviewees were also asked about what  might make them change their behaviour.  
 
NT:  So when she (the practice nurse) explains to you about  the complications, what  
makes you change the way you are, in terms of maybe what you eat or, or…..?   
 
Paul responded:   
 
“Well I  suppose you don’t…… I  don’t know the answer to that, I  know it’s just 
stupidity I  suppose, if someone’s telling you if you keep hitt ing your finger with that 
hammer, and you know you’re going to lose it, eventually you will stop doing it, I  
suppose that’s, so that’s what it is……… well for me I  don’t mind people saying well 
he’s fat, but I  wouldn’t like them to say he’s stupid.”  (Paul)  
    
Paul also ident ified the importance of not just informing patients about how kidney damage 
might progress, but also of shocking people into changing their behaviour:  
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“…..I  mean it’s all right telling people, yes I  suppose you’ve got to encourage, but I  
mean it’s the other one as well, about the shock one….. I  didn’t do it  and this is what 
happened to me, off come the legs, I ’m now walking with a st ick you know.”  (Paul)  
 
 
Paul also added:  
 
“They perhaps don’t frighten people enough.”  
 
 
Brian could clearly recollect one practice team member who tried to change his behaviour:  
 
“…so some doctor there used to hammer me, slaughter me, there….. ‘You’re not 
helping yourself …’ and they were giving me hell because I  was putting on weight 
and my blood pressure wasn’t good.”  (Brian) 
 
Some people thought that kidney damage should be made to sound serious:  
 
“ I  think with the kidney thing it ’s different because it’s a vital organ, it ’s like having 
heart problems, you’ve got to take that very seriously.”  (Judy) 
 
“ I ’d tell it straight, that’s what you’ve got to do.”  (Paul) 
 
“They should tell us the downfalls of diabetes, not to brush it  off …....” . (Richard) 
 
“ I  mean kidney damage is a bit more serious I  think and if there’s a way of slowing it 
down then yeah all well and good, I  mean if you can find a way of slowing down 
losing your eyesight every month then I ’d be interested.”  (Fred) 
 
A number of people were concerned that they were not being told the truth about what could 
happen if kidney damage progressed:  
 
“ I  think a picture will tell a thousand words…..if you can get people to watch a video 
or DVD showing how it is and what will happen, not  may…..that  would, oh crikey, 
that would make me think……”  (Paul)  
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“ I  think specific instruction from people who know is actually very helpful and also to 
be told the truth. I  don’t  want anyone to tell me anything other than the truth about  
myself.”  (Tom) 
 
Raju showed his mistrust  of medical staff, which could also result in not  taking health-care 
advice:  
 
“my parents are of a generat ion where they believe doctors are Gods and we now 
know that’s not the case.”  (Raju)  
 
 
The question that was partly answered in these interviews by a small number of respondents 
was how far good education might have changed behaviour:   
 
“Would it have changed me?  I  don't know, I  wouldn’t have thought  so.  The first five 
years of me knowing about it, it was just an inconvenience but if I  had been, how 
should I  say, a bit more regimental in the system I  probably wouldn’t  be in quite such 
a bad condition as I  am now but that was probably from misinformation or lack of 
information probably but when they put me under the specialist diabetes people at St  
M’s, they gave me some proper lectures and I  realised just how serious it  was.  
Before I  thought it was just one of those things because 6% of the population are 
diabetic.”  (Edward)  
 
Azam suggests though that even if a person received good education, it would make no 
difference:  
 
“Today’s generation have all the information available but …they drink a lot  and 
smoke all day long.”   
 
and he later added:   
 
“…that ’s what happens to Mauritian people or I ndian people, they don’t think oh well 
– I  mean when we are young we take chances.”  (Azam) 
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presumably meaning that people often don’t think that ill-health will happen to them.  
 
However when the interviewees were asked about how far it was an individual’s responsibility 
to look after one-self, a number of people were very clear about  their role:  
 
“ I  listen to the advice and deal with it  accordingly, put it that way!”(Edward) 
 
“Honestly if people want t o, they can help themselves.  You can help so much, but  
people have to help themselves” (Azam) 
 
“No, if there’s anything I  think will help me, then I ’ll do it.”  (David) 
 
“So, if they say something, you’ve got to t ry and do something about it yourself. I t ’s 
the only way you’ll do it, isn’t it?”(Brian) 
 
4.17. Summary of interview  findings 
 
I n this small group of patients it appeared that few people had good understanding of the 
possible risk of kidney disease, and the majority had little idea of exactly how they could 
control the condition themselves. With regards getting key messages across a few 
interviewees thought that  that  visual media (TV, film, internet) might be helpful whilst others 
preferred an individualised approach with a health-care professional.  Most spoke of the 
seriousness of kidney disease and how people would take notice if there was a clear 
message, underpinned by ‘truthfulness’ (clarity) about what could potentially happen. One 
potential barrier to taking on healthcare advice in this small group of pat ients was 
inconsistency of  message from health care professionals. 
 
 Each of these themes was taken into considerat ion when developing the self-management 
materials, and will be discussed in the following section. 
 
These extracts have highlighted the main issues that affect people with diabetes in this small 
sample. The main barriers to controlling the condition have been identified, alongside the 
different ways in which health care professionals can provide information and education to 
facilitate self-care.  
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4.18. Development of the self-management package 
 
4.18.1. Educational package:  contents 
 
Findings from the part icipant observation, a systematic review of the literature and the 
interviews informed the development of the pat ient-centred education package. Findings 
from the participant observat ion were presented in detail in Chapter 2;  findings from the 
literature review were discussed and analysed in Chapter 3. A summary of both is reviewed 
here. 
 
4.18.2. Findings from the 3-month participant  observation in 2004 
 
I n summary the findings relevant to the self-management package were staff and patient 
confusion over microalbuminuria testing and discrepancies over blood pressure measurement 
and management, possibly indicating an underlying lack of knowledge amongst primary care 
staff. 
   
4.18.3. Findings from the literature review 
 
I n summary the overall finding was that  the use of self-management programmes in chronic 
disease is developing, and some of these programmes are beginning to show success 
(Chodosh et al. 2005).  What is not  clear is exact ly how these programmes should be 
executed (face-to-face versus group education), what  the method of facilitating behavioural 
change should be, or what  the content should include. I t is difficult to compare findings 
across different studies because of differing methods and outcome measures. Health policy 
however is clear, with Department of Health report s consistently outlining the importance of 
implementing patient-centred self-management programmes (Department of Health 2008b).  
 
4.18.4. Findings from the interviews 
 
I t must be emphasised again that  the small number of respondents’ views were used only as 
a basis for the package development, rather than to make generalisable claims about the 
overall experiences of people with diabetes. 
 
One main finding was the importance of realist ic guidance for self-management:  guidance 
must  be not  based on unattainable goals with lack of empathy about how hard it can be to 
take on health-care advice.   
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A number of people were concerned that they were not being told the truth about what could 
happen if kidney damage progressed. The key issue appears to be that patients at  risk of 
kidney disease were not necessarily told (or perhaps did not hear) what might happen if they 
did not take on health care advice. 
 
Few respondents were aware of  the risk of kidney damage in diabetes. Not  one patient 
understood why they were providing a urine sample for microalbuminuiria. Most believed the 
sample was being taken to check there was no infect ion in the urine.  
 
When quest ioned directly about whether they themselves could do anything to prevent the 
kidney disease progression, only a few respondents were able to offer any suggestions:  blood 
pressure control (1 patient);  blood sugar control (1 patient):  diet (1 patient);  taking tablets as 
prescribed (1 patient). No-one mentioned lifestyle modification such as smoking cessat ion 
although two respondents thought that  alcohol was a key factor. Few understood the link 
between kidney disease and high blood pressure.  
 
The interviews confirmed my original anecdotal evidence that  led to this study, that although 
most people had some understanding of the possible risk of kidney disease, they had litt le 
idea of exactly how they could control the condition themselves.  
  
4.19. Curriculum  
Although the aim of this thesis is to develop and test an educational package, rather than an 
education programme, an outline ‘curriculum’ needed to be developed to make explicit the 
aims of the package, the philosophy underpinning the package, the content and the ways in 
which the package can be used by health care professionals (Diabetes Education Network 
2009).   
The aims of the package are:  
 
• To inform people with diabetes of the risk factors for developing kidney damage 
• To provide key points for managing the ways in which kidney damage can be slowed 
down in people with diabetes who are at risk 
• To give more detailed information on how they can self-manage their condition 
• To provide practical ways for increasing self-management 
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The educat ional philosophy that underpins the package emerged from the themat ic analysis 
of the interviews. I t was important to ut ilise a patient-centred approach, that is, one that was 
based on what the interviewees had said, and not one based on an educational theory that  
was rooted in academia.  
 
The three concepts that were ident ified from the literature review and patient  interviews 
were:  
 
(1)  Patient-centred  - with patients themselves telling the story (learning from each other)  
(2)  Empowering - with an emphasis on what can be done to control the condition 
(3)  Truthful - what can happen if kidney disease progresses. 
 
Overall the package was based on the concept of self-management – a concept that was 
encouraged by GPs and practice nurses in the diabetes clinics at the six participat ing 
surgeries, and reinforced by national policy (National I nstitute for Health and Clinical 
Excellence (NICE) 2003).  
 
The content  of the package was based on the findings of the case study, literature review 
and interviews, that is, topic areas that interviewees wanted to know more about or did not  
understand. A summary of these topics is shown in Figure 4.7. 
 
Figure 4.7:  A summary of the findings that informed the development of the educat ion 
package 
SELF-MANAGEMENT
TRUTHFUL EMPOWERING
PATIENT CENTRED
Patients telling the storyNo medical jargon
Urine test
Blood sugar
Blood pressure
Lifestyle modification
What can be doneWhat can happen
 133
 
 
As the study progressed it became clear that  there were a number of challenges in 
developing a t rue ‘patient-centred’ package. As much of the literature suggests, there are 
constraints on time, pressure to achieve targets and also the realisation that empowering 
people to control their condition may not necessarily mean that care is ‘patient-centred’. For 
some patients, there is a tension between the emphasis on self-management and doing what 
the individual wants. Some people may prefer to rely on professionals or family members to 
control their condition (a so-called external locus of control). An empowering educat ion 
package may not necessarily be a patient-centred one, or indeed may not appear to be 
pat ient-centred to the patient  (Funnell et al. 2005).    
 
4.20. Overall design of the package 
 
A number of criteria were considered important when developing the package. 
 
A range of different types of educat ional media had to be developed as people learn and take 
in health information in different ways (Honey and Mumford 1982). The package had to be 
able to stand-alone without the necessity of a health-care professional being present to 
explain the content. However there had to be a facility whereby patients could consolidate 
their learned knowledge and also had the opportunity to ask questions. The educational 
content had to be presented in a language that  was patient-friendly and also contained no 
hospital jargon. There was local Trust guidance and national guidance (Patient I nformat ion 
Forum (PiF) 2005) available on how to write clear and understandable patient informat ion 
materials, and this guidance was used to both help plan and write the materials. 
 
Figure 4.8 outlines the main issues to be considered and included when developing health 
information materials. The self-management package was developed using these 
recommendations  
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Figure 4.8:  Main issues to be considered when developing learning materials for pat ients 
• Details of who produced the information and when 
• Written in easy to understand language 
• Clearly arranged with helpful and appropriate illustrations 
• Contains contact details for the organisation, department and any support organisations 
• Based on current research informat ion and evidence 
• Answers patients’ questions 
• Clear about any risks, side effects and benefits of a procedure 
• Explains about the impact the condit ion or procedure will have on the patient’s everyday 
life 
(adapted from Patient I nformation Forum www.pifonline.org.uk)  
 
I t was also crucial that a range of materials were developed that  accounted for differing 
information needs and different leaning styles. Figure 4.9 demonstrates the range of 
materials that provide differing levels of information, which in turn can facilitate different 
levels of self-management. For example some people may want  simple messages about  
managing CKD, and headline messages for this purpose are shown on the fridge magnet. 
Other people may want to understand why they are providing an annual urine sample (as 
explained on the DVD), and then engage in discussion with their GP or pract ice nurse about  
taking ACEi/ARBs. This discussion could then be recorded in the monitoring diary. 
The contents of the package are shown in Figure 4.9 and a photograph of the package is 
shown in Figure 4.10. Further discussion about the development, implementation and 
evaluation of the package is provided in Chapter 8. Both versions of the package (before and 
after evaluation) can be found in Appendices A (before evaluation) and B (after evaluation). 
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Figure 4.9:  Contents of the self-management pack 
 
Kidney Disease: Reducing the Risk 
Self-help for people with Diabetes 
 
A fridge magnet (with key messages) 
 
 
Written information 
 
 
A 20-minute DVD filmed with pat ients. Eight sections including screening for MA, BP and 
blood sugar management, lifestyle modification, and a section on what can happen if kidney 
damage becomes worse. The emphasis is on what can be done to control the condition. 
 
 
A monitoring diary to record results and questions to be asked at clinic visits 
 
 
A blood pressure machine if required 
 
 
Depth of 
informat ion  
and  
opportunit ies  
for self-
management  
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Figure 4.10:  Photograph of the contents of the self-management pack 
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The costs, rationale for inclusion, a description and explanat ion of each of the materials now 
follows.  
 
4.21. Costs 
 
The project has been partially funded by a variety of different organisations and charities, 
and these are itemised in Appendix 2. I  developed a budget for the project prior to 
submit ting applications for funding. Once the funding had been secured, the total amount of 
money available to fund the development of the package was approximately £12,500. I t was 
envisaged that the majority of costs would be taken with the planning and filming of the DVD 
(see Appendix 7). Although the start-up costs were high, subsequent production costs will be 
approximately £1.00 per pack.   
 
4.22. Packaging 
I t was important that all the materials could be kept together in a small box. This would 
enable the materials to be kept clean and easy to store. The size of the box was determined 
by the minimum size (length and breadth)  that could hold a DVD, and also a depth that could 
easily keep all the other materials together. I t would also be beneficial for the box to be of a 
size that could easily be accommodated on a book shelf.  
 
The next consideration was price and the internet was searched to source the cheapest and 
most appropriately-sized box. A specialist company ‘The Bag N Box Man’ was able to provide 
boxes at approximately 15 pence each, although these boxes were delivered in a flat -pack 
and had to be assembled by hand.  
 
4.23. Logo and ‘house style’   
National guidance on developing patient information materials had highlighted the 
importance of using a ‘house style.’ This meant that  the use of logos, fonts and formatt ing 
had to be consistent throughout all the materials. I t was not necessary to include a hospital 
or primary care trust logo, but  rather to show that the project  had been funded and endorsed 
by a number of organisations and charities.  
 
The type font that  was used throughout was ‘Acoustic Bass’. An example is shown in Figure 
4.11. 
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Figure 4.11:  Acoust ic Bass font  
 
 
 
This font that had been found by the film production team (see section on film below) and 
was thought by the team to be contemporary and eye-catching. I  was unsure about the font, 
especially as it might possibly be difficult to read by an individual who had eye problems, 
which is common in diabetes.  
 
I n order to verify whether the font might be suitable, I  asked a small number of people with 
kidney disease and diabetes whether the font was clear to read. I n addition the Royal 
National I nstitute for the Blind (RNIB) website was searched to see if there were any 
recommendations for font type for those with impaired vision. The site suggested that as long 
as the colour was black on white, or white on black, and of  a font size of ≥14, it was likely 
that it would be readable.  
 
4.24. Pack contents 
 
4.24.1. Written information 
 
The written information was developed as an additional resource, either as a stand-alone 
learning tool, or to be read in conjunction with the film. The writ ten information was 
presented in the same format as the film, with sections on screening for MA, BP and blood 
sugar management, lifestyle modification, and a section on what can happen if kidney 
damage becomes worse. Each section was writ ten in an easy to read style without medical 
jargon. The information was reviewed by the second supervisor, a specialist renal nurse and 
a practice nurse. A pat ient  in the renal unit was asked to check the document for clarity and 
understanding.   
 
An A5 leaflet was developed and costed by the Medical I llustration Department in the local 
hospital. 200 copies could be printed for under £50 if the leaflet was printed in black and 
white, and one colour (red) to be used in the heading.    
 
4.24.2. Film 
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I  had been involved in giving a presentation at a national conference on chronic kidney 
disease, and the event  had been organised by a pharmaceutical company. The 
pharmaceutical company had used an advertising/marketing company to organise and 
promote the day, and the contact at this company was able to provide names of two film 
production companies.  
 
Both companies were contacted and given a brief. The brief was to develop, film, edit and 
produce a 15-minute film that  would be produced within a three-month timeframe (end April 
2006). One was selected as the director of the chosen company appeared to understand the 
remit and also because he used freelance cameramen and directors, so the price was 
considerably less. Once the price for filming had been negotiated, it was checked by a friend 
employed in a marketing company to confirm that the price was reasonable. A breakdown of 
the costs is shown in Appendix 7. 
 
I  met the director of the film company on two occasions to discuss the content of the film. 
After the second meeting a draft script was written (see Appendix 8). I  then met with the film 
director one week prior to filming to discuss practicalit ies of filming in a patient’s home, in a 
GP surgery and also in the hospital.  
 
4.24.2.1. Filming in a pat ient’s home 
 
A number of patients had been ident ified for a possible film case study during the 
interviewing process. I t was important to find a ‘typical patient’, one who would relate to 
other people in the same situat ion and one who was able to articulate on film the concerns 
and day-to-day experiences of having diabetes. I t was important to find people who had a 
positive attitude to their condition, and therefore gave the message that diabetes is a 
condition that  can be controlled. I t was vital to show that it is not always possible to take 
every bit of health-care advice on board and to be realistic about living with the condition. 
For these reasons the gentleman who was chosen was a retired man of 73 years, who lived 
at home with his wife. He is a man who manages his condition well, but at  the same time 
was able to talk eloquently about  how he loved food and how he sometimes struggled to 
keep to the advice offered.  
 
The day of filming went well. We arrived at the gentleman’s house at around 8:30 and 
surprisingly the film crew took up the offer of a cooked breakfast  from the gentleman’s wife 
so the start t ime was delayed. There were some anxious moments for me. When filming the 
gentleman taking his blood sugar using a not-quite perfect technique, there was the dilemma 
about whether I  should ask him to repeat the technique and next  time make sure that his 
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finger does not touch the test  strip. There was also a worrying time during filming when the 
gentleman was riding his bike with the film crew following in their 4x4 vehicle. I  was 
concerned that  he might fall from his bike as he was being filmed or whether he might return 
to the house very breathless after undertaking a number of circuits of the local roads. 
 
4.24.2.2. Filming in a GP surgery 
 
The second patient who was requested to take part was a 68 year-old lady who lived with her 
husband, and had been diagnosed with Type 2 diabetes around ten years ago. I  understood 
from her GP that  she had difficulty in coming to terms with needing insulin to keep her blood 
sugars under control, but nevertheless she worked hard to take exercise and heed dietary 
advice. She was delighted when I  asked her to take part, and enjoyed the experience of 
filming with the staff in her local surgery.  
 
I n the surgery it took some time to set up the equipment, as we needed to film in three 
locations:  the waiting room, the nurses’ consulting room and also the GPs office. Permission 
was taken from staff members (receptionist, nurse and GP) and also from a couple of 
pat ients who were waiting for an appointment in the wait ing area.  
 
Overall it took half a day to complete. The GP and practice nurse had been given an outline 
script before the filming took place. The scripts were based on the content of what some of 
the interviewees had been unsure about (such as target  blood pressure for people with 
diabetes).  
 
4.24.2.3. Filming in the hospital 
 
The Press Office at  the Trust  was contacted before filming commenced. They instructed me 
and film team to take informed consent from all the patients who were to appear in the film. 
I t was also necessary to inform the security team about the film crew and the Head of 
Security was advised that the Press Office were aware of the project.  
 
Filming in the renal unit was more problemat ical as many patients needed to be consented 
before filming took place. There were some ethical dilemmas for me at this point in the 
study, namely the difficulty in using people who by their own admission, had not  managed 
their diabetes very well. The dilemma was how far to approach people who had not  looked 
after themselves, such as non-attendance at diabetes clinics, not taking blood pressure 
medications or continuing to smoke. I  considered that it would be acceptable to request  
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people to take part if they had insight into how far their poor management had affected their 
kidney funct ion.  
 
The brief to staff was therefore to identify patients who had diabetes, who were on dialysis 
and had verbalised their insight into how poor management of their diabetes in previous 
years had to some extent  caused their kidney damage. There was one lady in particular who 
appeared to fit these criteria, and she was chosen to be the main interviewee on the film. I  
visited this lady on two occasions explaining the project, to make sure that she knew the aim 
of the film and why she had been chosen. Other pat ients who were dialysing on the same 
day as this lady, were also asked if they would mind being filmed/ interviewed. These pat ients 
were told that a film about prevention of kidney disease was being made and it would be 
very helpful if they could explain their experiences of being on dialysis.  
 
The aim of filming in the hospital was to show ‘what can happen’ if diabetic kidney disease 
progresses. I t was important however not to show a very negative side to the message, but 
rather to balance the difficulties of a life with dialysis with the possibility that  people can help 
themselves to delay progression of the disease.  
 
Once all the filming was complete the film company then took approximately two weeks to 
develop the first  draft  of the film (the “rushes”). At  this stage I  was keen to get feedback 
from the patients, the health care professionals who appeared in the film and also a selected 
‘lay’ audience. Over a two-week period I  visited both patients at home, and also sent  the film 
to the first and second supervisor, the GP and practice nurse who had appeared in the film. 
Two non-clinical members of staff at  the Trust  were also shown the film, and were requested 
to make comments. 
 
A few minor amendments were made at this point. The original version included a scene 
where a computer screen was showing the Diabetes UK website. One patient and his wife 
were concerned that important information was being shown on the screen that they could 
not read.  Although it was not the intention that the information should be visible, this part of 
the film was edited out  to save confusion. One other scene filmed in the dialysis unit was also 
removed as the non-clinical reviewers both considered that it  was disturbing and might 
potentially upset  patients. I  made a note to ask a specific question about whether the film 
was upsetting to part icipants at a later date.  
 
4.24.3. Key Messages:  ‘Fridge Magnet’ 
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A number of interviewees had spoken about the importance of having the main messages 
reinforced when taking on health-care advice. This is supported by health education literature 
that suggests that reinforcing key messages can change behaviour (Ko et al. 2004). I  was 
interested in evaluating how far the package could be relied on to ‘get the message across’. I  
undertook a web-based review on different ways of ‘getting the message across’ and found a 
number of sites that promoted ‘fridge magnets’ as doing just that. Refrigerator ( fridge) 
magnets are small magnetic strips, usually made of rubber or plastic and are often used to 
advertise products or services. Although there appears to be no evidence base to support the 
assertion that fridge magnets with key health messages can affect health outcomes, I  
decided that this could be another novel way to try to improve people’s knowledge of kidney 
disease.  The key messages incorporated on the magnet are shown in Figure 4.12.  
 
I  evaluated the plethora of websites that produce fridge magnets upon upload of a picture 
file, and selected the site that gave the best  price for 200 magnets. The magnet had to be 
small enough to fit in the box but  large enough for key messages to be visible (10x15 cms 
port rait). The magnet was manufactured in I srael and produced within three working days for 
a cost  of approximately 50 pence per magnet. 
 
Figure 4.12:  Key messages on the fridge magnet  
 
 
 
 
 
 
*  BP target needed amendment during evaluation phase as a result of national guidance 
 
 
4.24.4. Monitoring diary 
 
People with Type 1 diabetes and those with Type 2 diabetes on insulin/medicat ion are 
advised to undertake blood glucose monitoring in line with national guidance (Diabetes UK 
2006). All the patients in the six part icipating GP surgeries who monitored their own blood 
glucose were routinely given ‘monitoring diaries’ by their practice nurses. These diaries are 
Give a yearly urine sample 
 
Aim for blood pressure below 135 (top) and 75 (bottom)*  
 
Take blood pressure tablets as prescribed 
 
Keep blood sugar under control  
 
Try not to smoke 
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printed and distributed by pharmaceut ical companies. These diaries are of pocket size, and 
are printed with boxed type that allow patients to fill-in their blood glucose readings, blood 
pressure readings and any other relevant  informat ion such as clinic appointments.  
 
I n an early phase of the study I  considered printing an alternative ‘monitoring diary’, which 
would be developed specifically for the study. However after discussion with three practice 
nurses in the participating surgeries, each thought  that the patients would feel more 
comfortable in using the diaries that they were familiar with. I t was agreed that the diaries 
already used by the practices would be included in the pack, and additional information about  
their usage would be included in the pack’s written information. 
 
4.24.5. Blood pressure machine 
 
There has been much debate about how far patients are able to manage their own blood 
pressure, especially if they have access to a blood pressure machine at home. Since the 
literature review was completed in 2007, an additional recommendation from the American 
Heart Association has been published. A joint  scientific statement, recommends that  people 
should rout inely monitor their blood pressure at home (Pickering et al. 2008).  
 
For the purposes of this study, it was decided that  a small sample of pat ients would have 
access to a blood pressure machine to use at home. Although it would not be possible to 
purchase large numbers of BP machines, and therefore include the effects of home 
monitoring in the data analysis, it would be useful to understand the possible (qualitative) 
benefits or problems of home monitoring. The main difficulty was funding the equipment and 
the first  step was to compare reliability and costs of different machines.  
 
The British Hypertension Society assesses and recommends different meters, so their website 
http: / /www.bhsoc.org/blood_pressure_list.stm was consulted for a current list of machines 
that met their st rict criteria. There were a small number of different machines for home-use 
that appeared cost-effective, valid and reliable. 
  
Figure 4.13 shows the two different  models that were considered for ease-of-use, ease-of-
purchase and price, plus validity. Both the Boots Upper Arm (Coleman et al. 2005) and the 
Microlife devices (Cuckson et  al. 2002) had been validated in accordance with the European 
Society of Hypertension International Protocol. Both the Microlife ‘as easy as 123’ model and 
Boots ‘Upper Arm Omron’ devices were invest igated further. 
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Figure 4.13:  A comparison of two different models of BP machine suitable for self-monitoring 
Manufacturer Cost (rrp 
incl VAT)  
 
Features Cuff sizes 
(cm) 
 
Weight (g)  
 
Dimensions 
(l x w x h) 
(mm)  
 
Boots Upper Arm 
 
Model:   
Upper Arm 
(Omron HEM-
742-E) 
 
£49.95 4 x AA 
Battery 
 
Small adult  
(17-22) 
Standard 
adult (22-32)  
Large adult 
(32-42) 
 
830 177 x 135 x 112 
 
Microlife 
 
Model:   
‘As easy as 123’ 
£44.98 
 
Single button 
operat ion 
 
Last reading 
memory  
 
Mains 
adaptor 
available 
Standard 
adult (22-32, 
included) 
Large adult 
(32-42, 
available 
from 
Microlife) 
 
335 115 x 155 x 60 
 
 
The distributor for Microlife models in the UK was contacted by letter in the first instance. He 
was chosen to be contacted because the distributor’s website showed a photograph of the 
Managing Director of Microlife donating a number of devices for clinical research to the British 
Heart Foundation. I t  was hoped that perhaps he would do the same for this study. 
 
After two weeks he had not responded, so I  telephoned him. He told me that as he was the 
only distributor in the UK he was not able to donate the machines for free but rather would 
be able to sell them at cost  price. The retail price was around £45, and the cost  price was 
£23. Twelve machines were purchased at cost price for the study, two for each practice.  
  
4.25. Chapter summary 
The self-management package was developed for  and with patients. The pack contained a 
variety of educational learning materials, the aim of which was to cater for different  people 
with a variety of learning styles. The pack was to be distributed to all people in the six 
part icipating GP surgeries who had diabetes and confirmed microalbuminuria.   
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5.  RESEARCH REPORT: TESTI NG OF THE SELF-MANAGEMENT PACK 
 
5.1. I ntroduction 
 
Once the pack had been developed, the aim was to test the pack by collecting patient data 
before, during and after pack distribution.  
 
5.2. Rationale for research design 
 
Possible study designs were discussed at the start  of the study with my supervisors, after 
books and journal articles on research methods had been scrut inised. I  received feedback on 
the design from the grant reviewing committee of the Brit ish Renal Society/Kidney Research 
UK Fellowship. I  also consulted academics and clinicians in other institutions, who were 
experts in renal disease, diabetes or family pract ice.  
 
I t was important to evaluate the longitudinal effect of the intervention, and the interrupted 
time series design (ITSD) has been cited as being the strongest quasi-experimental approach 
for evaluating longitudinal effects (Green 2006). This design involves collect ing data at  
multiple time points before and after an intervent ion.  
 
The time series design can therefore be sensitive to trends in performance. The aim is to 
determine whether or not  the intervent ion had an effect  over and above any trend present in 
the data. For example, it is possible that  data collected prior to the educational package being 
implemented could have been affected by my presence. When I  visited the practices, I  was 
often asked general questions about managing pat ients with kidney disease, and as such, 
education could have resulted in changes in management, such as initiation of ACEis for 
microalbuminuria. This pharmacological intervention could have then resulted in reduction in 
blood pressure in the subjects in the study. 
 
The design was originally planned to be the most basic of the ITSDs: the simple interrupted 
time series. I n this design there is only one experimental group. This design can be depicted 
as follows, using the classical notation system (Campbell and Stanley 1963) 
 
O - O - O - X - O - O - O 
 
where O represents an observat ion or measurement and X represents an exposure of  a group 
to an experimental variable or event, the effects of which are to be measured.  
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5.3. Study design 
 
A summary of the design of the study is shown in Figure 5.1.  
 
Figure 5.1:  Summary of study design 
Part icipants – inclusion criteria • A diagnosis of Type 1 or Type 2 
diabetes mellitus (Read code C10) 
• Microalbuminuria, defined by two 
abnormal albumin-creatinine ratio  
(ACR) results 
> 2.5 mg/mmol (men) 
> 3.5 mg/mmol (women)  
I ntervention The self-management package 
Delivered September 2006-September 2007 
Objectives To measure the effectiveness of a self-
management package for people with 
diabetes at risk of kidney disease.  
Outcome measures 
 
Blood pressure (systolic and diastolic) mmHg 
HbA1c %  
Body Mass Index  
Smoking status 
Data collection time points Three data collections before intervention 
 - March 2005;  October 2005;  March 2006 
Two data collections during intervention  
- November 2006 and June 2007 
One data collect ion after intervention 
- January 2008 
 
Pat ient data from participating pract ices were originally planned to be collected on 6 
occasions, every 6 months during the study, that is:  in March and October 2005;  March and 
October 2006;  and in March and October 2007. The educational pack was originally planned 
to be distributed after the third data collection in mid 2006.  Unfortunately changes to this 
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t imeframe and to the study design had to be made because of national policy changes in 
managing CKD.  
 
5.3.1. Changes to study design 
 
CKD has been a high-profile, quick-changing issue, especially during the period 2004-2008, 
the timeframe for this study. There has been the introduction of the NSF for Renal Services in 
2004/ 2005, followed by the introduction of the Quality and Outcomes Framework (QOF) for 
CKD in 2006. As a consequence, many primary care physicians and practice nurses changed 
their clinical practice because of  national guidance and incentivised targets, and the evidence 
for this will now be presented.  
 
During 2006 it became clear that the clinical care of people with CKD was improving, 
part icularly in the area of microalbuminuria (MA) testing. Improved MA testing would result in 
more people with MA being identified, and in turn may mean more people being prescribed 
an ACEi or ARB, which could lead to reduced blood pressure. The improvements were 
reflected in the QOF scores (see Figure 5.2) but were also reflected in the way in which 
pract it ioners were engaging with, and questioning me about  CKD. I t became apparent that  
because of all the changes in kidney care it might not be possible to differentiate between 
changes that  could occur as a result  of the education package, and changes that have 
occurred as a result of the national initiat ives and targets. 
 
Figure 5.2:  QOF results (2004-2006) for %  people with diabetes having microalbuminuria 
testing in participating practices 
Surgery 2004/ 2005 (%) 2005/ 2006 (% ) 
1 76.6 84.4 
2 100 100 
3 72.1 100 
4 100 100 
5 91 100 
6 67.5 79.6 
 
 
As it would be difficult to demonstrate that  possible changes in the patients’ bio-physical data 
had come about as a result of the intervention rather than the effect of the national 
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init iatives, it was necessary to include a control group in the study to identify the impact of 
nat ional policy on physiological outcomes. I  submitted an amendment to the local research 
ethics committee (LREC), and my request to include a control group was granted by the LREC 
in March 2006.  
 
I n summary, the greatest threat to the internal validity of this study design is ‘history’ 
(changes to national policy), although other threats such as instrumentation and select ion 
can occur (Green 2006). Adding a non-equivalent control group to the simple interrupted 
time series has the potential to improve on some of the limitat ions mentioned. This design, 
called an interrupted time series with a non-equivalent control group (Campbell and Stanley 
1963) is depicted as follows.  
 
O - O - O - X - O - O – O 
O - O - O - - - O - O - O 
 
As shown, a series of observations are collected both prior to and following the administ rat ion 
of the treatment for the experimental group;  during this same time period, a series of 
observat ions are also collected for a comparison group, although in this study data in the 
control group were collected retrospectively (see sect ion 5.3.2). This design allows the 
researcher to control for history effects, as an historical event would most likely affect both 
treatment and control groups equally. 
 
5.3.2. Control group 
 
The original aim was to recruit six pract ices in the same PCT as control practices. I  searched 
QOF data to find six practices of the same list size, and QOF results (MA screening and BP 
control)  as the participating practices (matched pairs). I  identified six control practices within 
the same PCT that fulfilled these criteria, and approached the lead clinician in each practice 
by letter. The letter explained the aim of the study, their possible involvement, and offered 
them a fee of £150 for their t ime and inconvenience. The letter was followed up with a phone 
call two weeks later. Unfortunately only one pract ice agreed to participate. Following 
discussion with my supervisors and the statistician, it was agreed that one set  of control 
group data would be better than having no control data, so I  went ahead and made 
arrangements to collect data from the control pract ice.  
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5.3.2.1. Data from control practice 
 
I  had a challenge in overcoming the practical difficulties of obtaining retrospective data from 
the control surgery. I  needed to obtain data on the same patient group as the participat ing 
surgery group, that is, people with diabetes and microalbuminuria. The data needed to be 
found for the time period March 2005 onwards. 
 
During 2007 I  started to work with a Biomedical I nformat ics team at a different University, on 
a national study that is exploring the best ways to improve the management of CKD in 
primary care. This study is using Morbidity I nformation QUery and Export SynTax (MIQUEST) 
software to extract data from GP practices. This is a Department of Health sponsored data 
extraction tool, and the principal investigator suggested to me that I  use MIQUEST software 
to extract  the data from the control practice, rather than searching by hand which could take 
a great amount of t ime. The lead GP in the practice agreed that I  could collect data in this 
way. 
 
I  worked with the data team in the Biomedical I nformatics department to create a dataset for 
this control practice, by simplifying another dataset for CKD already in use by that  team. A 
programme was written to extract  anonymised data (no date of birth or postcode) from the 
control pract ice, on all patients registered on the date of data extraction.  The dataset  
included age, gender, ethnicity, Read codes for diabetes, blood pressure, HbA1c, body mass 
index, exercise and smoking status.  
 
A member of the data team accompanied me to the practice and helped me extract the data. 
The process took one half-day to complete, and once retrieved, the data were contained 
within a MS Excel spreadsheet. Data collection in the control practice took place in December 
2007, at the end of the data collection period. The control practice data were collected 
retrospectively from the date of extraction back to December 2004.  
 
5.3.3. Statistical tests 
 
At the study’s inception, and during the writing of the original protocol, statistical advice was 
sought  from another University. A statistician from this University had been recommended by 
the Local Research Ethics Committee (LREC), as statistical clearance had to be given by the 
LREC before ethical approval was granted. At this point  the stat istician gave very basic advice 
to me, and advised that patients could act as their own controls, as they were going to be 
mapped throughout the study, before, during and after the intervention. 
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At a later date a stat istician from City University advised and directed the statistical analysis. 
She advised on powering the study and discussed the possible ways in which the data could 
be compared. Unfortunately during Spring 2008 this statistician left  the University, but  was 
eventually replaced in September 2008. This third statistician advised on using SPSS and 
which statistical tests to use. 
 
5.3.4. Powering the study 
 
The original City University statistician understood the design and requested that  I  identify 
the numbers of people in each practice at the start of the study who met the inclusion criteria 
and had a blood pressure at the recommended target  of 135/75 mmHg. Figure 5.3 shows the 
BP readings of pat ients who met the study’s inclusion criteria in the participating surgeries in 
March 2005. 
 
Figure 5.3:  Number of patients with diabetes and MA achieving BP target of < 135/ 75 mmHg 
in the part icipating surgeries in March 2005 
 
Surgery Total number of patients 
who met study’s inclusion 
criteria in March 2005 
Total number of patients 
achieving BP target of 
< 135/75 mmHg 
1 56 34 
2 48 20 
3 62 23 
4 41 24 
5 65 15 
6 59 38 
 
 
These figures equated to 46.5%  of the total number of patients having BP values below the 
recommended targets. I  wanted this to increase to 100% following the intervention. 
 
I  asked the statistician to make a power calculation based on these data, and she undertook 
a standard sample size calculat ion. She calculated that  13 patients in each surgery needed to 
be given the intervention, for 5%  level of significance with 90% power. However it was 
necessary to increase this sample size to take account of the clustering of the practices.  
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5.3.5. Cluster design  
 
Cluster design trials are those in which groups of patients rather than individuals are being 
invest igated. The main consequence of adopting a cluster design is that the outcome for each 
pat ient can no longer be assumed to be independent  of that  for any other patient (Campbell 
and Grimshaw 1998) and patients within any one cluster are more likely to have similar 
outcomes. I n this study, all the patients in one surgery are allocated to the same 
intervention, so each GP practice forms a cluster. This needs to be taken into account  in the 
analysis, and preferably the design, of the study.  
 
Methods which ignore clustering may mislead, because they assume that all subjects are 
independent observat ions. This is not the case in a cluster design, because observations 
within the same cluster are correlated. I f simple statistical methods are applied to such data, 
without taking the clustering into account, this may lead to confidence intervals which are too 
narrow and p values which are too small (Bland 2004).  
 
The University statistician advised me on how to adjust the sample size to take account  of 
the cluster design. The calculation required to adjust the sample size to take account of the 
clustering was adapted from Bland (2004). 
 
I t was necessary to adjust  the sample size by Y, where Y= 1+ a (n-1), where a is the median 
intra-cluster correlation co-efficient, the correlation between pairs of subjects chosen at  
random from the same cluster, and n is the size of the cluster.  
 
For GP practices, ‘a’ is usually taken to be 0.04. This was the median intra-cluster correlat ion 
coefficient reported in a systematic review of trials in primary care (Eldridge et al. 2004). The 
average cluster size is 55, the average number of pat ients across 6 practices at the time of 
the first  data collection. The calculation then becomes 
  
Y =  1+ 0.04(55-1) =  3.16 
  
Therefore the sample size needed to be adjusted by 3.16. This gives a sample size per 
pract ice of 13 (original power calculation without clustering) x 3.16= 41.08. So a sample size 
of 42 per practice (rounded up) would be able to detect a difference with 90%  power at 5%  
level of significance. I n total 252 packs needed to be distributed for the study to be powered. 
Figure 5.4 summarises the sample size and stat istical methods used in the study.  
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Figure 5.4:  Sample size and stat istical methods 
Sample size Intervent ion practices:  436 patients identified 
as possible part icipants 
Control pract ice:  61 participants 
Primary outcome measure Systolic blood pressure 
Power calculation (with clustering taken into 
account) 
42 patients per practice needed to detect a 
difference with 90%  power at 5% level of  
significance. 
Statistical methods Repeated measures analysis of variance 
Comparison between 2 groups:  
Group 1:  patients from participat ing practices 
who did receive the pack 
Group 2:  patients in the control group 
Note:  there was an additional group:  patients 
from participat ing practices who did not 
receive the pack. The makeup of this group 
will be discussed in Chapter 7. 
 
An overview of the study timeframe is shown in Figure 5.5. 
 
Figure 5.5:  Timeframe of study                                                         
Data collection 1 2 3 4 5 6 
Date March 
2005 
October 
2005 
March 
2006 
November 
2006 
June 
2007 
January 
2008 
Intervention 
Sept 06 – Sept 07 
             
          
 
Although the packs were dist ributed between September 2006 and September 2007, 15% of 
packs had been distributed by November 2006, with the majority of packs (> 80%) being 
distributed by June 2007, time point 5. I t was important to collect data at least four months 
after the last  self-management pack was given out. This additional time period allowed time 
for the latest-distributed pack to have an effect, and also for the practices to sett le to ‘usual 
pract ice’ without the ef fect  of the researcher visits. 
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I n summary there was 
 
• a pre-intervent ion period of 18 months;   
• an intervention phase of one year;   
• a post-intervention phase of six months when there was only minimal contact 
between the researcher and the practices/participant . 
 
 
5.3.6.  Time to complete data collections 
 
Each round of data collections took approximately four weeks to complete. The process 
involved contacting the practice manager (PM) or information technology (IT)  manager in 
each of the practices to book a four-hour slot at a convenient time. Each practice had a 
different process for accessing the data, but for the majority, a login and password were 
created for me and the research nurse at the start of the study. All patient  data at  each of 
the time points were collected manually from practice computer databases.  
 
I n late 2004 I  first  had access to the participating practice computer databases. Extract ion of 
data from the primary care computer systems was a learning experience for me. At first  I  had 
to familiarise myself with the computer system used by each practice (EMIS LV), and to find 
out exactly where relevant  data were stored. I  had litt le training by the PM or IT manager in 
each surgery, although the main menu/screens were explained. I n the following six months I  
spent a great  deal of time liaising with the practice team, trying to identify exactly which 
pat ients might be eligible to participate. Time was also spent exploring the EMIS system, and 
understanding how good/poor the data entry was in each of the categories.  For example, 
ethnicity recording in early 2005 in the study practices was poor (around 10%  recording) 
although this appeared to be a national trend (Kumarapeli et al. 2006) 
 
5.4. Dataset 
 
The aim of this data collection was to evaluate how far the proposed education package 
could make a difference to influencing the control of the parameters that affect the condition. 
There were no additional investigations carried out over and above routine care. 
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5.4.1. Dataset pro-forma 
 
A pro-forma was developed to provide a framework for data extracted from individual 
pat ients’ records. The pro-forma was developed incorporating the risk-factors for diabetic 
kidney disease outlined in NICE guidelines (National I nstitute for Health and Cinical 
Excellence 2002) and these include 
 
• annual urine testing for microalbuminuria (MA) 
• prescription of an angiotensin-converting enzyme inhibitor (ACEi) or angiotensin 
receptor blocker (ARB) if MA is present  
• blood pressure to be controlled below 135/75 mm Hg 
• HbA1c to be maintained between 6.5-7.5% according to the individual’s target  
• pat ients to be given advice about smoking cessation, weight control and exercise 
 
See Appendix 9 for the developed data collection pro-forma. 
 
Baseline data were collected over a three month period (March-May 2005) and entailed: 
 
• type of diabetes (Type 1 /  Type 2)  
• latest microalbuminuria test result  (ACR) 
• latest serum creatinine result (to assess renal funct ion) (mmol/L)  
• estimated glomerular filtration rate (eGFR) was calculated from serum creatinine 
using the 4-variable Modification of Diet in Renal Disease (MDRD) formula, obtained 
from the Renal Association website. Although est imation of GFRs were available from 
pat ient records from Feb 2006, when it was introduced by hospital laboratories, it 
was possible that the calculation undertaken by the laboratory may have differed 
from that  calculated by me using the on-line calculator. For consistency, I  decided to 
continue with the on-line formula to allow greater consistency and enable 
comparison, so did not therefore use the laboratory calculation. 
• latest blood pressure recording (mm Hg) as recorded by the GP/practice nurse 
• latest HbA1c (glycated haemoglobin) result  (%) 
• most recent body mass index (BMI )  
• amount of exercise as recorded by the practice nurse at the last visit 
• smoking pat tern (number of cigarettes or ounces of tobacco per day) 
• medicines for blood pressure control 
• medicines for diabetes control 
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5.4.2. Rationale for dataset   
 
The variables that were originally identified were based on the known risk factors for kidney 
disease, as cited by NICE guidance (National I nstitute for Health and Cinical Excellence 
2002). Previous studies were also taken into account , and the variables were also discussed 
with the second supervisor, a consultant  nephrologist.  
 
Each of these variables will now be presented and the rationale for their inclusion in the 
dataset will be discussed.   
 
5.4.3. Risk factors associated with progression of CKD 
 
There is extensive clinical evidence that diabetes, hypertension, and the presence of 
proteinuria are well-recognised risk factors for the progression of CKD (National I nstitute for 
Health and Clinical Excellence 2008a). Data on each of these risk factors were collected as 
follows.  
 
5.4.3.1. Diabetes mellitus 
 
Pat ients with diabetes mellitus were identified using the Read Code C10. Each pract ice was 
asked to confirm at the start of the study whether this was the code in use for patients with 
diabetes (Type 1 or Type 2). Further down the coding hierarchy, it appeared that there was 
greater variability for using Read codes (such as coding for type of diabetes, or complicat ion 
such as kidney damage). A study of 17 pract ices in south-west London (Gray, Orr et al. 2003) 
found only one Read code (C10, diabetes mellitus) and its sub-codes was being used in all 
pract ices, although the use of other key Read codes for monitoring the care of  patients with 
diabetes varied widely between practices. Less than half of pat ients with diabetes had their 
type of diabetes coded and <  20%  of practices used the code for the locat ion of care.  
 
As it was likely that the C10 codes were being applied to those with diabetes, this code was 
used to identify the research part icipants. However I  could not be sure that  diabetes sub-
codes (C108 and C109) to identify type of diabetes were always being applied appropriately.  
 
5.4.3.2. Hypertension 
 
There is strong evidence that  lowering blood pressure reduces cardiovascular risk and 
progression of CKD (Coresh et al. 2003, Hallan et al. 2006, Haroun et al. 2003). Although it 
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would be simple to extract  blood pressure recordings from GP databases, it was important to 
discuss the possible methods that practices have for recording pat ients’ blood pressure 
readings.  Following discussion with participating practices, it became apparent that some 
pract it ioners took two readings in the surgery (before and after consultat ion) and then 
recorded the lowest value;  other practit ioners took the reading that  the patient had carried 
out at home; others recorded a blood pressure reading taken by another practit ioner (for 
example health care assistant) before the consultation. Although these issues are important  
to be integrated in the discussion, it  was decided that the only practical way to record blood 
pressure readings for this study was to extract the latest blood pressure measurement 
(systolic and diastolic)(mm Hg) from the GP database, before recording this value in the 
dataset.  
 
5.4.3.3. Proteinuria and microalbuminuria 
 
Proteinuria is a risk factor for progression of CKD. In the most common types of CKD (i.e. 
those due to diabetes, hypertension and glomerular disease) albumin is both the most  
abundant protein in urine and a sensitive marker of disease (I seki et  al. 2003). 
 
Microalbuminuria is a term for the excretion of albumin in the urine in amounts that are 
abnormal but below the limit  of detect ion of convent ional urine dipst icks. The recognition of 
microalbuminuria in people with diabetes mellitus allows identification of diabet ic kidney 
disease, and institut ion of treatment to reduce the risk of progressive kidney damage, at an 
earlier stage than would be possible with conventional protein dipstick testing. There is clear 
evidence that the detection of early diabetic nephropathy, manifested by microalbuminuria, is 
responsive to antihypertensive therapy, in particular  the use of ACEis or ARBs (National 
I nstitute for Health and Clinical Excellence 2002).  
 
Figure 5.6 shows national guidance (published by the Royal College of Physicians and the 
Renal Association, and the Royal College of General Practit ioners) for microalbuminuria 
testing (Joint  Specialty Committee on Renal Medicine of the Royal College of  Physicians and 
the Renal Association 2006).  
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Figure 5.6:  Recommendations for microalbuminuria testing 
Recommendation 
number  
Recommendation 
R28 Urine albumin should be measured using a laboratory method in an 
early morning (preferred) or random mid-stream urine sample and 
expressed as an albumin:  creatinine ratio. 
R29 An albumin:  creatinine rat io >  2.5 mg/mmol in a male or >  3.5 
mg/mmol in a female is consistent with microalbuminuria. Patients 
demonstrating albumin:  creatinine ratios above or equal to, this cut-off 
should have urine samples sent to the laboratory on two further 
occasions (ideally within one to three months) for albumin estimation. 
Patients demonstrating persistently elevated albumin:  creatinine ratios 
in one or both of these further samples have microalbuminuria. 
R 30 The diagnosis of microalbuminuria cannot be made in the presence of 
an acute metabolic crisis. As far as is practicable, the best possible 
metabolic control of diabetes should be achieved before investigat ing 
patients for microalbuminuria. Patients should not be screened during 
inter-current illness. 
R 33 Patients with diabetes mellitus who have persistent  proteinuria (as 
defined above) do not require testing for microalbuminuria 
R 34 All other patients with diabetes mellitus should undergo, as a minimum, 
annual testing for microalbuminuria. 
 
I n summary, the presence of  microalbuminuria, defined by an albumin:  creat inine ratio > 2.5 
mg/mmol in a male or > 3.5 mg/mmol in a female on two or more occasions, enables those 
at risk of kidney damage to be identified. Once MA had been identified, patients were 
included in the study. Once in the study, the latest  microalbuminuria test result (ACR) was 
collected from the GP database on each participant at each time point. 
 
5.4.3.4. Ethnicity 
 
Another risk factor for CKD is ethnicity, with South Asians and African-Caribbeans most at risk 
(Xue et al 2007). This risk applies to development of  kidney disease, progression of kidney 
disease and also numbers requiring dialysis and transplantation.  
 
I n a US study of over 40000 people, people of African-Caribbean descent with diabetes were 
2.4 t imes more likely to develop established renal failure (ERF) compared with Caucasians 
 158
 
with diabetes (Xue et al. 2007). I n the same study, African-Caribbeans with baseline 
hypertension (n= 51016) were 2.5 times more likely to develop ERF than Caucasians with 
baseline hypertension (n= 426300). Compared with Caucasians with neither baseline 
hypertension nor diabetes, African-Caribbeans with neither hypertension nor diabetes at  
baseline were 3.5 times more likely t o develop established renal failure (Xue et al. 2007).  
 
With regard to Type 2 diabetes, 100% of I ndo-Asians experienced a doubling of serum 
creat inine compared with 45% of African Caribbeans and 50% of Caucasians (p= 0.025) 
during follow-up (Xue et al. 2007). 
 
Asians and African-Caribbeans have significantly higher rates of dialysis or renal 
transplantation, compared with Caucasians (Roderick et al. 1996). Although ethnicity of 
part icipants is a risk factor in progression of diabetic kidney disease, it is well-known that  
ethnicity recording in primary care is variable (Jones 2007). However a number of practices 
emphasised to me that  recording of ethnicity data was being improved as a result of the 
Quality and Outcomes Framework (2006).  
 
5.4.3.5. Latest HbA1c (glycated haemoglobin) result (%) 
 
Haemoglobin A1c (HbA1c) has become established as the monitoring test of choice t o assess 
medium term diabetic control and as a key parameter on which to base changes in 
management of patients (Reynolds et al. 2006). One of the mainstays of therapy for slowing 
the progression of kidney disease in diabetes remains attaining optimum glycaemic control 
(Cooper 1998), although the prime importance of blood pressure control has received recent  
interest (Adler et al. 2003). Two landmark clinical trials, the UK Prospective Diabetes Study 
(UKPDS) (Adler et al. 2003) and the Diabetes Control and Complicat ions Trial (DCCT) (DCCT 
Research Group 1995), found a reduction in the microvascular complications of diabetes 
when HbA1c was intensively controlled. More recently it has been shown that a decrease in 
HbA1c by 1%  increased the probability for remission of kidney damage (Gaede et al. 2004).  
 
5.4.3.6. Body Mass Index 
 
There has been some controversy regarding the effect of obesity on renal disease 
progression. Although one clinical trial showed that  there were no significant changes in renal 
funct ion after 5 months of a low calorie diet, renal function significantly decreased in the 
usual diet group (Morales et  al. 2003). Two studies found that BMI  was not associated with 
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risk of renal disease progression (Evans et  al. 2005, Saiki et al. 2005) 
 
Although NICE guidance (National I nstitute for Health and Clinical Excellence 2008a) stated 
that it was not necessary to screen those with BMI  ≥30 for CKD, several  reviewed studies 
(Eknoyan and Eknoyan 2007) have found that observational, cross-sectional, and longitudinal 
studies have documented obesity as an independent risk factor for the onset , aggravated 
course, and poor outcomes of chronic kidney disease. Although it is debateable whether 
obesity may not  be an independent risk factor for CKD, obesity can lead to CKD through 
diabetes mellitus and hypertension.  Weight reduct ion is also one variable that can be 
controlled by people themselves, and therefore it was important to monitor BMI  within this 
study.  
 
5.4.3.7. Exercise 
 
Only one study was found that suggested that people with low physical activity have a 
significantly increased risk of established renal failure (ERF) or a CKD-related death compared 
with people who have high physical activity (Stengel et al. 2003). Although there appears to 
be litt le research to support  the assertion that  increasing the amount of exercise correlates 
with slowing down of kidney disease progression, it was important  to monitor the amount of 
exercise undertaken by the subjects. I f behaviour is going to change as a result of the 
intervention, then amount of exercise undertaken might  be one way to measure whether 
changes have been made.  
 
5.4.3.8. Smoking status and pat tern 
 
Three studies showed that smokers had a significantly increased risk for CKD compared with 
non-smokers (Haroun et  al. 2003, Orth et al. 2005, Retnakaran et al. 2006). I n a study of 
adults with diabetic nephropathy, smokers had significantly increased odds of a 20%  decline 
in GFR compared with non-smokers (Orth et al. 2005). As smoking is a risk factor for CKD, 
data on smoking patterns were collected from the subjects’ records. 
5.4.3.9. Medicines 
 
National policy guidance (National I nstitute for Health and Clinical Excellence 2002, Nat ional 
I nstitute for Health and Clinical Excellence 2008a) recommends tight control of blood 
pressure, particularly with two classes of drugs namely angiotensin converting enzyme 
inhibitors (ACEis) and angiotensin I I  receptor blockers (ARBs), for people with diabetes and 
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microalbuminuria. Data on these medicines prescribed to the study population were collected 
throughout the study. At baseline it was important to ascertain which patients were being 
prescribed this medication, as patients not prescribed were more likely to have progression of 
kidney damage, and this needed to be taken into account when comparing the effect of the 
intervention. 
 
5.4.3.10. Measurement of kidney function 
 
The study part icipants have diabetes and albuminuria, both risk factors for CKD progression. 
Data on other known risk factors, hypertension, poor glycaemic control and smoking were 
also collected. Data on possible risk factors (obesity and lack of exercise)  are also part of the 
dataset. I n order to identify whether the intervention has any effect on patient behaviour, 
and subsequent control of the risk factors, monitoring of kidney function also needed to be 
carried out. 
  
5.4.3.11. Latest serum creatinine result (mmol/L)  
 
NICE (National I nst itute for Health and Clinical Excellence 2002) guidance recommended 
annual measurement of serum creatinine concentration, irrespective of the presence of 
microalbuminuria or clinical proteinuria. Annual measurement of serum creat inine 
concentration in patients with diabetes mellitus is also a quality indicator in the NHS General 
Medical Services Contract. The SIGN guidelines (Scott ish Intercollegiate Guidelines Network 
2001) on management of diabetes mellitus also recommended that  patients with diabetes 
mellitus should have their serum creatinine measured at diagnosis and at regular intervals, 
usually annually. 
 
I n 2005, the Royal College of Physicians, the Renal Association and the Royal College of 
General Practit ioners drafted guidance, later published in 2006 (Joint Specialty Committee on 
Renal Medicine of the Royal College of Physicians and the Renal Association 2006) which 
gave a recommendation for measurement of serum creatinine concentration. 
Recommendation R12 stated that serum creatinine concentration should be measured at  
init ial assessment and then at least annually in all adult patients with conditions known to be 
associated with a high risk of silent development of CKD, including hypertension and diabetes 
mellitus.  
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5.4.3.12. Estimated glomerular filt rat ion rate (eGFR) 
 
Serum creatinine concentration is determined not  only by the rate of renal excretion of 
creat inine but also by the rate of production, which is dependent  on muscle mass. Thus 
serum creatinine may be above the upper limit of normal in patients with normal kidney 
funct ion but  higher than average muscle mass (for example young males), but  may remain 
within the reference range despite marked renal impairment in patients with low muscle mass 
(such as older females). I n other words, some pat ients may have a normal serum creat inine 
but may have moderately reduced kidney function. 
 
Because of this, the National Service Framework for Renal Services (Part Two) (Department 
of Health 2005) recommended the use of the four-variable Modificat ion of Diet in Renal 
Disease (MDRD) formula to estimate glomerular filtration rate (GFR). The formula requires 
the gender, age, serum creatinine and ethnicity (black/non-black) of the patient. This is 
known as the 4-variable MDRD equation. Assumption of Caucasian ethnicity should be made 
if ethnicity is unknown. However the local hospital laboratory did not  start report ing eGFR 
until February 2006, so a calculation of eGFR was performed using an electronic calculator on 
all the patients in this study for the durat ion of the study.  The electronic calculator used may 
be found on the Renal Association website http: / /www.renal.org/eGFRcalc/GFR.pl. 
 
5.5. Data collection 
 
All data were collected at  approximate six-seven monthly intervals following baseline data 
collection. Baseline data were collected in March 2005, followed by subsequent collect ions in 
October 2005, March 2006, November 2006, June 2007 and January 2008.  
 
On each occasion I  telephoned the practice manager to arrange a suitable t ime for accessing 
these data.  I n three surgeries the practice manager was the main point of contact, but in 
another three surgeries there was an identified information services manager who organised 
the appointment. I t was necessary for me to have access to the EMIS LV system, so in all 
cases a username and password were set up for the duration of the study.  
 
For two sets of data collection there was research money available to pay for a research 
assistant  to help with data collect ion. An internal advertisement was distributed to the 
nursing staff of the local Renal Unit, and one ward nurse contacted me and asked if she could 
help. Her mot ivat ion was to ‘do something a bit  different’ as her family were now grown-up, 
and it seemed she had a real interest  in prevention of chronic kidney disease.  After an 
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informal interview, arrangements were made regarding days to be worked and mechanisms 
for payment.  
 
After contacting the Research and Development Department at the NHS Trust, clearance was 
given for the assistant to retrieve research data from the surgeries, and research practices 
were also asked if they were happy with the arrangement.  Training was given to the 
assistant on a one-to-one basis. Training was initially given in the hospital, when the purpose 
and layout of the spreadsheets was explained. At  a later date, experiential training was 
carried out in three surgeries, with the assistant  eventually becoming confident and 
competent in retrieving data on her own.  The assistant  then retrieved half of the required 
data (three surgeries) during the data collection periods. This arrangement continued for one 
year before research funds were used up. The contribution from this very experienced renal 
nurse was invaluable, not  only in terms of time but also it was someone who I  could bounce 
ideas off regarding the best  ways in which to deliver the education programme.  
 
5.5.1. Management of quantitative data 
 
Pat ients who were included in the study had anonymised data collected at  six time points. 
There was no collection of  patient identifiers such as date of birth or postcode, and 
part icipants’ data were identified by the pract ice patient number only.  Data were t ransferred 
from the practice computer screen onto a paper version of the Excel spreadsheet  and later 
transferred onto an electronic version of the spreadsheet. See Appendix 9 for Excel 
spreadsheet. Finally the data were transferred to SPSS for Windows v12 for descriptive 
analysis. Each set of data collected took a visit of between two-three hours per practice, so 
each six-monthly data collection took around four full days including travel time. Transfer of 
manually collected data from the paper version to the electronic version of the spreadsheet  
took approximately 40 hours in total.  
 
Once on the electronic version of the spreadsheet, data were cleaned for errors before being 
transferred to SPSS.  Once in SPSS the data were cleaned again by checking categorical and 
continuous errors, such as examining maximum and minimum values, and mean scores.    
 
5.6. Evaluation of education package 
 
The aim was to distribute the education package to pat ients in the six participating GP 
surgeries and compare clinical outcomes of people who had received the pack with the 
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control group. I t  was also important to evaluate the pack itself (content, ease of 
understanding, usefulness) and this was evaluated in two ways:  
 
1. Ongoing feedback:  Each pack contained a feedback form that gave my contact number 
and address.  I  requested that  if anyone had questions or comments they were to contact me 
directly. 
 
2. Post-study feedback:  Through a short  questionnaire sent by post to 15 people who had 
received the pack. 
 
The findings of the evaluat ion are discussed in Chapter 8. 
  
5.7. Chapter summary 
 
This chapter has described the way in which the self-management pack was tested and 
evaluated. A rationale for the time series design was given and a rationale for the required 
change in study design to include a control group was presented. Data were collected at six 
time points and data on risk factors associated with progression of CKD (microalbuminuria, 
blood pressure, eGFR, HbA1c, body mass index, exercise and smoking patterns) were 
collected. 
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6. RESEARCH REPORT: RESULTS 
 
6.1. I ntroduction 
 
The results chapter will explore the quantitative data collected from the six participat ing 
pract ices and the control practice, and will draw conclusions about how far the educat ional 
package has enabled control of the parameters that can delay progression of kidney disease. 
 
Demographic statistics (age, gender, ethnicity) on all participants from all practices will be 
described. Clinical characteristics such as mean blood pressure, glycated haemoglobin 
(HbA1c) and Body Mass Index (BMI ), will be compared across all practices at the start and 
end of the study. Other parameters such as smoking status and exercise levels will also be 
analysed. 
  
Section 6.2 will compare the data from two groups:  
  
• Group 1 – patients from participating practices who did receive the self-management 
pack (the intervention group) 
• Group 2 – patients in the control group 
 
There was a third group, which included patients from participat ing practices who did not  
receive the self-management pack. This group warrants analysis and will be discussed in 
sect ion 7.2.4.  A discussion about the powering of the study will be included in this chapter, 
alongside data that describes the reasons for non-dist ribution of the educat ion pack. All the 
results are presented as mean and (SD) as all data are normally distributed.  
  
6.2. Data from participating and control practices 
 
6.2.1. I dent ification of the participants 
 
I n March 2005, across six practices in one London PCT with a combined list size of 61 800, 
there were 1946 people (3.14%) with diabetes. Of these, 370 people (19%) were identified 
as having microalbuminuria, and were therefore included in the study. I n early 2005 the 
screening rate for MA across the six practices was 71% . Later in the year, possibly because of 
QOF incentives, average screening rates for microalbuminuria had risen to 86%  across the six 
pract ices. An additional search for people who reached the inclusion criteria was then 
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repeated, and subsequent ly 450 people (23%) were identified as having microalbuminuria. 
Following checks for possible errors and data cleansing, 436 people in the participat ing 
surgeries were included in the study and 61 people in the control group, making a total of 
497 patients. See Figure 6.1.  
 
Baseline data in the six participating practices were collected in March 2005, followed by 
subsequent data collections in October 2005, March 2006, November 2006, June 2007 and 
January 2008, that is, six time periods. Data collection in the control practice took place in 
December 2007, at the end of the data collection period. The control practice data were 
collected retrospectively for the time period stated above, from December 2007 
retrospectively to late 2004. Data collection was carried out using Morbidity I nformat ion 
QUery and Export SynTax (MIQUEST) software. 
 
The results for the participating practices were input ted into Microsoft™Office Excel 2003, 
and from there were imported into the Statist ical Package for the Social Sciences (SPSS) for 
Windows®  version 16. The results shown below have been analysed using both Excel and 
SPSS programmes. The participating practices are named as Surgery 1-6. The control practice 
is named Surgery 7.  
 
6.2.2. Demographic data 
6.2.2.1. Age 
 
The mean age and age range of part icipants in each practice are shown in Figure 6.1. The 
age is the age of the participant in March 2005, the first data collection period.  
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Figure 6.1:  Mean age and age range of participants in March 2005 
Age of participants (years)  
Surgery N Mean Std. Deviat ion 
Age Range 
(years)  
1 83 68.43 12.994 33-88 
2 65 67.46 13.337 32-90 
3 82 66.72 13.187 34-100 
4 77 68.74 13.752 32-91 
5 56 64.70 15.633 22-90 
6 73 70.92 13.022 43-95 
7 61 61.34 11.162 38-87 
Total 497 67.14 13.515 22-78 
 
Figure 6.2 shows the ages of participants in each surgery divided into 20 year bands (20-39 
years;  40-59 years;  60-79 years;  over 80 years). This figure shows that the control surgery 
with a lower mean age of 61.34 years has a younger population with more participants in the 
age range 40-60 years, but  fewer participants in the 60-80 year and 80-100 year range. The 
reasons for this are unclear but possibly it is because this practice is located within the main 
town centre (population size 180 000) within the PCT, and may be more convenient  for 
families with children (schools, other amenities for children/ teenagers) and also for 
commuting into London. The train station into London is within ½  mile of the surgery with a 
commuting time of approximately 40 minutes. The other surgeries in the study, although 
within the same PCT, are not within the same town centre. 
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Figure 6.2:  Ages of participants in each surgery divided into 20 year bands 
 
 
 
 
Another possibility is that this control surgery has a higher ethnicity compared with other 
pract ices, with > 30% of the subjects in the control surgery recorded as being of Asian 
descent .  See Figure 6.5 below. Being of South Asian descent is a risk factor for not only 
developing diabetes, but  also developing diabetic nephropathy (Davis 2008), so it  is possible 
that the control group with higher ethnicity has developed microalbuminuria at a younger age 
than white participants. These suggestions must be considered with caut ion though, as 
ethnicity recording was variable across practices. 
 
6.2.2.2. Gender 
 
The gender of the participants in the practices is shown in Figure 6.3.  
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Figure 6.3:  Gender of participants 
Gender 
 
Surgery Male Female Total 
1 46 55.4%  37 44.6%  83 100% 
2 33 50.8%  32 49.2%  65 100% 
3 59 71.9%  23 28.1%  82 100% 
4 47 61.0%  30 39.0%  77 100% 
5 28 50.0%  28 50.0%  56 100% 
6 38 52.1%  35 47.9%  73 100% 
7 43 70.5%  18 29.5%  61 100% 
Total 294 59.3%  202 40.7%  496 100% 
 
 
Part icipants in this study (having diabetes and microalbuminuria) are more likely to be men, 
with all surgeries having the same or greater percentage of men than women.  However as 
CKD is increasingly prevalent  with increased age, the female gender is predominant in older 
age groups with CKD. Some suggest that  this is largely a function of ageing and an 
epiphenomenon of the use of the Modification of Diet  in Renal Disease (MDRD) equation to 
estimate GFR (Levey et al. 2006), whereas others maintain that this is a true effect (NICE, 
2008).  
 
Results from this study appear to suggest that  for this cohort of people with diabetes and 
early kidney damage, there is also a skewed distribution of women in the older age groups, 
over 70 years. See Figure 6.4. Further discussion of age and effect on kidney damage and 
cardio-vascular risk will continue in section 7.2. 
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Figure 6.4:  Gender and age of part icipants   
 
 
 
6.2.2.3. Ethnicity 
 
Ethnicity recording in general practice is known to be variable, although improvements have 
been made (Bramley and Latimer 2007). The following figures for ethnicity and diabetes 
diagnosis recording show a column for missing data (numbers and percentage). There was 
quite a high percentage of missing ethnicity data in this study, especially in surgery 2 (57%  
missing).  
 
I n these cases the missing data has arisen because there were no data available on these 
part icipants at any time during the study. I  did repeat the search for ethnicity data at the 
penultimate collect ion period (November 2006) and some additional ethnicity data were 
found at this time. Figure 6.5 shows the ethnicity of part icipants by pract ice. 
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Figure 6.5:  Ethnicity of participants recorded in November 2006 
Ethnicity 
 
Surgery White 
African-
Caribbean Asian Mixed race 
Collected 
data  %  missing 
1 35 74.5%  1 2.1%  10 21.3%  1 2.1%  47/ 83 43.3%  
2 23 82.0%  2 7.1%  3 10.7%  0 0%  28/ 65 56.9%  
3 38 82.6%  1 2.2%  7 15.2%  0 0%  46/ 82 43.9%  
4 55 88.7%  0 0%  6 9.7%  1 1.6%  62/ 77 19.5%  
5 23 67.6%  1 2.9%  9 26.5%  1 2.9%  34/ 56 39.3%  
6 32 80.0%  1 2.5%  7 17.5%  0 0%  40/ 73 45.2%  
7 36 60.0%  2 3.3%  20 33.3%  2 3.3%  60/ 61 1.6%  
Total 242 76.3%  8 2.5%  62 19.5%  5 1.6%  317/ 497 36.2%  
 
Ethnicity data for this PCT from the 2001 census showed 90%  white;  2.5%  black;  4.7%  Asian 
and 2% mixed race (Office for National Statistics, 2001). The ethnicity of participants in all 
the practices (even with significant under-recording) shows a very different ethnicity spread 
from the census returns of 2001, indicating a possible significant change in the composit ion 
of the population since 2001. These increased percentages of ethnic groups could also have 
had an effect of diabetes prevalence in this PCT, especially in those of south Asian origin 
(Davis 2008). 
 
Since the final collection of ethnicity data in November 2007, ethnicity data collected in 2008 
for the participat ing practices and the whole PCT were published in June 2009 by the London 
Health Observatory (LHO)(London Health Observatory 2009). The LHO provides informat ion 
for policy makers and practit ioners to enable them to improve health and health care. The 
LHO works in partnership with the NHS, local authorities, the Greater London Authority, 
researchers and national agencies. Recently published data contain the breakdown of 
individual practice list populations, which includes geographical spread, age, gender and 
ethnicity.  
 
Figure 6.6 shows the ethnicity of the practice populat ions in the part icipating and control 
pract ices, adapted from 2008 LHO data 
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 Figure 6.6:  Ethnicity of the practice populations in the participating and control practices in 
2008 (from LHO data, 2009) 
Pract ice White African-
Caribbean 
Asian Mixed race 
1 82.0%  3.4%  7.3%  3.1%  
2 83.8%  4.5%  4.1%  3.1%  
3 79.3%  2.4%  10.3%  3.5%  
4 84.2%  3.0%  6.2%  2.8%  
5 83.6%  3.9%  6.6%  2.7%  
6 83.0%  4.0%  7.2%  2.7%  
7 80.0%  3.6%  6.1%  3.1%  
 
This shows a different picture from the data collected from the surgeries by me, with much 
less high rates of Asian ethnicity in all surgeries. This is possibly because surgeries were 
identifying people of Asian ethnicity by name alone (there is specific software available to do 
this) thus leading to a skewed distribution of people from Asian descent. There may also have 
been other reasons for the discrepancy but  these were difficult to identify after the data 
collection period had passed. I n general terms there is a lower ethnic diversity in this PCT 
compared with London PCTs overall where in 2001 71%  were white;  12.0% were Asian and 
10.9%  were African Caribbean (Office for National Statistics 2001). 
 
 
 
6.2.3. Diabetes 
 
Figure 6.7 shows the participants’ diagnoses (type of diabetes). 
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Figure 6.7:  Diabetes type of participants 
Diabetes 
 
Surgery Type 1 Type 2 Collected data % missing 
1 6 7.2%  77 92.8%  83/ 83 0%  
2 0 0%  10 100% 10/ 65 76.9%  
3 1 1.2%  81 98.8%  82/ 82 0%  
4 13 16.9%  64 83.1%  77/ 77 0%  
5 2 3.6%  54 96.4%  56/ 56 0%  
6 4 5.5%  69 94.5%  73/ 73 0%  
7 2 3.7%  52 96.3%  54/ 61 11.5%  
Total 28 6.4%  407 93.6%  435/ 497 12.5%  
 
 
The World Health Organisation (WHO) classifies diabetes into Type 1, Type 2 and other types 
of diabetes (Alberti and Zimmet 1998).  The general Read Code for diabetes is C10, whilst 
the codes for Type 1 and Type 2 are C10E and C10F respectively. I n this study, diabetes 
diagnosis data were missing on 62 participants, mostly in Surgery 2 where data were missing 
on 77% of patients. Although these patients were coded with the Diabetes Read code C10, 
there was no dist inct ion made between Type 1 and Type 2 diabetes.  I n other surgeries the 
codes for Type 1 diabetes (C10E) and Type 2 diabetes (C10F) had been used to differentiate 
between the two types. I t is possible that  surgery 4 had miscoded some of the patients as 
having Type 1 diabetes instead of Type 2, because of the high percentage of people with 
Type 1 diabetes (16.8%).  
 
I t is difficult  to compare these data with the general population as recent national data have 
been collected by the diagnosis of diabetes that  are accounted for by diet controlled, oral 
hypoglycaemic-treated and insulin t reated diabetes, rather than type of diabetes (Majeed and 
Moser 2005). I t is likely that  in the general population, prevalence of Type 1 diabetes 
compared with Type 2 is around 5-10%  of those with diabetes (The Information Centre 
National Clinical Audit Support Programme 2006). For the purposes of this study however, it 
is not essential to have the definite types, as there is no evidence that type of diabetes is a 
risk factor for microalbuminuria (Young et al. 2005). The diabetes codes were collected at  the 
start of the study and were not  re-visited or checked at  a later date. 
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6.2.4. Clinical characteristics 
 
Clinical characteristics (mean and SD) at start and end of the study are shown in Figures 6.9-
6.13. Clinical measurements of mean systolic and diastolic blood pressure, HbA1c, body mass 
index have been compared across practices. There is also a commentary on smoking status in 
this section. 
 
The results table for each clinical characteristic has a column which shows the number of 
collected data items in each pract ice over the total number of participants in the practice. An 
adjacent column shows the %  of missing data. I n these tables the high %  of missing data 
should not be at tributed to data not being measured or inputted. I n these cases it is due to 
the number of patients who had not joined the study in March 2005 or the number who had 
either moved away, had died or who had commenced dialysis at the end.  
 
I n total 497 people were included in the study. The numbers in each practice at the last data 
collection period in January 2008 are shown in Figure 6.8. Each practice had a number of 
part icipants who were not  included in the study for the entire time period. The reasons for 
non-inclusion are shown. 
 
Figure 6.8:  Status of participants in each surgery at January 2008 
Status at end of study 
 
Surgery 
 
I n study Moved away Died On dialysis Total 
1 71 85%  6 7.2%  6 7.2%  0 0%  83 100% 
2 48 74%  10 15.4%  6 9.2%  1 1.5%  65 100% 
3 67 82%  6 7.3%  9 11.0%  0 0%  82 100% 
4 60 78%  10 13.0%  7 9.1%  0 0%  77 100% 
5 47 84%  4 7.1%  4 7.1%  1 1.8%  56 100% 
6 48 66%  6 8.2%  17 23.3%  2 2.7%  73 100% 
7 61 100%*  0*  0%  0*  0%  0*  0%  61 100% 
Total 400 80.5%  42 8.5%  49 9.9%  4  0.8%  497 100% 
 
* There were no people moving away or deaths in the control group as these data were 
collected retrospect ively at  the last data collection period 
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6.2.4.1. Blood pressure 
 
Figures 6.9 and 6.10 show the mean systolic and diastolic blood pressures at  the start and 
end of the study. These results have to be considered against  changes to policy during the 
study. At the start and end of the study the blood pressure target  for people with Type 1 
diabetes and microalbuminuria was 130/ 80 mmHg (Nat ional I nstitute for Health and Clinical 
Excellence 2004). For Type 2 diabetes the target at the start of the study was 135/75 mmHg 
(National I nstitute for Health and Clinical Excellence 2002) although NICE guidance had been 
amended by the end of the study (National I nstitute for Health and Clinical Excellence 2008a) 
to a target of 130/ 80mmHg for people with Type 1 and Type 2 diabetes. 
  
Figure 6.9:  Mean systolic blood pressure (mm Hg) at March 2005 and January 2008 
Surgery Mean BP 
systolic 
start  
SD Collected 
data 
start  
Mean BP 
systolic 
end 
SD Collected 
data 
end 
1 144.72 16.687 64/ 83 137.30 16.532 71/ 83 
2 138.92 14.862 49/ 65 131.58 18.729 48/ 65 
3 137.89 20.270 55/ 82 134.49 15.863 67/ 82 
4 137.54 15.712 63/ 77 131.75 8.453 60/ 77 
5 138.15 21.283 40/ 56 134.72 20.276 47/ 56 
6 145.40 17.302 67/ 73 134.10 16.598 48/ 73 
7 134.41 14.372 61/ 61 136.15 16.392 61/ 61 
Total 139.81 17.476 399/ 497 134.46 16.260 402/ 497 
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Figure 6.10:  Mean diastolic blood pressure (mmHg) at March 2005 and January 2008 
Surgery Mean BP 
diastolic  
start  
SD Collected 
data 
start  
Mean BP 
diastolic 
end 
SD Collected 
data end 
1 78.12 9.361 64/ 83 74.79 11.254 71/ 83 
2 76.67 9.342 49/ 65 78.50 9.794 48/ 65 
3 75.85 8.623 55/ 82 74.24 7.758 67/ 82 
4 76.95 10.825 63/ 77 75.10 8.435 60/ 77 
5 76.82 13.015 40/ 56 73.02 12.458 47/ 56 
6 78.64 9.728 67/ 73 75.92 10.204 48/ 73 
7 78.08 10.688 61/ 61 77.57 9.065 61/ 61 
Total 77.4 10.155 399/ 497 75.54 9.944 402/ 497 
 
 
6.2.4.2. Glycated haemoglobin (HbA1c) 
 
I t is recommended that people with Type 1 diabetes should have HbA1c tested every 2-6 
months (NICE, 2004) and those with Type 2 diabetes should be tested at least  every six 
months (NICE, 2008). Targets for people with Type 1 diabetes are HbA1c <  7.5 %, with a 
target of < 6.5 %  for people with high arterial risk (microalbuminuria and BP > 130/80 
mmHg). For people with Type 2 diabetes, the HbA1c should be in a range of 6.5-7.5% . 
Figure 6.11 shows the mean HbA1c of the participants at the start and end of the study. 
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Figure 6.11:  Mean HbA1c (% ) at March 2005 and January 2008 
Surgery Mean 
HbA1c 
start  
SD Collected 
data start  
Mean 
HbA1c 
end 
SD Collected 
data end 
1 8.190 1.7559 62/ 83 7.720 1.3745 71/ 83 
2 8.006 2.1697 49/ 65 7.304 1.5121 48/ 65 
3 7.626 1.5364 53/ 82 7.640 1.9982 67/ 82 
4 7.755 1.6602 60/ 77 7.227 1.5975 60/ 77 
5 7.081 1.2202 37/ 56 6.932 1.7980 47/ 56 
6 7.343 1.6448 61/ 73 7.763 1.8046 46/ 73 
7 8.120 1.8377 61/ 61 7.990 1.7430 59/ 61 
Total 7.767 1.7493 383/ 497 7.534 1.7155 398/ 497 
 
6.2.4.3. Body Mass Index (BMI )  
 
Although there have been concerns raised about  the accuracy of BMI  in diagnosing obesity, 
part icularly for individuals in the intermediate BMI  ranges, in men and in the elderly (Romero-
Corral et al. 2008), the BMI  is the measure used by the GP practices in the study to evaluate 
degrees of weight loss over time.  
 
NICE (2006) recommends using BMI  to classify degrees of obesity (see Figure 6.12) but  also 
recommends that practit ioners use clinical judgement. For example BMI  may be less accurate 
in highly muscular people, risk factors may be of concern at lower BMI  in Asian people and 
for older people risk factors may become important at higher BMIs.  
 
Figure 6.12:  Classification of people who are overweight or obese 
Classification BMI  (kg/m2) BMI  (kg/m2)  
 
Healthy weight  18.5-24.9 
Overweight 25-29.9 
Obesity I  30-34.9 
Obesity I I  35-39.9 
Obesity I I I  ≥40 
Adapted from (Nat ional I nstitute for Health and Clinical Excellence 2006b)  
 
Figure 6.13 shows the mean BMI  of people in the participating surgeries at the beginning and 
end of the study. Although weight loss is one of the main priorit ies for people with Type 2 
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diabetes, these results show that weight loss strategies are difficult to maintain. The overall 
gain in mean BMI  was 0.34 kg/m2, with people in only 3 out of 7 practices managing to 
achieve a reduced mean BMI  by the end of the study. This compares with an Oxford study 
(Rosell et al. 2006) that found the mean annual weight gain in a health-conscious cohort of 
more than 20000 people in the UK was approximately 400 g. This equates to a BMI  increase 
of 0.5 kg/m2 over three years in a 60 Kg woman of average height, demonstrating that weight 
gain over time is inevitable for many, not just those with diabetes.  
 
Figure 6.13:  Mean BMI  of participants at March 2005 and January 2008 
Surgery Mean 
BMI  
start  
SD Collected 
data 
start  
Mean 
BMI  
end 
SD Collected 
data 
end 
1 30.38 6.332 60/ 83 29.17 6.761 71/ 83 
2 29.54 6.109 48/ 65 29.56 6.494 48/ 65 
3 27.62 5.241 54/ 82 29.44 5.571 67/ 82 
4 28.57 5.883 62/ 77 28.06 5.547 60/ 77 
5 31.36 6.394 40/ 56 30.88 7.826 47/ 56 
6 28.48 5.436 65/ 73 30.41 5.185 48/ 73 
7 27.90 4.974 12/ 61 29.53 4.877 61/ 61 
Total 29.16 5.924 341/ 497 29.50 6.079 402/ 497 
 
 
6.2.4.4. Smoking status 
 
There were differences across surgeries in the way in which smoking data were recorded. 
Some surgeries recorded whether the pat ients smoked, and if so, whether they received 
smoking cessation advice. Other practices recorded whether the patient smoked, and how 
many cigarettes/ ounces of tobacco were smoked per day and did not necessarily record 
whether advice about cessat ion had been given. 
 
Smoking status was recorded by either searching for free text in the diabetes screen, or by 
Read Code. Codes used with most frequency were 137R (current smoker);  137S (ex-smoker);  
1373 ( light smoker 1-9 cigarettes/day);  1374 (moderate smoker 10-19 cigaret tes/day) and 
1375 (heavy smoker 20-39 cigarettes/day). The code 137G was used for someone who keeps 
trying to stop smoking, and 8CAL for smoking cessation advice given. 
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For the purposes of this study, Read coded smoking status and free text entries were 
amalgamated for each participant, and coded as follows in Figure 6.14. 
 
Figure 6.14:  Codes used for smoking status 
Code 0 1 2 3 
Smoking status 
at start  
Does not 
smoke at start 
of study 
Smokes at start of 
study 
Smokes at  start  of 
study 
Smokes at start 
of study 
Smoking 
amount at  start  - 
Light smoker  
(0-5/day) 
Moderate smoker  
(5-19/day) 
Heavy smoker 
(≥20/day) 
Smoking status 
at end 
Does not 
smoke at end  
of study 
Smokes at  end of 
study   
Smoking 
amount at  end - 
Light smoker  
(0-5/day) 
Moderate smoker  
(5-19/day) 
Heavy smoker 
(≥20/day) 
 
Figure 6.15 shows the number of part icipants in each practice who were smoking in March 
2005. 
 
Figure 6.15:  Smoking status at March 2005 
Smoking status at start of study 
 
Surgery Non-smokers Smokers Collected data %  missing 
1 57 79.2%  15 20.8%  72/ 83 13.3%  
2 33 68.8%  15 31.2%%  48/ 65 20.8%  
3 46 85.2%  8 14.8%  54/ 82 34.1%  
4 41 87.2%  6 12.8%  47/ 77 38.9%  
5 39 83.0%  8 17.0%  47/ 56 16.1%  
6 51 85.0%  9 15.0%  60/ 73 17.8%  
7 50 82.0%  11 18.0%  61/ 61 0%  
Total 317 81.5%  72 18.5%  389/ 497 21.7%  
 
Overall the percentage of people who were smoking at the start of the study is 18.5%  of 
those for whom there was a record of smoking status. Considering that smoking can 
considerably worsen kidney disease and cardio-vascular risk in diabetes, these figures are of 
concern, although better than the latest figures for 2005, that showed that around a quarter 
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(24%) of the Brit ish population aged 16 and over smoke cigarettes (Goddard, 2006).  
 
Figure 6.16 shows the number of people who smoke light to heavy amounts (≥20 cigaret tes 
per day) at the start  of the study. The number who smoke more then 20 cigarettes/day is 
cause for concern (n= 33), but is mostly confined to surgery 2. Surgery 2 is considered to be 
in an area of social deprivation compared with the other pract ices, and data suggests that  
29%  of  adults in manual occupations smoked compared with 19%  of those in non-manual 
occupat ions (Goddard, 2006). Further analysis of these data with respect  to social deprivat ion 
can be found in Chapter 7.  
 
Figure 6.16:  Smoking amount at March 2005 
Smoking amount at start of study 
 
Surgery 
Number of 
smokers Light Moderate Heavy 
Collected 
data 
1 15 1 7 7 72/ 83 
2 15 1 1 13 48/ 65 
3 8 4 2 2 54/ 82 
4 6 1 2 3 47/ 77 
5 8 3 1 4 47/ 56 
6 9 2 5 2 60/ 73 
7 11 2 7 2 54/ 61 
Total 72 14 25 33 382/ 497 
 
 
Figure 6.17 shows the smoking amount at the end of the study. At the end of the study, the 
numbers of people who still smoked were less, and in surgery 2 there was a reduction in the 
number of people who were heavy smokers.  
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Figure 6.17:  Smoking amount at January 2008 
Smoking amount at January 2008 
 
Surgery 
Number of  
smokers Light Moderate Heavy 
Collected 
data 
1 9 3 5 1 62/ 83 
2 11 3 4 4 32/ 65 
3 7 4 2 1 43/ 82 
4 6 2 3 1 58/ 77 
5 8 4 2 2 46/ 56 
6 7 3 4 0 48/ 73 
7 10 2 5 3 56/ 61 
Total 58 21 25 12 345 
 
I n the three years from the start to the end of the study, there was a decrease in the number 
of people who smoked. The total number of smokers had decreased by 14 (almost  20% of 
those who had smoked at the start), and the majority of heavy smokers in surgery 2 had 
reduced their smoking amount to becoming moderate smokers.  
 
This reduct ion in smoking amount may reflect the publication of ‘Smoking Kills’ (Department 
of Health 1998)  that has seen increased spending on mass media anti-smoking campaigns, a 
ban on tobacco advertising and promotion, more prominent health warnings and wider 
access to stop smoking services (National I nstitute for Health and Clinical Excellence 2006a). 
I n addition in 2004, a public health white paper (Department of Health 2004) confirmed that  
all NHS premises and government departments would be smoke-free from the end of 2006 
and a ban on smoking in enclosed public spaces in England by summer 2007.  
 
The reduct ion in smoking amount may also reflect the Department  of Health targets for 
smoking cessation introduced in 2004, that aimed to achieve a reduct ion in smoking rates 
from 26%  in 2002 to 21%  of the general population by 2010 (Department of Health 2004).   
These targets resulted in the introduction of primary care support  services for people who 
wished to give up smoking, such as the NHS Stop Smoking services with £112 million over 
two years (2006-2008) allocated to PCTs. 
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6.2.4.5. Exercise level 
 
At the start of the study data on exercise levels were collected from the six participat ing 
surgeries. Unfortunately this had to be abandoned early on during the study because of poor 
data recording. The majority of surgeries were simply recording whether advice on exercise 
had been given, and in a minority of cases how much (self-reported) exercise had been 
undertaken. Because it was unlikely that any firm conclusions could be drawn from these 
scant data it was decided at t ime period three to stop collecting these qualitative measures.  
 
6.2.4.6. Progression of CKD 
 
I t is also important to consider the progression of kidney disease during the study, although it 
was never hypothesised that the self-management pack could directly affect  kidney disease 
progression because of the relative short-t ime period of the study. Kidney damage can be 
quantified by amount of albuminuria (ACR) and also by measurement of estimated glomerular 
filtration rate (eGFR). eGFR can be equated to the stages of CKD (see Glossary for an 
explanation). Both parameters were measured at each of the six time points. Figure 6.18 
shows the percentage of people with stages 1-5 CKD in the six participat ing surgeries over 
the period of the study. 
 
Figure 6.18:  % participants with different stages of CKD 
Stage of 
CKD 
Mar 2005 Oct 2005 Mar 2006 Nov 2006 June 2007 Jan 2008 
1 2.6 1.6 1.4 5.0 5.2 5.2 
2 38.6 33.2 35.2 36.2 40.0 36.8 
3a 24.1 25.2 21.7 18.7 24.5 23.5 
3b 11.3 12.9 12.3 10.1 11.1 11.1 
4 2.8 3.2 3.4 2.2 3.2 4.0 
5 0.4 0.4 0.2 0.2 0.6 0.2 
 
I t is difficult to interpret  these data very easily as over the period of the study a large 
proportion of people (84/ 436) moved away, died or commenced dialysis. See Figure 6.8. 
What can be said for this cohort  is that there were not large numbers of people reaching 
stage 4 CKD, or requiring dialysis/ transplantation. I n the course of the study only four people 
required dialysis. I t must also be reiterated that people in the participating practices with 
microalbuminuria at the start of the study were excluded if they had already been referred to 
the renal unit. This meant that  those at  risk of  progressive disease, who may have already 
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reached stage 3b or stage 4, were not included at the start. I t is possible that  if this high-risk 
group had been included then a greater proport ion of people may now be requiring renal 
replacement therapy, although it is known that people with CKD stages 3b-4 are also at  
higher cardio-vascular risk and as a consequence have high mortality rates (Bilous 2008). 
 
I t is known that  proteinuria is a risk factor for cardio-vascular morbidity and mortality (Wali et 
al. 2005). An interesting discussion might be whether those participants with proteinuria 
(ACR≥70), compared with those who had microalbuminuria, did have faster deteriorating 
kidney funct ion and/ or experienced earlier mortality. This will be discussed further in Chapter 
7. 
 
 
6.3. Distribution of packs 
 
Before an analysis of how far the self-management package was able to influence blood 
pressure, blood sugar control, weight management and smoking status can be carried out, 
the powering the study will be discussed.  
 
6.3.1. Powering of study 
 
I n Chapter 5, a description was given of how the study was powered. The study was 
powered on an outcome measure of blood pressure. I t  was calculated on the numbers of 
part icipants who had reached a target blood pressure of 135/ 75 mmHg (National I nstitute for 
Health and Clinical Excellence 2002) at baseline compared with the numbers who might be 
expected to achieve this target at the end of the study. 
 
I n order for the study to have 90%  power with 5%  significance, it was necessary to dist ribute 
the self-management packs to 42 patients in each surgery, that is, 252 packs in all.   
 
6.3.2. Numbers not possible or suitable for self-management pack 
 
Ultimately it  was not possible to distribute this number of packs, with only 116 packs being 
distributed across the 6 intervent ion surgeries. There were two main reasons why part icipants 
were not offered the pack:   non-possibility and non-suitability. Figure 6.19 shows the reasons 
why it  was either not  possible or not suitable for part icipants to be offered the self-
management pack.  
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Figure 6.19:  Reasons why participants could not receive the pack 
Not possible Not suitable 
Moved away 
Died  
Referred to renal unit  (with progressive CKD) 
No protein in urine and eGFR ≥60 
In residential care 
Learning difficulties 
Malignancy and receiving active/non-active treatment/unwell 
 
I t was either not possible to give people packs (people who died or moved away), or it  was 
not appropriate to do so. I t was not  appropriate to give packs to people who had no protein 
in their urine and who also had an eGFR ≥60 at the t ime of distribution as this group could 
not defined as being at  risk of CKD. This was a surprisingly large group with 92/ 436 (21.1%) 
in this category.   
 
Those who had been referred and were nearing renal replacement were not suitable either. 
There were also a large group of pat ients for whom educat ional intervent ion was considered 
not appropriate in discussion with practice staff – either if very elderly and/or in residential 
care or if suffering learning difficulties. A small number of people had other long-term 
conditions, such as cancer, and in these cases the practice nurses advised against pack 
distribution. 
 
A summary of the numbers of people possible and suitable to receive the pack is shown in 
Figure 6.20. I n each pract ice there were a high percentage (mean 60%) to whom the pack 
could not be distributed.    
 
Figure 6.20:  Participant possibility and suitability for the self-management pack  
SURGERY Total 
number of 
possible 
participants  
Number 
not 
possible 
Number 
not 
suitable 
Total not  
possible/ suitable 
Total 
available 
to 
participate 
1 83 15 36 51 32 
2 65 14 33 47 18 
3 82 13 28 41 41 
4 77 13 38 51 26 
5 56 8 24 32 34 
6 73 21 20 41 32 
Total 436 84 179 263 173 
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Figure 6.21 shows the reasons for non-distribution of packs in more detail, and further 
analysis of the issues involved will be discussed in section 7.2.  
 
Figure 6.21:  Reasons for non-distribut ion of  packs (by percentage of total number of 
part icipants)  
 
 
0%
20%
40%
60%
80%
100%
1 2 3 4 5 6
Surgery
Percentage of patients in each surgery not 
suitable or possible for education pack
Other not suitable
ACR normal
Referred
Moved
Died
 
 
 
Once the number of pat ients for whom the pack was either not suitable or possible was taken 
into account (Figure 6.20), there were only 173 people to whom the pack could have been 
given, that is, pack distribution was achieved in 67%  (116/ 173) possible patients.   
 
Of those who were suitable to receive packs, there was still difficulty in achieving full 
distribution. Despite excellent support from the participat ing practices, it proved challenging 
to reach all suitable patients. 134 patients in total were contacted, and of t hese 18 people 
refused to participate. Reasons for non-part icipation included being ‘not interested’, ‘too old 
for that sort  of thing’ and literacy problems (including native English speakers). I t proved 
difficult to contact younger people who were employed especially if the participant was well 
and was not  due at an imminent annual review appointment. I f a participant  was not due at a 
clinic within the timeframe for distribut ion of packs, then they were contacted by me on two 
occasions, once by mail and then followed up with a telephone call. I f there was no response 
then I  did not  try again. Further analysis on the reasons for non-distribution of packs will be 
discussed in the next chapter.  Figure 6.22 shows the percentage of people who received a 
pack of the total who were eligible. 
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Figure 6.22:  Percentage of eligible people who received a pack 
Percentage of packs given/not given to those 
eligible (n=173)
Pack given by 14.09.07
Pack not given
 
 
Pack distribution was achieved in 67%  of those who were eligible. 
 
6.4. Outcomes 
 
6.4.1. Effects on study of nat ional policy 
 
I t is important to consider the possible effects of national policy initiatives that occurred 
during the study t ime period. The main initiatives and policy changes during this time were 
the publicat ion of the National Service Framework for Renal Services (Part 2) in January 
2005;  the publication of national guidance on CKD in December 2005, followed by local 
guidance in early 2006;  the quality indicator for CKD in the QOF in April 2006 and the 
introduction of estimated GFR (eGFR) recording in this PCT in February 2006.  Figure 6.23 
shows the timelines for the six data collections alongside the publication of CKD policy 
init iatives. These policy changes are important because they may have affected clinical 
pract ice in the participating surgeries, which in turn may have had a direct effect  on 
part icipants’ blood pressure, HbA1c and BMI  during this time period.  
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Figure 6.23:  Data collections and CKD policy changes 
  
1 2 3 4
2005 2006 2007 2008
1 2 3 4 5 6
DATA COLLECTIONS 1-6
POLICY INITIATIVES
1. National Service Framework for Renal Services
2. National guidance for CKD
3. Local guidance for CKD
4. Introduction of eGFR recording
 
 
Data were analysed across two different groups.  The analysis was carried out in SPSS using 
repeated measures analysis of variance. The groups were:  
 
• Group 1 – patients from participating practices who did receive the self-management 
pack 
• Group 2 – patients in the control group 
 
Analyses were undertaken for the six time periods, and compared blood pressure (systolic 
and diastolic), glycated haemoglobin (HbA1c) and Body Mass Index (BMI ) across the 
intervention and control groups. I t  is possible that , if self-management initiatives are to 
impact on specific outcome measures, then these outcome measures are the most likely to 
be influenced. For example, blood pressure control might be influenced by people 
understanding the need to take regular medication, reducing salt intake and/ or self-
monitoring blood pressure. Diet and exercise can influence HbA1c readings and body mass 
index. 
 187
 
6.4.1.1. Systolic blood pressure 
 
Systolic BP was compared across the two groups during the six data collection periods. Figure 
6.24 shows the analysis. 
 
Figure 6.24:  Changes in mean systolic blood pressure over six time periods between 
intervention and control groups  
 
 
 
 
I n the intervention group, systolic blood pressure was reduced after the first four data 
collection periods compared with the control group, but this fell just  short  of statistical 
significance. 140.3 ±  16.0 mmHg vs. 134.4 ±  14.4 mmHg in March 2005;  to 129.2 ±  19.2 
mmHg vs. 134.6 ±  15.0 mmHg in November 2006 (p= 0.057 for systolic BP).  
 
At the end of the study period in January 2008 the patients who had received the self-
management package had a mean systolic BP of 132.1 ±  14.2 mmHg vs. 136.2 ±  16.4 
mmHg in the control group (p= 0.15). Although not statistically significant, the group who 
received the self-management pack had a mean blood pressure that is much nearer the NICE 
(2008) target of 130/80 mmHg. This may have important clinical implications in terms of 
cardio-vascular risk reduction. 
 
 188
 
I t was interesting to note the ‘rebound’ in blood pressure in the 5th data collection period in 
June 2007, in the participating pract ices visited by the researcher. There may be a variety of 
reasons for this finding. Two main possibilities are:  
 
1. Following the publication of policy guidance during 2006, practices had immediate 
interest in controlling blood pressure in this group, yet this interest began to wane 
during 2007. 
2. That I  stopped making appointments to visit the primary teams in the practices 
during the summer of 2007, after the final batch of  packs had been distributed. 
Following September 2007 I  only returned once to the practices for the final round of 
data collection in January 2008. I t is possible that  there was a positive effect on 
blood pressure control following the visits. 
  
Further analysis of these findings will be discussed in the next chapter.  
 
6.4.1.2. Diastolic blood pressure 
 
Figure 6.25 shows the analysis for diastolic blood pressure. Here the diastolic blood pressure 
showed a decreasing trend in the group that received the pack, unt il a mean diastolic blood 
pressure of 74.9 ±  8.5 mmHg was reached at the end of the study. I nterestingly diastolic 
blood pressure appeared to rise in the control group following time period 3 and 2 
respectively, yet t his did not happen in the group that  received the pack.  
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Figure 6.25:  Changes in mean diastolic blood pressure over six time periods between 
intervention and control groups  
 
 
 
 
There was no significant difference in diastolic blood pressure between the participants in the 
control practice and the participants who received the pack, apart from marginal significance 
at time period 5 (p= 0.053). However at the end of the study, mean diastolic blood pressure 
was 74.9 ±  8.5 mmHg in the intervention group. This compares with a mean diastolic blood 
pressure of 77.6 ±  9.1 mmHg in the control group. Although not statistically significant a 
difference of almost 3 mmHg in diastolic blood pressure may have implications for reduct ion 
in cardio-vascular risk. This assert ion will be discussed in detail in Chapter 7. 
 
6.4.1.3. HbA1c 
 
Figure 6.26 shows the differences in glycated haemoglobin between the two groups. I n 
general terms, HbA1c dropped in the intervention group from t ime points 3-5, but then rose. 
The control group had a higher HbA1c throughout and experienced the same fall until t ime 
point  5. There was no significant difference between the intervent ion group (with pack) and 
the control group at  any time point. The most significant time point was time point 4, when 
p= 0.108. 
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Figure 6.26:  Changes in mean HbA1c over six time periods between intervention and control 
groups  
 
 
 
Although these data are difficult to interpret  it can be said that  mean HbA1c values in the 
control surgery were well above the recommended target  of  6.5-7.5% (Nat ional I nstitute for 
Health and Clinical Excellence 2008b) at the start  of the study. Although NICE (2008) 
recommends that  people should be involved in decisions about their individual HbA1c target  
level, and this may lead to an agreed target well above that of 6.5%  set for people with Type 
2 diabetes in general, the mean value of 8.1% could contribute to an increased risk of clinical 
grade proteinuria and rising serum creat inine (Bilous 2008). 
 
There was also a fall in HbA1c for both groups between time points 1-4, possibly as a result  
of QOF incent ivisation, yet  interestingly there was a rebound in HbA1c for both groups, after 
time point 5. 
 
6.4.1.4. Body Mass Index 
 
Figure 6.27 shows the differences in Body Mass Index between the intervention and control 
groups.  
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Figure 6.27:  Changes in mean BMI  over six time periods between intervent ion and control 
groups  
 
 
 
 
Overall the findings show that the group who received the self-management pack started and 
ended the study with a higher BMI  than those who did not receive the pack or those in the 
control group. I t is difficult to draw any firm conclusions from these findings, especially 
because a large amount of data (80.3%) for the control group at time period one is missing 
(49/ 61 records missing). This is because the BMI  data that were collected with MIQUEST 
software only collected the latest 5 readings for BMI . This is an error on my part, as when I  
compiled the dataset I  assumed that  the latest  5 BMI  readings would capture readings for the 
previous 3 years. This was clearly not  the case in the majority of cases, as for most 
part icipants the latest 5 readings only captured data that covered the previous two years. I n 
other words, the majority of participants had a weight  and BMI  calculated at  least twice per 
year. 
 
I t is clearly challenging to support and help people to lose weight. Self-management 
strategies have been shown to be effective in weight management (Deakin et al. 2005) 
although it is possible that a group-based approach is needed for a significant change in body 
mass index.  
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6.5. Chapter summary 
 
One of the main aims for primary care management of diabetes is to minimise the risk of 
cardio-vascular complicat ions. The main finding from this study is that self-management 
techniques such as understanding of, and subsequent concordance with, prescribed 
medication may provide the opportunity for an individual to control their own blood pressure. 
I t is also possible that active involvement from a renal nurse in identifying abnormal ACR 
results and subsequent initiation of medicines that  modify the renin-angiotensin pathway, 
may also have an effect on blood pressure control. This assertion is supported by the 
downward trend in both mean systolic and diastolic blood pressure recordings in the 
part icipating practices during time periods 1-4, prior to the intervention being rolled-out.  The 
importance of maintaining blood pressure to target is that it can slow the rate of CKD 
progression and reduce cardio-vascular risk (Bilous 2008). 
 
Similar effects have not been seen for control of blood sugar and weight loss. This may be 
because blood sugar and body weight are more difficult to control from an individual’s 
perspective, and rely much more on behaviour change (diet, exercise) than change in 
concordance with medication. The following chapter will analyse the findings and discuss the 
assertion that “diabetes self-management is a multi-faceted process involving much more 
that helping patients to monitor their blood glucose or take their medication as prescribed.” 
(Clark 2008)(p. 118). 
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7. DI SCUSSI ON 
 
7.1. I ntroduction 
 
The focus of this study has been the development and evaluation of a self-management 
package for people with diabetes at risk of kidney disease. The research quest ion was:  
 
“Can an innovative self-management  package control the parameters that  contribute to the 
progression of kidney disease caused by diabetes?”  
 
The aims of the study were:  
 
• To develop a self-management education package which informs pat ients with diabetes 
about the risks of kidney disease 
• To test the self-management package by comparing with a control group 
• To evaluate the self-management package and consider ways to disseminate the package 
to a wider audience 
 
This chapter discusses the second and third aims of the study and will focus on five main 
areas:  the findings set within a context of recent published literature, the possible 
shortcomings of the method, the use of self-management initiatives in practice, the study 
implicat ions and my reflection on the research process.  
 
7.2. The findings 
 
The study’s findings need to be put into context before any recommendations can be made. 
The study population will now be scrutinised in terms of age, gender, ethnicity and social 
deprivation, and compared with national data and recent ly published literature where 
available.  I n the second part of this sect ion, the study’s clinical data will be reviewed and 
evaluated.  
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7.2.1. The study population:  demographics 
 
7.2.1.1. Age and gender 
 
Deteriorating kidney funct ion occurs normally with the ageing process (Maertens and Van 
Den Noortgate 2008). I t is therefore interesting to review whether the participants in this 
study, who were at risk of CKD, were more likely to have microalbuminuria as they get older. 
Firstly there needs to be a comparison of the age dist ribution of those in this study with the 
general population in the PCT. Figure 7.1 shows the age profile for men and women in 2007 
in the same PCT as the intervention/control practices (London Health Observatory 2008).  
 
Figure 7.1:  Age profile of PCT inhabitants in 2007 (Adapted from London Health Observatory 
2008) 
Age profile of PCT inhabitants in mid 2007
0.0
5.0
10.0
15.0
0 5-9
15
-
19
25
-
29
35
-
39
45
-
49
55
-
59
65
-
69
75
-
79
85
-
89
Age bands
Nu
m
be
rs
 
(th
o
u
sa
n
ds
)
Males
Females
  
 
Figure 7.2 shows the age profile for men and women in the study within the participat ing 
pract ices, including the control practice. 
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Figure 7.2:  Age profile of participants in 2007 
Age profile of participants in mid 2007
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I f Figure 7.1 and Figure 7.2 are compared it appears that  women in this study are more likely 
to have diabetes with microalbuminuria (MA) as they get older, with the greatest likelihood of 
having microalbuminuria in the 75-79 year band. I n contrast , men in this study appear to 
have microalbuminuria much earlier than women, shown by a steeper gradient from age 40 
years, up to age 65, then dipping slight ly before peaking at  75-79 years, as with women.  
 
I t is clear that more men in certain age groups have diabetes. A recent publication from 
Diabetes UK (Diabetes UK 2009) reported that 6% (around 197,050) of men aged 45-54 have 
diabetes compared with 3.6%  (around 120,670) of women their age. I n the older age groups 
(55–64 years) there are 8.5%  of men with diabetes compared with 6.0%  of women, and in 
the 65–74 age group 15.7%  of men have diabetes compared with 10.4% of women. 
 
However it is not clear whether MA appears sooner in men after diagnosis of diabetes. This 
question has to be considered in view of the mean screening rate of 71%  (for both men and 
women) at the start of the study (ie. 29%  of people with diabetes had not  been tested for 
MA) and a mean screening rate of 86%  in 2006. I n the six intervention practices in 2006, 
23%  of people with diabetes were identified as having abnormal ACR values and of those 
approximately 60%  were men. Although claims cannot  be made about progression of 
proteinuria in the wider diabetes population, it is interesting to consider why men in this 
study had microalbuminuria (MA) at a younger age than women. No published evidence could 
be found which demonstrated that  there were differences in MA progression due to gender 
alone, although one study was identified that found that risk factors for MA in Type 2 
diabetes, did include poor glycaemic control and male gender (Kohler et  al. 2000).  
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Recommendation for further research 
Further research is needed to explore the natural progression of microalbuminuria, especially 
whether male gender is a factor in progression of the condition. 
 
As MA progression is correlated with blood pressure and blood glucose control (Yamada et al. 
2005) it is possible that there are differences in the way in which men and women take on 
health care advice regarding blood pressure and blood sugar control. One study (Heo et al. 
2008)found that higher perceived control and better knowledge were related to better self-
care behaviours in men (p< 0.001), while higher self-care confidence and poorer funct ional 
status were related to bet ter self-care behaviours in women (p< 0.001).  
 
However another study group (McCollum et al. 2005) found that women with diabetes scored 
lower on measures of health status and functioning-factors when compared with men. The 
authors proposed that these lower scores were likely to affect self-care activities, and 
concluded that gender differences should be considered when developing screening and 
treatment programmes for people with diabetes. 
 
The implications for this study regarding gender differences are twofold. Firstly, men may be 
at risk of MA at an earlier age than women, so the educat ional intervention may need to 
come sooner. Secondly, that men may take on health-care advice in different  ways from 
women, and these differences need to be considered when developing educat ional resources. 
For example, men may need to be given strategies that help them feel that  they are 
controlling their condition, such as ensuring that dietary advice is consistent across different  
health care professionals. Women may need constant reassurance that their self-care 
behaviours are indeed helping their condit ion.  
 
One study (Leeman et al. 2008) recognised that older people may learn in different ways 
from younger people and tailored a diabetes self-care programme to this group. The content  
of the educational intervention was individualised to experience of symptoms, self-care 
pract ices, and coping strategies, all delivered in a story-telling format. An initial pilot of the 
intervention with 43 older women over 75 years found high levels of participant  satisfact ion 
with the intervention, improvements in diabetes self-care practices, and a trend toward 
greater metabolic control.  
 197
 
 
Pract ice recommendation  
I t is crucial that educational materials are developed with the main target audience in mind. 
For this thesis, consideration must  be given to the age of the majority of people af fected by 
MA, that is, more than 65 years of age. Practical issues such as font size and colour of written 
materials are important, and will be reviewed before the final edition of the self-management 
pack is published. 
 
7.2.1.2. Ethnicity 
 
There was poor ethnicity recording in the study pract ices (36% missing data overall) at the 
time of this study, although LHO data have since been published. At the time of the analysis 
it  was not  possible to draw conclusions about how far people from different ethnic groups 
were more likely to engage in self-care practices or not .  
 
Authors of a recent study into prevalence of CKD (de Lusignan et al. 2009) recommended 
that there needs to be an improvement in ethnicity recording. I n their study, ethnicity 
recording was present in only around 25% of people with CKD.  Although substantial 
investments have been made in other parts of the country to achieve much higher rates of 
ethnicity recording (Kumarapeli et al. 2006), this has not happened in all practices. However, 
even if ethnicity recording had been better, there are still relatively low numbers of people 
from black and minority ethnic (BME) groups in this study’s primary care trust (PCT), 
compared with other parts of London (QRESEARCH and The Health and Social Care 
Information Centre 2008). Due to small recorded numbers of people from BME groups in this 
PCT, it will be difficult  to show that any differences in self-management behaviours across 
different ethnic groups.  
 
However it is important to consider the possible effects of ethnicity on self-management. I n a 
survey of more than 6000 people with diabetes in the USA (Oster et  al. 2006), African-
Americans were significantly less likely than whites to monitor their diet, take exercise and 
not smoke;  while Hispanics were less likely to monitor their diet  than other groups. However 
all racial/ ethnic groups had low levels of self-management behaviours. The authors 
recommended that further research was warranted to identify why racial disparit ies remain in 
settings where services are universally available.  
 
Another study team (Glasgow et al. 2007) found that problem solving, an important patient 
skill for execut ing self-management behaviours, appears to be present across all racial and 
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ethnic groups. However it is possible that differences in self-management behaviours could 
be att ributed to the type of facilitation and learning resources provided for self-management. 
Further work into what method of learning and teaching (written materials;  one-to-one 
facilitation;  peer support etc) might work best for different ethnic groups is clearly warranted.  
On reflection, more emphasis could have been placed on whether this study’s self-
management pack was culturally appropriate, not  just in terms of content (advice on diet, 
medicines etc) but also with respect to learning style and health beliefs. 
 
Pract ice Recommendation 
Consideration must  be given to cultural appropriateness of the learning materials in the self-
management pack (such as dietary advice) and these will be reviewed before the final edition 
of the pack is published. 
 
7.2.1.3. Deprivation 
 
There are commonly used methods for calculating pract ice-level deprivation found in the 
literature, for example the Townsend scoring system (Townsend et al. 1988). However this 
method requires patient-level geographical data (identifiable data such as whole postcodes), 
which were not collected in this study because of data protection issues. Another method can 
use the deprivat ion score associated with the small area in which the pract ice resides, but 
this only provides a proxy for the socioeconomic deprivation experienced by the practice 
population as a whole. Given that  the majority of a practice's registered patient populat ion 
live in areas surrounding the practice that may have deprivation scores different  from that of 
the area in which the practice is located or not, this assumption has its limitations (Strong et 
al. 2007). 
 
However this second method was used as an approximat ion of social deprivation in this 
study, as ident ifiable data were not  available. Data on the social grades of inhabitants of the 
ward (a small geographical area selected for electoral purposes) in which the practices are 
located were used. This may of course be different from the actual population of the practice, 
which may be from a wider geographical area.  
 
Although it is recognised that  there are difficulties in assigning deprivation scores through the 
social grades of inhabitants, this is one measure of deprivation that can be easily used. Social 
deprivation across the participat ing practices is varied. Fig 7.2 shows the percentage of social 
grades in the population in each ward where the participat ing practices are located. Data are 
from the 2001 census. 
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Figure 7.3:  Social grades in participating practice populations 
Social grades in practice populations
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Key to Figure 7.3 
AB Higher and intermediate managerial /  administrat ive /  professional 
C1 Supervisory, clerical, junior managerial /  administrat ive /  professional 
C2 Skilled manual workers 
D Semi-skilled and unskilled manual workers 
E On state benef it , unemployed, lowest grade workers 
 
 
Surgeries 1 and 3 have many more inhabitants in social grades AB and C1, whereas surgery 2 
has more people in grades C2-E, which implies a higher level of deprivation in surgery 2. This 
assertion is supported by my own observations and experience of working in this PCT. 
Surgery 2 is situated within an area of high levels of social housing, whereas surgery 3 is 
situated in a desirable leafy suburb known for attract ing wealthy professionals.  
 
Prevalence of diabetes in the participating practices in 2005 (according to the Quality and 
Outcomes Framework (QOF) returns) is shown in Figure 7.4. 
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Figure 7.4:  Size of pract ice and prevalence of diabetes in participating pract ices in 2005 
Surgery Practice size Number diagnosed 
with diabetes 
Diabetes 
prevalence (% ) 
1 10536 315 3.0 
2 7958 219 2.8 
3 14241 393 2.8 
4 9405 336 3.6 
5 9041 247 2.7 
6 10810 436 4.0 
7 7629 267 3.5 
 
There are differences between prevalence rates of diabetes in the part icipating practices 
(range 2.7-4.0%), although in these practices, prevalence does not appear to be correlated 
with deprivation. For example, it  might be expected that surgeries 1 and 3 might have a 
lower prevalence of diabetes, with surgery 2 having a higher prevalence, and this is not the 
case. 
 
The observed prevalence rates across deprivat ion quintiles found in the National Diabetes 
Audit (The Information Centre National Clinical Audit Support Programme 2006) provides a 
different picture. Data from the National Diabetes Audit (NDA) is based on 28%  of the 1.8 
million people who make up the registered diabetic population of England. Figure 7.5 shows 
prevalence rates of diabetes by deprivation quintile.  
 
Figure 7.5:  Prevalence rates by deprivation quintile 
Deprivation Quintile Prevalence rate 
Quintile 1 (least  deprived) 2.78%  
Quintile 2 2.90%  
Quintile 3 3.46%  
Quintile 4 3.45%  
Quintile 5 (most deprived) 3.70%  
 
There is a difference of almost  1%  in the observed prevalence of diabetes between areas 
which are least (Quintile 1) and most deprived (Quintile 5) having the highest prevalence of 
diabetes.  
 
However, the difference in prevalence between the practices in the present study could be 
due to differences in people report ing symptoms of diabetes (thirst, urinary frequency) and 
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attending for diagnostic test s. Prevalence could also be correlated with the mean age of the 
pract ice population. I nterest ingly though, surgery 5 and 6 share the same building and have 
the same pract ice population, yet the prevalence of diabetes in 2005 between these two 
pract ices differed by 1.3% . There may also be clinical coding variat ions at pract ice level that  
also have to be taken into account. 
 
There is also evidence that deprivation can affect  clinical parameters such as blood pressure 
(QRESEARCH and The Health and Social Care Information Centre 2008). However, it has 
been suggested that  blood pressure differences in people with diabetes between areas of 
high and low deprivation, have been eradicated since the introduction of the Quality and 
Outcomes Framework in 2004 (Ashworth et al. 2008). Since the reporting of performance 
indicators for blood pressure monitoring and control were introduced, there have been 
substantial improvements in achievement, that have been accompanied by the near 
disappearance of the achievement gap between least and most deprived areas (Ashworth et 
al. 2008). The following section will explore differences in clinical parameters across the 
part icipating and control practices, followed by an evaluation of the differences between 
intervention and control groups. 
 
7.2.1.4. Summary 
 
This section has compared the study population with national data where available, in terms 
of age, gender, ethnicity and social deprivat ion. I t has been found that  in the study 
population, men had microalbuminuria (MA) at a younger age than women, although it  was 
not clear why this was the case.  
 
Due to the poor ethnicity recording in the study pract ices (36% missing data overall), it has 
not been possible to draw conclusions about the ef fects of ethnic diversity on the findings. 
Social deprivation across the participating practices is varied, although differences in 
deprivation are not correlated with diabetes prevalence rates as expected.    
 
7.2.2. The study population:  clinical parameters 
 
7.2.2.1. Blood pressure 
 
Nationally collected data from primary care databases (QRESEARCH and The Health and 
Social Care Information Centre 2008) showed that mean systolic/diastolic blood pressure in 
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the general population in 2006/7 was 129/ 77 mmHg. Mean systolic and diastolic blood 
pressures in 2006/7 did not vary with level of deprivation.  
 
The National Diabetes Audit (NDA) of 2005-2006 (The Information Centre National Clinical 
Audit Support Programme 2006) scrutinised the records of more than 650,000 people with 
diabetes, with 85%  of these records being submitted from primary care. 
 
Analysis of these data from primary care only showed that  26.8% of people with diabetes 
achieved the NICE (2002) blood pressure target of less than 135/ 75 mm Hg which was an 
increase of 2.62% on the previous year. 88%  of people achieved the target of < 160/100 
mmHg. By comparison, 58%  of participants in the present study in 2005, had achieved the 
NICE target of 135/ 75 mmHg. I t is difficult  to compare these data direct ly, as all of the 
part icipants in this study had microalbuminuria and the percentage of those with 
microalbuminuria in the national audit sample was not stated. However it appears that  overall 
blood pressure control in the part icipating practices at  the start of the study was better than 
in the national sample.  
 
7.2.2.2. Blood sugar control:  HbA1c 
 
I n the NDA period of 2005-2006, 22% of people with diabetes achieved the lower HbA1c 
target of < 6.5% , and 60% achieved the target of < 7.5% recommended by NICE at that time 
(National I nst itute for Health and Clinical Excellence 2002). I n 2006 in the present study, 
57%  of people in the participating practices had an HbA1c result of < 7.5% , a similar finding 
to the national sample. 
 
7.2.2.3. Body Mass Index 
 
Obesity is defined as having a body mass index (BMI ) of 30 or above. I n the QResearch 
report (QRESEARCH and The Health and Social Care Information Centre 2008) 26% of people 
in the general population had a BMI> 30, and this included 11%  of registered patients who 
had BMI> 30 plus a diagnosis of coronary heart disease (CHD), hypertension or diabetes. I n 
2006/ 7 the highest  proportion of obese patients was in Wales (31%) and the lowest  was in 
London (22%). I n the present  study, baseline data found that 128 out of 342 patients (37%) 
of the study population in the intervention practices had a BMI> 30, a much higher 
percentage compared with the national sample. This is to be expected as being obese, 
part icularly at younger ages, substantially increases the lifetime risk of being diagnosed with 
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diabetes (Narayan et al. 2007). The NDA of 2005-2006 did not collect data on BMI  so a 
comparison with a diabetic populat ion is difficult. 
 
7.2.2.4. Smoking cessation 
 
The QRESEARCH study (QRESEARCH and The Health and Social Care Information Centre 
2008) identified that in March 2007, 80%  of registered patients aged 16+  had smoking 
information recorded within their electronic health record in the past  5 years. 22% of these 
were recorded as being current smokers. Smoking is more common among patients from the 
most  deprived areas. For example by the end of March 2007,  34%  of  patients from the most  
deprived areas were current  smokers compared with 14%  of patients from the most  affluent  
areas. 
 
I n 2006/ 7 the percentage of patients recorded as smokers in the past 5 years was highest in 
the North-East and London (25%) and lowest in the South-East and South-West (20%) 
(QRESEARCH and The Health and Social Care Information Centre 2008). 
 
The present study’s findings showed that the percentage of people who were smoking at  the 
start  of the study was 18.5%  of those for whom there was a record of smoking status. This is 
a smaller percentage than in the general population although surgery 2, which could be 
considered to be in an area of social deprivation compared with the other practices, recorded 
more than 30%  of the participants as smokers. 
 
7.2.2.5. Kidney disease progression 
 
Data which compare the rates of kidney disease progression can be difficult to analyse with 
respect to severity of CKD, as staging of CKD was only introduced into the UK in 2006, and 
retrospective data are difficult to find. For the purposes of  this study, retrospective serum 
creat inine results were converted into eGFR readings using the Modification of Diet in Renal 
Disease (MDRD) formula, found on the Renal Associat ion website  
http: / /www.renal.org/eGFRcalc/GFR.pl. 
 
The Information Centre (The Information Centre National Clinical Audit Support Programme 
2006) has published data on risk of renal failure (stage 5 CKD) in people who have diabetes. 
The prevalence in the population with diabetes is 0.21%, whilst the prevalence in the general 
population is 0.05% .  
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The highest prevalence rates for renal failure (stage 5 CKD) are found in the middle age 
bands, starting with a sharp rise at age 25-39 years. There is a higher complication rate of 
kidney failure in males (0.34%) compared with females (0.23%). There is lit t le variat ion in 
prevalence rates of renal failure across the country (The Information Centre National Clinical 
Audit Support Programme 2006). The authors suggest that known preventive care 
interventions in people with diabetes from a young age should result  in a reduction in these 
rates. 
 
I n the present study period of 3 years, there was litt le evidence of kidney disease 
progression, with only small numbers of people reaching stage 4 CKD, or requiring 
dialysis/ transplantation. I n the course of the study only four people required dialysis. 
However people were excluded from the study at  the start  if they had already been referred 
to the renal unit. This meant that those at risk of progressive disease, who may have already 
reached stage 3b or stage 4, were not included. I t is possible that if the high-risk group had 
been included then a greater proportion of people may now be requiring renal replacement 
therapy.  
 
I t is likely that the high number of deaths during the study (around 10%) may have been due 
to cardio-vascular disease, a well-documented independent risk factor in CKD (Go et al. 
2004). This means that many people with CKD may die of cardio-vascular disease before they 
progress to dialysis dependence. I t is possible that this conclusion is also applicable to this 
study, although data on cause of death were not collected.  
 
I n the general population, a recent study in Surrey (de Lusignan et al. 2009) found that CKD 
(stages 3-5)  is a condition which is more common with increasing age, and is more common 
in females than males. The data in the Surrey study were taken from 14 practices as part of a 
quality improvement initiat ive and were anonymised and extracted using MIQUEST software.  
 
The prevalence of CKD in the Surrey study was much higher in women than men. However, 
as renal function declined, the proportion of men with CKD increased. Just over a quarter of 
people with stage 3A CKD were men. Men account for just over one-third of people with 
stage 3B CKD and nearly half of those with stage 4 and 5 disease. This may provide some 
insight as to why CKD is much more prevalent in females but  renal replacement therapy is 
more common in men (de Lusignan et al. 2009). I nterestingly in the present study, more 
men had microalbuminuria at an earlier age. However as this cohort did not include people 
who had already been referred to a renal unit at  the start  of the study, it has not been 
possible to give an accurate comparison of how many men with MA had further CKD 
progression and eventually required renal replacement therapy. 
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7.2.3. The intervention versus control group:  clinical parameters 
 
The results chapter outlined the findings by comparing the intervent ion and control groups. 
Some analysis about differences between the two groups took place in the results chapter, 
but further discussion is warranted here. There now follows a discussion about the group of 
pat ients that did not receive the pack, but were registered at the participating surgeries. 
 
7.2.4. Characteristics of the group that did not receive the pack 
 
This group were not given the pack either because they could not take part (moved away or 
died n= 84) or because they were not  suitable (n= 179). Reasons for clinical non-suitability 
can be divided into renal causes or non-renal causes.  
 
7.2.4.1. People who did not receive the pack:  renal causes 
 
Renal causes were either because they had no microalbuminuria (n= 92) at the start  of the 
intervention period, or they had been referred to the renal unit for progressive CKD (n= 26).  
 
The high percentage (21%) of people who were not suitable because they had normal ACR 
results was surprising, yet very pleasing, to me. On reflection this may be due to two 
reasons. First that a small percentage of people may not have been accurately documented 
as having microalbuminuria and were therefore wrongly included in the study. This may be 
because of false positives such as infect ion. However despite published  guidelines and expert  
consensus opinions recommending the exclusion of a urinary tract infection (UTI ) if a test 
result for urinary albumin is positive, findings from a systematic review (Carter et al. 2006) 
concluded that it  is unnecessary to screen asymptomatic patients with demonstrable 
proteinuria or albuminuria for UTI .  I t is therefore likely that infection did not contribute to 
people being wrongly diagnosed with MA, therefore the number of false posit ives might be 
small. 
 
What is more likely is that there are differences in progression of microalbuminuria (MA) 
which had not been completely understood by me at the start of the study, partly because of 
the lack of epidemiological evidence on MA progression. A more recent search identified three 
pert inent studies that illustrated progression and reduction. First, in a study of people with 
Type 1 diabetes (Ficociello et al. 2007), microalbuminuria was often found to progress to 
proteinuria in those who were treated with ACEi/ ARBs (n= 373). Poor glycaemic control and 
elevated serum cholesterol were the major determinants/predictors of this progression.  
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However in a smaller study of people with Type 2 diabetes (n= 26) the converse appeared to 
be t rue (Atmaca and Gedik 2006). I n this study the albumin excretion rate had been reduced 
significantly in each group over a twelve month period after initiation of ACEi/ARB. In another 
small study (n= 20) (Cotter et al. 2008) regression towards normoalbuminuria occurred in 11 
pat ients (35.5%) taking ARBs vs. 9 (22.5%) patients taking ACEis (NS between groups). A 
review paper (Araki et al. 2008) supports this assertion by suggesting that in people with 
Type 2 diabetes treated with ACEi/ ARB, a reduction in microalbuminuria was more frequent  
than progression to overt proteinuria. They concluded by suggesting that a mult i-factorial 
approach was important in reducing microalbuminuria in this group.   
 
The conclusion is that rapid initiation of  ACEi/ARBs in people with MA can reap rewards in 
especially if implemented alongside other measures such as strict blood pressure and blood 
sugar control. The results from this present study suggest that it  is likely that  the 
part icipating practices were provided improved care to this cohort of people at risk of CKD 
following the case study period. The practices did this by improving the screening rates for 
MA and by timely prescribing of appropriate medication to those at risk. 
 
Pract ice recommendation 
CKD education programmes for primary care health-care professionals to focus on 
importance of MA screening to identify those at risk, in order that timely prescribing of 
ACEi/ ARBs can be initiated.  
 
7.2.4.2. People who did not receive the pack:  non-renal causes 
 
Some were not suitable because of another clinical condition (malignancy and receiving 
active/non-active treatment or being unwell with a long-term condition (n= 25)). There were 
also social reasons, such as in residential care or learning difficulties (n= 36), for why people 
in the part icipating surgeries did not receive a pack.  
 
I t is therefore difficult to draw conclusions about  this group because of its diversity, although 
it  might be useful to some extent to draw comparisons between this group and the group 
from the intervention practices that did receive the intervent ion, to see if any researcher 
effect could be identified. This will be discussed further in section 7.3. 
 
I t is pertinent to discuss some characteristics of this group that have relevance to long-term 
sustainability of the self-management pack. Firstly, in any practice there is always a transient 
 207
 
population, especially in inner-city areas, so long-term care and follow-up can be challenging. 
Secondly, people with diabetes and kidney damage are at increased cardio-vascular risk, so 
increased morbidity and mortality is likely. An important question is when education and self-
management support should be initiated in this high-risk group. 
 
There are implications from the findings of this study for init iation of self-management 
programmes for other long-term conditions. Apart  from the renal causes of non-participation, 
there was still a sizeable number of people (n= 61)(14%) who could not participate because 
of clinical or social reasons.  
 
Despite searching the literature it was not possible to compare these figures for non-
part icipation with other self-management studies or projects, as data on non-participat ion 
were rarely reported. The recommendation from this study is that development of future self-
management programmes have to be considered in light of the number of people who are 
not suitable for self-care, either because of clinical or social reasons.  
 
Pract ice Recommendation  
I t is important to recognise that any newly-developed self-management package or 
programme may not be suitable for people who either do not want, or are not able to self-
care. The recommendation is that packages or programmes cater for a range of self-care 
abilit ies, from simple messages (eg. how many tablets to take each day) to complex 
interventions, such as monitoring and managing insulin requirements. 
 
7.2.5. People who did not want t o participate 
 
I n this study 18 people refused to take part  and it is possible that  some people took part but  
did not actually use the pack at all. An important question is how far the general public and 
those with long-term conditions believe that self-management or self-care is beneficial. I n 
this study there was a minority (around 10%) who did not wish to have a pack, so 
presumably did not wish to self-manage.  
 
The Department of Health commissioned Ipsos-MORI  in 2008 to undertake a longitudinal 
study, exploring attitudes of the public towards self-care (Department of Health 2008a). The 
study aimed to investigate the general public's perceptions and behaviour with regard to self 
care of their health, and more importantly aimed to capture the attitudes and behaviour of 
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people with long-term health conditions.  Overall the study found that the vast  majority of 
British adults (89%) think that  people should take responsibility for their own well being. 
However, for those with a long-term condition, the results are somewhat different . Of those 
questioned (n= 1975), 5% reported that  they had diabetes, and over three-quarters of adults 
with diabetes and other long-term health conditions say they play an active role in treat ing 
their condition ‘all or most of the time’. More than four in five older people aged 55-64 say 
they take care of their long term condition ‘all or most of the time’ (85% compared with 80%  
aged 15-24) as do those in the higher social grades (89%  compared with 76%  social grades 
DE). However respondents from ethnic minority groups were less likely to take an active role 
‘all’ or ‘most’ of the time (59%), as were Londoners (48%).  
Another important issue which was raised was how many with a long-term health condit ion 
(22%) were unable to perceive an advantage in taking a greater role in care of their health 
and condition and a further 15%  did not know whether or not there were any advantages.  
The potential is clearly there to increase awareness amongst these groups of the advantages 
of self-care, and a recommendation for  this thesis is that people with diabetes and CKD need 
to have a full explanation of the advantages, especially potential slowing of kidney disease 
progression. 
 
Pract ice recommendation 
The written information in the self-management pack should have an introductory paragraph 
that explains the benefits of self-care. 
 
I n the same study undertaken for the Department of  Health (Department of Health 2008a) 
the results found that four in five adults with a long term health condition said they had not 
heard of a training course that would help them learn skills to self care for their health and 
condition. Although this present  study has developed a self-care package, and not a training 
course, this finding has implications for this study in terms of disseminat ion;  that is making 
sure that as many people as possible at risk of CKD have access to the package. This could 
be either in the original paper/DVD version, or on-line. Widening access for everyone with 
diabetes at risk of CKD is discussed in section 8.5.   
 
Another important part of the study (Department of Health 2008a) compared data with 
figures from a similar study in 2004-2005 (two years before) . I n 2006-2007, three in five 
people with a long-term health condition said that  they prepare questions ‘all’ or ‘most’ of the 
time for when they visit health or social care professionals such as doctors, nurses or social 
workers (60%). This has increased since 2004-05 when only around half said they prepared 
questions for health professionals (52%). A recommendation is that further emphasis is put  
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on preparing questions for the GP or practice nurse before the consultation, as preparing 
questions in advance can improve self-management skills (Sturt  et al. 2006b).  
 
Pract ice recommendation 
 
The written information in the self-management pack should contain a suggest ion that  
pat ients prepare questions for their GP or practice nurse prior to a consultation visit. 
 
 
 
 
7.2.6. Health-care professionals and self-management 
 
An important message is how far health-care professionals themselves encourage self-
management. I n the same study (Department of Health 2008a) people reported that when 
visiting their practice nurse they are more likely than those visit ing GPs, hospital doctors or 
pharmacists to be encouraged to self care and play a more active role in caring for their long 
term condition. More than four in five of those visiting their practice nurse said that they were 
encouraged to self-care (83%). A significant  proportion (62%) who visited their local 
pharmacist was encouraged to self care. 
 
However for most  people, the preferred source of information and advice about long-term 
health condit ions in the future is the GP (66%). Other preferred sources of information are 
pract ice nurses (23%), local pharmacists (17%) and hospital doctors (17%). The implicat ion 
is that GPs may need further training and support in facilitat ing self-care, as people with long-
term conditions may not engage in self-care if their doctor does not support or encourage it. 
 
I n summary, this section has provided some recommendat ions for the way in which people 
who did not want to participate in self-management might be encouraged to do so. These 
include explaining the benefits of self-care more explicitly, advert ising the pack more widely 
to make it more accessible, providing people with examples of questions they might ask of 
their health care professionals during consultat ion, and encouraging and training health-care 
professionals in this approach.  
 
7.2.7. Characteristics of the group that did receive the pack 
 
116 people (the intervention group) received the pack, although it  cannot be assumed that 
everyone who was given the pack then read or viewed the contents, or acted on the advice 
given. When the pack was developed the aim was that  it should be self-supporting, that is, 
that it did not require any additional explanation or information from the person giving out  
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the pack. What cannot be controlled was how far different pract ices or health care 
professionals supported or reinforced the advice given therein. Through observing the way in 
which different practice nurses took on the project, the nurses in practices 5 and 6 were the 
most enthusiastic for self-care. This observation was supported during my participant 
observat ion at  the start  of the study (see Chapter 2), such as conducting pat ient-centred 
consultations (“how are you coping with your diabetes?” ) and encouraging people to identify 
individualised targets for weight loss and smoking cessat ion. However, a number of different 
health-care professionals in each practice distributed the packs and some were given out by 
me either in the surgery or in the patient’s home.  The conclusion is that there was variat ion 
in the way in which the packs were given out, and how far subsequent self-care strategies 
were supported and implemented in each case. Although these differences are recognised, 
they cannot  be controlled for. I ndeed, the package is likely to be much more useful if its 
benefits are found to be independent of who delivers it.  I f the pack is to be distributed in 
future without  support ing information from the person who provides it, one important 
consideration is how far the pack is understood by the user.  
 
However it  would be useful if the person who delivers the pack is provided with some 
supporting informat ion regarding aims, content and possible frequently asked questions 
(FAQs) that patients may ask once they have received the pack. A recommendation is that 
the pack includes supplementary informat ion for health-care professionals that  outlines the 
aims, content and potential FAQs.  
 
Pract ice recommendation 
 
The written information in the self-management pack should include supplementary 
information for health-care professionals.  
 
 
 
7.2.8. Health literacy 
 
Since the start  of this research study, there has been a growing interest in health literacy. 
Health literacy can be defined as 
 
“ the degree to which individuals have the capacity to obtain, process, and understand 
basic health informat ion and services needed to make appropriate health decisions.”   
(Department of Health and Human Services (HSS) (USA) 2000). 
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A number of reviews (I shikawa and Yano 2008, Keller et al. 2008, Schaefer and Schaefer 
2008) have evaluated the effect of health literacy on health outcomes. Most authors conclude 
that further research is needed to explore the impact  that low health literacy may have on 
pat ient outcomes. However, it is agreed that health literacy goes beyond the commonly held 
belief that simply giving information in an understandable and readable format is enough to 
facilitate self-management. Although pract ical issues such as font size are clearly important, 
other factors which enable people to process and understand health information must be 
considered. One pertinent study (Sarkar et  al. 2006) suggested that  further study of the 
determinants of, and barriers to, self-management were warranted, whilst a review of health 
literacy and CKD (Devraj et al. 2009) concluded that despite the increasing prevalence of CKD 
and the considerable interest in health literacy, there has been limited research examining 
the role of health literacy in individuals at all stages of CKD. 
 
Although the research study presented in this thesis does go some way to address the deficit 
in information resources for diabetic kidney disease, further work needs to be carried out in 
understanding the ways in which people take in and process heath care information.  
 
Recommendation for further research 
As lit t le is known about how people with early CKD take-in and process health informat ion, a 
qualitative study is recommended that  investigates how people interpret  the informat ion in 
the self-management pack and use this to change their health behaviour. Semi-structured 
interviews with people who have received the pack could be undertaken. I nterview topics 
could include baseline knowledge about  risk of CKD, the aspects of the pack that were most 
useful, and the behaviours that were altered as a result of the informat ion received. 
 
  
7.2.9. Differences between groups:  clinical parameters 
 
7.2.9.1. Blood pressure 
 
The most  important finding was that  both systolic and diastolic blood pressure did fall in the 
intervention group compared with the control group although the differences were not  
significant.  At the end of the study period in January 2008, the patients who had received 
the self-management package had a mean systolic BP of 132.1 ±  14.2 mmHg  vs. 136.2 ±  
16.4 mmHg in the control group (p= 0.15). Although not statistically significant, the group 
who received the self-management pack had a mean blood pressure that was much nearer 
the NICE (2008) target of 130/80 mmHg. The lowest mean blood pressure recording of the 
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intervention group was at data collection period 4 (November 2006). At this time point, mean 
systolic BP was 129.2 ±  19.2 mmHg  and the mean systolic BP in the control group was 
134.6 ±  15.0 mmHg  (p= 0.057). I t was 3 months prior to time point 4 and during t ime point 
5, that the self-management packs were being distributed. The statistical analysis shows mild 
significance but it would have been helpful t o compare mean BPs in the intervention group 
with national data if those data had been available. 
 
I n the only study found that  can be used for comparison (de Lusignan et  al. 2009) the mean 
systolic blood pressure in people with CKD was 136.0 ±  17.5 mmHg, as compared with a 
mean of 126.8 mmHg in the rest of the population. Blood pressure control was no better in 
people with diabetes and CKD than without diabetes and CKD. The mean systolic BP in 
people with CKD with and without a positive proteinuria test (including dipstick tests) were 
136.9 and 137.1 mmHg respectively (p= ns). The systolic blood pressure in the intervent ion 
group at  the end of the present  study was 132.1 mmHg. This compares with 136.2 mmHg in 
the control group which is the same mean BP as in the CKD group in the de Lusignan (2009) 
study.  
 
I t is therefore likely that changes to BP in the intervent ion practices have occurred as a result 
of this study’s interventions rather than external influences. What cannot be explained is the 
exact reason for these resulting reductions in mean BP. I t  is possible that effects came about  
because of direct patient  behaviour, such as individuals understanding of the risks of high 
blood pressure and being more concordant with prescribed anti-hypertensive medications. I t 
is possible there was an effect  resulting from my visits to the intervention practices. This 
could have been because my frequent visits increased practice nurses’ understanding of the 
importance of BP control in this high-risk group, and this awareness prompted more diligent 
monitoring, recall and prescribing of anti-hypertensive medication.  
 
I t was interesting to observe that there was a ‘rebound’ in mean BP in the intervention group 
at time point 5 (133.4 ±  12.8 mmHg), although mean BP did fall again at time point 6 (132.1 
±  14.2 mmHg).  The reasons for this are not  clear but it is possible that BP control may relate 
to QOF incentivisat ion, with practices recalling patients for blood pressure checks and 
subsequent prescribing if the BP was over the QOF targets, towards the end of the financial 
year. Time point  5 occurred in June 2007 (after the end of the financial year) whereas time 
point  6 occurred in January 2008, just prior to t he end of the financial year and QOF visits.  
 
I t is also possible that  an intervention might have an immediate effect on learning and 
subsequent change on behaviour, but this effect diminishes with time (Boren et al. 2007). 
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Diastolic blood pressure in the intervent ion group also had similar reductions during the data 
collection period, but did not have a ‘rebound’ at time point 5. At  the end of t he study, mean 
diastolic blood pressure was 74.9 ±  8.52 mmHg in the intervention group. This compares 
with a mean diastolic blood pressure of 77.6 ±  9.01 mmHg in the control group (p= ns). 
I nterestingly there was a difference that fell just short  of being significant  (p= 0.053) at time 
point  5, with a mean BP in the intervention group of 75.7 ±  7.4 mmHg vs. 78.9 ±  10.6 
mmHg in the control group. 
 
The findings show that  it is possible to achieve the NICE (2008) diastolic BP target  of 130/ 80 
mmHg for people with CKD and diabetes. This is in contrast  with some other studies that  
found BP in people with diabetes difficult to control. One review (McLean et  al. 2006) found 
that fewer than one in eight people (n= 47964) with diabetes and hypertension have 
adequately controlled BP (defined by BP 130/85 mmHg), and recommended that there was 
an urgent need for mult idisciplinary, community-based approaches to manage this high-risk  
cohort. A primary care study in Nottingham (Bebb et al. 2007) found that only 46%  of 
part icipants had well-controlled blood pressure (defined by BP < 145/ 85 mmHg). 
 
I n terms of cardio-vascular risk reduction the reduced blood pressure in the intervent ion 
group has important implications. Numerous studies have shown that BP control is an 
important modifiable risk factor for cardiovascular events (Mourad and Le Jeune 2008). Blood 
pressure control with angiotensin-convert ing enzyme inhibitors in the MICRO-HOPE study 
showed significant reductions in the risk of vascular complications, and blockers of the renin-
angiotensin system produced substantial renal protective effects in patients with hypertension 
and diabetes (Gerstein 2002). An intensive mult i-factorial intervention, including BP control, 
achieved sustained reduction in the risk of vascular complications and death in patients with 
Type 2 diabetes in the Steno-2 study (Gaede et al. 2003). 
 
Although the BP endpoints from this current research study did not reach the NICE (2008) 
recommendations of < 130/80 mmHg, a different ial of > 3mmHg compared with the control 
group might  have significant effects on cardio-vascular risk reduction.  
 
7.2.9.2. Self-monitoring of blood pressure 
 
This study has not been able to invest igate whether self-monitoring of blood pressure has 
contributed to the reduct ions in mean blood pressure in the intervention group, due to the 
very small number of people (n= 4) with home monitoring machines who concluded the 
study. Studies into self-monitoring of BP are gaining interest  especially because of increasing 
evidence of their role in reducing blood pressure (Cappuccio et al. 2004, Ogedegbe and 
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Schoenthaler 2006). Unfortunately the reasons behind this assert ion are not clear (Cappuccio 
et al. 2004).  
 
 
Recommendation for further research 
A study that aims to understand the effects/ outcomes of using a home blood pressure 
machine by people with diabetes and MA is recommended.   
 
  
7.2.9.3. HbA1c 
 
I t was found that HbA1c did drop during time points 1-4 in all groups including the control 
group.  I t is possible that the fall in HbA1c could be due to QOF incent ivisation, as GPs and 
pract ice nurses aimed for tighter glucose control through more intensive prescribing of insulin 
and medication. This study did not find any significant differences between the intervent ion 
and control group, and this finding has been replicated in other studies. 
 
I n a recent Health Technology Assessment (HTA) (Loveman et al. 2008a), seven studies that  
had glycaemic control as an outcome measure were reviewed. One study (Kaplan et al. 1987) 
found that an intervention combining diet and exercise produced significantly lower HbA1c 
than in a control group who received only didactic education. The diet plus exercise 
intervention produced a sizeable reduction in HbA1c (–1.48%), whereas the drop was small 
in the diet group (–0.46%). HbA1c increased from baseline in the exercise group (+ 1.3%) 
and educat ion group (+ 0.36%). The diet plus exercise intervention was the most intensive 
intervention involving 20 hours of contact, but it lasted only 10 weeks. Therefore, this effect  
was reasonably long-lasting as the outcome was measured at 18 months.  
 
I n another similar study where both dietary advice and exercise were included in the 
intervention (Uusitupa et al. 1993) mean levels of HbA1c did not differ between the 
intervention and control groups (there was a marginal difference at 12 months), although the 
proportion of pat ients with HbA1c < 7.0% was greater in the intervention group. This was 
true at  both the 12- and 24-month evaluations. I n a larger study of 104 participants (Gilliland 
et al. 2002) there was an increase in HbA1c but  two intervention groups combined (group 
plus one-to-one education) showed a significantly smaller rise in HbA1c than the control 
group. Five further studies did not report any differences in measures of HbA1c between 
intervention and control groups or between different interventions.  
 
 215
 
The studies that  showed a change in HbA1c required intensive intervention, usually over a 
sustained period of time and often by specialist team members such as dieticians or a 
psychologist . The HTA concluded that  some studies showed a statistically significant effect of 
education on HbA1c, whilst others did not . They did not conclude what type of intervent ion 
was most likely to offer a positive outcome. However, they did ascertain that in the case of 
reduction in HbA1c, statistically significant  effect s were in the region of a 1%  change in many 
of the studies, and this reflected a clinically significant  effect . 
 
I n a systematic review of 31 studies (Norris et al. 2002a), it was found that self-management 
education improves HbA1c levels at immediate follow-up, and increased contact time 
increases the effect. However the benefit  declines 1-3 months after the intervention ceases, 
and the authors suggest that learned behaviours change over time.  
 
The implications for this study are that reduction in HbA1c is particularly difficult to obtain, 
even when specialist resources are used to intervene. Good glycaemic control can be 
challenging for many people (Ockleford et al. 2008) yet there is some evidence that intensive 
education and support can be of benefit.  
 
7.2.9.4. Weight loss 
 
I n this current  thesis, baseline data found that 128 out of 342 patients (37%) of the study 
population had a BMI> 30. At the end of the study, 165/ 402 patients (41%) had a BMI  of 
> 30. I t must  be re-emphasised here that  these data include the control group with a large 
amount of missing data at t ime point 1, so comparisons in BMI  pre- and post-study may be 
difficult. However the results show it can be very challenging for people with diabetes to lose 
weight , especially as there can be side-effects of weight  gain with the use of insulin (Russell-
Jones et al. 2007) and glitazones (Kushner et al. 2009).  
 
Other studies have also shown the challenge for health care professionals to support  people 
with diabetes to lose weight, regardless of the intervention. A Health Technology Assessment 
(Loveman et  al. 2008a) did find that a number of studies showed significant  effects of 
education on weight loss but fewer showed significant effects on BMI . The type of 
intervention that was most successful in reducing weight was a group intervention, and 
reasons for this could be that weight loss is best maintained through a number of crucial 
activit ies applied together, namely a change in diet, increase in exercise, but also support  
from others in the same situation and a realistic target and action plan. This is perhaps why 
Weightwatchers®  is so successful (Heshka et al. 2003), as it combines each of these 
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activit ies. Also a recent study (Sacks et al. 2009) found that attendance at a weekly group 
session was strongly associated with weight  loss. 
   
This assertion is also supported by the findings of  the DESMOND study (Davies et al. 2008) 
which evaluated the effectiveness of a structured group education programme on biomedical, 
psychosocial, and lifestyle measures in people with newly diagnosed Type 2 diabetes. The 
results showed that the intervention group had a greater weight loss (-2.98 kg) compared 
with 1.86 kg in the control group (p= 0.027 at 12 months). I nterestingly the DESMOND study 
did not find a significant difference in HbA1c levels up to 12 months after diagnosis, between 
the two groups, but  this may be due to the problems with using HbA1c as an outcome 
measure as discussed in section 3.9.3.  
 
A number of authors have hypothesised why people with diabetes do not change their 
behaviour despite understanding the consequences of not doing so. One interesting study 
(Ockleford et al. 2008) interviewed 36 people newly-diagnosed with Type 2 diabetes who 
were participating in the randomised controlled-trial of methods of educat ion, with the 
intervention arm based on the DESMOND programme. The research team discussed the 
importance of a ‘diabetic identity’ (Bury 1982) in accepting the diagnosis and making 
subsequent behavioural changes. As an example, people who were categorised as ‘acceptors’ 
fully accepted their diagnosis, and were committed to changing their behaviour in response. 
‘Resisters’ found it difficult  to accept they had diabetes, and were not able to make any 
changes either to their ident ity or lifestyle. However acceptance of the ‘diabet ic ident ity’ is no 
guarantee that  they would always follow health-care advice, and many spoke of times when 
they would lapse away from recommended advice. 
 
I t is possible that people who took part in this doctoral study were more likely to be 
‘acceptors’ than ‘resistors’, as presumably the ‘resistors’ were more likely t o be the people 
who refused to take part . However as Ockelford et al (2008) suggested, acceptance of the 
diabetic identity alone is insufficient to bring about subsequent behaviour change following an 
educational intervention. Their findings support other research that identified that  some 
people with Type 2 diabetes may not believe that it is a serious disease (Lawton et al. 2005). 
Perhaps most  importantly for this thesis, Ockelford et  al (2008) concluded that one type of 
educational approach is unlikely to suit all people with diabetes. 
 
The conclusion is that weight loss, and more particularly a significant reduct ion in BMI  is very 
difficult to achieve. I t  is possible that education has an effect on helping people deal with 
their condition, rather than bringing about  changes in biomedical markers. Although this 
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present study’s intervention did not show any benefit in terms of weight loss, there were data 
collection errors in the control group which have to be taken into account (see Chapter 6).  
 
 
7.3. Shortcomings of method 
 
7.3.1. Recording of data 
 
I t is recognised that there may be issues concerning validation of the collected data. As 
discussed in the methods chapter, there may be inaccuracies in the manual method used for 
data collection, that is, data were copied from practice computer screens to paper then 
inputted back into a computer programme. Data were cleansed as far as possible for obvious 
inputt ing mistakes. 
 
A more important  consideration is the quality of the data that were inputted at source, by the 
pract ice nurses or GPs, such as blood pressure recordings that  are input ted manually. Other 
data collected in this study, such as blood results (HbA1c, serum creatinine and eGFR) were 
transferred electronically from the hospital laboratories. 
 
Some studies have highlighted the difficulty with blood pressure end-digit preference (EDP). 
One study (Kim et al. 2007) found that that low-quality BP data, reflected in EDP, remains 
common in primary care of adults with diabetes. The authors found that EDP was highly 
prevalent in the BP measurements taken by non-physicians (in 4,333 readings, 50%  of 
systolic and 50%  of diastolic readings ended in zero;  p <  0.001) and in physicians (in 1,347 
readings, 69%  of systolic, 64%  of diastolic readings ended in zero;  p <  0.001). Another study 
(Broad et  al. 2007) found that 64%  of systolic and 62% of diastolic blood pressure recordings 
ended with a zero end-digit, despite guidelines recommending measurement to the nearest  2 
mmHg. They concluded that zero end-digit  preference significantly decreases a patient's 
likelihood of being classified as eligible for drug therapy to reduce cardio-vascular risk. 
 
At first glance it appeared that one pract ice (surgery 2) appeared to be using a manual 
sphygmomanometer, as 49 %  BP recordings at time point  1 had a preference for end-digits 
ending in 0 or 5. Upon closer inspection, it was found that a greater than expected %  of 
recordings throughout all the pract ices (including the control) at  time point 1 also recorded 
an EDP of either 0 or 5 (167/ 399 (41.9%)). I n t hese other practices BP was usually taken on 
an electronic device, although some individual pract ice nurses and GPs preferred to use a 
manual sphygmomanometer. I t has not been possible to identify the proportion of BP 
recordings in each practice that  have been taken either by a manual or an electronic device.   
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I n total at time point  1 there were 42/399 (10.5%) people with a systolic blood pressure 
recorded exact ly as 140mmHg and 39/ 399 (9.8%) people with a systolic BP recorded exactly 
as 130 mmHg. This phenomenon might be explained by the findings of another study 
(Burnier and Gasser 2008). 
 
This study in Switzerland (Burnier and Gasser 2008) found that despite the use of electronic 
BP machines, end-digit preference remained a common feature of BP measurements. The 
authors investigated the frequency of end-digit preference and evaluated the impact of this 
bias on BP, which was measured either with an electronic device or with a conventional 
sphygmomanometer. Very marked digit preferences were observed for both the convent ional 
and the automatic measurements, being most prominent for the digit 0 (52%  and 25% , 
respectively) followed by a preference for the digit 5 (19% and 15%).  
 
Although the authors explained the use of the electronic device could reduce the frequency of 
the bias to a certain extent, they suggested that the problem remains if professionals have to 
transfer the BP values into computer records. This might be the case in practices 1 and 3-7 
where GPs and practice nurses take an electronic reading but then round down the systolic 
and diastolic pressures to the nearest 5 or 10 mmHg.  
 
The implications are that patients may not be given optimal care for blood pressure 
management because t rue blood pressure readings are not being recorded. I n the case of 
this present  study it is possible that this practice was occurring in one surgery, with a high 
proportion of BP readings being rounded down to an EDP of 0 or 5 results in consistent  
achievement of the NICE (2008) blood pressure target of < 130/80 mmHg. In this practice, 
mean systolic blood pressure was 129.4 mmHg at t ime point 3, 128.6 mmHg at time point  4 
and 128.7 mmHg at time point 5. At time point 6, mean systolic BP in this practice was 131.2 
mmHg. This was the only practice that managed to achieve the < 130/ 80 mmHg target  at  
three different time points, and it is possible that this target was achieved through the end-
digit preference bias. 
 
Another consideration is the possibility that  the mean fall in blood pressure was related to the 
QOF incent ivisation, particularly since the introduction of the BP target of 145/85 mmHg for 
those on the diabetes register occurred just  before the start of the study in 2004. I t is 
unlikely that the fall in BP seen in the intervention group was related to the QOF as the 
control group did not see similar effects, but it may be true to say that clustering of BP 
readings just below the QOF target may be a likely effect of incentivisation.    
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One study (Carey et al. 2009) found this to be the case, as they found that there was a trend 
towards recording systolic values just below, rather than just above the 150 mmHg systolic 
BP cut-off for diagnosing hypertension. I n 2000–2001, before the QOF, 2.3%  of patients had 
148–149 recorded and 1.8%  had 151–152. I n 2004–2005, the figures were 4.2 and 1.3% , 
respectively. By smoothing the distribution the authors estimated that the true percentage of 
pat ients with systolic BP> 150 mm Hg in 2004–2005 was 23% , rather than the 19%  recorded. 
However they concluded that although BP readings were being clustered just below the QOF 
target, there was no evidence of adverse effect s of this on clinical management. I t is possible 
that this phenomenon also occurred in this study but  because BPs were generally much lower 
than the QOF target, it is less likely. 
 
 
Pract ice recommendation 
For pract it ioners to record blood pressure to the nearest 2 mmHg when using a manual 
sphygmomanometer and to record the exact reading when using an electronic device.  
 
7.3.2. Powering the study 
 
I n order for the study to have 90%  power with 5%  significance, it was necessary to dist ribute 
the self-management packs to 42 patients in each surgery, that  is, 252 packs in all.  As 
described in Chapter 7, it was not possible to dist ribute this number of packs (only 116 were 
distributed), so the study is underpowered, and results should be viewed with caution. 
 
As the study was underpowered it was not possible to identify significant differences between 
the intervention and control groups. At time points where there were marginal significant 
differences in systolic blood pressure between the two groups it is possible that, if the study 
had been powered, then significant differences may have been identified. 
 
7.3.3. I nfluences on the study 
 
7.3.3.1. National policy 
 
As stated in other sections of this thesis, the care of people with CKD in primary care has 
changed dramatically over the past five years. This has mostly been due to four important  
nat ional initiatives, namely:  
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• the publicat ion of the National Service Framework (NSF) for Renal Services (Part  Two) in 
February 2005, followed by local and national guidance for managing people with early 
CKD 
• the General Medical Services (GMS) contract for 2006/07 including a new Quality and 
Outcomes Framework (QOF) domain for CKD (amended in 2008 and 2009) 
• the recommendation that  all hospital laboratories should report estimated glomerular 
filtration rate (eGFR) as a measure of kidney funct ion (alongside serum creat inine) from 
April 2006  
• NICE guidance for CKD, published in September 2008 
 
The question is whether the differences in clinical parameters found in the intervention group 
in this study might have happened as a result of the national initiatives, although the 
amendment to the method to include a control group did aim to eradicate the effect of the 
policy changes. Although there was a downward trend in mean systolic and diastolic blood 
pressures in the intervention group which was not seen in the control group, it is possible 
that national policy changes did affect the management of patients in the participat ing 
pract ices observed by the falling mean BP recordings that  occurred before the intervent ion 
was rolled-out.  
7.3.3.2. Researcher influence 
 
I t is important to consider the effect that  I  had on the intervention practices, specifically the 
effect on blood pressure control. I  was visiting the practices throughout the implementat ion 
of the above policy changes, and clearly recall the numerous questions from practices about  
proteinuria, prescription of ACE inhibitors and ARBs, and GFR reporting, especially following 
introduction of the QOF domains. I t is possible that my presence in the practices during the 
policy changes influenced the care that pract ice nurses gave to the patients. Care may have 
changed in the following ways:  
 
1. More rigorous monitoring of microalbuminuria 
2. More immediate prescription of ACE inhibitors/ ARBs once microalbuminuria was 
found. 
3. More aggressive prescription of ACE inhibitors/ARBs to achieve lower blood pressure 
targets.  
 
I t is difficult to find evidence that supports these assert ions, although to some extent the 
QOF results for 2005/ 2006, 2006/2007 and 2007/ 2008 can be utilised to underpin these 
points. The QOF targets for diabetes are:  
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DM12: The percentage of pat ients with diabetes in whom the last  blood pressure is 145/ 85 or 
less 
DM13: The percentage of pat ients with diabetes who have a record of micro-albuminuria 
testing in the previous 15 months (exception reporting for patients with proteinuria)  
DM14: The percentage of patients with diabetes with proteinuria or microalbuminuria who 
are treated with ACE inhibitors (or angiotensin receptor blockers)  
 
Figures 7.6-7.8 show the QOF returns for the intervent ion and control practices. 
Figure 7.6:  QOF returns for DM 12:  blood pressure less than 145/85 mm Hg  
Surgery 2004/ 2005 (%) 2005/ 2006 (% ) 2006/ 2007 (%) 
1 100 100 100 
2 100 100 100 
3 100 100 100 
4 100 100 100 
5 100 100 100 
6 100 100 100 
7 100 100 100 
 
Figure 7.7:  QOF returns for DM 13:  microalbuminuria testing 
Surgery 2004/ 2005 (%) 2005/ 2006 (% ) 2006/ 2007 (%) 
1 76.6 84.4 81 
2 100 100 100 
3 72.1 100 100 
4 100 100 100 
5 91 100 100 
6 67.5 79.6 81 
7 100 100 100 
 
Figure 7.8:  QOF returns for DM 15:  ACE inhibitor/ARB prescription 
Surgery 2004/ 2005 (%) 2005/ 2006 (% ) 2006/ 2007 (%) 
1 100 100 100 
2 100 100 100 
3 100 100 100 
4 100 100 100 
5 100 100 100 
6 100 100 100 
7 100 100 100 
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I n summary all practices were reaching QOF targets in blood pressure control and 
prescription of ACE inhibitors/ ARBs in all three years of QOF returns shown here. There were 
some dif ferences in microalbuminuria test ing, although the control surgery was testing 100% 
of pat ients, even in 2004/ 2005.  I t can be assumed that the QOF policy changes stated above 
had the same effect on all pract ices, even the control which was not visited by me during the 
study period.  
 
These data might still have to be interpreted with caution in light of the number of people 
who have been exception-reported for each of the domains, that is, the number of people for 
whom the target has not been applied. This is because patients with specific diseases can be 
excluded from the denominators of individual QOF indicators if the pract ice is unable to 
deliver recommended treatments to those pat ients (Health and Social Care Informat ion 
Centre 2005). For example if the domain DM12 (number of people with BP < 145/ 85 mm Hg) 
is scrutinised, then the percentage of people exception-reported is variable. Across all 
part icipating practices, the percentage of people except ion-reported for DM12 in 2006/2007 is 
almost 20%  (range 18-23%). 
 
Even bearing this in mind, it  is likely that  the effect on blood pressure seen in the study is an 
effect that  has been achieved by the education pack rather than the effect  of my visiting the 
intervention practices. I t was not possible at the outset of the study to predict the huge 
changes in national policy and publicity surrounding the management of kidney disease in 
primary care during the study period 2004-2009. I f this had been known at the start an 
alternat ive method could have employed, such as a cluster randomised trial (CRT). Practices 
could be recruited as before, but randomised (at  practice level) to the intervention or to usual 
pract ice. I f data are collected by a non-clinician (not  a renal nurse) or data are collected 
retrospectively, this will remove the possible researcher effect on clinicians which could result 
in tighter blood-pressure control in pat ients. 
 
Recommendation for future research 
For this study to be replicated as a cluster-randomised trial, ensuring that the professional 
staff (practice nurses and GPs) in the practices randomised to usual practice are not visited 
by a clinical researcher during the study. I ntervention pract ices should only be visited for data 
collection and pack distribution. 
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7.3.4. Summary 
 
The process by which people take on health care advice and then translate this advice into 
behaviour change is a very complex process, with several inter-connecting components. This 
can present  a challenge for evaluation and also for the interpretation of  any demonstrated 
effects. I t can be difficult to establish what exactly the ‘act ive ingredient’ causing any such 
effect is, and, in this case, it may be that a number of variables contributed to the effect of 
reducing blood pressure.  
 
I t may be, for example, that patients did receive more knowledge about blood pressure 
tablets from the pack, which t ranslated into improved adherence to their prescription. I t may 
be that the effect  of my visits to the intervent ion practices raised the profile of CKD 
management so that  practice nurses were more vigilant with BP control. There is also the 
effect of nat ional policy and the QOF incentivisation to consider.  
 
I t is clear that this intervention has had an effect, although it is not possible to identify the 
key variable that is responsible for the effect. I t may be that  a subtle combination of  factors 
are responsible, which might be difficult  to reproduce beyond the setting in which this 
intervention was undertaken.  
 
7.4. Self-management initiatives in practice 
 
I t is important to evaluate the findings in the context  of results from research studies that  
have been published since the start of this thesis.  
 
7.4.1. Commentary on wider use of self-management educat ion packages 
 
The overall rationale for the study was that there were no published data or published 
evidence on the use of self-management packs for people with, or at risk of chronic kidney 
disease. Since the start of the study in 2004, there has been increasing interest  in self-
management, in terms of self-management techniques, self-management programmes and 
an increasing commentary on how health-care professionals can facilitate a self-management 
approach. This sect ion will review the findings in light of recently published literature, and will 
discuss the ways in which self-management initiatives should be planned, implemented and 
evaluated.  
 
7.4.2. Planning of self-management programmes and interventions 
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Although briefly discussed earlier, there are differences between the ways in which self-
management programmes are organised and implemented. A systematic review on risk-
reducing intervent ions as part of diabetes self-management (Boren et al. 2007) concluded 
that there are many multi-faceted self-management programmes which have been shown to 
produce clinically important benefits, but the “specific elements of the programme that 
produce these benefits are difficult to determine.”  (Boren el. 2007)(p.1075). Of the 33 studies 
that were reviewed, there were some commonly featured interventions, such as educat ion 
and counselling sessions, and follow-up, reminders and feedback via telephone. There were 
also a variety of educational resources, such a booklets, let ters, newsletters, videos and 
personal reports. 
 
I n the same review there were found to also be a variety of outcome measures, most  
commonly HbA1c (15 studies), cholesterol (10 studies), blood pressure (8 studies) and BMI  
(6 studies). 85%  of the reviewed studies indicated that at least  one outcome measure was 
significantly better in the intervent ion group than the control group. The main 
recommendation from this review was that there is some evidence for the beneficial effects 
of self-management interventions in diabetes, but  future published studies should specify the 
content of the intervention, patient sample and materials used to ensure that  findings can be 
compared with other similar projects. The review concluded that  future research should focus 
on “diabetes risk reduction in areas where evidence is lacking, such as diabetic 
nephropathy….” (Boren et al. 2007)(p. 1075).  
 
This present  study implemented a self-management initiative that  focussed on giving 
information that promoted the self-care ideology, rather than an intervention that 
emphasised behavioural and psychosocial strategies.  These strategies are clearly important  
and a number of self-management programmes have drawn on social, cognitive and 
behavioural theories during their development (Barlow et al. 2002). As discussed before, it is 
difficult to extrapolate which aspect of a multi-faceted intervent ion is the most effect ive. For 
this study, one of the most  crucial considerations in developing of the package was how far 
the intervention could be incorporated into ‘real life’, that is, an intervent ion that  was not  only 
clinically-effective but also cost-effective. As the Barlow et  al (2002) review concluded, one of 
the major issues with individualised approaches involving one-to-one contact  with health 
professionals relates to cost.  
 
7.4.3. Methods to support implementat ion of self-management initiatives 
 
I t has been suggested that if self-management programmes and init iatives are to be 
successfully integrated into primary care, there needs to be a system put in place to support  
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this (Crespo and Shrewsberry 2007). I n a study that  evaluated the introduction of a self-
management programme in four rural health centres, the health centres that fully 
implemented the self-management programmes made targeted efforts in organisational 
change. These efforts included a commitment to keep self-management on the agenda in 
management meetings, with clinical staff setting an example by adopting self-management 
behaviours themselves. They also implemented pat ient self-management support  in multiple 
pat ient care venues.  
 
I n practice this means that the ‘senior leaders’ in GP practices need to commit to integrat ing 
self-management in their surgery, and that a core group of staff members might become 
self-management champions. Most importantly health care professionals need to be trained 
in self-management skills, and also be encouraged to employ self-management techniques 
themselves (Crespo and Shrewsberry 2007).  
 
Pract ice recommendation 
I f self-management programmes are to be successfully implemented in primary care then 
each practice needs the support of the senior partner, learning opportunities in how to 
promote self-management skills for patients, and identification of ‘self-management 
champions’. 
 
7.4.3.1. Staff training 
 
Training for staff in self-management techniques is recommended, as there sometimes may 
be a tension between a health-care professional’s (paternalist ic) approach to managing a 
long-term condit ion and an individual pat ient’s aspiration for empowerment. Although it has 
been recognized as a crit ical linkage, the explicit impact  of health care professional support  
on self-care management in chronic illness has attracted a relatively scant body of research 
(Thorne and Paterson 2001). As an example, there has been recent  debate on health-care 
professionals’ misunderstandings about  the concept  of self-management (Lau-Walker and 
Thompson 2009). Lau-Walker and Thompson (2009) suggest that  effective pat ient self-
management (self-efficacy) support  from health-care professionals needs to address patients’ 
confidence in their ability to manage specific activities rather than just convincing pat ients of 
the value of such activities.  
 
For this present  study, the relevance might be that  it  is not enough just t o tell people of the 
importance of blood pressure control, but rather that their confidence in managing their own 
blood pressure needs to be assessed and discussed.  
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Pract ice recommendation 
Facilitator skills for empowering self-management techniques to be made available for health 
care professionals who care for people with diabetes mellitus. 
 
Some centres are beginning to evaluate their current capacity t o support  and implement 
consistent patient-centred self management practices (Brownson et al. 2007). The Primary 
Care Resources and Supports for Chronic Disease Self-Management (PCRS) instrument is a 
user-friendly self-assessment tool, and initial evaluation has indicated that the PCRS is 
applicable across different types of primary care teams and chronic illness condit ions 
(Brownson et al. 2007).  
 
7.5. Summary of recommendations 
 
A number of recommendations from this study have been discussed, and these are now 
summarised. 
 
7.5.1. Recommendations for practice 
7.5.1.1. Recommendations for format and content of the self-
management package 
 
- To include supplementary information for health care professionals, explaining the aim, 
content and FAQs. 
- To include an introductory paragraph that explains the benefits of self-care. 
- To check suitability of font size and colour of written materials for older people. 
- To check cultural appropriateness of the learning materials. 
- To cater for a range of self-care abilit ies, from simple messages (eg. how many tablets to 
take each day) to complex interventions, such as monitoring and managing blood pressure. 
 
7.5.1.2. Recommendations for MA screening and blood pressure 
management 
 
Educat ion programmes on CKD for primary care health-care professionals to focus on 
importance of annual MA screening to identify those with diabetes at risk, in order that timely 
prescribing of ACEi/ ARBs can be initiated.  
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For pract it ioners to record blood pressure to the nearest 2 mmHg when using a manual 
sphygmomanometer and to record the exact reading when using an electronic device. 
 
 
7.5.1.3. Recommendations for the implementat ion of self-management 
initiatives in primary care 
 
Successful implementation is dependent on the support of the senior leader/partner in the 
pract ice and identification of ‘self-management champions’. 
 
Facilitator skills for empowering self-management techniques should be made available for 
health care professionals who care for people with diabetes mellitus. 
 
7.5.2. Recommendations for further research 
 
1. Further research is needed to explore the natural progression of microalbuminuria, 
especially whether male gender is a factor in progression of the condition. 
 
2. A qualitative study that invest igates how people might take the information in the self-
management pack and use this t o change their health behaviour is recommended. Semi-
structured interviews with people who have received the pack could be undertaken. I nterview 
topics could include baseline knowledge about  risk of CKD, the aspects of the pack that  were 
most useful and the behaviours that were altered as a result of the information received. 
 
3. A study that aims to examine the effects/outcomes of using a home blood pressure 
machine is recommended.   
 
4. Replication of the present study as a cluster-randomised trial is recommended.  
 
 
7.6. Dissemination and spread 
 
The findings of this study have important implications for people with diabetes at risk of 
kidney disease and the implications of disseminating this intervent ion to a wider audience will 
be considered. 
 
The specific dissemination of the self-management package to the study and control 
pract ices, and to the local PCT will be discussed in Chapter 8 (the artefact). Although the 
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project has been developed locally, it  is important to consider how it  can be disseminated on 
a national level. 
 
Dissemination (now termed spread) means taking the learning that has taken place and 
sharing it  with other parts of the organisation, whilst sustainability can be defined as holding 
onto the improvements and evolving the improvements as required (NHS Institute for 
I nnovat ion and Improvement 2007). The terms ‘spread’ and ‘sustainability’ are current terms 
commonly used in implementing improvement init iatives and have been defined in the NHS 
Sustainability Model published in 2003, and revised in 2007 (NHS Institute for I nnovat ion and 
Improvement 2007). The NHS Sustainability Model consists of ten factors relat ing to process, 
staff and organisat ional issues that play a very important role in spreading and sustaining 
change in healthcare. See Figure 7.13. 
 
This Model has been designed for use at a local project level and also for use at the 
beginning, during and at  the end of a project. Although it could be argued that this thesis is a 
research project rather than a quality improvement initiative, the Model can act as a checklist 
to ident ify and understand key barriers t o spread and sustainability. 
 
The model used as a theoretical framework in Chapters 2 and 3, Silverman’s (1970) act ion 
approach to organisations (Figure 7.9), complements the NHS Sustainability Model. Silverman 
(1970) asserted that  change is dependent on the interrelationship of a number of factors, 
including the knowledge, at titudes and beliefs held by the wider society, by the organisational 
structure, as well as by individuals (pat ients and pract it ioners). Two of these categories are 
replicated by those of the NHS Sustainability Model, namely ‘Staf f’ and ‘Organisat ion’. 
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Figure 7.9:  Silverman’s (1970) act ion approach to organisations 
Society
Patients and practitionersOrganisat ional system
 
7.6.1. The Spread Acceleration Model 
 
The Spread Acceleration Model (Fraser 2002) describes how any innovator needs to consider 
the way in which an idea can be implemented in areas that have not used it  before. The key 
factors that must be considered when spreading an innovation are shown in Figure 7.10. 
Those factors identified with a   are those which have been considered and supported by the 
innovation, that is, the self-management pack developed and tested in the present study. 
Those identified with a ß are those which require further work.  
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Figure 7.10:  Key factors for spread of self-management pack into clinical practice 
Relative advantage   
How clear and how much is this new idea/pract ice better then current situation? 
Current lack of consistency for incorporat ing self-management initiatives into diabetes 
annual reviews 
 
Compat ibility ß 
How closely does new idea/practice reflect beliefs and values of adopter(s)? 
Most pract it ioners support self-care philosophy in principle, but  only some support  in 
pract ice. 
 
Complexity   
How easy is it to understand the new pract ice/ idea? 
Self-management pack easy to use – see Chapter 8 for patient evaluation 
 
Communicability ß 
How easily can it be shared with others? 
Not shared with others at present 
 
Observability ß 
How visible is the new practice or idea and its results? 
Not visible at present  
 
Trailability   
How easy is it to test the new idea? 
Already tested 
 
Reversibility ß 
How easily can the adopter revert to the old ways? 
New ways have not  been implemented yet 
 
Uncertainty ß 
How certain can an adopter be of positive results from the change? 
Positive results need to be spread 
 
Adapted from Fraser (2002) Accelerating the spread of good practice , Kingsham Press, 
Chichester, England 
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For the findings from this thesis to be adopted into usual practice it is crucial that attention is 
paid to ‘communicability’ and ‘observability’ factors. One way in which these findings can be 
communicated and made visible on a wider scale is through conference presentations and 
journal publications. 
 
Appendix 10 shows relevant presentations and publicat ions related to the study’s method and 
findings. For this study, it  was important to not only disseminate the research findings via 
conference presentations and journal publications, but to communicate the findings to the 
pract ice nurses and GPs who would not usually attend these events or read these 
publications. 
 
There is often a tension between spreading the findings to an academic community and 
spreading the findings to those who are caring for people who are affected by the results. For 
me, both arenas are equally important .  
 
7.6.2. Study findings and translation into national programmes and initiatives 
 
Since the study began, I  have been involved in a number of nat ional initiatives that  aim to 
improve the care and management of people with early CKD in primary care. These initiatives 
have developed as a direct and also indirect  result of the findings. These initiatives can be 
broadly divided into the areas of pat ient empowerment and also education of health 
professionals. 
 
7.6.3. Patient empowerment 
 
Since March 2007 I  have worked as the project  co-ordinator for the Quality Improvement in 
CKD study (QICKD), a Health-Foundation funded study, which is due to be completed in 
March 2010.  One of the interventions focuses on pat ient  empowerment and my thesis 
findings have contributed to shaping this intervent ion. 
 
A multi-disciplinary expert group was formed to develop the intervent ion, including patients, 
primary care staff, experts in self-care and renal healthcare professionals. There was a high 
degree of concordance of aims and object ives within the group, who worked exceptionally 
well together, mot ivated by a shared commitment to enhance patient empowerment in CKD. 
In terms of defining the intervention, research around initiatives underway in other disease 
areas, such as diabetes, was examined, including the findings from the present study.  
 
 232
 
A package of different t ools has been developed for this empowerment programme aimed at  
people with stage 3b CKD and is being tested in a large GP practice. Tools include a self-
efficacy questionnaire (measures patient confidence in self management) and a patient 
concerns sheet (on which patients set out their concerns). These will be used to establish a 
baseline before an empowerment programme begins. 
 
Subsequently, patients are provided with information in the form of ‘Frequently Asked 
Quest ions’ (FAQs) and a DVD. A care plan will be completed in partnership with the health 
care professionals. There will also be a group educat ion session for patients. Crucially the 
pract ice nurses facilitating the empowerment approach needed to be taught not only how to 
manage and care for people with CKD, but  also, how to empower people to manage their 
condition.  Therefore a separate part of the intervention focuses on the healthcare 
professionals themselves and I  am giving them education sessions about CKD. Group 
facilitation skills training is also being carried out . 
 
Evaluation will be via a post self-ef ficacy questionnaire to help establish any interim and 
longer-term changes. There will also be a questionnaire about the group sessions to 
determine the effectiveness of the sessions and a staff questionnaire to find out about the 
success of the new service development (used in conjunction with the confidence 
questionnaire). 
 
7.6.4. Education of health care professionals  
 
I  am the Chair of the CKD Forum, a project group of the British Renal Society. The main aim 
of the Forum is to provide leading-edge professional development and education in early CKD 
for health care professionals. Some activities of t his Forum have been shaped by my PhD 
study findings, specifically the finding that patients need more information about CKD and 
also need to be taught about opportunities for self-management. 
 
7.6.5. Collaboration with the DH Kidney Care team 
 
The CKD Forum was contacted by the Kidney Care team at the Department of Health to see if 
Forum members could collaborate with, and contribute to, two special issue journals on CKD, 
for health care professionals working in primary care. The Journals are the British Journal of 
Primary Care Nursing (BJPCN) and the Primary Care Cardiovascular Journal (PCCJ), and they 
have a joint circulation of 25000 readers. 
 
The Editor of the BJPCN said 
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“ I  want to thank the Renal Tsar, Dr Donal O’Donoghue, and NHS Kidney Care, led by 
Beverley Matthews, for recognising the importance of practice nurses in improving the 
detection and management of CKD in primary care and supporting this special issue of 
BJPCN. Thanks also to the members of the CKD Forum who have very willingly (even gladly!) 
given their time and writing skills to ensure that the articles in this issue are absolutely on 
target to help us improve the primary care management of CKD throughout the UK.”  (BJPCN 
2009, Special I ssue on CKD, p. 5)  
 
An article on self-management in this issue was included as a direct  result of the thesis 
findings. A summary of the interview findings was also included in the ‘Evidence in Practice’ 
sect ion. An information sheet for patients was also devised (see Appendix 11 for all these 
publications). 
 
7.6.6. Development of learning resources:  ckdonline 
 
As there has been t remendous change to the management of CKD in primary care since 
2005, the CKD Forum wanted to find out the impact of the introduction of national and local 
CKD Guidelines. I n Spring 2007, 10,000 questionnaires were sent to GPs in each of the ten 
Strategic Health Authorit ies in England, and it was hoped that the findings would help shape 
the CKD Forum’s future strategy and educational philosophy.  
 
A two-page questionnaire asked them for their opinions on the eGFR, the Quality and 
Outcomes Framework (QOF) and management of CKD. The results shown below are from the 
questionnaires that  were returned in Summer 2007. I t is possible that  views of GPs might 
have changed in the intervening period, especially since there have been further amendments 
to the QOF and publication of NICE guidance for CKD since then.  
 
The return of the questionnaire on a single mail shot was 15 %  (approximately 1500 
returns). There were a number of interesting findings. Those most  relevant to this thesis 
were those concerning proteinuria and blood pressure control. A large percentage of 
respondents had poor understanding of the difference between albumin:creatinine ratios 
(ACRs) and protein: creatinine ratios (PCRs) to quantify proteinuria. Over 60%  strongly 
agreed with the statement that “ I  find the distinction between ACRs and PCRs confusing.”  
With regards blood pressure control, almost  70%  responded that  they found a blood pressure 
target of <  130/ 80 mmHg in people over 70 years old unrealistic.  
 
The GPs were asked about their own education and it  was found that only 50%  of GPs felt 
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that they had had sufficient  education about  CKD. In terms of ongoing education the majority 
would prefer local half days (38%), local evening sessions (30%) or online material (29%) as 
opposed to national meetings (3%). The overwhelming majority would prefer this to be given 
by the local nephrologists and specialist nursing staff. See Figure 7.11. 
 
Figure 7.11:  Results of GP survey:  where/how education on CKD should be delivered 
 
Where/How should education be delivered
National meeting
On-line material
Evening session
Local half day
3%
29%
38%
30%
The majority would like this done 
by Consultants from their local unit
 
7.6.7. Development of an on-line learning module 
 
As a result of the questionnaire findings, the CKD Forum went about  developing an on-line 
resource to supplement education provided by renal units to local primary care teams. The 
development was undertaken in collaboration with OCB Media, based at  the University of 
Leicester. This company runs medical educational act ivities, provides multimedia product ion 
services and specialises in e-learning development.  
 
The module is called Chronic kidney disease - a guide for primary care and is available at 
www.CKDonline.org. Content  of the module is shown in Figure 7.12, and was developed as a 
result of the questionnaire findings which showed that greater understanding of eGFR, CKD 
progression, proteinuria, and information for patients was warranted. The section on how to 
inform and educate patients was included as a direct result of the findings from this thesis. 
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Figure 7.12:  Content of on-line learning module 
 
 
• CKD - Why it has become an important issue 
 
• Causes of CKD  
 
• Medicines Management  
 
• Management of hypertension  
 
• Nutrit ion  
 
• What to tell patients including self-management opportunities 
 
• Primary care  
 
• I ssues for the future  
 
 
I  wrote the sect ion on ‘what to tell patients’ and the learning object ives for this sect ion were:  
 
• To identify the main points to convey to patients when first diagnosed with CKD 
• To review the ways in which self-management of CKD can be promoted  
• To identify and evaluate a variety of patient learning materials for CKD  
 
Each sect ion is presented in an easy to use and engaging manner, populated throughout with 
illustrations and videos and underpinned with a cross-referenced glossary. There are multiple 
choice questions (MCQs) included after each section to review the learning that has taken 
place. 
 
This resource is free to use as a reference tool, however, different levels of educat ional 
training certificates are available for a small administ rat ion fee. The on-line resource was 
launched at the end of 2008, and efforts are being made to advertise the modules to primary 
care. The website is recording the number of hits that  have been made to the site, and asks 
respondents to provide feedback after complet ion. By March 2009 (three months after 
launch) there were 539 registered users, with 327 visits to the site in one month. I n August  
2009 there were 300 visits to the site, with 67%  of those visiting the site for the first t ime. An 
advertising flyer is shown in Appendix 12. 
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7.6.8. Other publications and presentations to primary care professionals 
 
I  was commissioned to write the following article:   
 
Thomas, N (2009) Diabetes and CKD: what does the new NICE guidance say? 
Journal of Diabetes Nursing, 13, 4, p126-136.  
 
I  included a sect ion on the opportunities for people with chronic kidney disease (CKD) to 
exercise self-management. See Appendix 13. 
 
I  was asked to contribute to the on-line NHS Choices resource. NHS Choices is a Department 
of Health website where people can find out about  medical services, medical advice for 
specific conditions, topical news stories and what to do (such as pandemic flu) and most  
importantly how people can help themselves to manage their conditions or concerns. The 
CKD section was being updated in 2007/ 8 and I  worked with a medical writer to write some 
‘questions to ask’ for people with early kidney disease. I  also recorded a film for the site and 
this can be found at  
http: / /www.nhs.uk/condit ions/ Kidney-disease-chronic/ Pages/ Introduction.aspx 
 
I n addition I  am asked frequently asked to contribute to continuing professional development 
activit ies external to City University. With regards teaching, I  have recently provided 
education sessions on early CKD to St  Georges University of  London, University of Warwick 
and Southmead Hospital, Bristol. I  have also been asked to update care managers employed 
by NHS Direct  on managing people with CKD. I  was invited to present a 45 minute session at  
the Primary Care Live exhibition and conference in October 2009. I n all these sessions I  have 
included discussions on ‘what to tell patients’ and have ident ified ‘self-management 
opportunit ies’. I  frequently describe direct  quotes from the interviews undertaken from this 
thesis to illustrate my points. 
 
7.7. Sustainability 
 
The Sustainability Model identifies factors that  can influence sustainability, and includes 
process, staff and organisat ional factors, see Figure 7.13.  
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Figure 7.13:  The NHS Sustainability Model 
 
© NHS Institute for I nnovat ion and Improvement 2006 
 
For the self-management pack to be successfully implemented and sustained, the following 
specific factors need to be considered in the participat ing practices and in the local PCT. 
 
7.7.1. Staff 
 
Staff factors that  need consideration include staff training (how to identify who would benefit 
from a pack/how to distribute the pack during a usual consultation), staff attitudes to 
sustaining the improvement, and senior leadership engagement. 
 
7.7.2. Process 
 
Factors concerning process include identifying the benefits of using the pack and assessing 
the credibility of those benefits.  Also how easy it is to adapt to the process of pack 
distribution and how ef fect ive is the system that has been put in place to monitor the results. 
 
7.7.3. Organisation 
 
I ssues that require consideration are how far the change fits with organisation’s strategic 
aims and culture, and whether there is an infrastructure for sustainability in place. All of these 
issues will be discussed in more detail in Chapter 8.  
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7.8. My reflection on the research process 
 
7.8.1. Relationship with practices 
 
At the start of the study I  was not familiar with the workings of primary care. I  was naïve 
about how people with long-term conditions were managed, such as timings of clinics, 
management templates, patient educat ion initiatives, the QOF and the system for recall of 
non-attendees. I  did not understand the role of the practice nurse, and the working 
relationships between practice nurses and GPs. As described in Chapter 2 these issues 
became the main aims of the case study, so were subsequently resolved during the period of 
part icipant observation in 2004.   
 
Although these practice issues were resolved there remained some misunderstanding at the 
outset about my role in the participating pract ices, partly because I  had not thought through 
the boundaries of being a practit ioner-researcher (Meyer et al. 2003).  On reflection, my 
naivety in both the complexities of  primary care teams, and also my role as a researcher, led 
to the misunderstandings. I  was insecure in both the role of researcher and the context of 
the research environment, so probably clung to what I  knew best, that  is, my role as a 
specialist renal nurse. When I  first began to visit the six participat ing practices, I  introduced 
myself as a renal nurse (not researcher), and emphasised my experience in managing people 
with chronic kidney disease. Whilst observing consultat ions with patients, the practice nurses 
and GPs would sometimes ask my opinion, and occasionally would ask me to explain renal 
issues directly to the patient. This was within my comfort zone, and I  willingly gave of my 
expertise. Sometimes the practice nurses would telephone me to discuss referral of pat ients 
to the renal unit, and again I  was very willing to support them.  
 
7.8.2. Ethical issues 
 
Having expert knowledge can have both benefits and disadvantages. Although there is a 
possibility for ethical issues to be raised when a researcher becomes involved in patient  care, 
researcher involvement can lead to a therapeutic interaction for the participant (Eide and 
Kahn 2008) as described above. However these potential benefits for the patient have to be 
balanced with possible detrimental effects on the research process. As discussed in Chapter 
4, my ingrained clinical knowledge could have posed a threat  to identifying the t rue patient  
perspective, as my clinical knowledge was deep-rooted and often subconscious and intuitive 
(Wilson and Wilson 2008). 
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Whilst the difficulties of being involved in patient  care are recognised, participation can bring 
about change in the researcher bringing out new observation, while this new observat ion in 
turn can change how the researcher participates (Bailey 2007). I n other words, being 
involved in care can produce serendipitous findings that would not  have necessarily evolved if 
the observation period had been t ruly non-participatory.  
 
An example was when I  was observing a consultation between a lady and her husband and a 
pract ice nurse. The patient was having difficulties in understanding one aspect  of dietary 
advice. I t appeared that she had been given conflicting messages about  eating fruit  and 
vegetables, and I  was asked directly if I  could help clarify the advice. On gentle questioning it 
transpired that  she had been referred to a renal diet it ian, who had given the advice (rightly 
or wrongly) on reducing fresh fruit intake, because of rising serum potassium levels. Although 
I  am not  sure that I  was able to advise the patient successfully, it starkly demonstrated to me 
the importance of giving consistent advice to patients. I nconsistent  advice leads to 
uncertainty and less possibility for control and empowerment (Lowery and Ducette 1976).  
 
On balance I  think that my participation in the ‘non-participation’ observation period did allow 
a better working relationship with the practice nurses, who valued my advice and support in 
times of changing CKD practice and management. Although my interact ions with practice 
nurses and patients may have gone some way to influence the mean reduct ions in BP found 
in the participating pract ices, it would never have been possible to differentiate those 
influences from the effects of the intervention. 
 
As the study moved on, I  became more comfortable in my researcher role, and when the 
time came for me to end my secondment with the local renal unit, I  was ready to relinquish 
my ‘specialist nurse’ persona. Today I  am still st ruggling with my insecurity as a non-clinical 
nurse, but  I  have grown in my role as researcher.  The doctoral journey has been so very 
enjoyable and rewarding, and has contributed enormously to my personal and professional 
development.  
 
7.8.3. Challenges of undertaking a part -time Doctorate  
 
To date the Doctorate has taken five and a half part-time years. During this time my 
employment has changed a number of times, although my main base has cont inued at City 
University. At the start of my Doctorate in February 2004, I  was employed on a secondment 
within a hospital trust. Three years into the study, I  returned to City University three days per 
week. I n April 2007 I  secured another secondment opportunity to Kidney Research UK, a 
charity based in Peterborough, to work as a project co-ordinator for two days per week on a 
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nat ional Quality Improvement project , funded by the Health Foundation. This work has given 
me the opportunity to work within a multi-professional research team based within another 
academic institution, a hospital trust and a charity. 
 
My research funding continued for most  of the project from June 2004 to November 2008, 
and covered my salary for one day per week. Addit ionally during this time I  have carried out 
external consultancy to a number of hospital Trusts, academic institutions and pharmaceutical 
companies.  
 
Although it might have been more comfortable for me to have stayed within the hospital t rust 
for the durat ion of the Doctorate, in retrospect, the growth in my academic maturity might  
have been curtailed if this had been the case. The benefits of working within a multi-
professional research environment, as within the Kidney Research UK team, cannot  be 
underestimated. Within this team I  have learnt  to appreciate wider ethical issues, the 
economics of undertaking research, aspects of project  management and the difficulties 
associated with mult i-site working. Most importantly I  have been the opportunity to make 
nat ional and international contacts in the subject area of self-management, and already have 
had opportunities to apply for further research funding.   
 
7.9. Chapter summary  
 
This chapter has analysed the findings set within a context of recent published literature. The 
chapter discussed the possible shortcomings of the method, which included the challenges of 
distributing the intervention in order to power the study and the quality of the data such as 
end-digit preference in blood pressure recordings. 
 
The discussion on the use of self-management initiatives in practice suggested that the 
implicat ions of the study could be replicated for other long-term conditions, although the 
simple action of self-management pack distribution needs to be accompanied by a 
commitment to a self-care ideology.  A culture change from a passive, to an active self-care 
philosophy, requires the support of ‘self-care champions’ and lead clinicians responsible for 
diabetes practice.    
 
The main implication of the study is that there is a place for implement ing self-management 
packages or programmes in primary care for people with diabetes mellitus at risk of kidney 
damage. The study has shown that the main outcome measure, mean systolic blood 
pressure, can be reduced to a level near to that recommended by the National I nstitute for 
Health and Clinical Excellence (2008).  
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The main recommendation for practice is that there are parts of the self-management pack 
that need to be amended prior to further dissemination.  
 
The main recommendat ions for further research are twofold. First, the undertaking of a 
qualitative study, which investigates how people might take the information in the self-
management pack and use this t o change their health behaviour. I n other words assessing 
the problem-solving and decision-making skills that enable a person to apply new informat ion 
in order to function successfully as a health-care consumer (health literacy)(Nath 2007). 
 
Secondly, that replication of this study as a cluster-randomised trial ( to remove researcher 
bias) is undertaken.  
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8. THE ARTEFACT 
 
8.1. I ntroduction 
 
A requirement of this thesis has been to develop an ‘artefact’. The artefact is the final version 
of the self-management package that has been developed, tested and evaluated as the study 
has progressed.  This thesis has described each of these stages, and a summary is now 
included. 
 
8.2. Summary of artefact development 
 
The self-management package was developed for and with patients. The development of the 
pack was informed by the observations made during the case study visits to GP pract ices, the 
findings of the literature review and the interviews with people who have diabetes and were 
at high risk of progression of CKD. The pack contains a variety of educational learning 
materials (writ ten information, 20 minute DVD, a fridge magnet (with key messages), a 
monitoring diary and a blood pressure machine (if required), the aim being to cater for 
different people with a variety of learning styles.  
 
8.2.1. Summary of how the artefact was tested  
 
Testing of the package was undertaken in six GP practices, with one addit ional control 
pract ice. Patients with Type 1 or Type 2 diabetes at risk of kidney disease (defined by the 
presence of microalbuminuria) were included. Data on renal function (serum creatinine, eGFR 
and proteinuria) systolic and diastolic blood pressure, glycated haemoglobin (HbA1c), body 
mass index (BMI ) and smoking status were collected at six time points:  before, during and 
after the intervent ion. Outcomes in patients in the part icipating surgeries who did receive a 
pack (n= 116) were compared with patients in the control group (n= 61). 
 
8.2.2. Results of the test ing phase 
 
At time point 4 mean systolic BP in the intervention group was 129.2 ±  19.2 mmHg vs. 134.6 
±  15.0 mmHg  in the control group (p= 0.057). At time point 5 there was mild significance 
(p= 0.053) in mean diastolic BP. At  the end of the study (time point 6)  the intervention group 
had a mean systolic BP of 132.1 ±  14.2 mmHg  vs. 136.2 ±  16.4 mmHg and mean diastolic 
BP of 74.9 ±  8.5 mmHg vs. 77.6 ±  9.1mmHg in the control group (p= ns). There were no 
significant differences in HbA1c and BMI  at  any time period.
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The main focus of t his chapter is to explain how the self-management package was evaluated 
at the end of the study by users and professionals, and how their comments were used to 
amend the package prior to final disseminat ion. 
 
8.3. Evaluation of artefact and subsequent changes made 
 
I t was important t o gain a qualitative understanding of whether people were able to 
understand the content of the pack, whether they found the pack useful, and whether they 
took the messages from the pack and changed their behaviour as a consequence.  
 
The original aim was to evaluate the pack (content, ease of understanding, usefulness) in 
four ways:  
 
1. Ongoing feedback from patients:  Each pack contained a feedback form that  gave my 
contact number and address.  I  requested that if anyone had questions or comments they 
were to contact me directly. 
 
2. Post-study feedback from patients:  Through a short questionnaire sent by post  to 15 
people who had received the pack, and by 3 face-to-face interviews. 
 
3. Post-study feedback from practice nurses. 
 
4. Post-study update of educat ional resources that  may have changed as a result of nat ional 
policy/guidance. 
 
 
8.3.1. Ongoing feedback 
 
Of the 116 packs that were dist ributed only two people contacted me with questions. Of 
course it is possible that other questions were asked of the primary care pract it ioners and 
were answered face-to-face during consultations, although pract ice nurses did not report that  
this was the case when quest ioned. 
 
One question concerned the use of blood glucose monitors and the need for monitoring in 
people with Type 2 diabetes. One man telephoned me and asked whether it was necessary 
for people with Type 2 diabetes on tablets to monitor their blood glucose at home.  
Unfortunately this was at  the same time period at which there had been local and nat ional 
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debate about the use of self-monitoring of blood glucose (SMBG) in people with Type 2 
diabetes.  At t he time of the enquiry (July 2007) the Diabetes UK website stated that  
 
“People with Type 1 and Type 2 diabetes should have access to self-monitoring of 
blood glucose (SMBG) based on individual clinical need, type of diabetes, personal 
circumstances and informed consent - not on ability to pay. 95 per cent of diabetes 
care is self-care.”    
 
At the same time the website was also carrying a ‘news item’ on a recently published study. 
This study (Farmer et al. 2007) concluded that there was no convincing evidence of an effect  
of self monitoring blood glucose, with or without instruction, in improving glycaemic control 
compared with usual care, in reasonably well controlled non-insulin treated patients with Type 
2 diabetes.  
 
The local PCT at  that time had recently sent  guidance to GP practices which stated that  
people with diabetes, not  t reated with insulin, should not  be recommended to undertake 
SMBG, presumably because of lack of evidence and also cost. This was a confusing picture 
for this one particular patient, and he had therefore sought clarification. The issue was not  
easily resolved despite my contact with the patient’s GP, who told me that  the health care 
professionals themselves were uneasy about the PCT’s decision. I  contacted the patient again 
and told him that I  have been advised by his GP that SMBG was not necessary for people 
with diabetes controlled on oral medication.  
I n my opinion this was an unsat isfactory outcome but unfortunately I  was not  in a posit ion to 
question the PCT decision. Since 2007, the issue of SMBG in people with Type 2 diabetes is 
still att racting debate over the evidence base (Welschen et al. 2005) and also the cost (Belsey 
et al. 2009), with mean national expenditure on home BGM being £73.64 per patient per 
year. The current posit ion statement from Diabetes UK on SMBG  (Diabetes UK 2006), states 
that people with Type 2 diabetes who control their condition with healthy eating, physical 
activity and with or without oral medication, should have their glycaemic control monitored 
through regular HbA1c testing based on NICE (2002) guidelines. However the posit ion 
statement also specifies that   “people with diabetes who prefer to monitor their blood 
glucose to proactively review and inform lifestyle changes should be able to do so.”  
For the purposes of this self-management package, the advice on SMBG needs to be made 
more explicit, with further informat ion on the evidence/cost  debate and Diabetes UK 
guidance. 
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Another pat ient enquired whether the troublesome tickly cough that he was experiencing 
might be due to the BP medication (ramipril) that  he was taking. I  confirmed that  this might  
be likely but  that  he should visit his GP for advice and assessment.  
 
I n summary, the opportunity for patients to contact me about  the pack did not  produce many 
questions although the query about  SMBG did raise a pertinent debate, which has alerted me 
to provide more information on this in the artefact . 
 
8.3.2. Post-study feedback from patients 
8.3.2.1. Questionnaire 
 
At the end of the distribution period, it  was planned that a small number of people who had 
received the pack would help me to evaluate the contents of the pack for ease of 
understanding. The original study protocol stated that  evaluation of the pack would be 
carried out with 15 patients and a short questionnaire (see Appendix 14) was developed. The 
aim was to find out whether they understood the content of the pack and whether they could 
make any recommendations for improvement. 
 
Pat ients were randomly selected from the 116 who had received the pack and then it  was 
checked with practice nurses in the participating practices that  these patients were not  
acutely unwell or suffering any sort of life crisis. Questionnaires were distributed by post and 
if not returned within three weeks people were sent a reminder.  
 
I  received only 5 replies despite the reminders. The results are shown in Figure 8.1.  
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Figure 8.1:  Summary of pat ient  replies to evaluation quest ionnaire 
Pat ient 
number 
Did you 
look at  
the 
pack? 
How soon 
after 
receiving 
did you look 
at it? 
Which 
parts 
did you 
look 
at? 
Which 
parts were 
most 
useful? 
Was there 
anything 
you did not  
understand? 
Any further 
suggestions or 
comments? 
1 Yes One week DVD “Nothing 
said that I  
did not  
know 
already”  
No “Everyone 
sounded most  
miserable and 
down-beat about  
it all” 
2 “ I  do not  
recall 
receiving  
a pack” 
     
3 Yes Immediately All “DVD 
reminded 
me what I  
needed to 
do. The 
fridge 
magnet 
least 
useful.”  
No No 
recommendations 
4 Yes Within one 
week 
All 
except 
DVD 
“DVD was 
fiddly and 
required 
too much 
effort – no 
compelling 
reason to 
watch”  
No No 
recommendations 
5 Yes Immediately All All No  
 
 
Because of the small number of respondents, and subsequent small amount of qualitative 
data, it was recommended by my first  supervisor to undertake 3 face-to-face semi-structured 
interviews with patients, to elicit further in-depth evaluation. 
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8.3.2.2. I nterviews 
 
Three patients who had received the pack were randomly selected from one practice, and 
agreed to meet me at a forthcoming diabetes clinic. The semi-structured interview was based 
on the quest ions in the paper questionnaire. Two men (one white man aged 77 years and 
one Asian man aged 66 years) and one woman (white, aged 64 years) were interviewed. 
 
During the interview with the female patient I  made some notes. This became a litt le 
problematic as she talked quite quickly and I  was not  confident that  I  was able to capture all 
her thoughts and recommendations. Subsequently both interviews with the male interviewees 
were taped, with their permission. Figure 8.2 shows a summary of the interview findings.  
 
Figure 8.2:  Summary of post-study interview findings 
Pat ient 
number 
Did 
you 
look at 
the 
pack? 
How soon 
after receiving 
did you look at 
it? 
Which parts 
did you look 
at? 
Which parts 
were most 
useful? 
Was there 
anything you 
did not 
understand? 
Any further 
suggestions 
or 
comments? 
1. Female  Yes Immediately All of it DVD No Good to keep 
everything in 
a box 
2. Male Yes A few days 
later 
Could not 
get the DVD 
to work on 
my 
computer 
Writ ten 
information 
No Elaborate on 
how serious 
diabetes can 
be 
3. Male  Yes Straight away All of it with 
my wife 
I  do not use the 
book (monitoring 
diary) as my 
machine records 
it (blood sugar) 
all 
Everything to 
me is OK 
Nothing to 
improve 
 
Some of the comments from the interviews are now described in detail. 
 
NT:  Which bits of the pack were most useful? 
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“ I  have always been a big reader, so I  like the written information. I f you see a film 
you can miss bits, so I  would always prefer the piece of paper.”  
 “The bit about BP control, I  took note of that. My BP is always high so that was very 
interesting.” 
 
NT: Would you find it useful to have a BP machine at home? 
“Not really. I  know it is high……so if it high, what can you do about  it, apart from 
taking the tablets?”  
 
NT:  What about the fridge magnet? 
“Well it is still on my fridge!  I  do glance at  it, but it is a bit gimmicky I  suppose!”  
 
NT:  Was there anything that was not in layman’s language that you did not 
understand? 
“Not that I  can remember – it all seemed fine.”  
 
I  asked some additional questions based on the comments received from the quest ionnaire. I  
was concerned that some parts of the DVD might be distressing. 
  
NT:  Did you find the DVD depressing? 
No, not at all!  
NT: What about the part which shows people on the kidney machine? 
No I  did not  find that at all, everything was perfect. I  understood what it meant, and 
what that  bit meant t o say. 
 
NT: Do you remember the bit about the dialysis machines? Was it frightening? 
I  don’t think it was frightening at  all….you should tell people the worst that can 
happen.  
 
NT:  I  was thinking about putting the DVD on-line. Would you be able to access it? 
“Well I  go to the library to access my emails. I  don’t  have a phone line at home.”  
 
NT:  Did you do anything differently after looking at the pack? 
“ I  did not realise how important the monitoring of the diabetes and also the blood 
pressure was, for kidney damage. But apart from taking the tablets then I ’m not sure 
what I  can do about that .”  
 
“ I  am quite pleased with myself as I ’ve given up smoking now.”  
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NT:  I s there anything else you can recommend for me to change in the pack? 
“You could elaborate on the seriousness of it  all. People don’t realise how important it 
is.” 
 
 
8.3.3. Post-study feedback from practice nurses 
 
I  visited 5 out of the 6 practice nurses in the participating surgeries in the beginning of 2008. 
The practice nurse in practice 4 had recently left  and a replacement had not yet been 
employed. I  asked them about their experiences of distributing the pack, and for any 
suggest ions they might have for improving the pack. 
 
I  have categorised their comments into themes, namely, ease of distribution, evaluation of 
developed resources and ideas for dissemination. 
 
8.3.3.1. Ease of distribution 
 
Overall none of the practice nurses found it diff icult to incorporate the pack distribution into a 
usual consultation. The obtaining of the consent took time, but this of course will not be 
necessary in the future if it becomes part  of usual practice.  None of the nurses could 
remember if they had been asked to clarify or explain any of the information in the pack. Two 
pract ice nurses commented that the box that contained the resources was very useful, as the 
contents did not become damaged and the packs were easy to store and locate when 
required.  
 
8.3.3.2. Evaluation of developed resources 
 
All the nurses thought it necessary to have a variety of resources to cater for a variety of 
learning styles and varying levels of required information. One practice nurse particularly liked 
the ‘key messages’ on the fridge magnet, and suggested it  was important to keep the overall 
message simple. One practice nurse suggested that the leaflet should have the key message 
on the first page:  “Are you at risk? I f so, what can you do about it?”  
 
 Two practice nurses said that  the DVD was too long for some people to sit through, although 
recognised that some individuals required that level of knowledge. 
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8.3.3.3.  I deas for dissemination 
 
All the practice nurses were enthusiastic about  having a range of resources to help inform 
people about CKD. Ways in which they could continue to have access to these resources 
included: 
 
• Having a (master) paper copy that could be photocopied 
• Uploading the DVD to a well-recognised and easily accessed website, such as 
Diabetes UK. The website link could then be incorporated into the written 
information. 
• Writing an article for the Diabetes UK pat ient magazine to reach a wider audience. 
 
Other issues included continuing education of practice nurses and GPs about CKD, including 
suggest ions about  when to start  giving information about self-management of CKD. There 
was also a suggestion that the practice computer database could be searched to identify 
people with CKD and microalbuminuria and each identified patient record flagged to ensure 
that the self-management pack/ resources are given when the patient  at tends clinic.  
 
8.3.4. Post-study update of national guidance that has affected pack content  
 
I n 2008 the NHS published specific guidance for the development of patient informat ion 
materials (Department of Health Branding Team 2008). This guidance includes 
recommendations for writing style (writ ing from pat ient ’s point of view and use of everyday 
language) and optimum engagement. Other pertinent  recommendations include advice on  
• Short sentences:  in general, no more than 15 to 20 words long.  
• Lowercase letters:  are easier to read, although uppercase is always required for the 
first letters of names and sentences.  
• Quest ion and answer format:  will help divide up your text.  
• Bulleted or numbered points:  will help to break down complicated informat ion, and 
will help patients to digest it.  
• Small blocks of text:  long paragraphs can look daunting on the page;  use headings 
and paragraph breaks to divide your information up.  
• Large bold font:  very useful for highlighting and emphasising text, whereas 
uppercase letters, italics and underlining can make text more difficult to read.  
• Font size of at least 12 point  (14 point for older people) 
• Use Frutiger Roman for professionally produced materials. I f this is not  available, use 
Arial instead. 
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• For the best print contrast, set dark print against a light  background. 
‘Your health, your way - a guide to long term conditions and self care’ (Department of Health 
2008b) was launched on NHS Choices on 2 November 2008, setting out the support that  
pat ients should expect to receive from their Primary Care Trusts and local authorit ies. ‘Your 
health, your way’ is not new policy, but draws together all the strands of work and 
information that already exist.  
 
The core aims are to empower and support people with long term conditions to understand 
their own needs and be able to make an informed choice about the self care support they 
wish to access from the resources available.  Five key areas of self care have been identified 
to achieve these aims. These are:  
 
1.  I nformation 
2.  Skills and knowledge training 
3.  Tools and self-monitoring devices 
4.  Healthy lifestyle choices 
5.  Support networks 
 
This artefact provides information on a long-term condition and healthy lifestyle, and also 
ways in which individuals can self-monitor. I t does not overtly provide skills for self-
management, or provide support networks, so a recommendation is that health care 
professionals involved in the subsequent use of the artefact provide opportunities for 
individuals to acquire these skills. 
 
Part ly as a result of this DH initiat ive, the NHS Kidney Care team launched the ‘Kidney Care 
Plan’ in March 2009. Every adult pat ient with chronic kidney disease will now be given a 
personal folder, ‘My Kidney Care Plan’. The Plan is to ‘help you get involved in your own care 
by helping you to think about the things that are important to you.’ People with CKD will be 
able to use the Plan to discuss in detail their needs and concerns with a specialist nurse or 
other trained member of  their kidney team and keep notes in their folder. The care plan 
folder shows examples of topics that people with kidney disease may wish to talk about 
during a consultation or care planning meeting. Examples are food and drink, my blood test  
results, my kidney disease. There is an insert  which has the heading “ I  would like to talk 
about….” 
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As there is overlapping content  with the Kidney Care Plan and this artefact, it is important  
that the two resources are compatible, especially as the Care Plan will have a national 
implementation plan. Although the Care Plan has only been piloted with people who have 
already been referred to a renal team, there are possibilit ies for it to be used by people with 
early CKD. As a consequence, it is possible that some parts of the Kidney Care Plan could be 
incorporated into this artefact.  
 
During the study period 2004-2009, there was one change to guidance on blood pressure 
targets. This came as a result of NICE (2008) recommendations for the management of CKD 
in primary care. The blood pressure target recommended for people with diabetes and CKD is 
now 130/ 80 mmHg, compared with 135/75 mmHg at the start of the study (NICE, 2002).  
 
As a result the BP targets contained within the writ ten information and DVD had to be 
amended. 
 
8.4. Overall changes to design of pack as result of thesis findings 
 
There were a number of recommendations that  arose from the findings and discussion 
chapters in this thesis. Firstly the structure of the pack will be changed to cater for requests 
for differing amounts of information. This will mean inclusion of three different pamphlets 
within the pack, rather than just one. These are:  key messages, benefits of self-care and 
further information. Key messages will also be further highlighted within the DVD, with 
changes made to the opening sequence. 
 
The importance and possible benefits of self-care were highlighted as not  receiving enough 
emphasis, so this is the reason for supplementary information. The different ways in which 
men and women take on health-care advice has been reviewed. I t appears important that  
women are given encouragement to believe that self-care st rategies do work – another 
reason for including more encouraging text on the benefits of self-care. For men, consistency 
of message appears important  to enable good control of their condition. Consistency of 
message across all learning materials has been checked. 
 
The cultural appropriateness of the materials has been checked, and studies (Sanders 
Thompson et al. 2008, Schouten et al. 2006) that have recommended strategies to enhance 
cultural issues have been reviewed, and recommendations incorporated. 
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The suitability of the font size/ font colour of the written informat ion for older people has been 
checked against national guidance (Department of Health Branding Team 2008), and 
subsequently amended.  
 
Further informat ion about self-monitoring of blood glucose has been included. I nformat ion 
about medicines (ACEis and ARBs) now contains further informat ion about harm and benefit, 
especially adverse effects that could arise (Raynor et al. 2007). Recently published NICE 
guidance (National I nstitute for Health and Clinical Excellence 2009) on medicines adherence 
has been reviewed and recommendations have been incorporated. These include a clear 
explanation of what  the medicine is and likely benefits;  possible side-effects;  a suggest ion 
where patients might find reliable information after a consultation, such as on the NHS 
Choices website. 
 
8.4.1. Detailed changes to self-management pack 
 
Figure 8.3 shows the specific changes that have been made to the self-management pack. 
The final version of the pack is contained in Appendix B. 
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Figure 8.3:  Specific changes made to self-management pack 
Learning 
material 
Overall 
Presentation 
Format Content Available 
media 
Box No change  I nclude background informat ion 
for health-care professionals 
 
Written 
informat ion 
Change from 
one A5 folded 
sheet, to three 
A5 
sheets/booklet 
Change font size to 
Arial 14 point and 
include more bullet 
points rather than 
text. 
Change text to 
question and answer 
format 
Key Messages 
As before except for BP target, 
and include questions:  Are you at 
risk? I f so, what can you do about 
it? 
Self-care 
• Benefits 
• Questions to ask  
Further information 
• Kidney disease 
• Screening 
• Blood Pressure 
Ways it can be controlled 
Side effects of medication 
Blood pressure machines 
• Blood sugar monitoring 
especially in Type 2 diabetes 
• Lifestyle 
• What can happen 
Paper 
 
On-line 
Seeking 
permission 
to include  
on NHS 
Choices 
website  
Film No change Change opening 
sequence to include 
key messages  
BP target  changed from 135/75 
to 130/80 mmHg 
DVD 
 
On-line 
Seeking 
permission 
to include  
on NHS 
Choices 
website 
Fridge 
magnet 
Not included 
in final version 
Content added to 
written information 
BP target  changed from 135/75 
to 130/80 mmHg 
 
 
Monitoring 
diary 
Not included 
in final version 
Recommendations for 
monitoring added to 
written information 
  
Blood 
pressure 
machine 
Not included 
in final version 
Recommendations for 
buying a BP machine 
added to written 
information 
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8.5. Dissemination 
 
8.5.1. Local dissemination 
 
Communication with the six intervention practices has been ongoing throughout the study. I n 
each practice there has been one named contact person, usually the most senior practice 
nurse or nurse pract it ioner in the practice. During the data collection and intervention periods 
I  formally communicated with the practices every three months by letter (sent by post). I t 
was important to ensure written communicat ion with one named person during the durat ion 
of the study as sometimes, when I  visited the practice, the named contact was not present. I  
asked the named contact to ensure that  information was communicated to other key practice 
staff for the entire study period. I n all practices except one, I  had the same named contact  
for the duration of the study. 
 
At the start  of the study my letter updated the practices on the aims of the study, the 
different phases of the study, and when to expect my visits. I  also communicated details such 
as what was expected of the practice, what  exactly would be carried out , such as length of 
time spent in the pract ice with pat ients, and what would happen next. I  always ensured that  
they were comfortable with the amount of feedback from me and what was expected of 
them. 
 
After the end of the pack distribut ion period (October 2007) I  visited the pract ices once more, 
at the last data collection period in January 2008. Since then, I  have communicated by letter 
only:  once in September 2008 and again in June 2009 to inform them of the results.  
 
I n September 2008 I  sent  them a copy of the paper that  had been published in the Journal of 
Renal Care (see Appendix 16), outlining the development of the package.  I n June 2009 I  
wrote to the practices for the final time explaining my results. I  also requested that they 
contact me if they had immediate questions, and subsequently visited each practice in 
September 2009 to give a formal thank-you for all their assistance and to distribute 30 copies 
of the amended self-management pack (DVD and written information only).  
 
8.5.1.1. Sustainability 
 
I n Chapter 7 there was a discussion about how far this artefact could be sustainable, and a 
check-list for sustainability was ident ified (NHS I nstitute for I nnovation and Improvement 
2007). There now follows a discussion about the recommendations for sustaining the 
incorporation of the artefact into the part icipating surgeries and in the local PCT.  
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Attention needs to be paid to the process of incorporat ing the artefact into everyday practice. 
This includes convincing the practice nurses and GPs in participating practices of the benefits 
of using the artefact, beyond helping pat ients.  I t is also crucial to ensure that  it is easy to 
adapt to the improved process and how effective is the system that has been put in place to 
monitor the results. This means that  I  must  spend time with the practice nurses in the 
part icipating practices, discussing ways in which the artefact can be introduced to the people 
at risk and perhaps more importantly how the process can be sustained and evaluated. 
 
Possible ideas include the use of the EMIS system to flag people who are at risk (by flagging 
abnormal ACRs), and to introduce practices to the NICE (2008) audit  support toolkit that  
shows how current pract ice in CKD management can be measured against NICE 
recommendations. For example audit criterion 10 in the toolkit is:  
 
“ I n people with CKD and diabetes aim to keep the systolic blood pressure below 130 mmHg 
(target  range 120-129 mmHg) and the diastolic blood pressure below 80 mmHg.”  
 
Staff factors that  need consideration include staff training in facilitating self-care. The DH 
document ‘Your health, Your Way’ (Department of Health 2008b) outlines an example of 
good pract ice from NHS Kirklees. This example of a self-care pathway for practit ioners 
working with people with a long-term condit ion shows how the patient and health care 
pract it ioner together can use the care plan to identify self-care support and resources. This 
artefact  serves as a suitable informat ion resource, although could benefit  from additional 
knowledge and skills training such as DESMOND or the Expert Patient Programme.   
 
I t is also crucial that  senior leaders in each practice engage with the recommendations of this 
thesis, so a summary of the thesis’s findings and recommendations have been sent to the 
senior partners and practice managers in the participat ing practices.   
 
Finally it  is important to consider how far the integrat ion of the artefact into usual practice 
(the change) fits with the practice’s strategic aims and culture. Although it is not always 
possible as an outsider to evaluate the culture of  an organisation, the case-study observat ion 
period did give me some insight into the services offered to patients. Overall the culture in 
the participating practices did seem to be one that tried to do its best for the patients, and all 
the practice nurses involved did respond to suggest ions and practice changes as a result of 
nat ional CKD management policy. I t is five years since I  first had contact with the practices 
and an excellent relationship with them has developed. I  am hoping that my final visit to the 
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pract ices will result  in a positive outcome, that is, one that takes my recommendations and 
improves patient opportunities for self-management.  
 
8.6. The Medical Research Council (MRC)  Framework for Complex 
I nterventions 
 
8.6.1. I ntroduction 
 
The difficulties in isolating the ‘active ingredient’ of the self-management package (the 
intervention) were discussed in section 7.3.4. As the intervention developed in this thesis 
included a variety of components, including organisational and delivery methods (Bradley et 
al. 1999), the intervent ion could be described as complex. The MRC (Medical Research 
Council 2000) described a complex intervention as follows:   
 
“Complex interventions in health care, whether therapeutic or preventative, comprise a 
number of separate elements which seem essential to the proper functioning of the 
intervention, although the active ingredient that  is effective is difficult to specify.”  (Medical 
Research Council 2000) 
 
I t has been recommended that  complex intervent ions should be carefully planned and 
designed and to help researchers, the MRC in 2000 published a five-phase framework for 
developing and evaluat ing complex interventions.  
 
There are a number of reasons why a framework might be necessary. I f the intervention is 
relatively simple, clearly defined and can be standardised (as in randomised controlled trials 
(RCTs)) then differences can be confident ly att ributed to interventions. I n an intervent ion 
which includes mult iple intervention components, attributing differences to one part of the 
intervention can be more difficult (Victoria et al. 2004). I n addition, standardising the 
intervention is more challenging if the intervention is aimed at changing behaviours and may 
consist  of multiple interrelated and interdependent components, such as pract it ioner and 
pat ient behaviours (Blackwood 2006). I t has also been suggested that as the components of 
interventions are not always reported, it is very difficult to draw conclusions or comparisons 
across different studies (Lindsay 2004). I t has also been recognised that  there are challenges 
facing systematic reviewers of complex intervent ions although a recent paper has suggested 
several ways of addressing them (Shepperd et al. 2009). 
 
The MRC Framework was first  published in 2000 and later revised in 2008 (Medical Research 
Council 2008). One framework (Bradley et  al. 1999) particularly contributed to the 
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development of the original MRC Framework, whilst later publications (Hawe et al. 2004, van 
Meijel et  al. 2004) informed the subsequent development of the Framework.  
 
The original MRC Framework drew on the principles developed by the earlier frameworks, 
and includes five phases:  preclinical, modelling, exploratory, definit ive RCT and long-term 
implementation. Figure x shows the original MRC Framework for Complex Intervent ions 
(2000). 
 
Figure 8.4:  The MRC Framework (2000) for the design and evaluation of complex 
interventions 
THEORETICAL
Prior theory and 
empirical 
evidence used to 
formulate the 
intervent ion and 
how it would 
work in theory
MODELLING
Practicalit ies
and concrete 
structure of the
intervention
are developed
and refined
EXPLORATORY 
TRIAL
I ntervention is 
refined in an
exploratory trial
DEFINITIVE 
RCT
Refined 
intervention is 
subject to a 
definitive RCT
LONG TERM 
IMPLEMENTATION
Following 
successful 
RCT the 
intervent ion
is implemented in 
routine clinical 
pract ice
Preclinical Phase I Phase II Phase III Phase IV
Continuum of increasing evidence
 
 
 
The original Framework (Medical Research Council 2000) with an accompanying paper 
(Campbell M et al. 2000) was updated in 2008 (Medical Research Council 2008) to provide a 
more flexible, less linear model. The rationale for updating the Framework was described in 
the introductory paragraph:  
 
“ I t updates the advice provided in the 2000 MRC Framework ......taking account of 
the valuable experience that  has accumulated since then, and extending the 
coverage in the guidance of non-experimental methods, and of complex interventions 
outside the health service. I t is intended to help researchers to choose appropriate 
methods, research funders to understand the constraints on evaluation design, and 
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users of evaluat ion to weigh up the available evidence in the light of these 
methodological and practical constraints.”  (Medical Research Council 2008)(p.4)  
 
The updated Framework includes questions to be asked during the stages of development, 
feasibility/piloting, evaluation and implementat ion.   
 
 
8.6.2. Review of papers using the MRC Complex Intervention Framework 
 
This section reviews papers that  have been published within the topic areas of diabetes, 
cardio-vascular disease and other long-term condit ions. Following the publication of the 
Framework in 2000, a number of researchers started using the Framework in their studies. 
 
8.6.2.1. Diabetes 
 
Three have been identified that have used the Framework in the field of diabetes. One study 
group in Germany (Muhlhauser and Berger 2002) examined the available evidence for 
diabetes treatment and teaching programmes implemented in Germany over the previous 20 
years. They concluded that  although a number of researchers had developed programmes for 
people with diabetes that had used elements of the Framework, the majority had not  used 
the Framework in a systematic way. They recommended the use of the Framework to 
develop and report such interventions, which in turn will enable systematic appraisal across 
different methodologies. 
 
I n contrast to the apparent lack of systematic use of the Framework in the German review, 
one UK study (Sturt et al. 2006c) used the MRC Framework to systemat ically develop and 
evaluate a Self-Efficacy Goal Achievement nursing intervent ion for Type 2 diabetes. The 
Preclinical study included literature analysis and findings from parallel studies. The Phase I  
study was a small trial of the intervention, evaluation of its feasibility and identification of 
appropriate outcome measures. The important  message from this phase (demonstrating the 
utility of the Framework) was that parts of the intervent ion were adjusted to remove the less 
effective components and enhance the more effective. I t was only when Phase I  had been 
evaluated and redefined that the Phase I I  (exploratory) and Phase I I I  RCT was developed 
(Sturt et al. 2006a).  
 
Paul (2007) also used the MRC Framework to shape a complex intervention of peer support 
for people with Type 2 diabetes for a randomised control trial in a primary care setting. The 
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Preclinical Phase included a review of the literature relating to Type 2 diabetes and peer 
support. I n Phase I  the theoretical background and qualitative data from four focus groups 
were combined to define the main components of the intervention. The preliminary 
intervention was conducted in Phase I I . This was a pilot study conducted in two general 
pract ices and amongst twenty-four patients and four peer supporters. Focus groups and semi 
structured interviews were conducted to collect  addit ional qualitative data to inform the 
development of the intervention. Four components (peer supporters;  peer supporter training;  
retention and support  for peer supporters and peer support meet ings) were identified from 
the Preclinical Phase and Phase I . The preliminary intervent ion was implemented in Phase I I . 
Findings from this phase allowed further modelling of the intervent ion, to produce the 
definitive intervention (Paul et  al. 2007). I n some ways this sequence mirrors the method 
developed in the current thesis and this comparison will be discussed further in sect ion 8.6.4. 
 
8.6.2.2. Cardio-vascular disease 
 
I n the area or cardio-vascular disease, four published papers were found. One paper (Byrne 
et al. 2006) described how the MRC Framework assisted in the development and evaluat ion 
of a complex primary health care intervention that aimed to promote the secondary 
prevention of coronary heart disease. The authors explained how the Framework helped 
clarify how the intervention could be tailored to individual practices, practit ioners and patient 
needs, while at the same t ime preserving the theoret ical functions of the components. I n a 
pract ical sense, findings from the pilot phase informed further modelling of the intervention, 
such as reducing administrative time, increasing the practical content of t raining and omitt ing 
unhelpful pat ient information.  
 
I n another study (Robinson et al. 2005) the researchers used the Framework to develop an 
intervention that facilitated coping skills in new carers of  stroke pat ients. As in the Byre 
(2006) study the intervention was modified after Phase I  and Phase I I . A systematic review 
of complex intervent ions for st roke care (Redfern et al. 2006) was undertaken. The MRC 
Framework was used to st ructure the review and overall the authors asserted that few 
complex interventions in stroke care had been adequately developed or evaluated. They 
suggested that these issues may explain failures to demonstrate efficacy and recommended 
that greater attent ion is needed to theoretical development and methodological quality. 
 
Another study (Corrigan et al. 2006) aimed to examine the contribution of qualitative 
research in developing a complex intervention for secondary prevention of heart disease. The 
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authors described how focus groups undertaken in Phase I  could identify components of the 
intervention that had not been considered beforehand, such as practical approaches to 
minimising administration and providing information about  stress management. The 
important message was that use of the Framework enabled tailoring of the intervent ion 
components to individuals' needs in different healthcare systems.  
 
8.6.2.3. Long-term condit ions 
 
Other published papers in the general field of long-term conditions were identified (Wong 
2004, Eldridge et al. 2005, Thompson and Weiss 2006, Murchie et al. 2007, Klinkhammer-
Schalke et al. 2008). I n these studies the Preclinical stage ensured that  the interventions 
were based on sound evidence;  Phase I  was extremely valuable in identifying the barriers 
that could have derailed the successful implementation of the interventions;  whilst Phase I I  
ident ified problem implementat ion areas such as administrative or practical aspects. 
    
8.6.3. Critique of the MRC Framework 
 
There have been a number of advantages identified by researchers.  I n the systematic review 
of st roke care (Redfern et al. 2006), the authors explained how the Framework can set  
standards for theoretical and methodological development within an RCT design. Other 
authors have discussed how it is useful to apply the Framework even when planning and 
implementation has taken place (Rowlands et al. 2005), whilst it has been argued that the 
stages of Framework may be useful even if they are not systematically applied (Eldridge et  al. 
2005, Greenhalgh et al. 2005) 
 
There has however been some debate about the possible limitations of the Framework, such 
as whether all the recommended stages are indeed crucial. One review (Treweek and Sullivan 
2006) asked whether Phase I I  testing made a difference to outcome. The findings were not 
that conclusive with two-thirds (22/ 34) of those testing their interventions not believing that 
more or different testing would have produced a more effective intervention. The authors 
suggest  t hat conclusions are difficult  because testing is often not described in trial reports, 
and this makes it hard to judge whether a trial result could be improved with a better 
intervention, or whether further work with a different intervention is required. 
 
Other authors have described difficulties with the modelling phase (Lovell et al. 2008);  have 
asserted that an RCT may not be necessary if an intervention is feasible and soundly-
developed (van Meijel et  al. 2004);  and that long-term implementation, although 
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recommended by the MRC as a separate study, may be difficult in terms of funding/ resources 
(Blackwood 2006).  
 
There has been recent debate about the specific difficulties in defining, developing, 
documenting, and reproducing complex interventions that give rise to the challenges for 
researchers in systematically reviewing complex intervent ions (Shepperd et al. 2009). One 
review (Redfern et al. 2006) has claimed that  there is no convincing evidence that a well-
developed complex intervention in st roke care has improved outcomes. I n addition, it appears 
that a decade after the MRC Framework was published that some researchers are still 
developing complex interventions without using a rigorous approach (Shepperd et  al. 2009).  
 
 
8.6.4. Reflection on the use of the Framework in different stages of this thesis 
 
On reflection use of the MRC Framework to guide development of the complex intervent ion 
developed and evaluated in this thesis would have been extremely helpful. Looking back at  
the work of this thesis, some of the recommended phases of the suggested Framework were 
undertaken but these were not explained in an explicit way. Figure 8.5 shows where the 
development stages of the intervention in this thesis are related to those within the MRC 
Framework. I n addit ion, the updated MRC Framework guidance recommends that researchers 
ask specific questions of the intervention during each phase (Medical Research Council 2008). 
The questions which relate to the different phases of the Framework and which also relate to 
the different aspects of the thesis are shown in Figure 8.5. 
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Figure 8.5:  MRC Framework (2000 and 2008):  the main elements of the process and key 
questions to be asked  
 
 
Stage Section in thesis Questions to be asked 
Preclinical:  Theoretical Case study 
Literature review 
Does your intervention have a coherent  
theoretical basis?  
 
Phase I :  Modelling Development of 
intervention:   
 
- Theoret ical frameworks 
- I nterviews 
- I ntegration of case 
study, literature review 
and interview findings to 
develop intervent ion 
 
Have you used this theory systematically to 
develop the intervention? 
 
Phase I I :  Exploratory 
Trial 
Testing of intervention:  
 
- Six practices and 
control group 
- Dataset 
- Data analysis 
Have you done enough piloting and 
feasibility work to be confident  that  the 
intervention can be delivered as intended?  
 
Can you make safe assumptions about  
effect sizes and variability and rates of 
recruitment and retention in the main 
evaluation study?  
 
Phase I I I  and IV:  
Definitive RCT and 
long-term 
implementation  
Discussion 
 
- recommendations for 
future studies 
What design are you going to use, and 
why?  
I s an experimental design preferable and if 
so, is it  feasible? I f a convent ional parallel 
group randomised controlled t rial is not 
possible, have you considered alternatives 
such as cluster randomization or a stepped 
wedge design? 
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8.6.4.1. Preclinical:  Literature review 
 
The theoretical basis could be improved. Firstly there was some debate (p. 50) on how far 
the literature review could be systematic especially in view of the identified qualitative/grey 
literature that  was pert inent to the review. I n retrospect the literature review should have 
been more systemat ic and based more closely on the CRD (2009) guidance. The review 
should have had more explicit aims and specific inclusion/exclusion criteria. A discussion of 
how far  qualitative/grey literature can be appraised should have been included, especially as 
there are published methods for synthesising qualitative studies in systematic reviews 
(Thomas and Harden 2008, Dixon-Woods et al. 2007). Finally the review should have been 
updated more thoroughly prior to submission.  
 
I t is important that the findings of the review are used to develop the intervention. Further 
discussion that identified and explained the gaps in the theoretical basis should have been 
included such as the evaluation of the different stages between receiving an educat ional 
intervention and the possible subsequent behaviour change.  
  
8.6.4.2. Phase I :  Modelling 
 
The use of the underpinning theory was not entirely clear especially as the work of both 
Kirkpatrick and Funnell & Anderson was cited. On reflection the Kirkpatrick Model (1967) had 
the potential to be extremely useful but it was not  used in the thesis to its fullest  extent. I t 
could have been used more constructively to form a basis for the review search strategy and 
could have provided a framework for reviewing the findings, as the Kirkpatrick Model outlines 
a hierarchy of levels of evaluation as follows:   
 
- RESULTS: Effect on learning environments 
 
- BEHAVIOUR: Transfer of learning into behaviour 
 
- LEARNING: Effects on knowledge, at titudes and beliefs 
 
- REACTION: Evaluat ion of the learning experience 
 
The literature review could have been structured around this hierarchy, that is, studies with 
outcomes that simply measured the learning experience would be evaluated together in one 
sect ion. This could be followed by studies that measured the effects of the intervention on 
knowledge, attitudes and beliefs. Higher level studies that analysed how an intervention 
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translated learning into behaviour change would then be scrutinised, followed finally by those 
that changed learning environments. 
 
The work of Funnell and Anderson (1995, 2000, 2004, 2005, 2008) was alluded to in this 
thesis but  the use of their measurement instruments such as the Diabetes Empowerment 
Scale (Anderson et  al. 2000) could have been scrut inised to a greater extent . I n retrospect 
their empowerment philosophy (Funnell and Anderson 2004) should have been introduced at  
the start of the thesis and key concepts within the philosophy should have been used to 
check that any part  of the result ing intervention adhered to their recommendations. One 
example is that the words ‘should’ and ‘ought’ (as mentioned in the DVD) are not conducive 
to an approach which purports t o support empowerment. 
 
8.6.4.3. Phase I I :  Exploratory t rial 
 
The exploratory trial was undertaken in six GP practices and 116 patients received the 
intervention. On reflection the external influences that could have affected the outcomes 
were not  considered fully enough. One possible influence was the differing practit ioner 
explanations of the self-management pack when it was given out . For example some 
pract it ioners may have used a facilitative approach when explaining the aims of the pack 
(emphasising what the patient can do to help themselves) whilst others may have focussed 
on what should be done or not  done, such as stopping smoking. Although further evidence is 
needed to clarify how far the performance of diabetes educators can influence outcomes 
(Loveman et al. 2008b), further guidance for practit ioners would have been beneficial. I n 
addit ion, a guide for practit ioners that explained how to answer patients’ questions that arose 
as result of the intervention, may also have contributed to removing practit ioner bias.  
 
I t is also recognised that there are a number of stages between the giving of information (the 
intervention) and possible changes in outcome, such as reduced BP and HbA1c, which were 
not explored fully in the thesis.  The American Diabetes Association (Funnell et al. 2008) has 
published national standards for diabetes self-management education. Standards 1-6 give 
best pract ice guidance for the practical aspects of the education such as the use of an 
advisory group and the qualifications of instructors. Standards 7-10 are concerned with 
pat ient aspects, most importantly individualised assessment, goal set ting and effectiveness of 
the programme.  Goal setting in diabetes education often relates to Social Cognitive Theory 
(Baranowski et al. 2002), and includes the process of identifying behaviours (self-control), 
greater confidence to perform behaviours (self-efficacy) (Krichbaum et al. 2003), positive 
reinforcement and other constructs presumed to maximize goal (behaviour) attainment 
(Sprague et al. 2006). 
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The intervention developed for this thesis did not explicit ly include the assessment and goal 
setting stages, although these stages might have been included in generic one-to-one 
discussions with pract ice nurses during annual review clinics or regular check-ups. I t is 
recognised that the omission of these stages is a limitation of this current study.  
Recommendations for changes to the current intervention are discussed further in section 
8.6.4.3.   
 
I t could be argued that some assumptions written up in earlier parts of the thesis are 
unsound. For example on p.212 I  concluded that:   
 
 “ I t is therefore likely that the changes to BP in the intervention practices have occurred as a 
result of this study’s interventions rather than external influences”.   
 
Blood pressure control improved during the course of the study, yet it is not entirely clear 
which parts of the intervention might have affected blood pressure. I t is possible that  the 
pract it ioners’ confidence in managing blood pressure to target improved as the study 
progressed, and this in turn improved blood pressure control. This increased confidence may 
have resulted as a consequence of my visits to the pract ice or as a result of QOF 
incentivisation (Carey et al. 2009). I t  is difficult to extrapolate whether practit ioners’ titrated 
blood pressure medication to maximum levels to achieve QOF targets, whether they invested 
more t ime in explaining the benefits of blood pressure tablets to slow down kidney disease 
progression, or a mixture of the two. A refinement to the intervention could be the inclusion 
of a ‘Confidence in Managing CKD’ questionnaire (personal communication) undertaken 
before and after the intervention, which would identify in part whether changes in outcome 
were directly due to practit ioner interventions.   
 
Another issue that  required further analysis was the assertion that people who did not  want  
to take part in the study did not want to self-manage (p.208). There are of course numerous 
reasons why people may not wish to take part in research studies. Pertinent reasons for this 
thesis might include a general mistrust of participation in research studies and 
misunderstandings about the nature of the project itself (Williams et al. 2007). A refinement 
to the intervent ion should be that  more care is taken to explain the precise nature of 
part icipation. I n addition, the study information sheet should go beyond standardised 
guidelines for its design and instead proact ively seek out and address areas of concern or 
potential misunderstanding (Williams et al. 2007). 
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8.6.4.4. Phase I I I  and IV:  Definitive RCT and long-term implementat ion 
 
I t is recognised that there were difficulties in identifying the key variable that effected 
changes in BP in the intervention group. I t was important  to eradicate the effects of national 
policy on CKD management as far as possible by including a control group, but this was very 
challenging in the time period 2004-2008 because of new QOF targets for  CKD and the 
publication of NICE guidance for CKD.  
 
A definit ive RCT in the future is recommended, although it is not  possible to undertake an 
RCT (at patient level) because of practit ioner effects in one GP pract ice. I f the intervent ion 
was randomised at patient  level then pract it ioners might find it difficult  to provide the 
intervention in one patient  followed by unchanged usual practice in the next. I n addition, 
individual practices might have differing populations,  differing QOF achievement scores or 
differing approaches to self-management.  A cluster-randomised trial (CRT) (at  practice level) 
would be the method of choice. However it  is recognised that  it is not possible to fully 
account  for all effect s such as practit ioner confidence in managing diabetes/CKD and 
pract it ioner confidence in facilitating a self-management approach, although if these 
measures are incorporated into the design of the Phase I I I  study, then the effect s of these 
variables might to some extent be reduced.   
 
 
8.6.5. Next steps 
 
The following recommendat ions are based on selected ‘Further questions’ of the MRC 
Guidance (2008, p.14). 
 
‘Have you conducted a systematic review?’  
I  aim to revisit and update the literature review as discussed above in section 8.6.4.1 and aim 
to submit  for publication as the first  stage of the MRC Framework (preclinical) by September 
2010. 
 
Who is the intervention aimed at? 
As the intervention seeks to achieve change in more than one area (both patients and 
pract it ioners) , processes and outcomes need to be ident ified and measured at both levels. As 
discussed in sect ion 8.6.4.3, the intervention needs to include a patient-centred measure 
such as self-efficacy, measured prior to and after the intervention. From a practit ioner 
perspective, the intervention should also include a way to measure confidence in promot ing 
an empowering approach (practit ioners). Both of these patient and practit ioner aspects are 
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being measured and evaluated in another study (Jain et al. 2009) that I  am involved with. 
Once validated for CKD, the instruments could be incorporated within the current intervent ion 
although it is recognised that inclusion of too many additional measures could overcomplicate 
the method and result  in inconclusive findings.  
  
Can you describe the intervention fully? 
The intervention needs to be described fully t o allow reproducibility in different set tings and 
to enable comparison with other studies, as in a systematic review. I  aim to publish the 
refined exploratory trial protocol by registering the study in the NIHR Clinical Research 
Network Port folio. 
 
How variable is the intervention? Can you describe the context and environment in which the 
evaluation is being undertaken? 
Further discussion on context needs to be considered before developing the intervent ion 
further. The exploratory study was undertaken in a suburban PCT with a low ethnicity mix 
compared with other areas. The challenges of reaching so-called ‘hard to reach groups’ need 
to be considered, especially the challenge of developing an intervention for people who do 
not have English as their first language.  
 
Have you reported your evaluation appropriately? 
To date some aspects of the Phase I  part of the study have been reported (Thomas et al. 
2008). The Preclinical stage (literature review) will be reported as in section 8.6.4.1 above, 
whilst the Phase I I  study could be published once further refinements to the exploratory t rial 
have been undertaken. Phase I I I  evaluation would be published according to CONSORT 
criteria for cluster-randomised trials (Campbell et al. 2004).  
 
 
8.6.6. Conclusion 
 
The question is now whether wider dissemination and application of the intervention is at  
present merited. Dissemination of the findings to date has only been within the six 
part icipating practices within one PCT. The next  stage will be to publish the theoretical basis 
for the study (the evidence from the case study and literature review). Further refinement of 
the intervent ion is required before another exploratory t rial is undertaken. This refinement 
will include additional measures such as validated instruments to measure practit ioner and 
pat ient confidence. 
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I t has been most useful to reflect  on the thesis with respect to MRC Framework for Complex 
Interventions. The reflection has provided the opportunity to consider addit ional work that  
needs to be carried out prior to future publications and grant applicat ions. These activit ies will 
contribute to the refinement of the intervention prior to another exploratory trial being carried 
out in a different  cohort of intervention and control practices. 
 
 
8.7. Chapter summary  
 
This chapter has summarised the way in which the artefact has been developed, and has 
described the changes that have to be made to the final version. These include changes to 
the design, format and content . The ways in which the artefact now needs to be 
disseminated and sustained have been examined and some of these activities will continue to 
facilitate sustainability. The final section reviewed the potential use of the MRC Framework 
for Complex Interventions in this thesis.  
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9. FI NAL CONCLUSI ONS AND RECOMMENDATI ONS 
 
 
9.1. I ntroduction 
 
This final chapter will review and analyse the conclusions that have been drawn from the 
different parts of this Doctorial thesis, namely the case study, literature review, research 
project and artefact. The use of the theoretical frameworks that have been used in this thesis 
will be evaluated. The chapter will review and develop the recommendat ions that have been 
made in Chapter 7 and will identify potent ial areas for wider dissemination of the artefact .  
 
9.2. Conclusions: the case study 
 
The case study was undertaken in 2004 and it  is recognised that  diabetes management in 
primary care is likely to have changed and developed since then. The int roduct ion of the QOF 
targets for both diabetes (2004) and CKD (2006) has certainly made practit ioners aware of 
how they might improve the care of people at risk of CKD. 
 
However, at the time of writing the conclusions that were drawn provided a very useful 
framework upon which to base the literature review and resulting research project. The main 
conclusions were that practice nurses and GPs were finding some aspects of CKD 
management difficult . These aspects were measurement and monitoring of microalbuminuria 
and measuring blood pressure and controlling to target. My observat ions concluded that the 
educational strategies used by the practice nurses to facilitate self-management of diabetes 
were varied. Patients were given information verbally but this was not  backed up with written 
materials or other educational media. Despite there being a nat ional drive (Department  of 
Health 2004) at  this time to facilitate self-care, these recommendations were not necessarily 
being implemented at practice level, especially when managing people with CKD. 
 
9.3. Conclusions: the literature review  
 
The literature review was first developed and written in 2004/ 5 and it is recognised that the 
number of articles and research papers that have been published on the effectiveness of 
educational interventions for people with diabetes have risen since then. Reports on the 
effectiveness of general self-management programmes such as the Expert Patient 
Programme (National Primary Care Research and Development Centre 2007) and specific 
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programmes such as DESMOND (Davies et  al. 2008) have been published. There have also 
been reports on who might benefit from such programmes (Reeves et al. 2008, Skinner et al. 
2008). There have been systematic reviews of diabetes education models undertaken 
(Loveman et al. 2008a, Vermeire et  al. 2009) although the question of whether any particular 
type of education or intervention is more effect ive than another remains unanswered. The 
suggest ion is that some educational interventions can produce improvement in diabetic 
control in Type 1 diabetes, but there are mixed results for Type 2 diabetes (Vermeire et al. 
2009).   
 
I  also found it difficult  to draw firm conclusions from my own literature review partly because 
it  is challenging to judge the size of the effect of the intervention, when results are based on 
very different reported outcomes. Some outcomes were measured by how well the 
part icipants evaluated the learning experience (were the facilitators friendly, were the 
learning resources easy to read), some were measured by change in knowledge (can 
part icipants explain what might happen with a low blood sugar), whilst some studies 
measured the transfer of learning into behaviour. With studies into diabetes, the most  
common measurable outcome utilised by researchers is a physiological measure, that is, the 
effect on HbA1c, although this too can have shortcomings (Herman et al. 2009). 
 
9.4. Conclusions: the research project 
 
The underlying rationale for the research project was that despite the evidence that the 
course of diabetic kidney disease can be slowed by managing blood pressure to target, 
improving glycaemic control and giving advice and support on lifestyle changes, it  appeared 
that management of this condition in primary care was less than optimal. Health-care 
professionals have a role in supporting people to manage their own diabetes, yet  at  the start  
of the research project there were no evidence-based educational resources available to help 
people achieve the aim of slowing CKD progression through self-care.  
 
The main aim of the research project was to develop and test a self-management education 
package that educates people with diabetes about the risks of kidney disease and empowers 
them to self-manage their condition. The findings from the case study, literature review and 
pat ient interviews informed the development of the package. The package was tested in six 
part icipating and one control practice. 
 
The main conclusion from the research project was that self-management techniques such as 
understanding of, and subsequent concordance with, prescribed medication may provide the 
opportunity for an individual to control their own blood pressure. I t is also possible that  active 
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involvement from a renal nurse in identifying abnormal ACR results and subsequent initiat ion 
of medicines that modify the renin-angiotensin pathway, may also have an effect on blood 
pressure control. The importance of maintaining blood pressure to target  is that it can slow 
the rate of CKD progression and reduce cardio-vascular risk (Bilous 2008). 
 
The implications are that the methods used in this study could be replicated for other long-
term conditions, although the simple action of self-management pack development and 
distribution needs to be accompanied by a commitment to a self-care ideology.  A culture 
change from a passive to an act ive self-care philosophy requires the support of lead clinicians 
responsible for managing long-term conditions.     
 
9.5. Conclusions: the artefact 
 
There were parts of the self-management pack that required further amendment following 
pat ient evaluation and these changes have now been made. I  still have slight reservations 
however about the emphasis of the film (DVD). Within the film there is an underlying 
message that kidney function can deteriorate if the condition is not managed well and this 
could result in serious consequences such as the need for dialysis. Despite some interviewees 
being convinced that the best way to change behaviour was to use a shock tactic:  
 
“They perhaps don’t frighten people enough.”  
 
I  am still not  certain that this is the best method for everyone. Sections of  the DVD contain 
interviews with people on dialysis and this may be upsetting for some. Clearly further 
evaluation of the package and research into how far the package could potent ially change 
behaviour is required. 
  
9.6. Evaluation of the theoretical frameworks used in the study 
 
The theoretical framework utilised in the literature review was Silverman’s action approach to 
organisations (Silverman 1971). This theory suggests that change is dependent on the 
interrelationship of a number of factors, including the knowledge, at titudes and beliefs held 
by the wider society, by the organisational structure, as well as by individuals. See Figure 2.3 
.  
 
As discussed in Chapter 7 this framework has a number of overlapping themes with the NHS 
Sustainability Model (NHS Institute for I nnovation and Improvement 2007) and I  am 
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confident that despite the fact  that the Silverman model was published over 30 years ago, 
this model is still relevant and useful today.  
 
The Kirkpatrick model (Kirkpatrick 1967) used to evaluate some of the papers used in the 
review was of great value, especially as on reflection it could be usefully utilised to evaluate 
self-management programmes/packages in future studies. See Figure 9.1. 
 
Figure 9.1:  The Kirkpatrick Model (1967)  
 
RESULTS
Effect  on learning environments
BEHAVIOUR 
Transfer of learning into behaviour
LEARNING  
Effects on knowledge, attitudes and beliefs
REACTION 
Evaluation of the learning experience
 
I n practical terms this would mean taking each of the four components ( reaction, learning, 
behaviour and results) and using these to evaluate self-management programmes/ packages.   
• react ion of participant - what they thought and felt about the training/education 
• learning of participant - the resulting increase in knowledge, skills or attitudes 
• behaviour of participant – the extent  of behaviour change  
• results of programme/package – wider effects on the programme/package such as 
the effect  of reducing BP on cardiovascular risk  
I f the package developed and tested in this present study is successfully rolled-out to a wider 
cohort, subsequent evaluat ion of the package based on these four components is 
recommended. 
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9.7. Summary of recommendations  
 
Chapter 7 ident ified the main recommendations for pract ice, education and research arising 
from this present study. The main recommendations for clinical practice are concerned with 
rapid init iation of ACEi/ARBs in people with MA and recommendations regarding blood 
pressure management (practit ioners should record blood pressure to the nearest 2 mmHg 
when using a manual sphygmomanometer and record the exact reading when using an 
electronic device). I t  is also recommended that a study that aims to understand the 
effects/ outcomes of using a home blood pressure machine by people with diabetes and MA is 
undertaken. 
 
The main practice recommendation for the artefact is that it  should contain an introductory 
paragraph that explains the benefits of self-care and should cater for a range of self-care 
abilit ies, from simple messages (eg. how many tablets to take each day) to complex 
interventions, such as monitoring and managing insulin requirements. The written 
information in the self-management pack should also contain a suggest ion that pat ients 
prepare questions for their GP or practice nurse prior to a consultation visit.  
 
To promote practice nurse and GP engagement with self-management techniques there are 
recommendations for education and training in how to promote self-management skills for 
pat ients. The written information in the self-management pack should include supplementary 
information for health-care professionals to explain the approach. 
 
The main recommendat ions for further research are twofold. First , to undertake a qualitative 
study which investigates how people might  take the informat ion in the self-management pack 
and use this to change their health behaviour. Secondly, that replication of this study as a 
cluster-randomised trial (to remove researcher bias) is undertaken.  
 
9.8 . Further development and dissemination of the artefact  
 
There are two main issues to be resolved before the artefact can be further disseminated and 
sustained across a wider location:  one issue concerns practical implementat ion support from 
the PCT and the other, which may be harder to achieve, is GP and practice nurse support for 
a self-management philosophy. 
 
Firstly, for the artefact to be disseminated across a wider geographical area it has to be 
implemented across the PCT in which it was piloted. At the t ime of thesis submission, I  was 
in contact with the PCT Head of Commissioning for Equalit ies and Patient/Public 
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Engagement. This PCT has outlined two strategic goals for the future direction of health 
policy:  
 
• to maximise the quality of life of the population through the provision of the earliest 
and most clinically and cost-effective care provided in the least intrusive way 
 
• to reduce health inequalit ies (health promot ion, and preventat ive health agendas), 
thereby improving life expectancy and to achieve greater health gain focused on 
deprived communities. 
 
These goals aim to focus in particular around eight  areas of identified need, two of which are 
diabetes and coronary heart disease. At the time of the submission of this thesis the Head of 
Commissioning had been in touch with me and discussed the following initiatives:  
 
i) To incorporate the self-management pack materials within the PCT pat ient education 
programme for people who have been diagnosed with Type 2 diabetes.  
 
ii) To run a disease-specific Expert Patient Programme for diabetes and explore the possibility 
of incorporating the learning materials in the pack as a learning resource for pat ients.  
 
Secondly there has been increasing evidence that health care professionals are having 
difficulties in integrating a self-management approach into day-to-day practice. One study 
(Blakeman et al. 2006) found that although GPs valued increased patient involvement in their 
health care, this was in conflict with other values concerning professional responsibility. The 
authors concluded that  providing GPs with training in consultation skills is required in order to 
encourage the delivery of effective self-management. 
 
Another study that explored pract ice nurses’ involvement in facilitation of self-management 
for long-term conditions (Macdonald et al. 2008) found that nurses seemed to lack resources 
beyond personal experience and intuitive ways of working for encouraging effective self-care. 
The authors concluded that the practice nurses’ identified ways of working are unlikely to be 
sufficient to support pat ients' self-management. This in turn points to a need for educat ion to 
equip nurses with techniques to work effect ively with pat ients dealing with longer-term 
effects of chronic illness. 
 
I t appears that there is support for patients having increased involvement in their care but 
sometimes health-care professionals need specific training to help them engage with and 
promote self-management. Researchers from the National Primary Care Research and 
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Development Centre (Kennedy et al. 2005) have reported on a complex self-management 
intervention in a randomized controlled trial (RCT) involving 700 patients with established 
inflammatory bowel disease (IBD) attending outpatient  clinics. They described how this 
training could be undertaken, which included a demonstration video, role-play, and video-
feedback training. Results confirmed and highlighted the value of t raining in pat ient-centred 
communication and its potential for promoting self-management effects. 
 
No other UK studies that have evaluated self-management training for health-care 
professionals could be found, although one American paper was identified (Siminerio and 
Siminerio 2006).  Clearly there is a need for t raining of self-management in this PCT and 
elsewhere in the UK if GPs and practice nurses are to support and facilitate self-care 
effectively. I  am hoping to discuss the possibility of PCT training for health-care professionals 
in facilitation skills for empowering self-management with the PCT Head of Commissioning for 
Equalit ies and Patient/Public Engagement. 
 
 
9.9. Conclusion 
The University guidelines for submission of this type of Doctorate state that the emphasis is 
on developing a thesis that contains one or more reflective accounts of case study work, a 
crit ical review of literature, a main research area and a dissemination artefact and plan. I  
have undertaken each of these components separately but  I  have ensured that  they have 
been written up as one coherent and reasoned whole.  The aims were to carry out  a case 
study in six general practice surgeries, to perform a literature review on diabetes and self-
care and to undertake a research project that developed and tested a self-management 
package. All of these aims were achieved and it is hoped that self-management training for 
health-care professionals and further dissemination of the self-management package to a 
wider audience will cont inue after this thesis has been examined. 
 
I f self-management can change an individual’s attitude to their condition then there is the 
potential for improved clinical outcomes such as delaying progression of kidney disease 
 
“ I  think if I  had taken it seriously in those days and learnt what I  know now, I  would 
be a completely different  person.”  
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